| QC162648 | Cefprozil Impurity 48
CAS# NA
M.F.: C26H26N2O5S
M.W.: 478.56 |
|  |
| QL011488 | Landiolol Impurity 88
CAS# NA
M.F.: C12H14O4
M.W.: 222.24 |
| |
| QL011483 | Landiolol Impurity 83
CAS# NA
M.F.: C16H23N3O4
M.W.: 321.38 |
| |
| QD030485 | Diclofenac sodium Impurity 85
CAS# NA
M.F.: C28H20Cl4N2O4
M.W.: 590.28 |
| |
| QD030484 | Diclofenac sodium Impurity 84
CAS# NA
M.F.: C15H13Cl2NO2
M.W.: 310.17 |
| |
| QD030483 | Diclofenac sodium Nitroso Impurity 1
CAS# NA
M.F.: C12H8Cl2N2O
M.W.: 267.11 |
| |
| QC013126 | Carbazochrome Impurity 26
CAS# NA
M.F.: C10H14N4O8S2
M.W.: 382.36 |
| |
| QO243100 | Oxantel pamoate
CAS# 68813-55-8
M.F.: C13H16N2O.C23H16O6
M.W.: 216.28 388.38 |
| |
| QD192046 | Dasatinib Impurity 46
CAS# NA
M.F.: C12H14ClNO2
M.W.: 239.70 |
| |
| QG052802 | Geranyl acetate
CAS# 105-87-3
M.F.: C12H20O2
M.W.: 196.29 |
| |
| QD098700 | Diphemanil Methylsulfate
CAS# 62-97-5
M.F.: C21H27NO4S
M.W.: 389.51 |
| |
| QA690301 | (+)-Abscisic Acid Glucose Ester-d6
CAS# NA
M.F.: C21H25D5O9
M.W.: 431.49 |
| |
| QO132091 | N-Nitroso Olmesartan Medoxomil
CAS# NA
M.F.: C29H29N7O7
M.W.: 587.59 |
| |
| QD150308 | Docusate sodium Impurity 8
CAS# 7423-42-9
M.F.: C12H20O4
M.W.: 228.29 |
| |
| QB011559 | Baloxavir marboxil Impurity 59
CAS# NA
M.F.: C24H19F2N3O4S
M.W.: 483.49 |
| |
| QB011558 | Baloxavir marboxil Impurity 58
CAS# NA
M.F.: C24H19F2N3O4S
M.W.: 483.49 |
| |
| QB011557 | Baloxavir marboxil Impurity 57
CAS# NA
M.F.: C21H16F2O3S2
M.W.: 418.47 |
| |
| QB011556 | Baloxavir marboxil Impurity 56
CAS# NA
M.F.: C15H12F2O3S2
M.W.: 342.37 |
| |
| QB011555 | Baloxavir marboxil Impurity 55
CAS# NA
M.F.: C30H31F2N3O4S
M.W.: 567.65 |
| |
| QB011554 | Baloxavir marboxil Impurity 54
CAS# NA
M.F.: C30H31F2N3O4S
M.W.: 567.65 |
| |
| QB011553 | Baloxavir marboxil Impurity 53
CAS# NA
M.F.: C14H10F2O3S
M.W.: 296.29 |
| |
| QB011552 | Baloxavir marboxil Impurity 52
CAS# NA
M.F.: C14H10F2O2S
M.W.: 280.29 |
| |
| QB011551 | Baloxavir marboxil Impurity 51
CAS# NA
M.F.: C10H11N3O4
M.W.: 237.22 |
| |
| QB011550 | Baloxavir marboxil Impurity 50
CAS# 1745-46-6
M.F.: C14H12OS
M.W.: 228.31 |
| |
| QB011549 | Baloxavir marboxil Impurity 49
CAS# 1820001-80-6
M.F.: C14H11FOS
M.W.: 246.30 |
| |
| QD091009 | Dicloxacillin sodium Impurity 9
CAS# NA
M.F.: C21H21Cl2N3O7S
M.W.: 530.37 |
| |
| QB031813 | Bromocriptine mesilate Impurity 13
CAS# NA
M.F.: C33H42BrN5O5S
M.W.: 700.69 |
| |
| QD091008 | Dicloxacillin sodium Impurity 8
CAS# 934986-84-2
M.F.: C21H21Cl2N3O7S
M.W.: 530.37 |
| |
| QD091007 | Dicloxacillin sodium Impurity 7
CAS# 883225-99-8
M.F.: C13H10Cl2N2O4
M.W.: 329.13 |
| |
| QI151623 | Ioversol Impurity 5
CAS# NA
M.F.: C13H14I3N3O6
M.W.: 688.98 |
| |
| QB011548 | Baloxavir marboxil Impurity 48
CAS# 2826217-70-1
M.F.: C24H19F2N3O4S
M.W.: 483.49 |
| |
| QB011547 | Baloxavir marboxil Impurity 47
CAS# 2136287-88-0
M.F.: C30H31F2N3O4S
M.W.: 567.65 |
| |
| QF120807 | Flecainide acetate Nitroso Impurity 2
CAS# NA
M.F.: C17H19F6N3O4
M.W.: 443.35 |
| |
| QT142434 | Tranexamic Acid Impurity 34
CAS# NA
M.F.: C10H17NO3
M.W.: 199.25 |
| |
| QC1825125 | Canagliflozin Impurity 125
CAS# NA
M.F.: C12H14O8
M.W.: 286.24 |
| |
| QR091133 | Rimegepant Impurity 33
CAS# 1452167-10-0
M.F.: C25H32FNO3Si
M.W.: 441.62 |
| |
| QR091129 | Rimegepant Impurity 29
CAS# 1397526-11-2
M.F.: C25H33F2NO2Si
M.W.: 445.63 |
| |
| QB052525 | Benzylpenicillin sodium Impurity 25
CAS# NA
M.F.: C32H38N4O9S2
M.W.: 686.80 |
| |
| QT080305 | Thiocolchicoside Hydrate EP Impurity E
CAS# 219547-29-2
M.F.: C26H31NO10S
M.W.: 549.59 |
| |
| QT010628 | Tafluprost Impurity 28
CAS# 2065-23-8
M.F.: C9H10O3
M.W.: 166.18 |
| |
| QT092616 | Tizanidine Impurity 16
CAS# 767-64-6
M.F.: C6H5N3S
M.W.: 151.19 |
| |
| QC061879 | Cefuroxime Axetil Impurity 79
CAS# 65866-86-6
M.F.: C7H7NO4
M.W.: 169.14 |
| |
| QT090310 | Thioctic Acid Impurity 10
CAS# 97023-76-2
M.F.: C13H16O2
M.W.: 204.27 |
| |
| QT090309 | Thioctic Acid Impurity 9
CAS# NA
M.F.: C13H16O2
M.W.: 204.27 |
| |
| QC155700 | Corosolic acid
CAS# 4547-24-4
M.F.: C30H48O4
M.W.: 472.71 |
| |
| QC132676 | Cefmetazole sodium Impurity 76
CAS# NA
M.F.: C28H27N7O5S3
M.W.: 637.75 |
| |
| QD030482 | Diclofenac sodium Impurity 82
CAS# 1470584-30-5
M.F.: C11H12Cl2O2
M.W.: 247.12 |
| |
| QI142602 | Insulin icodec B-FVNQHLCGSHLVEALHLVCGERGFHYTPK
CAS# NA
M.F.: NA
M.W.: NA |
| |
| QI142601 | Insulin icodec A-GIVEQCCTSICSLEQLENYCN
CAS# NA
M.F.: NA
M.W.: NA |
| |
| QB053308 | Belumosudil Impurity 8
CAS# NA
M.F.: C36H41N7O5
M.W.: 651.77 |
| |
| QG121824 | Glycyrrhizic acid methyl ester
CAS# 104191-95-9
M.F.: C43H64O16
M.W.: 836.97 |
| |
| QA181901 | Aristolochic acid
CAS# 313-67-7
M.F.: C17H11NO7
M.W.: 341.28 |
| |
| QP090343 | Sodium Picosulfate Impurity 43
CAS# NA
M.F.: C18H13NNa2O12S3
M.W.: 577.46 |
| |
| QP090342 | Sodium Picosulfate Impurity 42
CAS# NA
M.F.: C18H15NO6S
M.W.: 373.38 |
| |
| QP090341 | Sodium Picosulfate Impurity 41
CAS# NA
M.F.: C19H15NNa2O11S3
M.W.: 575.48 |
| |
| QP090340 | Sodium Picosulfate Impurity 40
CAS# NA
M.F.: C19H17NO5S
M.W.: 371.41 |
| |
| QB051340 | Bempedoic acid Impurity 40
CAS# 2127387-65-7
M.F.: C19H34O4
M.W.: 326.48 |
| |
| QB051339 | Bempedoic acid Impurity 39
CAS# NA
M.F.: C19H38O4
M.W.: 330.51 |
| |
| QB051338 | Bempedoic acid Impurity 38
CAS# NA
M.F.: C10H20O3
M.W.: 188.27 |
| |
| QB051337 | Bempedoic acid Impurity 37
CAS# 14250-73-8
M.F.: C9H18O2
M.W.: 158.24 |
| |
| QB051336 | Bempedoic acid Impurity 36
CAS# NA
M.F.: C21H36O10
M.W.: 448.51 |
| |
| QP160204 | Prednisolone Sodium Phosphate USP Impurity F
CAS# NA
M.F.: C21H27O7P
M.W.: 422.41 |
| |
| QP160203 | Prednisolone Sodium Phosphate Impurity 3
CAS# NA
M.F.: C21H29O8P
M.W.: 440.43 |
| |
| QP160202 | Prednisolone Sodium Phosphate Impurity 2
CAS# NA
M.F.: C21H29O8P
M.W.: 440.43 |
| |
| QP160201 | Prednisolone Sodium Phosphate Impurity 1
CAS# NA
M.F.: C21H29O8P
M.W.: 440.43 |
| |
| QP160200 | Prednisolone Sodium Phosphate
CAS# 125-02-0
M.F.: C21H27Na2O8P
M.W.: 484.39 |
| |
| QM041516 | Medroxyprogesterone Acetate Impurity 16
CAS# NA
M.F.: C25H36O4
M.W.: 400.56 |
| |
| QM041515 | Medroxyprogesterone Acetate Impurity 15
CAS# 136803-81-1
M.F.: C25H32O4
M.W.: 396.53 |
| |
| QM041514 | Medroxyprogesterone Acetate Impurity 14
CAS# 2128317-86-0
M.F.: C31H41NO4
M.W.: 491.67 |
| |
| QO240125 | Oxacillin sodium Impurity 25
CAS# NA
M.F.: C19H18ClN3O5S
M.W.: 435.88 |
| |
| QH041834 | Cholesterol 5beta,6beta-Epoxide
CAS# 4025-59-6
M.F.: C27H46O2
M.W.: 402.66 |
| |
| QH041833 | Cholesterol 5alpha,6alpha-Epoxide
CAS# 1250-95-9
M.F.: C27H46O2
M.W.: 402.66 |
| |
| QO022047 | Obeticholic Acid Impurity 47
CAS# NA
M.F.: C27H44O4
M.W.: 432.65 |
| |
| QT142433 | Tranexamic Acid Impurity 33
CAS# NA
M.F.: C10H17NO3
M.W.: 199.25 |
| |
| QT142432 | Tranexamic Acid Impurity 32
CAS# 10473-24-2
M.F.: C10H17NO3
M.W.: 199.25 |
| |
| QT260437 | Trazodone hydrochloride Impurity 37
CAS# NA
M.F.: C16H25ClN2O
M.W.: 296.84 |
| |
| QT260436 | Trazodone hydrochloride Impurity 36
CAS# NA
M.F.: C19H22ClN5O
M.W.: 371.87 |
| |
| QC061621 | Cefpodoxime Proxetil EP Impurity A-d3 Sodium Salt
CAS# NA
M.F.: C15H13D3N5NaO6S2
M.W.: 452.45 |
| |
| QE042888 | Edoxaban Impurity 88
CAS# 141354-54-3
M.F.: C9H9BrN2O3
M.W.: 273.09 |
| |
| QD052604 | Dexchlorpheniramine maleate Impurity 4
CAS# NA
M.F.: C16H19ClN2O2
M.W.: 306.79 |
| |
| QB151300 | Bongkrekic acid
CAS# 11076-19-0
M.F.: C28H38O7
M.W.: 486.61 |
| |
| QE070600 | E7766 diammonium salt
CAS# 2242635-03-4
M.F.: C24H32F2N12O8P2S2
M.W.: 780.66 |
| |
| QP092721 | Pinaverium Bromide Impurity 21
CAS# NA
M.F.: C17H31NO2
M.W.: 281.44 |
| |
| QP081212 | Glycerol Phenylbutyrate Impurity 12
CAS# NA
M.F.: C33H36O7
M.W.: 544.64 |
| |
| QP081211 | Glycerol Phenylbutyrate Impurity 11
CAS# NA
M.F.: C33H36O7
M.W.: 544.64 |
| |
| QB011545 | Baloxavir marboxil Impurity 45
CAS# NA
M.F.: C25H21F2N3O6S2
M.W.: 561.57 |
| |
| QB011544 | Baloxavir marboxil Impurity 44
CAS# NA
M.F.: C27H22ClF2N3O7S
M.W.: 605.99 |
| |
| QP081210 | Glycerol Phenylbutyrate Impurity 10
CAS# NA
M.F.: C46H54O9
M.W.: 750.93 |
| |
| QP081209 | Glycerol Phenylbutyrate Impurity 9
CAS# NA
M.F.: C46H54O9
M.W.: 750.93 |
| |
| QP081208 | Glycerol Phenylbutyrate Impurity 8
CAS# NA
M.F.: C33H36O7
M.W.: 544.64 |
| |
| QP081207 | Glycerol Phenylbutyrate Impurity 7
CAS# NA
M.F.: C13H18O4
M.W.: 238.28 |
| |
| QP081206 | Glycerol Phenylbutyrate Impurity 6
CAS# 1292210-87-7
M.F.: C13H18O4
M.W.: 238.28 |
| |
| QP081205 | Glycerol Phenylbutyrate Impurity 5
CAS# 864811-35-8
M.F.: C23H28O5
M.W.: 384.47 |
| |
| QP081204 | Glycerol Phenylbutyrate Impurity 4
CAS# 1443417-10-4
M.F.: C23H28O5
M.W.: 384.47 |
| |
| QP010701 | Paederosidic acid methyl ester
CAS# 122413-01-8
M.F.: C19H26O12S
M.W.: 478.47 |
| |
| QT142430 | N-Nitroso Tranexamic Acid EP Impurity A
CAS# NA
M.F.: C16H26N2O5
M.W.: 326.39 |
| |
| QM050114 | Metamizole sodium Impurity 14
CAS# NA
M.F.: C13H17N3O7S2
M.W.: 391.41 |
| |
| QO240124 | Oxacillin sodium Impurity 24
CAS# NA
M.F.: C19H20N4O4S
M.W.: 400.45 |
| |
| QD150100 | Domoic acid
CAS# 14277-97-5
M.F.: C15H21NO6
M.W.: 311.33 |
| |
| QB051335 | Bempedoic acid Impurity 35
CAS# 2511500-14-2
M.F.: C21H40O5
M.W.: 372.55 |
| |
| QC061878 | Cefuroxime Axetil Impurity 78
CAS# NA
M.F.: C19H21N3O8S
M.W.: 451.45 |
| |
| QC061877 | Cefuroxime Axetil Impurity 77
CAS# NA
M.F.: C21H23N3O10S
M.W.: 509.49 |
| |
| QF181653 | Faropenem Impurity 53
CAS# NA
M.F.: C24H28N2O10S2
M.W.: 568.61 |
| |
| QO022046 | Obeticholic Acid Impurity 46
CAS# 1516887-32-3
M.F.: C27H42O4
M.W.: 430.63 |
| |
| QO022045 | Obeticholic Acid Impurity 45
CAS# NA
M.F.: C28H48O4Si
M.W.: 476.77 |
| |
| QO022044 | Obeticholic Acid Impurity 44
CAS# 77341-09-4
M.F.: C28H48O4Si
M.W.: 476.77 |
| |
| QO022043 | Obeticholic Acid Impurity 43
CAS# NA
M.F.: C30H54O4Si2
M.W.: 534.93 |
| |
| QO022042 | Obeticholic Acid Impurity 42
CAS# 14773-00-3
M.F.: C25H40O4
M.W.: 404.59 |
| |
| QO022041 | Obeticholic Acid Impurity 41
CAS# 7753-72-2
M.F.: C25H38O4
M.W.: 402.58 |
| |
| QP185402 | Prulifloxacin hydrochloride Impurity 2
CAS# NA
M.F.: C37H36F2N6O9S2
M.W.: 810.84 |
| |
| QP185401 | Prulifloxacin hydrochloride Impurity 1
CAS# NA
M.F.: C16H16FN3O3S
M.W.: 349.38 |
| |
| QS050709 | Selegiline hydrochloride Impurity 9
CAS# NA
M.F.: C13H18ClN
M.W.: 223.74 |
| |
| QS050708 | Selegiline hydrochloride Impurity 8
CAS# NA
M.F.: C11H17N.HCl
M.W.: 163.26 36.46 |
| |
| QB054800 | Betulinic acid
CAS# 472-15-1
M.F.: C30H48O3
M.W.: 456.71 |
| |
| QP1824114 | Parecoxib Sodium Impurity 114
CAS# NA
M.F.: C19H18N2O5S
M.W.: 386.42 |
| |
| QP080513 | Phenytoin Sodium Impurity 13
CAS# NA
M.F.: C17H14Cl2N2O2
M.W.: 349.21 |
| |
| QR0512104 | Relugolix Impurity 104
CAS# NA
M.F.: C29H27F2N7O5S
M.W.: 623.64 |
| |
| QA190218 | L-Isoascorbic acid
CAS# 26094-91-7
M.F.: C6H8O6
M.W.: 176.12 |
| |
| QC042044 | Cefditoren pivoxil Impurity 44
CAS# NA
M.F.: C26H30N6O8S3
M.W.: 650.74 |
| |
| QA190217 | D-Ascorbic acid
CAS# 10504-35-5
M.F.: C6H8O6
M.W.: 176.12 |
| |
| QP052209 | Pentoxyverine hydrogen citrate Impurity 9
CAS# 5296-89-9
M.F.: C12H15NO
M.W.: 189.26 |
| |
| QP052208 | Pentoxyverine hydrogen citrate Impurity 8
CAS# 103-80-0
M.F.: C8H7ClO
M.W.: 154.59 |
| |
| QP052207 | Pentoxyverine hydrogen citrate Impurity 7
CAS# 103-81-1
M.F.: C8H9NO
M.W.: 135.17 |
| |
| QM041853 | Minodronic Acid Impurity 53
CAS# 21801-86-5
M.F.: C9H9N3O
M.W.: 175.19 |
| |
| QM041852 | Minodronic Acid Impurity 52
CAS# 2717-95-5
M.F.: C10H13N3
M.W.: 175.24 |
| |
| QB210302 | Bucladesine sodium Impurity 2
CAS# 70253-67-7
M.F.: C14H17N5NaO7P
M.W.: 421.28 |
| |
| QB210301 | Bucladesine sodium Impurity 1
CAS# 55443-13-5
M.F.: C14H17N5NaO7P
M.W.: 421.28 |
| |
| QF151406 | Fondaparinux Sodium Impurity 6
CAS# 348625-84-3
M.F.: C13H21NO19S3
M.W.: 591.48 |
| |
| QG122729 | Glycopyrronium Bromide Impurity 29
CAS# 64471-43-8
M.F.: C13H16O3
M.W.: 220.27 |
| |
| QD030480 | Diclofenac sodium Impurity 80
CAS# NA
M.F.: C13H11Cl2NO2
M.W.: 284.14 |
| |
| QD030481 | Diclofenac sodium Impurity 81
CAS# NA
M.F.: C14H7Cl2NO3
M.W.: 308.11 |
| |
| QD030479 | Diclofenac sodium Impurity 79
CAS# NA
M.F.: C22H18Cl2N2O4
M.W.: 445.30 |
| |
| QB091302 | Bismuth subcitrate-d8
CAS# NA
M.F.: C12H2D8BiK3O14
M.W.: 712.52 |
| |
| QP090339 | Sodium Picosulfate Impurity 39
CAS# 1122-72-1
M.F.: C7H7NO
M.W.: 121.14 |
| |
| QD0207110 | Dabigatran Etexilate Impurity 110
CAS# NA
M.F.: C21H22N6O2
M.W.: 390.45 |
| |
| QP090338 | Sodium Picosulfate Impurity 38
CAS# 599-64-4
M.F.: C15H16O
M.W.: 212.29 |
| |
| QP090337 | Sodium Picosulfate Impurity 37
CAS# 586-98-1
M.F.: C6H7NO
M.W.: 109.13 |
| |
| QA181903 | Aristolochic acid C
CAS# 4849-90-5
M.F.: C16H9NO7
M.W.: 327.25 |
| |
| QF120377 | Folic Acid Impurity 77
CAS# NA
M.F.: C38H40N14O11
M.W.: 868.83 |
| |
| QI142518 | Indocyanine Green Impurity 18
CAS# NA
M.F.: C18H21NO4S
M.W.: 347.43 |
| |
| QM093100 | Midecamycin Acetate
CAS# 55881-07-7
M.F.: C45H71NO17
M.W.: 898.05 |
| |
| QE151701 | Etoposide Phosphate Impurity 1
CAS# NA
M.F.: C27H31O16P
M.W.: 642.50 |
| |
| QE151700 | Etoposide Phosphate
CAS# 117091-64-2
M.F.: C29H33O16P
M.W.: 668.54 |
| |
| QP010301 | Dehydropachymic acid
CAS# 77012-31-8
M.F.: C33H50O6
M.W.: 542.76 |
| |
| QL140338 | Lincomycin Hydrochloride Impurity 38
CAS# NA
M.F.: C17H32N2O7
M.W.: 376.45 |
| |
| QL140337 | Lincomycin Hydrochloride Impurity 37
CAS# NA
M.F.: C18H34N2O6S
M.W.: 406.54 |
| |
| QC-P181579 | Piscidic acid
CAS# 469-65-8
M.F.: C11H12O7
M.W.: 256.21 |
| |
| QP052206 | Pentoxyverine hydrogen citrate Impurity 6
CAS# 17380-62-0
M.F.: C12H13ClO
M.W.: 208.69 |
| |
| QT130618 | Tamoxifen Citrate Impurity 18
CAS# NA
M.F.: C18H20
M.W.: 236.36 |
| |
| QT031893 | DL-α-Tocopherol acetate
CAS# 52225-20-4
M.F.: C31H52O3
M.W.: 472.75 |
| |
| QV3077135 | Vitamin K1 Impurity 135
CAS# NA
M.F.: C31H46O4
M.W.: 482.71 |
| |
| QT011509 | Tauroursodeoxycholic Acid Impurity 9
CAS# NA
M.F.: C29H51NO6S
M.W.: 541.79 |
| |
| QT011508 | Tauroursodeoxycholic Acid Impurity 8
CAS# NA
M.F.: C29H51NO6S
M.W.: 541.79 |
| |
| QT011507 | Tauroursodeoxycholic Acid Impurity 7
CAS# NA
M.F.: C29H50N2O10S2
M.W.: 650.84 |
| |
| QT011506 | Tauroursodeoxycholic Acid Impurity 6
CAS# NA
M.F.: C29H50N2O10S2
M.W.: 650.84 |
| |
| QT011505 | Tauroursodeoxycholic Acid Impurity 5
CAS# NA
M.F.: C27H46O4
M.W.: 434.66 |
| |
| QT011503 | Tauroursodeoxycholic Acid Impurity 3
CAS# NA
M.F.: C26H45NO7S
M.W.: 515.71 |
| |
| QA220194 | Avatrombopag Nitroso Impurity 2
CAS# NA
M.F.: C8H14N2O3
M.W.: 186.21 |
| |
| QD171225 | Dequalinium chloride Impurity 25
CAS# NA
M.F.: C30H39Cl2N3O
M.W.: 528.56 |
| |
| QD171224 | Dequalinium chloride Impurity 24
CAS# NA
M.F.: C20H31ClN2O
M.W.: 350.93 |
| |
| QD171223 | Dequalinium chloride Impurity 23
CAS# NA
M.F.: C20H17N3
M.W.: 299.38 |
| |
| QD171222 | Dequalinium chloride Impurity 22
CAS# 27063-27-0
M.F.: C10H10N2
M.W.: 158.20 |
| |
| QD171221 | Dequalinium chloride Impurity 21
CAS# NA
M.F.: C18H18N2O
M.W.: 278.36 |
| |
| QD171220 | Dequalinium chloride Impurity 20
CAS# NA
M.F.: C18H16N2O
M.W.: 276.34 |
| |
| QD171219 | Dequalinium chloride Impurity 19
CAS# NA
M.F.: C28H26N4O
M.W.: 434.54 |
| |
| QD171218 | Dequalinium chloride Impurity 18
CAS# 634-47-9
M.F.: C10H8ClN
M.W.: 177.63 |
| |
| QD171217 | Dequalinium chloride Impurity 17
CAS# 112-47-0
M.F.: C10H22O2
M.W.: 174.28 |
| |
| QD171216 | Dequalinium chloride Impurity 16
CAS# 2162-98-3
M.F.: C10H20Cl2
M.W.: 211.17 |
| |
| QD171215 | Dequalinium chloride Impurity 15
CAS# 607-66-9
M.F.: C10H9NO
M.W.: 159.19 |
| |
| QD171214 | Dequalinium chloride Impurity 14
CAS# NA
M.F.: C12H15NO2
M.W.: 205.26 |
| |
| QT022056 | Terbutaline Impurity 56
CAS# 27628-06-4
M.F.: C22H20O3
M.W.: 332.40 |
| |
| QB201362 | Betamethasone Acetate Impurity 62
CAS# 18769-18-1
M.F.: C24H32O6
M.W.: 416.51 |
| |
| QB180810 | Brompheniramine maleate Impurity 10
CAS# 18453-10-6
M.F.: C15H17BrN2
M.W.: 305.22 |
| |
| QC180301 | Carbodenafil Impurity 1
CAS# 2196244-90-1
M.F.: C25H34N6OS2
M.W.: 498.71 |
| |
| QN010617 | Nafamostat Impurity 17
CAS# NA
M.F.: C10H12N2O2S
M.W.: 224.28 |
| |
| QP092720 | Pinaverium Bromide Impurity 20
CAS# NA
M.F.: C26H43Br2NO5
M.W.: 609.44 |
| |
| QP092719 | Pinaverium Bromide Impurity 19
CAS# NA
M.F.: C27H44BrNO5
M.W.: 542.56 |
| |
| QS150410 | Alendronic Acid Impurity 10
CAS# NA
M.F.: C16H33NO17P2
M.W.: 573.38 |
| |
| QG122124 | Glucuronic acid 3-sulfate
CAS# 110231-93-1
M.F.: C6H10O10S
M.W.: 274.20 |
| |
| QG122123 | Glucuronic acid 2-sulfate
CAS# 98517-62-5
M.F.: C6H10O10S
M.W.: 274.20 |
| |
| QB030512 | 10-Deacetyl-10-Triethylsiloxybaccatin III
CAS# 207680-15-7
M.F.: C35H50O10Si
M.W.: 658.86 |
| |
| QB030511 | 7-Triethylsilyl-10-Deacetylbaccatin III
CAS# 115437-18-8
M.F.: C35H50O10Si
M.W.: 658.86 |
| |
| QB030510 | 13-Oxobaccatin III
CAS# 32981-89-8
M.F.: C31H36O11
M.W.: 584.62 |
| |
| QU130509 | Umeclidinium bromide Impurity 9
CAS# 2253743-40-5
M.F.: C35H38BrNO2
M.W.: 584.60 |
| |
| QU130508 | Umeclidinium bromide Impurity 8
CAS# 2253743-38-1
M.F.: C35H38BrNO2
M.W.: 584.60 |
| |
| QU130507 | Umeclidinium bromide Impurity 7
CAS# 2253743-36-9
M.F.: C35H38BrNO2
M.W.: 584.6 |
| |
| QT211501 | Taurochenodeoxycholic Acid-2,2,4,4-d4 Sodium Salt
CAS# 2410279-85-3
M.F.: C26H40D4NNaO6S
M.W.: 525.71 |
| |
| QF122925 | Fluocinolone acetonide Impurity 25
CAS# NA
M.F.: C24H32F2O9S
M.W.: 534.57 |
| |
| QL140336 | Lincomycin Hydrochloride Nitroso Impurity 1
CAS# NA
M.F.: C17H31N3O7S
M.W.: 421.51 |
| |
| QS180649 | Sorafenib tosylate Impurity 49
CAS# 284461-74-1
M.F.: C20H14ClF3N4O3
M.W.: 450.80 |
| |
| QV3077134 | Vitamin K1 Impurity 134
CAS# NA
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QH042511 | Hydrocortisone acetate Impurity 11
CAS# 50733-54-5
M.F.: C23H31BrO6
M.W.: 483.40 |
| |
| QB200112 | 6-Bromo-betamethasone-17,21-dipropionate
CAS# 1186048-34-9
M.F.: C28H36BrFO7
M.W.: 583.49 |
| |
| QC651211 | Cloxacillin Sodium Impurity 11
CAS# NA
M.F.: C27H30ClN5O8S2
M.W.: 652.13 |
| |
| QC651210 | Cloxacillin Sodium Impurity 10
CAS# NA
M.F.: C38H38Cl2N6O11S2
M.W.: 889.77 |
| |
| QW011829 | Warfarin sodium Impurity 29
CAS# NA
M.F.: C18H20O2
M.W.: 268.36 |
| |
| QW011828 | Warfarin sodium Impurity 28
CAS# NA
M.F.: C17H16O3
M.W.: 268.31 |
| |
| QW011827 | Warfarin sodium Impurity 27
CAS# NA
M.F.: C17H16O3
M.W.: 268.31 |
| |
| QC061916 | Ceftaroline Fosamil Impurity P
CAS# 54639-48-4
M.F.: C28H24N2O5S
M.W.: 500.57 |
| |
| QC651209 | Cloxacillin Sodium Impurity 9
CAS# NA
M.F.: C13H11ClN2O4
M.W.: 294.69 |
| |
| QC651208 | Cloxacillin Sodium Impurity 8
CAS# NA
M.F.: C27H30ClN5O8S2
M.W.: 652.13 |
| |
| QM131933 | Mometasone Furoate Impurity 33
CAS# 151265-36-0
M.F.: C22H27ClO3
M.W.: 374.91 |
| |
| QC061875 | Cefuroxime sodium Impurity 75
CAS# NA
M.F.: C15H15N3O6S
M.W.: 365.36 |
| |
| QW011826 | Warfarin sodium Impurity 26
CAS# NA
M.F.: C35H24O6
M.W.: 540.57 |
| |
| QW011825 | Warfarin sodium Impurity 25
CAS# NA
M.F.: C26H20O4
M.W.: 396.44 |
| |
| QW011824 | Warfarin sodium Impurity 24
CAS# NA
M.F.: C35H26O7
M.W.: 558.59 |
| |
| QT211204 | Tulathromycin A Impurity 4
CAS# NA
M.F.: C29H56N2O9
M.W.: 576.77 |
| |
| QR457061 | Rocuronium bromide Impurity 61
CAS# NA
M.F.: C27H44N2O2
M.W.: 428.66 |
| |
| QR457060 | Rocuronium bromide Impurity 60
CAS# NA
M.F.: C24H41NO3
M.W.: 391.60 |
| |
| QR457059 | Rocuronium bromide Impurity 59
CAS# NA
M.F.: C23H35NO
M.W.: 341.54 |
| |
| QR457058 | Rocuronium bromide Impurity 58
CAS# NA
M.F.: C23H35NO2
M.W.: 357.54 |
| |
| QR457057 | Rocuronium bromide Impurity 57
CAS# NA
M.F.: C23H35NO2
M.W.: 357.54 |
| |
| QR457056 | Rocuronium bromide Impurity 56
CAS# NA
M.F.: C23H37NO2
M.W.: 359.55 |
| |
| QR457055 | Rocuronium bromide Impurity 55
CAS# NA
M.F.: C23H37NO2
M.W.: 359.55 |
| |
| QH042510 | Hydrocortisone acetate Impurity 10
CAS# 33744-76-2
M.F.: C24H32O7
M.W.: 432.51 |
| |
| QH042509 | Hydrocortisone acetate Impurity 9
CAS# 115098-60-7
M.F.: C23H28O5
M.W.: 384.47 |
| |
| QG121823 | Glycyrrhizic Acid Impurity 23
CAS# NA
M.F.: C48H74O16
M.W.: 907.10 |
| |
| QG121822 | Glycyrrhizic Acid Impurity 22
CAS# NA
M.F.: C46H70O16
M.W.: 879.05 |
| |
| QG121821 | Glycyrrhizic Acid Impurity 21
CAS# NA
M.F.: C46H70O16
M.W.: 879.05 |
| |
| QG121820 | Glycyrrhizic Acid Impurity 20
CAS# NA
M.F.: C44H66O16
M.W.: 851.00 |
| |
| QG121819 | Glycyrrhizic Acid Impurity 19
CAS# NA
M.F.: C44H66O16
M.W.: 851.00 |
| |
| QG121818 | Glycyrrhizic Acid Impurity 18
CAS# NA
M.F.: C44H66O16
M.W.: 851.00 |
| |
| QV200110 | 5,6-Epoxy Vitamin A Palmitate
CAS# 3012-64-4
M.F.: C36H60O3
M.W.: 540.87 |
| |
| QA190216 | Ascorbic Acid Impurity 16
CAS# NA
M.F.: C7H10O7
M.W.: 206.15 |
| |
| QB200500 | Bethanechol Chloride
CAS# 590-63-6
M.F.: C7H17ClN2O2
M.W.: 196.68 |
| |
| QC010333 | [Ser29-O-Acetyl]Calcitonin (salmon)
CAS# NA
M.F.: C147H242N44O49S2
M.W.: 3473.93 |
| |
| QC010332 | [Ser13-O-Acetyl]Calcitonin (salmon)
CAS# NA
M.F.: C147H242N44O49S2
M.W.: 3473.93 |
| |
| QC010331 | [Ser5-O-Acetyl]Calcitonin (salmon)
CAS# NA
M.F.: C147H242N44O49S2
M.W.: 3473.93 |
| |
| QC010330 | [Ser2-O-Acetyl]Calcitonin (salmon)
CAS# NA
M.F.: C147H242N44O49S2
M.W.: 3473.93 |
| |
| QC010329 | [Asp26]Calcitonin (salmon)
CAS# NA
M.F.: C145H239N43O49S2
M.W.: 3432.88 |
| |
| QC010328 | [Asp3]Calcitonin (salmon)
CAS# NA
M.F.: C145H239N43O49S2
M.W.: 3432.88 |
| |
| QC010327 | [Glu14]Calcitonin (salmon)
CAS# NA
M.F.: C145H239N43O49S2
M.W.: 3432.88 |
| |
| QN151878 | Noradrenaline (Norepinephrine) Impurity 78
CAS# NA
M.F.: C17H17NO4
M.W.: 299.33 |
| |
| QN151877 | Noradrenaline (Norepinephrine) Impurity 77
CAS# NA
M.F.: C17H21NO4
M.W.: 303.36 |
| |
| QO022040 | Obeticholic Acid Impurity 40
CAS# 1834605-28-5
M.F.: C26H40O4
M.W.: 416.60 |
| |
| QC031645 | Cefcapene pivoxil Impurity 45
CAS# NA
M.F.: C47H58N10O16S4
M.W.: 1147.28 |
| |
| QC031644 | Cefcapene pivoxil Impurity 44
CAS# NA
M.F.: C32H38N8O12S3
M.W.: 822.88 |
| |
| QC031643 | Cefcapene pivoxil Impurity 43
CAS# NA
M.F.: C28H37N5O9S2
M.W.: 651.75 |
| |
| QF120376 | Folic Acid Impurity 76
CAS# NA
M.F.: C21H27N7O6
M.W.: 473.49 |
| |
| QD122065 | Dolutegravir Impurity 65
CAS# NA
M.F.: C17H14F2N2O6
M.W.: 380.30 |
| |
| QE191837 | Estradiol Valerate Impurity 37
CAS# 182624-54-0
M.F.: C23H32O3
M.W.: 356.50 |
| |
| QM050113 | Metamizole sodium Impurity 13
CAS# NA
M.F.: C13H19N3O7S2
M.W.: 393.43 |
| |
| QF061340 | Fosfomycin Trometamol Impurity 40
CAS# NA
M.F.: C5H13O5P
M.W.: 184.13 |
| |
| QA180267 | Arbidol Impurity 67
CAS# 40945-79-7
M.F.: C15H17NO4
M.W.: 275.30 |
| |
| QO022039 | Obeticholic Acid Impurity 39
CAS# 462122-38-9
M.F.: C27H44O4
M.W.: 432.65 |
| |
| QO022038 | Obeticholic Acid Impurity 38
CAS# 863239-59-2
M.F.: C27H42O4
M.W.: 430.63 |
| |
| QP180806 | Pralidoxime Iodide Impurity 6
CAS# 873-69-8
M.F.: C6H6N2O
M.W.: 122.13 |
| |
| QP180805 | Pralidoxime Iodide Impurity 5
CAS# 3785-03-3
M.F.: C7H7IN2
M.W.: 246.05 |
| |
| QP180804 | Pralidoxime Iodide Impurity 4
CAS# 3313-51-7
M.F.: C7H10INO
M.W.: 251.07 |
| |
| QP180803 | Pralidoxime Iodide Impurity 3
CAS# 3784-97-2
M.F.: C7H8INO
M.W.: 249.05 |
| |
| QP180802 | Pralidoxime Iodide Impurity 2
CAS# 45750-74-1(cation form)
M.F.: C7H9IN2O
M.W.: 264.07 |
| |
| QP180801 | Pralidoxime Iodide Impurity 1
CAS# 694-85-9
M.F.: C6H7NO
M.W.: 109.13 |
| |
| QP186303 | (E)-Pralidoxime Chloride
CAS# 14018-50-9
M.F.: C7H9ClN2O
M.W.: 172.61 |
| |
| QP186302 | (Z)-Pralidoxime Chloride
CAS# 13698-37-8
M.F.: C7H9ClN2O
M.W.: 172.61 |
| |
| QP186300 | Pralidoxime Chloride
CAS# 51-15-0
M.F.: C7H9ClN2O
M.W.: 172.61 |
| |
| QP186301 | Pralidoxime Chloride Impurity 1
CAS# 3697-38-9
M.F.: C7H8ClNO2
M.W.: 173.60 |
| |
| QP180800 | Pralidoxime Iodide
CAS# 94-63-3
M.F.: C7H9IN2O
M.W.: 264.07 |
| |
| QP052205 | Pentoxyverine hydrogen citrate Impurity 5
CAS# 4535-96-0
M.F.: C13H16O2
M.W.: 204.27 |
| |
| QP052204 | Pentoxyverine hydrogen citrate Impurity 4
CAS# 1421930-96-2
M.F.: C18H27NO3
M.W.: 305.42 |
| |
| QP052203 | Pentoxyverine hydrogen citrate Impurity 3
CAS# NA
M.F.: C16H21ClO3
M.W.: 296.79 |
| |
| QP052202 | Pentoxyverine hydrogen citrate Impurity 2
CAS# 1378312-51-6
M.F.: C16H23NO
M.W.: 245.37 |
| |
| QS221207 | Sivelestat sodium Impurity G
CAS# NA
M.F.: C20H22N2O7S
M.W.: 434.46 |
| |
| QC052013 | Cetrorelix Impurity 13
CAS# NA
M.F.: C72H94ClN17O15
M.W.: 1473.10 |
| |
| QS150409 | Alendronic Acid Impurity 9
CAS# NA
M.F.: C4H13NO8P2
M.W.: 265.09 |
| |
| QF120375 | Folic Acid Impurity 75
CAS# 31690-08-1;301298-88-4(Ca salt)
M.F.: C20H25N7O6
M.W.: 459.46 |
| |
| QL051518 | Calcium Levofolinate Nitroso Impurity 2
CAS# NA
M.F.: C21H23N7O8
M.W.: 501.46 |
| |
| QL051517 | Calcium Levofolinate Nitroso Impurity 1
CAS# NA
M.F.: C20H22N8O8
M.W.: 502.44 |
| |
| QL252032 | Lysine aspirin Impurity 32
CAS# NA
M.F.: C15H20N2O5
M.W.: 308.33 |
| |
| QC022035 | Cabazitaxel Impurity 35
CAS# 949459-78-3
M.F.: C22H25NO6
M.W.: 399.44 |
| |
| QF061339 | Fosfomycin Trometamol Impurity 39
CAS# 76274-77-6
M.F.: C3H9O4P
M.W.: 140.07 |
| |
| QF061338 | Fosfomycin Trometamol Impurity 38
CAS# 53621-85-5
M.F.: C3H9O4P
M.W.: 140.07 |
| |
| QF061337 | Fosfomycin Trometamol Impurity 37
CAS# NA
M.F.: C11H23O3P
M.W.: 234.28 |
| |
| QH042453 | Hydroxychloroquine sulfate Impurity 53
CAS# NA
M.F.: C20H30ClN3O
M.W.: 363.93 |
| |
| QH042452 | Hydroxychloroquine sulfate Impurity 52
CAS# NA
M.F.: C20H30ClN3O
M.W.: 363.93 |
| |
| QE201634 | Ertapenem Impurity 34
CAS# NA
M.F.: C44H48N6O13S2
M.W.: 933.02 |
| |
| QH042451 | Hydroxychloroquine sulfate Impurity 51
CAS# 4203-18-3
M.F.: C9H5Cl2N
M.W.: 198.05 |
| |
| QH042450 | Hydroxychloroquine sulfate Impurity 50
CAS# 23432-43-1
M.F.: C9H6ClNO
M.W.: 179.6 |
| |
| QH042449 | Hydroxychloroquine sulfate Impurity 49
CAS# 57797-97-4
M.F.: C9H6ClNO
M.W.: 179.60 |
| |
| QN151876 | Noradrenaline (Norepinephrine) Impurity 76
CAS# NA
M.F.: C9H13NO6S
M.W.: 263.26 |
| |
| QI091642 | Ipratropium Bromide Impurity 42
CAS# NA
M.F.: C18H25NO3
M.W.: 303.40 |
| |
| QI091641 | Ipratropium Bromide Impurity 41
CAS# NA
M.F.: C18H23NO3
M.W.: 301.39 |
| |
| QI091640 | Ipratropium Bromide Impurity 40
CAS# NA
M.F.: C19H25NO4
M.W.: 331.41 |
| |
| QL051302 | Folinic Acid Impurity 2
CAS# NA
M.F.: C15H18N6O3
M.W.: 330.35 |
| |
| QV051834 | Verapamil Impurity 34
CAS# 114847-42-6
M.F.: C26H36N2O4
M.W.: 440.58 |
| |
| QF090570 | Finerenone Impurity 70
CAS# NA
M.F.: C25H26N4O4
M.W.: 446.51 |
| |
| QG121817 | Glycyrrhizic Acid Impurity 17
CAS# NA
M.F.: C44H64O18
M.W.: 880.98 |
| |
| QG121816 | Glycyrrhizic Acid Impurity 16
CAS# 2270962-44-0
M.F.: C44H66O16
M.W.: 851.00 |
| |
| QB050434 | Bedaquiline Fumarate Impurity 34
CAS# 1972612-60-4+857086-94-3
M.F.: C32H31BrN2O2
M.W.: 555.50 |
| |
| QB050433 | Bedaquiline Fumarate Impurity 33
CAS# NA
M.F.: C32H29BrN2O
M.W.: 537.50 |
| |
| QG121815 | Glycyrrhizic Acid Impurity 15
CAS# NA
M.F.: C45H68O16
M.W.: 865.02 |
| |
| QG121814 | Glycyrrhizic Acid Impurity 14
CAS# NA
M.F.: C45H68O16
M.W.: 865.02 |
| |
| QG121813 | Glycyrrhizic Acid Impurity 13
CAS# NA
M.F.: C42H62O17
M.W.: 838.94 |
| |
| QG121812 | Glycyrrhizic Acid Impurity 12
CAS# NA
M.F.: C42H62O17
M.W.: 838.94 |
| |
| QG121811 | Glycyrrhizic Acid Impurity 11
CAS# NA
M.F.: C42H62O17
M.W.: 838.94 |
| |
| QI142517 | Indocyanine Green Impurity 17
CAS# 63450-66-8
M.F.: C32H34N2O4S
M.W.: 542.69 |
| |
| QI142516 | Indocyanine Green Impurity 16
CAS# 41532-84-7
M.F.: C15H15N
M.W.: 209.29 |
| |
| QL251101 | (+)-Lyoniresinol 3α-O-β-D-glucopyranoside
CAS# 87585-32-8
M.F.: C28H38O13
M.W.: 582.60 |
| |
| QB050432 | Bedaquiline Fumarate Impurity 32
CAS# 2443970-23-6;2443970-24-7(HCl salt)
M.F.: C16H17NO
M.W.: 239.32 |
| |
| QP156702 | Poricoic acid B
CAS# 137551-39-4
M.F.: C30H44O5
M.W.: 484.68 |
| |
| QE161264 | Epalrestat Nitroso Impurity 1
CAS# NA
M.F.: C2H4N2O3
M.W.: 104.07 |
| |
| QE161263 | Epalrestat Impurity 63
CAS# 39486-57-2
M.F.: C5H6N2O2S2
M.W.: 190.24 |
| |
| QD0207109 | Dabigatran Etexilate Impurity 109
CAS# 2498-50-2
M.F.: C7H9N3.2HCl
M.W.: 135.17 72.92 |
| |
| QD0207108 | Dabigatran Etexilate Impurity 108
CAS# 1416446-45-1
M.F.: C33H39N7O5
M.W.: 613.72 |
| |
| QD0207107 | Dabigatran Etexilate Impurity 107
CAS# 1349500-09-9
M.F.: C35H43N7O5
M.W.: 641.77 |
| |
| QZ151216 | Zoledronic acid Impurity 16
CAS# NA
M.F.: C16H32N2O17P2
M.W.: 586.38 |
| |
| QR241236 | Ruxolitinib Impurity 36
CAS# NA
M.F.: C22H26N6O2
M.W.: 406.49 |
| |
| QD0207106 | Dabigatran Etexilate Impurity 106
CAS# 1354892-78-6
M.F.: C29H32N6O4
M.W.: 528.61 |
| |
| QR457054 | Rocuronium bromide Impurity 54
CAS# NA
M.F.: C32H53BrN2O4
M.W.: 609.69 |
| |
| QD030478 | Diclofenac sodium Impurity 78
CAS# NA
M.F.: C17H17Cl2NO3
M.W.: 354.23 |
| |
| QC061452 | Cefdinir Impurity 52
CAS# NA
M.F.: C7H8N4O3S
M.W.: 228.23 |
| |
| QM050112 | Metamizole sodium Impurity 12
CAS# 92569-10-3
M.F.: C12H15N3O3
M.W.: 249.27 |
| |
| QL1412170 | Lenalidomide Impurity 170
CAS# 220514-28-3
M.F.: C9H8BrNO4
M.W.: 274.07 |
| |
| QC120211 | Clobetasol Propionate Impurity 11
CAS# 59860-99-0
M.F.: C22H27FO4
M.W.: 374.45 |
| |
| QP081868 | Phloroglucinol Impurity 68
CAS# NA
M.F.: C10H8O6
M.W.: 224.17 |
| |
| QC062148 | Ceftazidime Impurity 48
CAS# 86299-47-0
M.F.: C13H19N3O5S
M.W.: 329.37 |
| |
| QU180138 | Urapidil Nitroso Impurity 1
CAS# 2219339-64-5
M.F.: C11H15N3O2
M.W.: 221.26 |
| |
| QP092106 | Primaquine Diphosphate Nitroso Impurity 2
CAS# NA
M.F.: C15H20N4O2
M.W.: 288.35 |
| |
| QP092105 | Primaquine Diphosphate Nitroso Impurity 1
CAS# NA
M.F.: C15H20N4O2
M.W.: 288.35 |
| |
| QO130201 | N-Nitroso Omidenepag Isopropyl
CAS# NA
M.F.: C26H27N7O5S
M.W.: 549.61 |
| |
| QO130200 | Omidenepag Isopropyl
CAS# 1187451-19-9
M.F.: C26H28N6O4S
M.W.: 520.61 |
| |
| QL010101 | (E)-Latanoprostene Bunod
CAS# 2099033-66-4
M.F.: C27H41NO8
M.W.: 507.62 |
| |
| QM161852 | Metoprolol Impurity 52
CAS# NA
M.F.: C12H19NO3
M.W.: 225.29 |
| |
| QM030501 | N-Nitroso Meclofenamic acid
CAS# NA
M.F.: C14H10Cl2N2O3
M.W.: 325.15 |
| |
| QM030500 | Meclofenamic acid
CAS# 644-62-2
M.F.: C14H11Cl2NO2
M.W.: 296.15 |
| |
| QP1824113 | Parecoxib Sodium Impurity 113
CAS# 2242749-02-4
M.F.: C19H18N2O4S
M.W.: 370.42 |
| |
| QM201850 | Metaraminol Impurity 50
CAS# NA
M.F.: C13H17NO7
M.W.: 299.28 |
| |
| QR052004 | 3,4-Didehydroretinoic acid
CAS# 4159-20-0
M.F.: C20H26O2
M.W.: 298.43 |
| |
| QI210102 | Ivacaftor Nitroso Impurity 2
CAS# NA
M.F.: C24H27N3O4
M.W.: 421.50 |
| |
| QB180809 | Brompheniramine maleate Impurity 9
CAS# NA
M.F.: C16H19BrN2O2
M.W.: 351.24 |
| |
| QB180808 | Brompheniramine maleate Impurity 8
CAS# NA
M.F.: C16H19BrN2O
M.W.: 335.25 |
| |
| QT081303 | 11-Dehydro Thromboxane B2
CAS# 67910-12-7
M.F.: C20H32O6
M.W.: 368.47 |
| |
| QI142515 | Indocyanine Green Impurity 15
CAS# NA
M.F.: C24H26NNaO4S
M.W.: 447.52 |
| |
| QI142514 | Indocyanine Green Impurity 14
CAS# NA
M.F.: C86H92N4Na2O12S4
M.W.: 1547.92 |
| |
| QI142513 | Indocyanine Green Impurity 13
CAS# NA
M.F.: C30H32N2O3S
M.W.: 500.66 |
| |
| QU121609 | N-Nitroso N-Desmethyl Ulipristal Acetate
CAS# NA
M.F.: C29H34N2O5
M.W.: 490.60 |
| |
| QI142512 | Indocyanine Green Impurity 12
CAS# 17432-66-5
M.F.: C11H11NO
M.W.: 173.22 |
| |
| QP010402 | N-Nitroso N-Desmethyl Padimate O
CAS# NA
M.F.: C16H24N2O3
M.W.: 292.38 |
| |
| QO181459 | Ornidazole Impurity 59
CAS# 13551-86-5
M.F.: C6H8ClN3O3
M.W.: 205.60 |
| |
| QM182504 | Maropitant Citrate Impurity 4
CAS# 142035-23-2
M.F.: C20H24N2
M.W.: 292.43 |
| |
| QM182503 | Maropitant Citrate Impurity 3
CAS# 155681-48-4
M.F.: C27H30N2
M.W.: 382.55 |
| |
| QM200516 | N-Nitroso N-Desmethyl Methylene Blue
CAS# NA
M.F.: C15H15ClN4OS
M.W.: 334.82 |
| |
| QM013301 | N-Nitroso N-Desmethyl Maralixibat chloride
CAS# NA
M.F.: C39H53ClN4O5S
M.W.: 725.39 |
| |
| QM013300 | Maralixibat chloride
CAS# 228113-66-4
M.F.: C40H56ClN3O4S
M.W.: 710.42 |
| |
| QE182059 | N-Nitroso N-Desmethyl Erythromycin Ethylsuccinate
CAS# NA
M.F.: C42H72N2O17
M.W.: 877.04 |
| |
| QD0207105 | N-Nitroso Dabigatran Etexilate
CAS# NA
M.F.: C34H40N8O6
M.W.: 656.74 |
| |
| QB054701 | Berotralstat Nitroso Impurity 1
CAS# NA
M.F.: C30H25F4N7O2
M.W.: 591.57 |
| |
| QP051706 | Pentamidine diisetionate Impurity 6
CAS# NA
M.F.: C19H22N2O4
M.W.: 342.40 |
| |
| QP051705 | Pentamidine diisetionate Impurity 5
CAS# NA
M.F.: C21H26N2O4
M.W.: 370.45 |
| |
| QP051704 | Pentamidine diisetionate Impurity 4
CAS# 1252-44-4
M.F.: C23H30N2O4
M.W.: 398.50 |
| |
| QP051703 | Pentamidine diisetionate Impurity 3
CAS# 7467-71-2
M.F.: C19H18N2O2
M.W.: 306.37 |
| |
| QP051702 | Pentamidine diisetionate Impurity 2
CAS# 91945-01-6
M.F.: C12H14BrNO
M.W.: 268.15 |
| |
| QP120207 | Polymyxin B Sulfate
CAS# 1405-20-5
M.F.: C56H98N16O13.H2O4S
M.W.: 1203.50 36.46 |
| |
| QB200111 | Betamethasone Dipropionate Impurity 11
CAS# NA
M.F.: C28H37FO7
M.W.: 504.60 |
| |
| QP156701 | Poricoic acid A
CAS# 137551-38-3
M.F.: C31H46O5
M.W.: 498.70 |
| |
| QA260507 | Azelnidipine Impurity 7
CAS# NA
M.F.: C33H34N4O7
M.W.: 598.66 |
| |
| QF181958 | Furosemide Impurity 58
CAS# 4818-85-3
M.F.: C12H12N2O5S
M.W.: 296.30 |
| |
| QG042424 | Gadoxetate Disodium Impurity 24
CAS# NA
M.F.: C21H26GdN3O8
M.W.: 605.70 |
| |
| QG042423 | Gadoxetate Disodium Impurity 23
CAS# NA
M.F.: C21H26GdN3O8
M.W.: 605.70 |
| |
| QM142425 | Minoxidil Impurity 25
CAS# 1637646-87-7
M.F.: C5H11NO2
M.W.: 117.15 |
| |
| QT260433 | Trazodone hydrochloride Impurity 33
CAS# NA
M.F.: C40H46Cl2N10O2
M.W.: 769.78 |
| |
| QF121946 | Fulvestrant Impurity 46
CAS# 96045-13-5
M.F.: C14H31BrOSi
M.W.: 323.39 |
| |
| QV3077131 | Vitamin K1 Impurity 131
CAS# NA
M.F.: C31H46O3
M.W.: 466.71 |
| |
| QV200109 | all-trans-Retinyl Stearate
CAS# 631-87-8
M.F.: C38H64O2
M.W.: 552.93 |
| |
| QM092218 | Mivacurium chloride Impurity 18
CAS# NA
M.F.: C25H36ClNO6
M.W.: 482.01 |
| |
| QV3077130 | Vitamin K1 Impurity 130
CAS# 102608-53-7
M.F.: C20H40O
M.W.: 296.54 |
| |
| QT142600 | Tanshinone IIA
CAS# 568-72-9
M.F.: C19H18O3
M.W.: 294.35 |
| |
| QS041924 | Sodium Valproate Impurity 24
CAS# 6967-47-1
M.F.: C8H13NO2
M.W.: 155.20 |
| |
| QC042043 | Cefditoren pivoxil Impurity 43
CAS# NA
M.F.: C25H28N6O8S3
M.W.: 636.71 |
| |
| QP090336 | Sodium Picosulfate Impurity 36
CAS# NA
M.F.: C19H15NNa2O8S2
M.W.: 495.43 |
| |
| QC061620 | Cefpodoxime Proxetil Impurity 20
CAS# NA
M.F.: C44H56N10O18S4
M.W.: 1141.22 |
| |
| QP132619 | Promethazine Nitroso Impurity 1
CAS# NA
M.F.: C3H7NO2
M.W.: 89.09 |
| |
| QV3077129 | Vitamin K1 Impurity 129
CAS# NA
M.F.: C31H44O2
M.W.: 448.69 |
| |
| QV3077128 | Vitamin K1 Impurity 128
CAS# NA
M.F.: C31H44O2
M.W.: 448.69 |
| |
| QC061874 | Cefuroxime sodium Impurity 74
CAS# NA
M.F.: C16H18N4O9S
M.W.: 442.40 |
| |
| QN151875 | Noradrenaline (Norepinephrine) Impurity 75
CAS# NA
M.F.: C16H19NO6
M.W.: 321.33 |
| |
| QN151874 | Noradrenaline (Norepinephrine) Impurity 74
CAS# NA
M.F.: C16H19NO6
M.W.: 321.33 |
| |
| QN151873 | Noradrenaline (Norepinephrine) Impurity 73
CAS# NA
M.F.: C16H15NO6
M.W.: 317.30 |
| |
| QN151872 | Noradrenaline (Norepinephrine) Impurity 72
CAS# NA
M.F.: C16H15NO6
M.W.: 317.30 |
| |
| QF061336 | Fosfomycin Trometamol Impurity 36
CAS# NA
M.F.: C7H15O4P
M.W.: 194.17 |
| |
| QF061335 | Fosfomycin Trometamol Impurity 35
CAS# NA
M.F.: C3H6ClO3P
M.W.: 156.5 |
| |
| QP093300 | Pipecuronium Bromide
CAS# 52212-02-9
M.F.: C35H62Br2N4O4
M.W.: 762.71 |
| |
| QB053225 | Beraprost Impurity 25
CAS# NA
M.F.: C24H29NaO5
M.W.: 420.48 |
| |
| QF061334 | Fosfomycin Trometamol Impurity 34
CAS# NA
M.F.: C5H11O4P
M.W.: 166.11 |
| |
| QF061333 | Fosfomycin Trometamol Impurity 33
CAS# 433979-70-5
M.F.: C6H7O4P
M.W.: 174.09 |
| |
| QF061332 | Fosfomycin Trometamol Impurity 32
CAS# 1416734-33-2
M.F.: C6H14O8P2
M.W.: 276.12 |
| |
| QF061331 | Fosfomycin Trometamol Impurity 31
CAS# NA
M.F.: C3H6ClO3P
M.W.: 156.50 |
| |
| QF061330 | Fosfomycin Trometamol Impurity 30
CAS# NA
M.F.: C6H7O3P
M.W.: 158.09 |
| |
| QV3077127 | Vitamin K1 Impurity 127
CAS# NA
M.F.: C20H40
M.W.: 280.54 |
| |
| QV3077126 | Vitamin K1 Impurity 126
CAS# NA
M.F.: C20H40
M.W.: 280.54 |
| |
| QF061329 | Fosfomycin Trometamol Impurity 29
CAS# NA
M.F.: C3H5O3P
M.W.: 120.04 |
| |
| QF061328 | Fosfomycin Trometamol Impurity 28
CAS# 55343-62-9
M.F.: C3H5O4P
M.W.: 136.04 |
| |
| QF061327 | Fosfomycin Trometamol Impurity 27
CAS# NA
M.F.: C11H18NO4P
M.W.: 259.24 |
| |
| QM150925 | Morinidazole Impurity 25
CAS# NA
M.F.: C15H25N5O4
M.W.: 339.40 |
| |
| QE191347 | Esmolol Impurity 47
CAS# NA
M.F.: C16H14O5
M.W.: 286.28 |
| |
| QE191346 | Esmolol Impurity 46
CAS# 69098-04-0
M.F.: C9H10O4
M.W.: 182.18 |
| |
| QB191635 | Bisoprolol Impurity 35
CAS# NA
M.F.: C10H12O3
M.W.: 180.20 |
| |
| QP092718 | Pinaverium Bromide Impurity 18
CAS# NA
M.F.: C9H9Br3O2
M.W.: 388.88 |
| |
| QA190215 | 6-O-Acetylascorbic acid
CAS# 20229-76-9
M.F.: C8H10O7
M.W.: 218.16 |
| |
| QM131932 | Mometasone Furoate Impurity 32
CAS# NA
M.F.: C32H32Cl2O8
M.W.: 615.50 |
| |
| QC031642 | Cefcapene pivoxil Impurity 42
CAS# NA
M.F.: C27H37N5O8S2
M.W.: 623.74 |
| |
| QO120501 | Oleanolic acid 3-acetate
CAS# 4339-72-4
M.F.: C32H50O4
M.W.: 498.75 |
| |
| QA130253 | Ambroxol Impurity 53
CAS# NA
M.F.: C7H5Br2NO
M.W.: 278.93 |
| |
| QT142429 | Tranexamic Acid Impurity 29
CAS# 23358-95-4
M.F.: C16H22O6
M.W.: 310.35 |
| |
| QH150923 | Hyoscine Butylbromide Impurity 23
CAS# NA
M.F.: C19H25NO4
M.W.: 331.41 |
| |
| QA200376 | Cisatracurium Besylate Impurity 76
CAS# 1075727-00-2
M.F.: C34H45NO9S
M.W.: 643.79 |
| |
| QA200375 | Cisatracurium Besylate Impurity 75
CAS# NA
M.F.: C32H41NO9S
M.W.: 615.74 |
| |
| QT260432 | Trazodone hydrochloride Impurity 32
CAS# 1781591-94-3
M.F.: C6H4ClN3O
M.W.: 169.57 |
| |
| QT260431 | Trazodone hydrochloride Impurity 31
CAS# 333988-45-7
M.F.: C9H11Cl2N.HCl
M.W.: 204.09 36.46 |
| |
| QA031616 | Acipimox Impurity 16
CAS# 6890-38-6
M.F.: C6H8N2O2
M.W.: 140.14 |
| |
| QM092217 | Mivacurium chloride Impurity 17
CAS# NA
M.F.: C61H86Cl2N2O15
M.W.: 1158.26 |
| |
| QC-C121541 | Coenzyme A
CAS# 85-61-0
M.F.: C21H36N7O16P3S
M.W.: 767.53 |
| |
| QM161850 | Metoprolol Impurity 50
CAS# NA
M.F.: C15H23NO2
M.W.: 249.35 |
| |
| QB030509 | 7,10-Bis[O-(triethylsilyl)]-10-deacetyl Baccatin III
CAS# 149107-84-6
M.F.: C41H64O10Si2
M.W.: 773.12 |
| |
| QI040167 | Indacaterol Impurity 67
CAS# NA
M.F.: C13H14F3NO
M.W.: 257.26 |
| |
| QB050430 | Bedaquiline Fumarate Impurity 30
CAS# NA
M.F.: C28H20BrNO2
M.W.: 482.38 |
| |
| QD150307 | Docusate sodium Impurity 7
CAS# NA
M.F.: C12H21NaO7S
M.W.: 332.34 |
| |
| QD150306 | Docusate sodium Impurity 6
CAS# 29454-16-8
M.F.: C4H5NaO7S
M.W.: 220.13 |
| |
| QB030508 | Baccatin III Impurity 8
CAS# NA
M.F.: C79H76N2O18
M.W.: 1341.47 |
| |
| QB030507 | Baccatin III Impurity 7
CAS# NA
M.F.: C35H42O13
M.W.: 670.71 |
| |
| QB030506 | Baccatin III Impurity 6
CAS# NA
M.F.: C39H54O12Si
M.W.: 742.93 |
| |
| QB030505 | Baccatin III Impurity 5
CAS# NA
M.F.: C43H66O11Si2
M.W.: 815.16 |
| |
| QB030504 | Baccatin III Impurity 4
CAS# NA
M.F.: C39H54O12Si
M.W.: 742.93 |
| |
| QB030503 | 7,10,13-tris(triethylsilyl)-10-deacetylbaccatin III
CAS# 194720-19-9
M.F.: C47H78O10Si3
M.W.: 887.39 |
| |
| QO1920149 | Oseltamivir Impurity 149
CAS# NA
M.F.: C25H42N2O4
M.W.: 434.62 |
| |
| QT691559 | Testosterone Undecanoate Impurity 59
CAS# NA
M.F.: C30H46O3
M.W.: 454.70 |
| |
| QE192701 | Estetrol Impurity 1
CAS# 1426679-35-7
M.F.: C25H30O4
M.W.: 394.51 |
| |
| QB051334 | Bempedoic acid Impurity 34
CAS# NA
M.F.: C10H18O3
M.W.: 186.25 |
| |
| QB051333 | Bempedoic acid Impurity 33
CAS# NA
M.F.: C13H26O3
M.W.: 230.35 |
| |
| QC132675 | Cefmetazole sodium Impurity 75
CAS# NA
M.F.: C15H17N7O6S3
M.W.: 487.52 |
| |
| QC132674 | Cefmetazole sodium Impurity 74
CAS# NA
M.F.: C14H15N7O5S3
M.W.: 457.50 |
| |
| QF030344 | Famciclovir Impurity 44
CAS# NA
M.F.: C14H19N5O5
M.W.: 337.34 |
| |
| QM201849 | Metaraminol Impurity 49
CAS# NA
M.F.: C15H22ClNO3
M.W.: 299.80 |
| |
| QA182301 | Artemisinic Aldehyde
CAS# 125276-60-0
M.F.: C15H22O
M.W.: 218.34 |
| |
| QM050111 | Metamizole sodium Impurity 11
CAS# NA
M.F.: C13H15N3O
M.W.: 229.28 |
| |
| QO240122 | Oxacillin sodium Impurity 22
CAS# 91059-01-7
M.F.: C11H7Cl2NO2
M.W.: 256.08 |
| |
| QO240121 | Oxacillin sodium Impurity 21
CAS# 1598387-74-6
M.F.: C11H7Cl2NO2
M.W.: 256.08 |
| |
| QO240120 | Oxacillin sodium Impurity 20
CAS# NA
M.F.: C11H7Cl2NO2
M.W.: 256.08 |
| |
| QO240119 | Oxacillin sodium Impurity 19
CAS# 1143-82-4
M.F.: C13H13NO3
M.W.: 231.25 |
| |
| QS041923 | Sodium Valproate Impurity 23
CAS# 1085698-06-1
M.F.: C11H20O4
M.W.: 216.28 |
| |
| QD171213 | Dequalinium chloride Impurity 13
CAS# NA
M.F.: C20H30Cl2N2
M.W.: 369.37 |
| |
| QD171212 | Dequalinium chloride Impurity 12
CAS# 77726-78-4
M.F.: C10H12N2O
M.W.: 176.22 |
| |
| QC081350 | Calcitriol Impurity 50
CAS# NA
M.F.: C27H44O3
M.W.: 416.65 |
| |
| QA161893 | Aprepitant Impurity 93
CAS# NA
M.F.: C20H18F7NO2
M.W.: 437.36 |
| |
| QG124602 | Glycine Nitroso Impurity 2
CAS# 25081-31-6
M.F.: C4H6N2O5
M.W.: 162.10 |
| |
| QT211203 | Tulathromycin A Impurity 3
CAS# NA
M.F.: C41H81N3O13
M.W.: 824.11 |
| |
| QA163046 | Apremilast Impurity 46
CAS# NA
M.F.: C12H17NO4S
M.W.: 271.33 |
| |
| QP092717 | Pinaverium Bromide Impurity 17
CAS# NA
M.F.: C26H41Br2NO4
M.W.: 591.43 |
| |
| QM050110 | Metamizole sodium Impurity 10
CAS# NA
M.F.: C12H15N3O2
M.W.: 233.27 |
| |
| QM050109 | Metamizole sodium Nitroso Impurity 2
CAS# NA
M.F.: C12H14N4O5S
M.W.: 326.33 |
| |
| QM050108 | Metamizole sodium Impurity 8
CAS# 62902-13-0
M.F.: C13H17N3O2
M.W.: 247.30 |
| |
| QU190452 | Ursodeoxycholic Acid Impurity 52
CAS# 73465-45-9
M.F.: C25H42O4
M.W.: 406.61 |
| |
| QP081866 | Phloroglucinol Impurity 66
CAS# NA
M.F.: C18H14O9
M.W.: 374.30 |
| |
| QA030613 | N-Nitroso Aceclofenac
CAS# NA
M.F.: C16H12Cl2N2O5
M.W.: 383.18 |
| |
| QF151500 | Fospropofol disodium
CAS# 258516-87-9;258516-89-1(free acid)
M.F.: C13H19Na2O5P
M.W.: 332.24 |
| |
| QD150228 | Dobutamine Impurity 28
CAS# NA
M.F.: C16H21NO4
M.W.: 291.35 |
| |
| QD150227 | Dobutamine Impurity 27
CAS# NA
M.F.: C18H23NO4
M.W.: 317.39 |
| |
| QC013700 | Catharanthine sulfate
CAS# 70674-90-7
M.F.: C21H24N2O2.H2O4S
M.W.: 336.44 98.07 |
| |
| QP090335 | Sodium Picosulfate Impurity 35
CAS# NA
M.F.: C30H24N2O3
M.W.: 460.53 |
| |
| QG211208 | Sodium Gualenate Impurity 8
CAS# NA
M.F.: C15H16O2
M.W.: 228.29 |
| |
| QG211207 | Sodium Gualenate Impurity 7
CAS# NA
M.F.: C15H16O
M.W.: 212.29 |
| |
| QG211206 | Sodium Gualenate Impurity 6
CAS# NA
M.F.: C15H17NaO3S
M.W.: 300.35 |
| |
| QC031641 | Cefcapene pivoxil Impurity 41
CAS# NA
M.F.: C55H61N13O16S6
M.W.: 1352.53 |
| |
| QC031640 | Cefcapene pivoxil Impurity 40
CAS# NA
M.F.: C16H18N4O5S2
M.W.: 410.46 |
| |
| QE160512 | Eperisone Impurity 12
CAS# NA
M.F.: C19H29NO.HCl
M.W.: 287.45 36.46 |
| |
| QF090533 | Finerenone Impurity 33
CAS# NA
M.F.: C26H23N3O4
M.W.: 441.49 |
| |
| QU160116 | Upadacitinib Impurity 16
CAS# NA
M.F.: C29H29N5O4S
M.W.: 543.64 |
| |
| QZ121631 | Zolpidem tartrate Impurity 31
CAS# 258273-50-6
M.F.: C18H18N2O2
M.W.: 294.35 |
| |
| QZ121630 | Zolpidem tartrate Impurity 30
CAS# NA
M.F.: C18H18N2O3
M.W.: 310.35 |
| |
| QB141700 | Benztropine Mesylate
CAS# 132-17-2
M.F.: C21H25NO.CH4O3S
M.W.: 307.44 96.10 |
| |
| QB050429 | Bedaquiline Fumarate Impurity 29
CAS# NA
M.F.: C32H31BrN2O3
M.W.: 571.52 |
| |
| QU181201 | Urolithin A
CAS# 1143-70-0
M.F.: C13H8O4
M.W.: 228.20 |
| |
| QK200321 | Ketoconazole Impurity 21
CAS# 29098-85-9
M.F.: C12H7Cl3O2
M.W.: 289.54 |
| |
| QH040325 | Hydrocortisone Impurity 25
CAS# NA
M.F.: C25H36O7
M.W.: 448.56 |
| |
| QR457053 | Rocuronium bromide Impurity 53
CAS# NA
M.F.: C23H39NO3
M.W.: 377.57 |
| |
| QR457052 | Rocuronium bromide Impurity 52
CAS# NA
M.F.: C32H52N2O4
M.W.: 528.78 |
| |
| QR457051 | Rocuronium bromide Impurity 51
CAS# NA
M.F.: C32H53BrN2O4
M.W.: 609.69 |
| |
| QR457050 | Rocuronium bromide Impurity 50
CAS# NA
M.F.: C32H51BrN2O3
M.W.: 591.68 |
| |
| QR457049 | Rocuronium bromide Impurity 49
CAS# NA
M.F.: C32H51BrN2O3
M.W.: 591.68 |
| |
| QD152613 | 7-ketodeoxycholic acid
CAS# 911-40-0
M.F.: C24H38O5
M.W.: 406.56 |
| |
| QC061450 | Cefdinir Impurity 50
CAS# NA
M.F.: C42H39N15O15S6
M.W.: 1186.22 |
| |
| QR182484 | Brexpiprazole Impurity 84
CAS# 2190474-85-0
M.F.: C50H54N6O4S2
M.W.: 867.14 |
| |
| QF051300 | Fenoldopam Mesylate
CAS# 67227-57-0;67227-56-9(free base)
M.F.: C16H16ClNO3.CH4O3S
M.W.: 305.76 96.10 |
| |
| QC052009 | Cetrorelix Impurity 9
CAS# NA
M.F.: C64H80ClN13O13
M.W.: 1274.87 |
| |
| QL091687 | Lipoic Acid Impurity 87
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QV3077125 | Vitamin K1 Impurity 125
CAS# NA
M.F.: C31H46O3
M.W.: 466.71 |
| |
| QR190800 | Ro 19-8022
CAS# 104604-66-2
M.F.: C25H21ClN2O3
M.W.: 432.90 |
| |
| QC0303142 | Cinacalcet Impurity 142
CAS# 27557-86-4
M.F.: C13H15N
M.W.: 185.27 |
| |
| QM092216 | Mivacurium chloride Impurity 16
CAS# NA
M.F.: C36H51Cl2NO9
M.W.: 712.70 |
| |
| QM092215 | Mivacurium chloride Impurity 15
CAS# 104758-49-8
M.F.: C22H29NO5
M.W.: 387.48 |
| |
| QM092214 | Mivacurium chloride Impurity 14
CAS# NA
M.F.: C14H22Cl2O4
M.W.: 325.23 |
| |
| QM092213 | Mivacurium chloride Impurity 13
CAS# 48059-97-8
M.F.: C8H12O4
M.W.: 172.18 |
| |
| QI142510 | Indocyanine Green Impurity 10
CAS# 52568-84-0
M.F.: C15H15N
M.W.: 209.29 |
| |
| QI142511 | Indocyanine Green Impurity 11
CAS# NA
M.F.: C43H47N2NaO6S2
M.W.: 774.97 |
| |
| QI142509 | Indocyanine Green Impurity 9
CAS# 20893-80-5
M.F.: C10H7ClN2
M.W.: 190.63 |
| |
| QN162446 | (+/-)-Naproxen D3
CAS# 958293-79-3
M.F.: C14H11D3O3
M.W.: 233.28 |
| |
| QF121613 | Flupentixol Impurity 13
CAS# NA
M.F.: C19H20F3NO2S
M.W.: 383.43 |
| |
| QS210309 | Sucrose Octasulfate Octatriethylamine Salt
CAS# 869561-07-9
M.F.: C12H22O35S8.8C6H15N
M.W.: 982.75 8(101.19) |
| |
| QG122546 | Glycopyrrolate-d5 Bromide
CAS# NA
M.F.: C19H23D5BrNO3
M.W.: 403.37 |
| |
| QO240118 | Oxacillin sodium Impurity 18
CAS# NA
M.F.: C19H19N3O5S
M.W.: 401.44 |
| |
| QV051402 | Venetoclax Impurity 2
CAS# 2254393-29-6;1235865-77-6(free base)
M.F.: C33H35ClN4O3.HCl
M.W.: 571.12 36.46 |
| |
| QG121926 | Granisetron Impurity 26
CAS# NA
M.F.: C15H11ClN2O2
M.W.: 286.72 |
| |
| QT260430 | Trazodone hydrochloride Impurity 30
CAS# NA
M.F.: C40H46Cl2N10O2
M.W.: 769.78 |
| |
| QP081307 | Phentolamine Mesylate Impurity 7
CAS# NA
M.F.: C15H15NO3
M.W.: 257.29 |
| |
| QP081306 | Phentolamine Mesylate Impurity 6
CAS# NA
M.F.: C18H21N3O3S
M.W.: 359.44 |
| |
| QO022037 | Obeticholic Acid Impurity 37
CAS# NA
M.F.: C30H52O4
M.W.: 476.74 |
| |
| QO022036 | Obeticholic Acid Impurity 36
CAS# NA
M.F.: C28H48O4
M.W.: 448.69 |
| |
| QO022035 | Obeticholic Acid Impurity 35
CAS# 951694-73-8
M.F.: C27H46O4
M.W.: 434.66 |
| |
| QC031639 | Cefcapene pivoxil Impurity 39
CAS# NA
M.F.: C28H37N5O10S2
M.W.: 667.75 |
| |
| QO1920140 | Oseltamivir Impurity 140
CAS# NA
M.F.: C22H32N2O9
M.W.: 468.50 |
| |
| QC031638 | Cefcapene pivoxil Impurity 38
CAS# NA
M.F.: C14H20N2O4S
M.W.: 312.38 |
| |
| QC031637 | Cefcapene pivoxil Impurity 37
CAS# NA
M.F.: C24H31N5O9S2
M.W.: 597.66 |
| |
| QC031636 | Cefcapene pivoxil Impurity 36
CAS# NA
M.F.: C28H37N5O9S2
M.W.: 651.75 |
| |
| QC031635 | Cefcapene pivoxil Impurity 35
CAS# NA
M.F.: C22H28N4O6S2
M.W.: 508.61 |
| |
| QC031634 | Cefcapene pivoxil Impurity 34
CAS# NA
M.F.: C28H37N5O10S2
M.W.: 667.75 |
| |
| QC031633 | Cefcapene pivoxil Impurity 33
CAS# NA
M.F.: C29H39N5O11S2
M.W.: 697.78 |
| |
| QC031632 | Cefcapene pivoxil Impurity 32
CAS# NA
M.F.: C33H45N5O11S2
M.W.: 751.87 |
| |
| QC031631 | Cefcapene pivoxil Impurity 31
CAS# NA
M.F.: C21H24N4O6S2
M.W.: 492.57 |
| |
| QC031630 | Cefcapene pivoxil Impurity 30
CAS# NA
M.F.: C19H28N2O6S
M.W.: 412.50 |
| |
| QC031629 | Cefcapene pivoxil Impurity 29
CAS# NA
M.F.: C14H20N2O6S
M.W.: 344.38 |
| |
| QC031628 | Cefcapene pivoxil Impurity 28
CAS# NA
M.F.: C27H36N4O9S2
M.W.: 624.72 |
| |
| QC031627 | Cefcapene pivoxil Impurity 27
CAS# NA
M.F.: C27H36N4O8S2
M.W.: 608.73 |
| |
| QC031626 | Cefcapene pivoxil Impurity 26
CAS# NA
M.F.: C29H38N4O10S2
M.W.: 666.76 |
| |
| QC031625 | Cefcapene pivoxil Impurity 25
CAS# NA
M.F.: C29H39N5O10S2
M.W.: 681.78 |
| |
| QC031624 | Cefcapene pivoxil Impurity 24
CAS# NA
M.F.: C21H26N4O7S2
M.W.: 510.58 |
| |
| QC031623 | Cefcapene pivoxil Impurity 23
CAS# NA
M.F.: C21H26N4O6S2
M.W.: 494.58 |
| |
| QC031622 | Cefcapene pivoxil Impurity 22
CAS# NA
M.F.: C23H28N4O8S2
M.W.: 552.62 |
| |
| QC031621 | Cefcapene pivoxil Impurity 21
CAS# NA
M.F.: C22H27N5O8S2
M.W.: 553.61 |
| |
| QC031620 | Cefcapene pivoxil Impurity 20
CAS# NA
M.F.: C14H20N2O4S
M.W.: 312.38 |
| |
| QC031619 | Cefcapene pivoxil Impurity 19
CAS# NA
M.F.: C9H12N2O2S
M.W.: 212.27 |
| |
| QP072051 | Pioglitazone hydrochloride Impurity 51
CAS# NA
M.F.: C19H23NO3S
M.W.: 345.46 |
| |
| QP072050 | Pioglitazone hydrochloride Impurity 50
CAS# NA
M.F.: C18H22N2O2S
M.W.: 330.45 |
| |
| QO240117 | Oxacillin sodium Impurity 17
CAS# NA
M.F.: C38H38N6O10S2
M.W.: 802.87 |
| |
| QO240116 | Oxacillin sodium Impurity 16
CAS# NA
M.F.: C38H40N6O11S2
M.W.: 820.89 |
| |
| QO240115 | Oxacillin sodium Impurity 15
CAS# NA
M.F.: C38H38N6O10S2
M.W.: 802.87 |
| |
| QP092716 | Pinaverium Bromide Impurity 16
CAS# NA
M.F.: C12H17BrO3
M.W.: 289.17 |
| |
| QP092715 | Pinaverium Bromide Impurity 15
CAS# 3647-69-6;3240-94-6(free base)
M.F.: C6H12ClNO.HCl
M.W.: 149.62 36.46 |
| |
| QP092714 | Pinaverium Bromide Impurity 14
CAS# 4747-61-9
M.F.: C11H20O
M.W.: 168.28 |
| |
| QP092713 | Pinaverium Bromide Impurity 13
CAS# 54370-01-3
M.F.: C9H10BrClO2
M.W.: 265.53 |
| |
| QP092712 | Pinaverium Bromide Impurity 12
CAS# 1185300-68-8
M.F.: C13H20N2O2.2HCl
M.W.: 236.32 72.92 |
| |
| QD122059 | Dolutegravir Impurity 59
CAS# 2583719-60-0
M.F.: C14H16N2O6
M.W.: 308.29 |
| |
| QB050300D | Beclometasone Dipropionate Monohydrate
CAS# 77011-63-3
M.F.: C28H37ClO7.H2O
M.W.: 521.05 18.02 |
| |
| QF121705 | Flumetasone pivalate Impurity 5
CAS# NA
M.F.: C27H36F2O6
M.W.: 494.58 |
| |
| QF211505 | Fluocortolone pivalate Impurity 5
CAS# NA
M.F.: C27H37FO5
M.W.: 460.59 |
| |
| QH150922 | Hyoscine Butylbromide Impurity 22
CAS# NA
M.F.: C12H22BrNO2
M.W.: 292.22 |
| |
| QH150921 | Hyoscine Butylbromide Impurity 21
CAS# NA
M.F.: C12H22BrNO2
M.W.: 292.22 |
| |
| QV3077123 | Vitamin K1 Impurity 123
CAS# 25486-55-9
M.F.: C31H46O3
M.W.: 466.71 |
| |
| QC061873 | Cefuroxime sodium Impurity 73
CAS# 84522-17-8
M.F.: C6H5NO3
M.W.: 139.11 |
| |
| QU190451 | 7β-Hydroxy-5β-cholanoic Acid
CAS# 10601-78-2
M.F.: C24H40O3
M.W.: 376.58 |
| |
| QC061872 | Cefuroxime sodium Impurity 72
CAS# NA
M.F.: C15H13N3O8S
M.W.: 395.34 |
| |
| QN051521 | Neostigmine bromide Impurity 21
CAS# NA
M.F.: C26H33N3O3
M.W.: 435.57 |
| |
| QN051520 | Neostigmine bromide Impurity 20
CAS# 63468-95-1
M.F.: C17H22N2O2
M.W.: 286.38 |
| |
| QS213100 | Suplatast Tosylate
CAS# 94055-76-2
M.F.: C23H33NO7S2
M.W.: 499.64 |
| |
| QL091686 | Lipoic Acid Impurity 86
CAS# NA
M.F.: C24H44O6S6
M.W.: 620.97 |
| |
| QL091685 | Lipoic Acid Impurity 85
CAS# NA
M.F.: C24H44O6S6
M.W.: 620.97 |
| |
| QL091684 | Lipoic Acid Impurity 84
CAS# NA
M.F.: C16H30O4S4
M.W.: 414.65 |
| |
| QR091219 | Riluzole Impurity 19
CAS# NA
M.F.: C16H6F6N4O2S2
M.W.: 464.36 |
| |
| QC031618 | Cefcapene pivoxil Impurity 18
CAS# NA
M.F.: C16H16N4O4S2
M.W.: 392.45 |
| |
| QL092601 | Dimethyl lithospermate B
CAS# 875313-64-7
M.F.: C38H34O16
M.W.: 746.67 |
| |
| QD098400 | Difluocortolone Valerate
CAS# 59198-70-8
M.F.: C27H36F2O5
M.W.: 478.58 |
| |
| QF012227 | Favipiravir Impurity 27
CAS# 55321-99-8;1237524-82-1(Na salt)
M.F.: C5H5N3O2
M.W.: 139.11 |
| |
| QC031617 | Cefcapene pivoxil Impurity 17
CAS# 86978-24-7
M.F.: C13H18N2O4S
M.W.: 298.36 |
| |
| QS150408 | Alendronic Acid Impurity 8
CAS# 457942-40-4
M.F.: C11H13NO4
M.W.: 223.23 |
| |
| QS150407 | Alendronic Acid Impurity 7
CAS# NA
M.F.: C11H17NO9P2
M.W.: 369.20 |
| |
| QS150406 | Alendronic Acid Impurity 6
CAS# NA
M.F.: C12H19NO9P2
M.W.: 383.23 |
| |
| QS150405 | Alendronic Acid Impurity 5
CAS# NA
M.F.: C14H23NO9P2
M.W.: 411.28 |
| |
| QA190214 | Ascorbic Acid 3-Sulfate
CAS# 22430-27-9
M.F.: C6H8O9S
M.W.: 256.18 |
| |
| QA555935 | Adenosine 3'-monophosphate
CAS# 84-21-9
M.F.: C10H14N5O7P
M.W.: 347.22 |
| |
| QA130509 | Aminolevulinic Acid Impurity 9
CAS# NA
M.F.: C12H16N2O4
M.W.: 252.27 |
| |
| QA130508 | Aminolevulinic Acid Impurity 8
CAS# NA
M.F.: C11H14N2O4
M.W.: 238.24 |
| |
| QA130507 | Aminolevulinic Acid Impurity 7
CAS# NA
M.F.: C15H18N2O7
M.W.: 338.32 |
| |
| QA130506 | Aminolevulinic Acid Impurity 6
CAS# 56766-77-9
M.F.: C6H10O4
M.W.: 146.14 |
| |
| QA130505 | Aminolevulinic Acid Impurity 5
CAS# NA
M.F.: C10H16N2O5
M.W.: 244.25 |
| |
| QV011233 | Valproic acid-d15
CAS# 362049-65-8
M.F.: C8HD15O2
M.W.: 159.31 |
| |
| QI191659 | Isoproterenol Impurity 59
CAS# NA
M.F.: C11H11NO3
M.W.: 205.21 |
| |
| QC031616 | Cefcapene pivoxil Impurity 16
CAS# 118109-49-2
M.F.: C8H10N2O2S
M.W.: 198.24 |
| |
| QC031615 | Cefcapene pivoxil Impurity 15
CAS# 159860-40-9
M.F.: C13H18N2O4S
M.W.: 298.36 |
| |
| QP092711 | Pinaverium Bromide Impurity 11
CAS# NA
M.F.: C26H41Br2NO4
M.W.: 591.43 |
| |
| QC042042 | Cefditoren pivoxil Impurity 42
CAS# NA
M.F.: C31H40N6O10S3
M.W.: 752.87 |
| |
| QP181924 | Prasugrel Impurity X
CAS# 1373350-57-2
M.F.: C11H11Br2FO
M.W.: 338.01 |
| |
| QD098200 | Diffractaic acid
CAS# 436-32-8
M.F.: C20H22O7
M.W.: 374.39 |
| |
| QB052522 | Benzylpenicillin sodium Impurity 22
CAS# NA
M.F.: C32H36N4O8S2
M.W.: 668.78 |
| |
| QB053218 | Beraprost Impurity 18
CAS# 132203-90-8
M.F.: C17H22O5
M.W.: 306.36 |
| |
| QV3077122 | Vitamin K1 Impurity 122
CAS# NA
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QV3077121 | Vitamin K1 Impurity 121
CAS# NA
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QV3077120 | Vitamin K1 Impurity 120
CAS# NA
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QV3077119 | Vitamin K1 Impurity 119
CAS# 132487-93-5
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QV3077118 | Vitamin K1 Impurity 118
CAS# 132487-94-6
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QV3077117 | Vitamin K1 Impurity 117
CAS# 132487-95-7
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QB011534 | Baloxavir Impurity 34
CAS# NA
M.F.: C27H23F2N3O7S
M.W.: 571.55 |
| |
| QO240114 | Oxacillin sodium Impurity 14
CAS# NA
M.F.: C19H19N3O5S
M.W.: 401.44 |
| |
| QF052004 | Fenticonazole nitrate EP Impurity D
CAS# NA
M.F.: C24H21Cl2N3O4S
M.W.: 518.41 |
| |
| QM182502 | Maropitant Citrate Impurity 2
CAS# NA
M.F.: C32H40N2O
M.W.: 468.69 |
| |
| QP090334 | Sodium Picosulfate Impurity 34
CAS# 2563-78-2
M.F.: C12H10N2O2
M.W.: 214.22 |
| |
| QV3077115 | Vitamin K1 Impurity 115
CAS# 1637238-61-9
M.F.: C20H39Br
M.W.: 359.44 |
| |
| QV3077114 | Vitamin K1 Impurity 114
CAS# NA
M.F.: C21H20O2
M.W.: 304.39 |
| |
| QV3077113 | Vitamin K1 Impurity 113
CAS# 108977-34-0
M.F.: C20H18O2
M.W.: 290.36 |
| |
| QV3077112 | Vitamin K1 Impurity 112
CAS# 943232-38-0
M.F.: C20H39Br
M.W.: 359.44 |
| |
| QB051332 | Bempedoic acid Impurity 5-d4
CAS# 2408132-01-2
M.F.: C19H30D4O5
M.W.: 346.50 |
| |
| QC016600 | Carotegrast methyl
CAS# 401905-67-7
M.F.: C28H26Cl2N4O5
M.W.: 569.44 |
| |
| QB051331 | Bempedoic acid-d4
CAS# 2408131-70-2
M.F.: C19H32D4O5
M.W.: 348.52 |
| |
| QT031892 | Vitamin E Impurity 92
CAS# NA
M.F.: C31H52O3
M.W.: 472.75 |
| |
| QM050107 | Metamizole sodium Impurity 7
CAS# NA
M.F.: C13H17N3O7S2
M.W.: 391.41 |
| |
| QO022034 | Obeticholic Acid Impurity 34
CAS# 1516887-34-5
M.F.: C26H40O4
M.W.: 416.60 |
| |
| QP181265 | Prucalopride Impurity 65
CAS# NA
M.F.: C16H14Cl2N2O6
M.W.: 401.20 |
| |
| QT180508 | Trametinib Impurity 8
CAS# 871701-87-0
M.F.: C24H21FIN5O3
M.W.: 573.37 |
| |
| QC131434 | Cefminox Sodium Impurity 34
CAS# NA
M.F.: C12H12Cl2N6O4S2
M.W.: 439.29 |
| |
| QV3077111 | Vitamin B6 Impurity 111
CAS# 765235-25-4
M.F.: C10H15NO3
M.W.: 197.23 |
| |
| QO200910 | Otilonium Bromide Impurity 10
CAS# NA
M.F.: C33H51BrN2O4
M.W.: 619.69 |
| |
| QO200909 | Otilonium Bromide Impurity 9
CAS# NA
M.F.: C32H49BrN2O4
M.W.: 605.66 |
| |
| QO200908 | Otilonium Bromide Impurity 8
CAS# NA
M.F.: C31H47BrN2O4
M.W.: 591.63 |
| |
| QO200907 | Otilonium Bromide Impurity 7
CAS# NA
M.F.: C30H45BrN2O4
M.W.: 577.60 |
| |
| QO200906 | Otilonium Bromide Impurity 6
CAS# 49557-33-7
M.F.: C28H41BrN2O4
M.W.: 549.55 |
| |
| QO200905 | Otilonium Bromide Impurity 5
CAS# NA
M.F.: C27H39BrN2O4
M.W.: 535.52 |
| |
| QO200904 | Otilonium Bromide Impurity 4
CAS# NA
M.F.: C26H37BrN2O4
M.W.: 521.50 |
| |
| QO200903 | Otilonium Bromide Impurity 3
CAS# NA
M.F.: C25H35BrN2O4
M.W.: 507.47 |
| |
| QO200902 | Otilonium Bromide Impurity 2
CAS# 27830-12-2
M.F.: C15H22O3
M.W.: 250.34 |
| |
| QO200901 | Otilonium Bromide Impurity 1
CAS# 51444-79-2
M.F.: C22H27NO4
M.W.: 369.46 |
| |
| QE191827 | Estradiol Enantate
CAS# 4956-37-0
M.F.: C25H36O3
M.W.: 384.56 |
| |
| QF120606 | Flomoxef Impurity 6
CAS# NA
M.F.: C27H30F4N8O13S3
M.W.: 846.75 |
| |
| QA132457 | Amoxicillin Impurity 57
CAS# NA
M.F.: C15H21N3O4S
M.W.: 339.41 |
| |
| QO032808 | Octreotide EP Impurity I;N2.1-acetyloctreotide
CAS# NA
M.F.: C51H68N10O11S2
M.W.: 1061.28 |
| |
| QI242625 | MLN-9708
CAS# 1201902-80-8
M.F.: C20H23BCl2N2O9
M.W.: 517.12 |
| |
| QB011529 | Baloxavir Impurity 29
CAS# NA
M.F.: C26H19F2N3O8S
M.W.: 571.51 |
| |
| QB031811 | Bromocriptine mesilate Impurity 11
CAS# NA
M.F.: C33H42BrN5O5
M.W.: 668.63 |
| |
| QB031810 | Bromocriptine mesilate Impurity 10
CAS# NA
M.F.: C64H79BrN10O10
M.W.: 1228.30 |
| |
| QB031809 | Bromocriptine mesilate Impurity 9
CAS# NA
M.F.: C32H40ClN5O5
M.W.: 610.15 |
| |
| QS0102133 | Salbutamol Impurity 133
CAS# NA
M.F.: C9H7BrO3
M.W.: 243.06 |
| |
| QD053702 | anti-Dechlorane Plus
CAS# 135821-74-8
M.F.: C18H12Cl12
M.W.: 653.69 |
| |
| QD053701 | syn-Dechlorane Plus
CAS# 135821-03-3
M.F.: C18H12Cl12
M.W.: 653.69 |
| |
| QD053700 | Dechlorane Plus
CAS# 13560-89-9
M.F.: C18H12Cl12
M.W.: 653.69 |
| |
| QC121924 | Cilastatin EP Impurity G(epimer 2)
CAS# NA
M.F.: C16H26N2O5S
M.W.: 358.45 |
| |
| QG040501 | Gadobenate Dimeglumine Impurity 1
CAS# NA
M.F.: C12H19N3O7
M.W.: 317.30 |
| |
| QF132047 | Formoterol Impurity 47
CAS# 871266-45-4
M.F.: C15H12ClNO4
M.W.: 305.71 |
| |
| QC191701 | Cisplatin EP Impurity A
CAS# 14913-33-8
M.F.: Cl2H6N2Pt
M.W.: 300.05 |
| |
| QD151915 | Calcium Dobesilate Impurity 15
CAS# 609-46-1
M.F.: C6H6O4S
M.W.: 174.17 |
| |
| QD151914 | Calcium Dobesilate Impurity 14
CAS# 35857-70-6;2446301-91-1(diethylamine salt)
M.F.: C6H6O5S
M.W.: 190.17 |
| |
| QD151913 | Calcium Dobesilate Impurity 13
CAS# 17724-11-7;2446301-90-0(Bis-diethylamine salt)
M.F.: C6H6O8S2
M.W.: 270.23 |
| |
| QD151912 | Calcium Dobesilate Impurity 12
CAS# 81010-88-0
M.F.: C6H6O8S2
M.W.: 270.23 |
| |
| QH150920 | Hyoscine Butylbromide Impurity 20
CAS# NA
M.F.: C12H22BrNO2
M.W.: 292.22 |
| |
| QA164192 | Avanafil Impurity 92
CAS# NA
M.F.: C23H30ClN5O4
M.W.: 475.97 |
| |
| QC042041 | Cefditoren pivoxil Impurity 41
CAS# NA
M.F.: C31H38N6O9S3
M.W.: 734.86 |
| |
| QC042040 | Cefditoren pivoxil Impurity 40
CAS# NA
M.F.: C31H40N6O10S3
M.W.: 752.87 |
| |
| QC042039 | Cefditoren pivoxil Impurity 39
CAS# NA
M.F.: C50H56N12O14S6
M.W.: 1241.43 |
| |
| QC042038 | Cefditoren pivoxil Impurity 38
CAS# NA
M.F.: C25H28N6O7S3
M.W.: 620.71 |
| |
| QG042422 | Gadoxetate Disodium Impurity 22
CAS# NA
M.F.: C41H69N3O11
M.W.: 780.01 |
| |
| QG042421 | Gadoxetate Disodium Impurity 21
CAS# NA
M.F.: C37H63N3O9
M.W.: 693.92 |
| |
| QG042420 | Gadoxetate Disodium Impurity 20
CAS# NA
M.F.: C27H41N3O11
M.W.: 583.64 |
| |
| QA201627 | Nortropinone
CAS# 5632-84-8
M.F.: C7H11NO
M.W.: 125.17 |
| |
| QV3077110 | Vitamin K1 Impurity 110
CAS# 85761-30-4
M.F.: C20H42O
M.W.: 298.56 |
| |
| QV3077109 | Vitamin K1 Impurity 109
CAS# 29171-23-1
M.F.: C20H38O
M.W.: 294.52 |
| |
| QV3077108 | Vitamin K1 Impurity 108
CAS# NA
M.F.: C31H50O2
M.W.: 454.74 |
| |
| QV3077107 | Vitamin K1 Impurity 107
CAS# 859974-92-8
M.F.: C19H38O
M.W.: 282.51 |
| |
| QI142508 | Indocyanine Green Impurity 8
CAS# NA
M.F.: C43H48N2O7S2
M.W.: 768.98 |
| |
| QI142507 | Indocyanine Green Impurity 7
CAS# NA
M.F.: C13H13NO2
M.W.: 215.25 |
| |
| QE161255 | Epalrestat Impurity 55
CAS# 149789-77-5
M.F.: C6H7NO3S2
M.W.: 205.25 |
| |
| QS012601 | Salvianolic acid Y
CAS# 1638738-76-7
M.F.: C36H30O16
M.W.: 718.62 |
| |
| QP186000 | Prednienic acid
CAS# 37927-29-0
M.F.: C20H26O5
M.W.: 346.42 |
| |
| QT151235 | Tolvaptan Impurity 35
CAS# NA
M.F.: C18H18N2O2
M.W.: 294.35 |
| |
| QT151225 | Tolvaptan Impurity 25
CAS# 54620-98-3
M.F.: C20H21NO5S
M.W.: 387.45 |
| |
| QB152100 | alpha-Boswellic acid
CAS# 471-66-9
M.F.: C30H48O3
M.W.: 456.71 |
| |
| QD152612 | Deoxycholic Acid-d5
CAS# 52840-14-9
M.F.: C24H35D5O4
M.W.: 397.61 |
| |
| QE201006 | Ethacridine lactate monohydrate Impurity 6
CAS# NA
M.F.: C15H13N3O3.HCl
M.W.: 283.29 36.46 |
| |
| QE201005 | Ethacridine lactate monohydrate Impurity 5
CAS# 20304-69-2
M.F.: C15H11ClN2O3
M.W.: 302.71 |
| |
| QD151636 | Dopamine Impurity 36
CAS# 1519015-73-6
M.F.: C20H22N2O6
M.W.: 386.40 |
| |
| QR051264 | Relugolix Impurity 64
CAS# NA
M.F.: C23H19F2N3O5S
M.W.: 487.48 |
| |
| QP180522 | Prilocaine Impurity 22
CAS# 780037-66-3;677029-53-7(HCl salt)
M.F.: C15H22N2O
M.W.: 246.35 |
| |
| QP081854 | Phloroglucinol Impurity 54
CAS# NA
M.F.: C12H8O8
M.W.: 280.19 |
| |
| QG122728 | Glycopyrronium Bromide Impurity 28
CAS# 207856-85-7
M.F.: C18H25NO3
M.W.: 303.40 |
| |
| QP1903200 | Posaconazole Impurity 200
CAS# NA
M.F.: C13H20N2O3
M.W.: 252.31 |
| |
| QD030475 | Diclofenac sodium Impurity 75
CAS# 944251-06-3
M.F.: C14H11Cl2NO3
M.W.: 312.15 |
| |
| QG121505 | Glycocholic Acid Impurity 5
CAS# NA
M.F.: C30H50N2O7
M.W.: 550.74 |
| |
| QV3077106 | Vitamin K1 Impurity 106
CAS# 2211-27-0
M.F.: C13H12O3
M.W.: 216.24 |
| |
| QV3077105 | Vitamin K1 Impurity 105
CAS# 15448-59-6
M.F.: C11H8O3
M.W.: 188.18 |
| |
| QI091639 | Ipratropium Bromide Impurity 39
CAS# 259092-15-4
M.F.: C10H19NO
M.W.: 169.27 |
| |
| QF120374 | Folic Acid Impurity 74
CAS# NA
M.F.: C31H31N9O10
M.W.: 689.64 |
| |
| QF122924 | Fluocinolone acetonide Impurity 24
CAS# NA
M.F.: C19H22F2O4
M.W.: 352.38 |
| |
| QF122923 | Fluocinolone acetonide Impurity 23
CAS# NA
M.F.: C24H28F2O6
M.W.: 450.48 |
| |
| QB054400 | Betulonic acid
CAS# 4481-62-3
M.F.: C30H46O3
M.W.: 454.70 |
| |
| QN090500 | Nifekalant hydrochloride
CAS# 130656-51-8
M.F.: C19H27N5O5.HCl
M.W.: 405.46 36.46 |
| |
| QD030474 | Diclofenac sodium Impurity 74
CAS# NA
M.F.: C14H12Cl3N
M.W.: 300.61 |
| |
| QC061871 | Cefuroxime sodium Impurity 71
CAS# NA
M.F.: C14H13N3O7S
M.W.: 367.33 |
| |
| QD030473 | Diclofenac sodium Impurity 73
CAS# NA
M.F.: C14H12Cl3N
M.W.: 300.61 |
| |
| QC182711 | Sodium Cromoglicate Impurity 11
CAS# 16130-28-2
M.F.: C11H12O4
M.W.: 208.21 |
| |
| QL051516 | Calcium levofolinate Impurity 16
CAS# NA
M.F.: C20H25CaN7O6
M.W.: 499.54 |
| |
| QI190902 | Taurolithocholic acid
CAS# 516-90-5
M.F.: C26H45NO5S
M.W.: 483.71 |
| |
| QI190901 | Tauroursodeoxycholic Acid Impurity 4
CAS# 75808-01-4
M.F.: C26H43NO6S
M.W.: 497.69 |
| |
| QD0207103 | Dabigatran Etexilate Impurity 103
CAS# NA
M.F.: C41H53N7O7
M.W.: 755.92 |
| |
| QG120600 | Glatiramer acetate
CAS# 147245-92-9
M.F.: C25H45N5O13
M.W.: 623.66 |
| |
| QC182710 | Sodium Cromoglicate Impurity 10
CAS# 3361-18-0
M.F.: C11H14O5
M.W.: 226.23 |
| |
| QC182709 | Sodium Cromoglicate Impurity 9
CAS# 50521-64-7
M.F.: C12H10O5
M.W.: 234.21 |
| |
| QD092500 | Dihydrostreptomycin sulfate
CAS# 5490-27-7;128-46-1(free base)
M.F.: 2(C21H41N7O12).3(H2SO4)
M.W.: 2(583.60) 3(98.07) |
| |
| QA161889 | Aprepitant Impurity 89
CAS# NA
M.F.: C10H8F6O
M.W.: 258.16 |
| |
| QR182476 | Brexpiprazole Impurity 76
CAS# 2126178-13-8
M.F.: C20H18N2S2
M.W.: 350.50 |
| |
| QH091901 | Histamine Diphosphate
CAS# 51-74-1
M.F.: C5H9N3.2H3O4P
M.W.: 111.15 195.99 |
| |
| QI141400 | Inosinic acid
CAS# 131-99-7
M.F.: C10H13N4O8P
M.W.: 348.21 |
| |
| QC061915 | Ceftaroline Fosamil Impurity O
CAS# NA
M.F.: C22H20N8O5S4
M.W.: 604.69 |
| |
| QL252900 | LY-2940094 tartrate
CAS# 1307245-87-9
M.F.: C22H23ClF2N4O2S.C4H6O6
M.W.: 480.96 150.09 |
| |
| QC220900 | Cevidoplenib dimesylate
CAS# 2043659-93-2
M.F.: C25H27N7O3.2CH4O3S
M.W.: 473.54 192.20 |
| |
| QD095000 | Didemnin B
CAS# 77327-05-0
M.F.: C57H89N7O15
M.W.: 1112.37 |
| |
| QN221700 | NVR 3-778
CAS# 1445790-55-5
M.F.: C18H16F4N2O4S
M.W.: 432.39 |
| |
| QB181800 | Brr2 Inhibitor C9
CAS# 2104030-82-0
M.F.: C24H20N4O3S
M.W.: 444.51 |
| |
| QG141800 | GnRH antagonist 2
CAS# 1709823-61-9
M.F.: C28H27F2N9O5
M.W.: 607.58 |
| |
| QS203100 | STING inhibitor-2
CAS# 2249435-90-1
M.F.: C25H19FN2O4S
M.W.: 462.50 |
| |
| QC182708 | Sodium Cromoglicate Impurity 8
CAS# NA
M.F.: C19H16O9
M.W.: 388.33 |
| |
| QC182707 | Sodium Cromoglicate Impurity 7
CAS# NA
M.F.: C20H16O10
M.W.: 416.34 |
| |
| QC182706 | Sodium Cromoglicate Impurity 6
CAS# 802857-44-9
M.F.: C13H12O7
M.W.: 280.23 |
| |
| QA141900 | Ansamitocin P-3
CAS# 66584-72-3
M.F.: C32H43ClN2O9
M.W.: 635.15 |
| |
| QY021900 | Y-29794 Tosylate
CAS# 143984-17-2
M.F.: C23H34N2OS2.C7H8O3S
M.W.: 418.66 172.20 |
| |
| QO241100 | 3-Oxo-4,6-choladien-24-oic acid
CAS# 88179-71-9
M.F.: C24H34O3
M.W.: 370.53 |
| |
| QI200200 | IT1t Dihydrochloride
CAS# 1092776-63-0
M.F.: C21H34N4S2.2HCl
M.W.: 406.65 72.92 |
| |
| QG141101 | Ginkgolide B
CAS# 15291-77-7
M.F.: C20H24O10
M.W.: 424.40 |
| |
| QD010600 | DAF-2 DA
CAS# 205391-02-2
M.F.: C24H18N2O7
M.W.: 446.42 |
| |
| QA124300 | Alvespimycin Hydrochloride
CAS# 467214-21-7
M.F.: C32H48N4O8.HCl
M.W.: 616.76 36.46 |
| |
| QA122100 | Allura Red AC
CAS# 25956-17-6
M.F.: C18H14N2Na2O8S2
M.W.: 496.42 |
| |
| QF120373 | Folic Acid Nitroso Impurity 1
CAS# 26360-21-4
M.F.: C19H18N8O7
M.W.: 470.40 |
| |
| QE081800 | EGFR inhibitor
CAS# 879127-07-8
M.F.: C21H18F3N5O
M.W.: 413.40 |
| |
| QA133600 | AMI-1 Disodium Salt
CAS# 20324-87-2
M.F.: C21H14N2Na2O9S2
M.W.: 548.45 |
| |
| QM191000 | Maslinic Acid
CAS# 4373-41-5
M.F.: C30H48O4
M.W.: 472.71 |
| |
| QA121100 | ALK/IGF1R inhibitor
CAS# 1356962-20-3
M.F.: C24H25ClN6O
M.W.: 448.96 |
| |
| QB180400 | BRD4 Inhibitor-10
CAS# 1660117-38-3
M.F.: C25H27N5O2
M.W.: 429.52 |
| |
| QN093300 | Nicotinamide Riboside
CAS# 1341-23-7
M.F.: C11H15N2O5+
M.W.: 255.25 |
| |
| QY030900 | Y-39983 Hydrochloride
CAS# 471843-75-1
M.F.: C16H16N4O.HCl
M.W.: 280.33 36.46 |
| |
| QA133500 | AMG 487
CAS# 473719-41-4
M.F.: C32H28F3N5O4
M.W.: 603.60 |
| |
| QV3077102 | Vitamin B6 Impurity 102
CAS# 524-07-2
M.F.: C8H9NO4
M.W.: 183.16 |
| |
| QV3077101 | Vitamin B6 Impurity 101
CAS# NA
M.F.: C16H20N2O5
M.W.: 320.35 |
| |
| QZ121629 | Zolpidem tartrate Impurity 29
CAS# 14547-80-9
M.F.: C13H12N2O
M.W.: 212.25 |
| |
| QZ121628 | Zolpidem tartrate Impurity 28
CAS# 20972-36-5
M.F.: C11H10O3
M.W.: 190.20 |
| |
| QP190500 | Pseudovitamin B12
CAS# 13408-75-8
M.F.: C59H83CoN17O14P
M.W.: 1344.33 |
| |
| QT031891 | Vitamin E Impurity 91
CAS# 86993-71-7
M.F.: C30H52O2
M.W.: 444.74 |
| |
| QM141400 | Menaquinone 4;Menatetrenone
CAS# 863-61-6
M.F.: C31H40O2
M.W.: 444.66 |
| |
| QL090649 | Lifitegrast Impurity 49
CAS# 166599-84-4
M.F.: C9H6O3
M.W.: 162.14 |
| |
| QP080512 | Phenytoin Sodium Impurity 12
CAS# NA
M.F.: C15H11N3O4
M.W.: 297.27 |
| |
| QM092212 | Mivacurium chloride Impurity 12
CAS# NA
M.F.: C28H42ClNO7
M.W.: 540.09 |
| |
| QM092211 | Mivacurium chloride Impurity 11
CAS# NA
M.F.: C23H30INO5
M.W.: 527.40 |
| |
| QM092210 | Mivacurium chloride Impurity 10
CAS# NA
M.F.: C21H25NO6
M.W.: 387.43 |
| |
| QE261243 | Enzalutamide Impurity 43
CAS# NA
M.F.: C9H3F3N2S
M.W.: 228.19 |
| |
| QB152001 | (+)-Bornyl acetate
CAS# 20347-65-3
M.F.: C12H20O2
M.W.: 196.29 |
| |
| QR027025 | Rifampicin Impurity 25
CAS# NA
M.F.: C44H60N4O12
M.W.: 836.98 |
| |
| QC080311 | Cholic Acid Impurity 11
CAS# 15073-99-1
M.F.: C26H44O5
M.W.: 436.63 |
| |
| QA122616 | Alprazolam USP Related Compound A
CAS# 28910-89-6
M.F.: C17H15ClN4O
M.W.: 326.78 |
| |
| QG131819 | Gimeracil Impurity 19
CAS# NA
M.F.: C7H4Cl2N2O2
M.W.: 219.02 |
| |
| QV041426 | Vardenafil Impurity 26
CAS# 1417529-67-9
M.F.: C17H18N4O4
M.W.: 342.36 |
| |
| QG010600 | Gadoterate Meglumine
CAS# 92943-93-6
M.F.: C16H25GdN4O8.C7H17NO5
M.W.: 558.65 195.22 |
| |
| QL011430 | Landiolol Impurity 30
CAS# NA
M.F.: C5H14N4O
M.W.: 146.19 |
| |
| QL011427 | Landiolol Impurity 27
CAS# NA
M.F.: C26H42N6O7
M.W.: 550.66 |
| |
| QL011422 | Landiolol Impurity 22
CAS# 69630-20-2
M.F.: C11H13NO3
M.W.: 207.23 |
| |
| QG121504 | Glycocholic Acid Impurity 4
CAS# 26563-58-6
M.F.: C28H46N2O7
M.W.: 522.68 |
| |
| QI032000 | Icotinib hydrochloride
CAS# 1204313-51-8
M.F.: C22H21N3O4.HCl
M.W.: 391.43 36.46 |
| |
| QL091683 | Lipoic Acid Impurity 83
CAS# NA
M.F.: C10H20N2OS2
M.W.: 248.40 |
| |
| QL091682 | Lipoic Acid Impurity 82
CAS# NA
M.F.: C10H20N2OS2
M.W.: 248.40 |
| |
| QS041922 | Sodium Valproate Impurity 22
CAS# 66546-92-7
M.F.: C10H17NO2
M.W.: 183.25 |
| |
| QS041921 | Sodium Valproate Impurity 21
CAS# 66546-91-6
M.F.: C9H15NO2
M.W.: 169.22 |
| |
| QR051258 | Relugolix Impurity 58
CAS# 2814571-37-2
M.F.: C29H26F2N6O5S
M.W.: 608.62 |
| |
| QB142900 | Benzalkonium chloride
CAS# 8001-54-5
M.F.: NA
M.W.: NA |
| |
| QC141201 | Controlled Substance
(delta(9)-Tetrahydrocannabinolic acid)
CAS# 23978-85-0
M.F.: C22H30O4
M.W.: 358.48 |
| |
| QB152101 | beta-Boswellic acid
CAS# 631-69-6
M.F.: C30H48O3
M.W.: 456.71 |
| |
| QD162010 | Daptomycin Impurity J
CAS# NA
M.F.: C74H107N17O27
M.W.: 1666.76 |
| |
| QN140448 | Nintedanib Impurity 48
CAS# 54699-92-2
M.F.: C7H14N2O2
M.W.: 158.20 |
| |
| QN140426 | Nintedanib Impurity 26
CAS# 708279-23-6
M.F.: C13H18N4O3
M.W.: 278.31 |
| |
| QA010301 | Arachidonic acid-d11
CAS# NA
M.F.: C20H21D11O2
M.W.: 315.54 |
| |
| QO130400 | Omadacycline tosylate
CAS# 1075240-43-5;389139-89-3(free base)
M.F.: C29H40N4O7.C7H8O3S
M.W.: 556.66 172.20 |
| |
| QC182704 | Sodium Cromoglicate Impurity 4
CAS# NA
M.F.: C36H26O17
M.W.: 730.59 |
| |
| QV3077100 | Vitamin K1 Chromenol
CAS# 34044-00-3
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QV307799 | Vitamin K1 Impurity 99
CAS# 16825-16-4
M.F.: C18H36O
M.W.: 268.49 |
| |
| QD094600 | DL-Dihydroorotic acid
CAS# 155-54-4
M.F.: C5H6N2O4
M.W.: 158.11 |
| |
| QA031608 | Acipimox Impurity 8
CAS# 1368358-42-2
M.F.: C6H4N2O3
M.W.: 152.11 |
| |
| QI040158 | Indacaterol Impurity 58
CAS# NA
M.F.: C29H30N2O3
M.W.: 454.57 |
| |
| QR152459 | Roxadustat Impurity 59
CAS# NA
M.F.: C20H18N2O4
M.W.: 350.37 |
| |
| QL012407 | Latamoxef Impurity 7
CAS# NA
M.F.: C41H38N6O10S
M.W.: 806.85 |
| |
| QI210675 | Ibuprofen Impurity 75
CAS# NA
M.F.: C12H15ClO
M.W.: 210.70 |
| |
| QG040274 | Gadobutrol Impurity 74
CAS# NA
M.F.: C16H26CaN4O8
M.W.: 442.48 |
| |
| QS075495 | Sugammadex Impurity 95
CAS# NA
M.F.: C48H72Br7ClO32
M.W.: 1755.85 |
| |
| QC132673 | Cefmetazole sodium Impurity 73
CAS# NA
M.F.: C24H22N2O5S2
M.W.: 482.57 |
| |
| QC132671 | Cefmetazole sodium Impurity 71
CAS# NA
M.F.: C24H22N6O3S3
M.W.: 538.66 |
| |
| QD152507 | Doxycycline hyclate Impurity 7
CAS# NA
M.F.: C22H24N2O9
M.W.: 460.44 |
| |
| QC132670 | Cefmetazole sodium Impurity 70
CAS# NA
M.F.: C24H24N2O6S
M.W.: 468.52 |
| |
| QF022498 | Febuxostat Impurity 98
CAS# 2428631-65-4
M.F.: C17H15N3O3S
M.W.: 341.39 |
| |
| QD030472 | Diclofenac sodium Impurity 72
CAS# NA
M.F.: C14H8Cl4NNaO2
M.W.: 387.01 |
| |
| QD030471 | Diclofenac sodium Impurity 71
CAS# NA
M.F.: C14H7Cl4NO
M.W.: 347.02 |
| |
| QA180254 | Arbidol Impurity 54
CAS# 39830-85-8
M.F.: C30H32N2O8
M.W.: 548.59 |
| |
| QI182081 | Ibrutinib Impurity 81
CAS# 109384-19-2
M.F.: C10H19NO3
M.W.: 201.27 |
| |
| QO132087 | Olmesartan Medoxomil Impurity 87
CAS# NA
M.F.: C53H54N12O8
M.W.: 987.09 |
| |
| QE161250 | Epalrestat Impurity 50
CAS# NA
M.F.: C11H13NO3S2
M.W.: 271.35 |
| |
| QT260428 | Trazodone hydrochloride Impurity 28
CAS# 23431-04-1
M.F.: C5H4N4O
M.W.: 136.11 |
| |
| QA130504 | Aminolevulinic Acid Impurity 4
CAS# 106-65-0
M.F.: C6H10O4
M.W.: 146.14 |
| |
| QA130503 | Aminolevulinic Acid Impurity 3
CAS# 3878-55-5
M.F.: C5H8O4
M.W.: 132.12 |
| |
| QA163039 | Apremilast Impurity 39
CAS# 208774-55-4
M.F.: C10H11NO4
M.W.: 209.20 |
| |
| QZ151215 | Zoledronic acid EP Impurity A
CAS# NA
M.F.: C7H12N2O9P2
M.W.: 330.13 |
| |
| QI091638 | Ipratropium Bromide Impurity 38
CAS# NA
M.F.: C19H18O6
M.W.: 342.35 |
| |
| QZ140102 | Zanamivir EP Impurity C
CAS# NA
M.F.: C11H18N2O7
M.W.: 290.27 |
| |
| QT180925 | Triamcinolone hexacetonide EP Impurity B
CAS# NA
M.F.: C29H39FO7
M.W.: 518.62 |
| |
| QC124100 | Calcium gluconate
CAS# 18016-24-5
M.F.: C12H22CaO14.H2O
M.W.: 430.37 18.02 |
| |
| QT152800 | all-rac-α-Tocopheryl acetate
CAS# 7695-91-2
M.F.: C31H52O3
M.W.: 472.75 |
| |
| QD141648 | Donepezil Benzyl Chloride
CAS# 937362-16-8
M.F.: C31H36ClNO3
M.W.: 506.08 |
| |
| QM200513 | Methylene Blue Nitroso Impurity 1
CAS# NA
M.F.: C12H7N3O2S
M.W.: 257.27 |
| |
| QM200512 | Methylene Blue Impurity 12
CAS# 1195557-65-3
M.F.: C12H10IN
M.W.: 295.12 |
| |
| QM200511 | Methylene Blue Impurity 11
CAS# 2204245-78-1
M.F.: C12H9I2N
M.W.: 421.02 |
| |
| QM200510 | Leucomethylene Blue
CAS# 613-11-6
M.F.: C16H19N3S
M.W.: 285.41 |
| |
| QM200509 | Methylene Blue Impurity 9
CAS# 16078-95-8
M.F.: C12H11NS
M.W.: 201.29 |
| |
| QM200515 | Methylene Blue Impurity 15
CAS# 20255-70-3
M.F.: C12H9I2N
M.W.: 421.02 |
| |
| QM200514 | Methylene Blue Impurity 14
CAS# 61613-21-6
M.F.: C12H10IN
M.W.: 295.12 |
| |
| QT691544 | Testosterone Propionate EP Impurity E
CAS# NA
M.F.: C22H30O3
M.W.: 342.48 |
| |
| QT691543 | Testosterone Propionate EP Impurity D
CAS# NA
M.F.: C22H30O3
M.W.: 342.48 |
| |
| QT691539 | Testosterone Enantate EP Impurity H
CAS# NA
M.F.: C33H54O4
M.W.: 514.79 |
| |
| QT082103 | Terpin EP Impurity C;Limonene
CAS# 138-86-3
M.F.: C10H16
M.W.: 136.24 |
| |
| QT082100 | Terpin Monohydrate
CAS# 2451-01-6
M.F.: C10H20O2.H2O
M.W.: 172.27 18.02 |
| |
| QI041804 | Idarubicinone
CAS# 60660-75-5
M.F.: C20H16O7
M.W.: 368.34 |
| |
| QS210501 | Sulfacetamide sodium EP Impurity C
CAS# NA
M.F.: C10H12N2O4S
M.W.: 256.28 |
| |
| QS210500 | Sulfacetamide sodium monohydrate
CAS# 6209-17-2
M.F.: C8H9N2NaO3S.H2O
M.W.: 236.22 18.02 |
| |
| QS161603 | Spirapril EP Impurity D
CAS# NA
M.F.: C25H36N2O5S2
M.W.: 508.69 |
| |
| QE200394 | Entacapone Impurity 94
CAS# 80547-69-9
M.F.: C8H7NO5
M.W.: 197.15 |
| |
| QP032025 | Procaterol Impurity 25
CAS# NA
M.F.: C16H22N2O3
M.W.: 290.36 |
| |
| QP032024 | Procaterol Impurity 24
CAS# NA
M.F.: C16H22N2O2
M.W.: 274.36 |
| |
| QP032023 | Procaterol Impurity 23
CAS# NA
M.F.: C13H11Br2NO3
M.W.: 389.04 |
| |
| QF151405 | Fondaparinux Sodium Impurity 5
CAS# NA
M.F.: C32H42N3Na9O47S7
M.W.: 1651.99 |
| |
| QF151404 | Fondaparinux Sodium Impurity 4
CAS# NA
M.F.: C38H55N3Na10O49S8
M.W.: 1824.21 |
| |
| QF151403 | Fondaparinux Sodium Impurity 3
CAS# NA
M.F.: C32H44N3Na9O47S7
M.W.: 1654.01 |
| |
| QF151402 | Fondaparinux Sodium Impurity 2
CAS# NA
M.F.: C31H42N3Na11O52S9
M.W.: 1830.07 |
| |
| QF151401 | Fondaparinux Sodium Impurity 1
CAS# NA
M.F.: C31H44N3Na9O46S7
M.W.: 1626.00 |
| |
| QS0102121 | Salbutamol Impurity 121
CAS# 27566-09-2
M.F.: C14H21NO4
M.W.: 267.33 |
| |
| QS150404 | Alendronic acid
CAS# 66376-36-1
M.F.: C4H13NO7P2
M.W.: 249.10 |
| |
| QS0102119 | Salbutamol Impurity 119
CAS# 29754-58-3
M.F.: C10H10O6
M.W.: 226.18 |
| |
| QG042419 | Gadoxetate Disodium Impurity 19
CAS# NA
M.F.: C30H44N4O5
M.W.: 540.71 |
| |
| QG042418 | Gadoxetate Disodium Impurity 18
CAS# NA
M.F.: C13H22N2O2.2HCl
M.W.: 238.33 72.92 |
| |
| QG042417 | Gadoxetate Disodium Impurity 17
CAS# NA
M.F.: C18H23NO4S
M.W.: 349.45 |
| |
| QR122008 | Raltegravir potassium EP Impurity H
CAS# NA
M.F.: C34H36F2N8O8
M.W.: 722.71 |
| |
| QE160505 | Eperisone Impurity 5
CAS# 27465-51-6
M.F.: C11H14O
M.W.: 162.23 |
| |
| QP150707 | Proguanil hydrochloride EP Impurity G
CAS# NA
M.F.: C11H16ClN5
M.W.: 253.73 |
| |
| QP150706 | Proguanil hydrochloride EP Impurity F
CAS# NA
M.F.: C11H15Cl2N5
M.W.: 288.18 |
| |
| QP150705 | Proguanil hydrochloride EP Impurity E
CAS# NA
M.F.: C8H7ClN4
M.W.: 194.62 |
| |
| QP150303 | Prochlorperazine Maleate EP Impurity C
CAS# 1346602-34-3
M.F.: C20H24ClN3S
M.W.: 373.94 |
| |
| QP150302 | Prochlorperazine Maleate EP Impurity B;
Perazine
CAS# 84-97-9;14516-56-4(dimaleate)
M.F.: C20H25N3S
M.W.: 339.50 |
| |
| QP150301 | Prochlorperazine Maleate EP Impurity A
CAS# 10078-27-0
M.F.: C20H24ClN3OS
M.W.: 389.94 |
| |
| QP092104 | Primaquine Diphosphate EP Impurity D
CAS# NA
M.F.: C23H23N3O3
M.W.: 389.46 |
| |
| QP092103 | Primaquine Diphosphate EP Impurity C
CAS# 90-52-8
M.F.: C10H10N2O
M.W.: 174.20 |
| |
| QP092102 | Primaquine Diphosphate EP Impurity B
CAS# 85-81-4
M.F.: C10H8N2O3
M.W.: 204.19 |
| |
| QP092101 | Primaquine Diphosphate EP Impurity A;Quinocide
CAS# 525-61-1
M.F.: C15H21N3O
M.W.: 259.35 |
| |
| QE192902 | Estradiol Cypionate Impurity 2
CAS# NA
M.F.: C27H38O3
M.W.: 410.60 |
| |
| QE192901 | Estradiol Cypionate Impurity 1
CAS# NA
M.F.: C26H34O3
M.W.: 394.56 |
| |
| QE192900 | Estradiol Cypionate
CAS# 313-06-4
M.F.: C26H36O3
M.W.: 396.57 |
| |
| QT131214 | Timolol Maleate Impurity 14
CAS# NA
M.F.: C6H9N3O3S
M.W.: 203.22 |
| |
| QC181722 | Crotamiton Impurity 22
CAS# NA
M.F.: C13H18ClNO
M.W.: 239.74 |
| |
| QP081305 | Phentolamine Mesylate Impurity 5
CAS# NA
M.F.: C21H25N5O
M.W.: 363.47 |
| |
| QR152453 | Roxadustat Impurity 53
CAS# 39987-25-2
M.F.: C6H11NO4.HCl
M.W.: 161.16 36.46 |
| |
| QI192285 | Isavuconazole Impurity 85
CAS# NA
M.F.: C35H36F2N8O9S2
M.W.: 814.84 |
| |
| QT260426 | Trazodone hydrochloride Impurity Z
CAS# 2727463-29-6
M.F.: C40H46Cl2N10O2
M.W.: 769.78 |
| |
| QI152300 | Iothalamic acid
CAS# 2276-90-6
M.F.: C11H9I3N2O4
M.W.: 613.92 |
| |
| QA163020 | Apremilast Impurity 20
CAS# 113579-20-7
M.F.: C9H9NO4
M.W.: 195.17 |
| |
| QC130426 | Cefamandole Impurity 26
CAS# NA
M.F.: C18H17ClN6O4S2
M.W.: 480.94 |
| |
| QC130425 | Cefamandole Impurity 25
CAS# NA
M.F.: C27H26N8O9S3
M.W.: 702.73 |
| |
| QA161912 | Acetylsalicylic Acid Impurity 12
CAS# NA
M.F.: C14H13N3O4
M.W.: 287.28 |
| |
| QA161911 | Acetylsalicylic Acid Impurity 11
CAS# NA
M.F.: C14H12N2O5
M.W.: 288.26 |
| |
| QR021660 | Rabeprazole Impurity 60
CAS# NA
M.F.: C14H12ClN3OS
M.W.: 305.78 |
| |
| QO240113 | Oxacillin sodium Impurity 13
CAS# NA
M.F.: C19H20N4O6S
M.W.: 432.45 |
| |
| QC153700 | Combretastatin A4 Phosphate Disodium Salt
CAS# 168555-66-6
M.F.: C18H19Na2O8P
M.W.: 440.30 |
| |
| QC042433 | Cefadroxil Impurity 33
CAS# NA
M.F.: C48H48N8O14S2
M.W.: 1025.07 |
| |
| QB212539 | Butylphthalide Impurity 39
CAS# 72917-31-8
M.F.: C12H12O2
M.W.: 188.23 |
| |
| QA120744 | Alogliptin Impurity 44
CAS# 2749357-07-9
M.F.: C12H8ClN3O2
M.W.: 261.67 |
| |
| QC081341 | Calcitriol Impurity 41
CAS# NA
M.F.: C39H70O4Si2
M.W.: 659.16 |
| |
| QA132617 | Amorolfine Impurity 17
CAS# 67467-96-3
M.F.: C15H22O
M.W.: 218.34 |
| |
| QP092710 | Pinaverium Bromide Impurity 10
CAS# NA
M.F.: C15H22BrCl2NO3
M.W.: 415.15 |
| |
| QC181954 | Crisaborole Impurity 54
CAS# NA
M.F.: C16H16BrNO3
M.W.: 350.21 |
| |
| QI191651 | Isoproterenol Impurity 51
CAS# 28177-45-9
M.F.: C11H17NO5S
M.W.: 275.32 |
| |
| QC182703 | Sodium Cromoglicate Impurity 3
CAS# NA
M.F.: C45H30O20
M.W.: 890.72 |
| |
| QP160475 | Paliperidone Impurity 75
CAS# 1071864-06-6
M.F.: C30H31FN4O4
M.W.: 530.60 |
| |
| QA130311 | Aminocaproic acid Impurity K
CAS# 56403-09-9
M.F.: C12H22N2O2
M.W.: 226.32 |
| |
| QA130310 | Aminocaproic acid Impurity J
CAS# 19837-09-3
M.F.: C12H22N2O2
M.W.: 226.32 |
| |
| QA130309 | Aminocaproic acid Impurity I
CAS# 371-34-6
M.F.: C8H17NO2
M.W.: 159.23 |
| |
| QM041851 | Minodronic Acid Impurity 51
CAS# NA
M.F.: C9H11N2O4P
M.W.: 242.17 |
| |
| QM041850 | Minodronic Acid Impurity 50
CAS# NA
M.F.: C9H11ClN2O6P2
M.W.: 340.59 |
| |
| QT120231 | Tulobuterol Impurity 31
CAS# NA
M.F.: C28H48ClNO3
M.W.: 482.15 |
| |
| QL091681 | Lipoic Acid Impurity 81
CAS# NA
M.F.: C24H42O6S6
M.W.: 618.95 |
| |
| QU130506 | Umeclidinium bromide Nitroso Impurity 1
CAS# 1038-06-8
M.F.: C18H20N2O2
M.W.: 296.37 |
| |
| QC042036 | Cefditoren Pivoxil-13C-d3
CAS# NA
M.F.: C2413CH25D3N6O7S3
M.W.: 624.72 |
| |
| QC042035 | Cefditoren pivoxil Impurity 35
CAS# NA
M.F.: C51H59N13O14S6
M.W.: 1270.47 |
| |
| QM201600 | Mitoquinone
CAS# 444890-41-9
M.F.: C37H44O4P+
M.W.: 583.73 |
| |
| QG040500 | Gadobenate Dimeglumine
CAS# 127000-20-8
M.F.: C36H62GdN5O21
M.W.: 1058.16 |
| |
| QC061900 | Ceftaroline fosamil acetate
CAS# 400827-46-5
M.F.: C24H25N8O10PS4
M.W.: 744.72 |
| |
| QT120223 | Tulobuterol Impurity 23
CAS# NA
M.F.: C14H20ClNO2
M.W.: 269.77 |
| |
| QE160946 | Epinastine Impurity 46
CAS# NA
M.F.: C13H13N3
M.W.: 211.27 |
| |
| QV200108 | Vitamin A palmitate
CAS# 79-81-2
M.F.: C36H60O2
M.W.: 524.87 |
| |
| QL220340 | Levocarnitine propionate hydrochloride
CAS# 119793-66-7
M.F.: C10H20ClNO4
M.W.: 253.72 |
| |
| QV307798 | Dihydro Vitamin K1
CAS# 572-96-3
M.F.: C31H48O2
M.W.: 452.72 |
| |
| QL210901 | Lucidenic acid A
CAS# 95311-94-7
M.F.: C27H38O6
M.W.: 458.60 |
| |
| QG011404 | Ganoderic Acid G
CAS# 98665-22-6
M.F.: C30H44O8
M.W.: 532.67 |
| |
| QG011403 | Ganoderic Acid C2
CAS# 103773-62-2
M.F.: C30H46O7
M.W.: 518.69 |
| |
| QA010736 | Alanyl Glutamine Impurity 36
CAS# 2680610-96-0
M.F.: C8H12N2O4
M.W.: 200.19 |
| |
| QI142104 | Insulin degludec Impurity 4
CAS# NA
M.F.: C25H38N2O8
M.W.: 494.59 |
| |
| QI142103 | Insulin degludec Impurity 3
CAS# NA
M.F.: C29H48N2O9
M.W.: 568.71 |
| |
| QI142102 | Insulin degludec Impurity 2
CAS# NA
M.F.: C21H35NO6
M.W.: 397.51 |
| |
| QI142101 | Insulin degludec Impurity 1
CAS# NA
M.F.: C21H37NO7
M.W.: 415.53 |
| |
| QM050106 | Metamizole sodium Nitroso Impurity 1
CAS# NA
M.F.: C10H8N4O3
M.W.: 232.20 |
| |
| QN091242 | Nilotinib Impurity 42
CAS# 641571-06-4
M.F.: C11H10F3N3
M.W.: 241.22 |
| |
| QV071209 | Voglibose Impurity 9
CAS# NA
M.F.: C10H21NO7
M.W.: 267.28 |
| |
| QP092709 | Pinaverium Bromide Impurity 9
CAS# NA
M.F.: C15H22Br2ClNO3
M.W.: 459.60 |
| |
| QP092708 | Pinaverium Bromide Impurity 8
CAS# NA
M.F.: C15H23Br2NO4
M.W.: 441.16 |
| |
| QD151911 | Calcium Dobesilate Impurity 11
CAS# NA
M.F.: C8H8O5S
M.W.: 216.21 |
| |
| QB201345 | Betamethasone Impurity 45
CAS# 1202001-99-7;1201919-11-0(2Na salt)
M.F.: C22H30FO8P
M.W.: 472.45 |
| |
| QC0303136 | Cinacalcet Impurity 136
CAS# NA
M.F.: C22H22F3N
M.W.: 357.42 |
| |
| QE121200 | Ellagic acid
CAS# 476-66-4
M.F.: C14H6O8
M.W.: 302.19 |
| |
| QC192053 | Candesartan Cilexetil Impurity 53
CAS# NA
M.F.: C10H9NO6
M.W.: 239.18 |
| |
| QC192052 | Candesartan Cilexetil Impurity 52
CAS# NA
M.F.: C14H18N2O6
M.W.: 310.31 |
| |
| QM191400 | Masitinib mesylate
CAS# 1048007-93-7;790299-79-5(free base)
M.F.: C28H30N6OS.CH4O3S
M.W.: 498.65 96.10 |
| |
| QF120806 | Flecainide acetate Nitroso Impurity 1
CAS# NA
M.F.: C17H18F6N4O5
M.W.: 472.34 |
| |
| QF061322 | Fosfomycin Trometamol Impurity 22
CAS# NA
M.F.: C7H17O5P
M.W.: 212.18 |
| |
| QF061321 | Fosfomycin Trometamol Impurity 21
CAS# NA
M.F.: C5H13O5P
M.W.: 184.13 |
| |
| QC192051 | Candesartan Cilexetil Impurity 51
CAS# 62351-79-5
M.F.: C12H13NO6
M.W.: 267.24 |
| |
| QT201628 | Tiotropium bromide Impurity 28
CAS# NA
M.F.: C18H19NO4S2
M.W.: 377.47 |
| |
| QK201846 | Ketorolac Impurity 46
CAS# 144710-35-0
M.F.: C18H19NO5
M.W.: 329.35 |
| |
| QF022496 | Febuxostat Impurity 96
CAS# NA
M.F.: C29H26N2O8S2
M.W.: 594.65 |
| |
| QA131263 | Amlodipine Impurity 63
CAS# NA
M.F.: C32H45ClN2O15
M.W.: 733.16 |
| |
| QP050312 | Penicillamine Impurity 12
CAS# NA
M.F.: C8H15N3O2S
M.W.: 217.29 |
| |
| QF120372 | Folic Acid Impurity 72
CAS# 1182291-60-6
M.F.: C7H7N5O3
M.W.: 209.17 |
| |
| QP090333 | Sodium Picosulfate Impurity 33
CAS# NA
M.F.: C24H27NO8S2
M.W.: 521.60 |
| |
| QT1406195 | Tenofovir Disoproxil Fumarate Impurity 195
CAS# NA
M.F.: C58H88N15O30P3
M.W.: 1568.34 |
| |
| QL091680 | Lipoic Acid Impurity 80
CAS# 120476-62-2
M.F.: C8H13ClO2
M.W.: 176.64 |
| |
| QL091679 | Lipoic Acid Impurity 79
CAS# NA
M.F.: C10H17ClO2
M.W.: 204.69 |
| |
| QS200793 | Sitagliptin Impurity 93
CAS# 1246961-45-4
M.F.: C19H26F3NO4
M.W.: 389.42 |
| |
| QM092209 | Mivacurium chloride Impurity 9
CAS# NA
M.F.: C25H36ClNO6
M.W.: 482.01 |
| |
| QC061444 | Cefdinir Impurity 44
CAS# NA
M.F.: C13H15N5O4S2
M.W.: 369.41 |
| |
| QC042034 | Cefditoren pivoxil Impurity 34
CAS# NA
M.F.: C50H56N12O14S6
M.W.: 1241.43 |
| |
| QF132044 | Formoterol Impurity 44
CAS# NA
M.F.: C14H19NO5
M.W.: 281.31 |
| |
| QT0603171 | Tofacitinib Impurity 171
CAS# NA
M.F.: C4H5N3O2
M.W.: 127.10 |
| |
| QF122123 | Fluorouracil Impurity 23
CAS# NA
M.F.: C5H6N2O3
M.W.: 142.11 |
| |
| QC151309 | Clomifene citrate EP Impurity GH
CAS# 1795130-17-4;1795130-18-5(citrate salt)
M.F.: C26H27Cl2NO
M.W.: 440.41 |
| |
| QC192050 | Candesartan Cilexetil Impurity 50
CAS# NA
M.F.: C10H8N2O5
M.W.: 236.18 |
| |
| QC192049 | Candesartan Cilexetil Impurity 49
CAS# NA
M.F.: C12H14N2O6
M.W.: 282.25 |
| |
| QL090635 | Lifitegrast Impurity 35
CAS# NA
M.F.: C29H26Cl2N2O9S
M.W.: 649.49 |
| |
| QP090332 | Sodium Picosulfate Impurity 32
CAS# NA
M.F.: C18H12NNa3O11S3
M.W.: 583.44 |
| |
| QP090331 | Sodium Picosulfate Impurity 31
CAS# 105745-58-2
M.F.: C18H15NO2
M.W.: 277.32 |
| |
| QP090330 | Sodium Picosulfate Impurity 30
CAS# NA
M.F.: C12H11NO2
M.W.: 201.23 |
| |
| QK201844 | Ketorolac Impurity 44
CAS# NA
M.F.: C15H12ClNO3
M.W.: 289.72 |
| |
| QG121914 | Granisetron Impurity 14
CAS# NA
M.F.: C18H24N4O2
M.W.: 328.42 |
| |
| QP180353 | Piperacillin Impurity 53
CAS# NA
M.F.: C23H29N5O8S
M.W.: 535.57 |
| |
| QI161600 | Iptacopan hydrochloride
CAS# 1646321-63-2
M.F.: C25H30N2O4.HCl
M.W.: 422.53 36.46 |
| |
| QL091678 | Lipoic Acid Impurity 78
CAS# NA
M.F.: C24H44O6S6
M.W.: 620.97 |
| |
| QL091677 | Lipoic Acid Impurity 77
CAS# NA
M.F.: C26H48O6S6
M.W.: 649.02 |
| |
| QL091676 | Lipoic Acid Impurity 76
CAS# NA
M.F.: C16H30O4S4
M.W.: 414.65 |
| |
| QL091675 | Lipoic Acid Impurity 75
CAS# 108841-56-1
M.F.: C16H30O4S4
M.W.: 414.65 |
| |
| QC121920 | Cilastatin Impurity 20
CAS# NA
M.F.: C16H26N2O5S
M.W.: 358.45 |
| |
| QU181600 | Uroporphyrin I dihydrochloride
CAS# 68929-06-6
M.F.: C40H38N4O16.2HCl
M.W.: 830.76 72.92 |
| |
| QZ151214 | Zoledronic acid Impurity 14
CAS# 131468-90-1
M.F.: C4H6N2O
M.W.: 98.11 |
| |
| QZ151213 | Zoledronic acid Impurity 13
CAS# NA
M.F.: C5H11N3O7P2
M.W.: 287.10 |
| |
| QZ151212 | Zoledronic acid Impurity 12
CAS# NA
M.F.: C6H12N2O7P2
M.W.: 286.12 |
| |
| QB051330 | Bempedoic acid Impurity 30
CAS# NA
M.F.: C29H45NO6S
M.W.: 535.74 |
| |
| QB051329 | Bempedoic acid Impurity 29
CAS# NA
M.F.: C27H41NO6S
M.W.: 507.69 |
| |
| QC181949 | Crisaborole Impurity 49
CAS# 2227126-09-0
M.F.: C16H12BrNO3
M.W.: 346.18 |
| |
| QI142506 | Indocyanine Green Impurity 6
CAS# NA
M.F.: C18H20NNaO4S
M.W.: 369.41 |
| |
| QV1416147 | Vonoprazan Impurity 147
CAS# NA
M.F.: C18H18FN3O3S
M.W.: 375.42 |
| |
| QD151632 | Dopamine Impurity 32
CAS# NA
M.F.: C16H20N2O4.HCl
M.W.: 304.35 36.46 |
| |
| QB152003 | Isobornyl Acetate
CAS# 125-12-2
M.F.: C12H20O2
M.W.: 196.29 |
| |
| QR052003 | Retinoic acid Impurity 3
CAS# 53282-28-3
M.F.: C33H38ClP
M.W.: 501.09 |
| |
| QP181919 | Prasugrel Metabolite R-138727
CAS# 204204-73-9
M.F.: C18H20FNO3S
M.W.: 349.42 |
| |
| QA661232 | Ampicillin Impurity 32
CAS# NA
M.F.: C32H40N6O9S2
M.W.: 716.83 |
| |
| QA123800 | Alflutinib mesylate
CAS# 2130958-55-1
M.F.: C28H31F3N8O2.CH4O3S
M.W.: 568.61 96.10 |
| |
| QC031261 | Cefaclor Impurity 61
CAS# NA
M.F.: C29H28Cl2N6O6S2
M.W.: 691.60 |
| |
| QR051254 | Relugolix Impurity 54
CAS# NA
M.F.: C32H35F2N7O6S
M.W.: 683.73 |
| |
| QM041510 | Medroxyprogesterone Acetate Impurity 10
CAS# 984-46-3
M.F.: C24H34O5
M.W.: 402.53 |
| |
| QP081846 | Phloroglucinol Impurity 46
CAS# 531-02-2
M.F.: C12H10O4
M.W.: 218.21 |
| |
| QP180352 | Piperacillin Impurity 52
CAS# NA
M.F.: C25H33N5O8S
M.W.: 563.63 |
| |
| QA261967 | Azilsartan Impurity 67
CAS# NA
M.F.: C29H28N4O5
M.W.: 512.57 |
| |
| QB140444 | Benidipine Impurity 44
CAS# NA
M.F.: C16H22N2O2.HCl
M.W.: 274.36 36.46 |
| |
| QB140443 | Benidipine Impurity 43
CAS# NA
M.F.: C23H24N2O5.HCl
M.W.: 408.45 36.46 |
| |
| QT691527 | Testosterone octanoate
CAS# NA
M.F.: C27H42O3
M.W.: 414.63 |
| |
| QB011524 | Baloxavir Impurity 24
CAS# 1985607-69-9
M.F.: C22H23N3O6
M.W.: 425.44 |
| |
| QM031641 | Mycophenolate Mofetil Impurity 41
CAS# NA
M.F.: C17H24O8
M.W.: 356.37 |
| |
| QS150403 | Alendronic Acid-d6
CAS# 1035437-39-8
M.F.: C4H7D6NO7P2
M.W.: 255.13 |
| |
| QM092200 | Mivacurium chloride
CAS# 106861-44-3;133814-19-4(cation)
M.F.: C58H80Cl2N2O14
M.W.: 1100.18 |
| |
| QC620915 | Colchicine Impurity 15
CAS# NA
M.F.: C23H27NO6S
M.W.: 445.53 |
| |
| QR131908 | Ramosetron Impurity 8
CAS# 603-76-9
M.F.: C9H9N
M.W.: 131.18 |
| |
| QS023390 | SCH 23390 maleate
CAS# 87134-87-0
M.F.: C17H18ClNO.C4H4O4
M.W.: 287.79 116.07 |
| |
| QP1824112 | Parecoxib Sodium Impurity 112
CAS# NA
M.F.: C19H16N2O3S
M.W.: 352.41 |
| |
| QB011519 | Baloxavir Impurity 19
CAS# NA
M.F.: C17H15N3O4
M.W.: 325.32 |
| |
| QM154268 | Mirabegron Impurity 68
CAS# NA
M.F.: C32H36N4O3
M.W.: 524.67 |
| |
| QE191333 | Esmolol Impurity 33
CAS# 17449-03-5
M.F.: C10H8O5
M.W.: 208.17 |
| |
| QI142505 | Indocyanine Green Impurity 5
CAS# NA
M.F.: C45H52N2O6S2
M.W.: 781.04 |
| |
| QD152611 | Deoxycholic acid Impurity 11
CAS# NA
M.F.: C25H36O2
M.W.: 368.56 |
| |
| QD152610 | Deoxycholic acid Impurity 10
CAS# NA
M.F.: C25H36O3
M.W.: 384.56 |
| |
| QD152609 | Deoxycholic acid Impurity 9
CAS# NA
M.F.: C25H38O2
M.W.: 370.58 |
| |
| QD152608 | Deoxycholic acid Impurity 8
CAS# NA
M.F.: C24H36O2
M.W.: 356.55 |
| |
| QD152607 | Deoxycholic acid Impurity 7
CAS# NA
M.F.: C24H36O3
M.W.: 372.55 |
| |
| QD152606 | Deoxycholic acid Impurity 6
CAS# 3318-71-6
M.F.: C24H34O2
M.W.: 354.53 |
| |
| QM571813 | Megestrol Acetate-d3
CAS# 162462-72-8
M.F.: C24H29D3O4
M.W.: 387.53 |
| |
| QN012106 | Nalfurafine Impurity 6
CAS# NA
M.F.: C28H32N2O5
M.W.: 476.57 |
| |
| QC121919 | Cilastatin Impurity 19
CAS# NA
M.F.: C17H26N2O5S
M.W.: 370.46 |
| |
| QR051252 | Relugolix Impurity 52
CAS# NA
M.F.: C25H25F2N3O6S
M.W.: 533.55 |
| |
| QS011236 | Salmeterol Impurity 36
CAS# NA
M.F.: C29H45NO2
M.W.: 439.68 |
| |
| QB011510 | Baloxavir marboxil Impurity 10
CAS# NA
M.F.: C27H24FN3O7S
M.W.: 553.56 |
| |
| QF120371 | Folic Acid Impurity 71
CAS# NA
M.F.: C19H17N7O7
M.W.: 455.39 |
| |
| QC080310 | Cholic Acid Impurity 10
CAS# 10538-66-6
M.F.: C25H38O5
M.W.: 418.57 |
| |
| QC080309 | Cholic Acid Impurity 9
CAS# 10538-64-4
M.F.: C25H40O5
M.W.: 420.59 |
| |
| QC080308 | Cholic Acid Impurity 8
CAS# 14772-99-7
M.F.: C25H40O5
M.W.: 420.59 |
| |
| QI040153 | Indacaterol Impurity 53
CAS# NA
M.F.: C31H34N2O3
M.W.: 482.62 |
| |
| QA031604 | Acipimox Impurity 4
CAS# 98502-96-6
M.F.: C6H6N2O3
M.W.: 154.13 |
| |
| QA031602 | Acipimox Impurity 2
CAS# 51037-31-1
M.F.: C6H6N2O3
M.W.: 154.13 |
| |
| QB051328 | Bempedoic acid Impurity 28
CAS# 50592-83-1
M.F.: C9H16O2
M.W.: 156.23 |
| |
| QB051327 | Bempedoic acid Impurity 27
CAS# 143958-75-2
M.F.: C11H20O2
M.W.: 184.28 |
| |
| QB051326 | Bempedoic acid Impurity 26
CAS# NA
M.F.: C11H22O3
M.W.: 202.29 |
| |
| QB051325 | Bempedoic acid Impurity 25
CAS# NA
M.F.: C16H24O4S
M.W.: 312.42 |
| |
| QB051324 | Bempedoic acid Impurity 24
CAS# NA
M.F.: C16H24O5S
M.W.: 328.42 |
| |
| QB051323 | Bempedoic acid Impurity 23
CAS# NA
M.F.: C18H28O5S
M.W.: 356.48 |
| |
| QB051322 | Bempedoic acid Impurity 22
CAS# 1529323-27-0
M.F.: C9H18O3
M.W.: 174.24 |
| |
| QA020307 | Abacavir sulfate Impurity 7
CAS# NA
M.F.: C14H18N6O
M.W.: 286.34 |
| |
| QX050400 | XE 991 dihydrochloride
CAS# 122955-13-9
M.F.: C26H20N2O.2HCl
M.W.: 376.46 72.92 |
| |
| QF124001 | Flavine Adenine Dinucleotide-13C5 Ammonium Salt
CAS# NA
M.F.: C2213C5H33N9O15P2.xNH3
M.W.: 790.52+x(17.03) |
| |
| QC151307 | Clomifene citrate Impurity 7
CAS# NA
M.F.: C33H34ClNO.HCl
M.W.: 496.09 36.46 |
| |
| QO242013 | Oxytocin Impurity 13
CAS# NA
M.F.: C43H67N13O12S2
M.W.: 1022.20 |
| |
| QG121810 | Glycyrrhizic Acid Impurity 10
CAS# NA
M.F.: C45H68O17
M.W.: 881.01 |
| |
| QL011413 | Landiolol Impurity 13
CAS# NA
M.F.: C21H33N3O6
M.W.: 423.50 |
| |
| QL011412 | Landiolol Impurity 12
CAS# NA
M.F.: C22H35N3O6
M.W.: 437.53 |
| |
| QR122007 | Raltegravir potassium EP Impurity G
CAS# NA
M.F.: C22H27FN6O6
M.W.: 490.48 |
| |
| QR122006 | Raltegravir potassium EP Impurity F
CAS# NA
M.F.: C22H27FN6O6
M.W.: 490.48 |
| |
| QR122005 | Raltegravir potassium EP Impurity E
CAS# NA
M.F.: C20H22N6O5
M.W.: 426.43 |
| |
| QR122003 | Raltegravir potassium EP Impurity C
CAS# 1391918-17-4
M.F.: C20H23FN6O6
M.W.: 462.43 |
| |
| QM050700 | Melengestrol acetate
CAS# 2919-66-6
M.F.: C25H32O4
M.W.: 396.52 |
| |
| QR122000 | Raltegravir potassium
CAS# 871038-72-1;518048-05-0(free base)
M.F.: C20H20FKN6O5
M.W.: 482.51 |
| |
| QI091637 | Ipratropium Bromide Impurity 37
CAS# NA
M.F.: C19H25NO3
M.W.: 315.41 |
| |
| QC061239 | Cephalexin Impurity 39
CAS# 1323247-65-9
M.F.: C16H19N3O5S
M.W.: 365.40 |
| |
| QC205915 | Cytidine Impurity 15
CAS# 77172-20-4
M.F.: C9H13N3O5
M.W.: 243.22 |
| |
| QC-A131447 | (S)-2-amino-3-(3-nitrophenyl)propanoic acid
CAS# 19883-74-0
M.F.: C9H10N2O4
M.W.: 210.19 |
| |
| QB200110 | Betamethasone Dipropionate Impurity 10
CAS# NA
M.F.: C32H39FO8S
M.W.: 602.71 |
| |
| QT130612 | Tamoxifen Citrate Impurity 12
CAS# NA
M.F.: C18H20
M.W.: 236.35 |
| |
| QM053900 | Methylthioninium chloride hydrate
CAS# 122965-43-9
M.F.: C16H18ClN3S.xH2O
M.W.: 319.85+x(18.02) |
| |
| QN140418 | Nintedanib Impurity 18
CAS# 676326-36-6
M.F.: C12H11NO4
M.W.: 233.22 |
| |
| QM052601 | Methylrosanilinium chloride EP Impurity B
CAS# NA
M.F.: C24H28ClN3
M.W.: 393.95 |
| |
| QS120305 | Methyl salicylate EP Impurity L
CAS# 33528-09-5
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QS120304 | Methyl salicylate EP Impurity K
CAS# 4670-56-8
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QS120303 | Methyl salicylate EP Impurity J
CAS# 22717-57-3
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QS120302 | Methyl salicylate EP Impurity I
CAS# 23287-26-5
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QC120104 | Clavulanic Acid Impurity 4
CAS# 762-84-5
M.F.: C6H13NO
M.W.: 115.17 |
| |
| QC010303 | Calcitonin (Salmon) EP Impurity C;
Des-22-tyrosine-calcitonin (salmon)
CAS# NA
M.F.: C136H231N43O46S2
M.W.: 3268.68 |
| |
| QI091636 | Ipratropium Bromide Impurity 36
CAS# NA
M.F.: C19H28BrNO2
M.W.: 382.34 |
| |
| QR092000 | Ritalinic acid
CAS# 19395-41-6
M.F.: C13H17NO2
M.W.: 219.28 |
| |
| QP140831 | Penehyclidine Impurity 5
CAS# 4397-01-7
M.F.: C12H16O
M.W.: 176.25 |
| |
| QD030468 | Diclofenac sodium Impurity 68
CAS# NA
M.F.: C14H11NO2
M.W.: 225.24 |
| |
| QD030467 | Diclofenac sodium Impurity 67
CAS# NA
M.F.: C14H11NO3
M.W.: 241.24 |
| |
| QT081538 | Theophylline Impurity 38
CAS# NA
M.F.: C17H22N8O5
M.W.: 418.41 |
| |
| QE201827 | Emtricitabine Impurity 27
CAS# 64282-88-8
M.F.: C10H20O
M.W.: 156.27 |
| |
| QA152409 | Amphotericin B Impurity 9
CAS# NA
M.F.: C47H73NO16
M.W.: 908.08 |
| |
| QT182003 | Tropisetron hydrochloride Impurity 3
CAS# NA
M.F.: C26H25N3O3
M.W.: 427.50 |
| |
| QC042033 | Cefditoren pivoxil Impurity 33
CAS# NA
M.F.: C50H56N12O14S6
M.W.: 1241.44 |
| |
| QC042032 | Cefditoren pivoxil Impurity 32
CAS# NA
M.F.: C27H32N6O8S3
M.W.: 664.77 |
| |
| QZ151211 | Zoledronic acid Impurity 11
CAS# NA
M.F.: C5H10N2O8P2
M.W.: 288.09 |
| |
| QI120119 | Ilaprazole Impurity 19
CAS# NA
M.F.: C20H20N4O2S
M.W.: 380.46 |
| |
| QD152605 | Deoxycholic acid Impurity 5
CAS# 3245-38-3
M.F.: C25H42O4
M.W.: 406.60 |
| |
| QR051242 | Relugolix Impurity 42
CAS# NA
M.F.: C54H44F4N12O6S2
M.W.: 1097.13 |
| |
| QR051234 | Relugolix Impurity 34
CAS# NA
M.F.: C24H22F2N2O7S
M.W.: 520.50 |
| |
| QR051231 | Relugolix Impurity 31
CAS# NA
M.F.: C10H11N5O2
M.W.: 233.23 |
| |
| QV307797 | cis-Vitamin K1-d7
CAS# NA
M.F.: C31H39D7O2
M.W.: 457.74 |
| |
| QL052602 | Levomepromazine Maleate EP Impurity B
CAS# NA
M.F.: C19H24N2O2S
M.W.: 344.47 |
| |
| QL052601 | Levomepromazine Maleate EP Impurity A
CAS# 1771-18-2
M.F.: C13H11NOS
M.W.: 229.30 |
| |
| QJ150104 | Josamycin Propionate EP Impurity D
CAS# NA
M.F.: C48H77NO17
M.W.: 940.12 |
| |
| QM191232 | Mesalazine Impurity 32
CAS# NA
M.F.: C19H14N4O3
M.W.: 346.34 |
| |
| QA161213 | Apalutamide Impurity 13
CAS# NA
M.F.: C22H8F9N9
M.W.: 569.34 |
| |
| QJ150103 | Josamycin Propionate EP Impurity C
CAS# NA
M.F.: C46H75NO16
M.W.: 898.08 |
| |
| QJ150102 | Josamycin Propionate EP Impurity B
CAS# NA
M.F.: C42H69NO15
M.W.: 827.99 |
| |
| QJ150101 | Josamycin Propionate EP Impurity A
CAS# NA
M.F.: C42H67NO16
M.W.: 841.98 |
| |
| QG121503 | Glycocholic Acid Impurity 1
CAS# NA
M.F.: C52H84N2O11
M.W.: 913.23 |
| |
| QI130903 | Imiquimod Impurity 3
CAS# NA
M.F.: C13H15N3O2
M.W.: 245.28 |
| |
| QI142504 | Indocyanine Green Impurity 4
CAS# 63149-24-6
M.F.: C19H23NO3S
M.W.: 345.46 |
| |
| QG042416 | Gadoxetate Disodium Impurity O
CAS# NA
M.F.: C23H33N3O11
M.W.: 527.52 |
| |
| QG042415 | Gadoxetate Disodium Impurity N
CAS# NA
M.F.: C21H29N3O8
M.W.: 451.47 |
| |
| QG042414 | Gadoxetate Disodium Impurity M
CAS# NA
M.F.: C21H29N3O8
M.W.: 451.47 |
| |
| QG042413 | Gadoxetate Disodium Impurity L
CAS# NA
M.F.: C19H26N2O9
M.W.: 426.42 |
| |
| QG042412 | Gadoxetate Disodium Impurity K
CAS# NA
M.F.: C18H29N3O4
M.W.: 351.44 |
| |
| QG042411 | Gadoxetate Disodium Impurity J
CAS# NA
M.F.: C24H38N4O2.2HCl
M.W.: 414.58 72.92 |
| |
| QC030701 | Alanyl Glutamine Impurity 1
CAS# NA
M.F.: C8H12N2O4
M.W.: 200.19 |
| |
| QF140608 | Fenofibric acid-d6
CAS# 1092484-69-9
M.F.: C17H9D6ClO4
M.W.: 324.79 |
| |
| QT012801 | Taurocholic acid 3-sulfate
CAS# 67030-62-0;71781-33-4(2Na salt)
M.F.: C26H45NO10S2
M.W.: 595.77 |
| |
| QC080307 | Cholic acid 7-sulfate
CAS# 60320-05-0
M.F.: C24H40O8S
M.W.: 488.63 |
| |
| QQ211500 | Quinoline Yellow
CAS# 8004-92-0
M.F.: C18H9NNa2O8S2
M.W.: 477.38 |
| |
| QP184600 | Proadifen Hydrochloride
CAS# 62-68-0
M.F.: C23H31NO2.HCl
M.W.: 353.50 36.46 |
| |
| QM010400 | Madecassic acid
CAS# 18449-41-7
M.F.: C30H48O6
M.W.: 504.70 |
| |
| QR1922149 | Rosuvastatin Impurity 149
CAS# NA
M.F.: C20H28FN3O3S
M.W.: 409.52 |
| |
| QL011404 | Landiolol Impurity 4
CAS# 1253907-81-1;133242-29-2(free base)
M.F.: C25H39N3O8.HCl
M.W.: 509.59 36.46 |
| |
| QE201608 | Ertapenem Impurity 8
CAS# NA
M.F.: C12H14N2O4
M.W.: 250.25 |
| |
| QD152604 | Deoxycholic Acid 3-O-β-D-Glucuronide Disodium Salt
CAS# 59274-67-8
M.F.: C30H46Na2O10
M.W.: 612.66 |
| |
| QP090329 | Sodium Picosulfate Impurity 29
CAS# 158839-52-2
M.F.: C12H11NO2
M.W.: 201.22 |
| |
| QP090328 | Sodium Picosulfate Impurity 28
CAS# 33455-95-7
M.F.: C12H11NO2
M.W.: 201.22 |
| |
| QP090327 | Sodium Picosulfate Impurity 27
CAS# NA
M.F.: C18H14NNaO5S
M.W.: 379.36 |
| |
| QP090326 | Sodium Picosulfate Impurity 26
CAS# NA
M.F.: C18H14NNaO5S
M.W.: 379.36 |
| |
| QP090325 | Sodium Picosulfate Impurity 25
CAS# NA
M.F.: C18H14NNaO5S
M.W.: 379.36 |
| |
| QC-M011206 | Maleopimaric acid
CAS# 510-39-4
M.F.: C24H32O5
M.W.: 400.51 |
| |
| QP010300 | Pachymic acid
CAS# 29070-92-6
M.F.: C33H52O5
M.W.: 528.76 |
| |
| QC-M251804 | Myristic acid
CAS# 544-63-8
M.F.: C14H28O2
M.W.: 228.37 |
| |
| QH250700 | Hydrogenated lecithin
CAS# 92128-87-5
M.F.: C42H84NO8P
M.W.: 762.09 |
| |
| QE261240 | Enzalutamide Impurity 40
CAS# NA
M.F.: C18H10F6N4O
M.W.: 412.29 |
| |
| QP180463 | Perindopril Impurity 63
CAS# NA
M.F.: C10H19NO4
M.W.: 217.26 |
| |
| QH042508 | Hydrocortisone acetate EP Impurity G
CAS# 81968-66-3
M.F.: C25H34O7
M.W.: 446.53 |
| |
| QH042507 | Hydrocortisone acetate EP Impurity E
CAS# 7753-60-8
M.F.: C23H30O5
M.W.: 386.48 |
| |
| QH152002 | Homatropine methylbromide EP Impurity F;Methyl mandelate
CAS# 4358-87-6
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QC042031 | Cefditoren pivoxil Impurity 31
CAS# NA
M.F.: C27H32N6O8S3
M.W.: 664.77 |
| |
| QT1406193 | Tenofovir Impurity 193
CAS# NA
M.F.: C31H50N5O20P
M.W.: 843.72 |
| |
| QL090306 | 10,11-Dihydro-10-Hydroxy Carbamazepine-d4
CAS# 1188265-49-7
M.F.: C15H10D4N2O2
M.W.: 258.31 |
| |
| QA161910 | Acetylsalicylic Acid-d4 (Aspirin-d4)
CAS# 97781-16-3
M.F.: C9H4D4O4
M.W.: 184.18 |
| |
| QM031634 | Mycophenolate Mofetil-d4
CAS# 1132748-21-0
M.F.: C23H27D4NO7
M.W.: 437.52 |
| |
| QG121809 | Glycyrrhizic Acid Impurity E
CAS# NA
M.F.: C44H66O16
M.W.: 850.99 |
| |
| QG121808 | Licoricesaponin C2
CAS# 118525-49-8
M.F.: C42H62O15
M.W.: 806.93 |
| |
| QG121807 | Glycyrrhizic Acid Impurity D
CAS# NA
M.F.: C44H67NO16
M.W.: 866.00 |
| |
| QG121806 | Glycyrrhizic Acid Impurity C
CAS# 138268-00-5
M.F.: C42H62O16
M.W.: 822.93 |
| |
| QG121805 | Glycyrrhizic Acid Impurity B
CAS# 134250-15-0
M.F.: C42H64O15
M.W.: 808.95 |
| |
| QG121804 | Licoricesaponin E2
CAS# 119417-96-8
M.F.: C42H60O16
M.W.: 820.92 |
| |
| QG121803 | Licoricesaponin A3
CAS# 118325-22-7
M.F.: C48H72O21
M.W.: 985.07 |
| |
| QC120910 | Calcipotriol Impurity 10
CAS# NA
M.F.: C30H46O3
M.W.: 454.68 |
| |
| QH152001 | Homatropine methylbromide EP Impurity A
CAS# NA
M.F.: C17H22BrNO3
M.W.: 368.27 |
| |
| QH152000 | Homatropine methylbromide
CAS# 80-49-9
M.F.: C17H24BrNO3
M.W.: 370.28 |
| |
| QS150402 | Alendronic Acid Impurity 2
CAS# NA
M.F.: C4H12NO8P3
M.W.: 295.06 |
| |
| QS150401 | Alendronic Acid Dimeric Anhydride
CAS# 165043-20-9
M.F.: C8H22N2O12P4
M.W.: 462.16 |
| |
| QL091674 | rac α-Lipoic Acid-d5
CAS# 1189471-66-6
M.F.: C8H9D5O2S2
M.W.: 211.36 |
| |
| QB050323 | Beclometasone Dipropionate-d6
CAS# NA
M.F.: C28H31D6ClO7
M.W.: 527.08 |
| |
| QP032019 | Procaterol Impurity 19
CAS# NA
M.F.: C15H20N2O3
M.W.: 276.33 |
| |
| QC080306 | Cholic Acid Impurity 6
CAS# NA
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QC080305 | Cholic Acid Impurity 5
CAS# 105227-28-9
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QM031633 | Mycophenolic Acid Impurity 33
CAS# NA
M.F.: C21H28O6
M.W.: 376.44 |
| |
| QG051903 | Gestodene EP Impurity C;2-isopropanol-gestodene
CAS# NA
M.F.: C24H32O3
M.W.: 368.51 |
| |
| QI132070 | Imatinib Impurity 70
CAS# NA
M.F.: C30H33Cl2N7O
M.W.: 578.54 |
| |
| QC191901 | (E)-Cinnamyl alcohol
CAS# 4407-36-7
M.F.: C9H10O
M.W.: 134.18 |
| |
| QC191900 | Cinnamyl alcohol
CAS# 104-54-1
M.F.: C9H10O
M.W.: 134.18 |
| |
| QE160405 | Eptifibatide Impurity 5
CAS# NA
M.F.: C35H49N11O9S2
M.W.: 831.96 |
| |
| QB180501 | Brevianamide F
CAS# 38136-70-8
M.F.: C16H17N3O2
M.W.: 283.33 |
| |
| QC-P251834 | Pyrophosphoric acid
CAS# 2466-09-3
M.F.: H4O7P2
M.W.: 177.98 |
| |
| QN150400 | Nordeoxycholic acid
CAS# 53608-86-9
M.F.: C23H38O4
M.W.: 378.55 |
| |
| QT012100 | Taurohyocholic acid
CAS# 32747-07-2
M.F.: C26H45NO7S
M.W.: 515.70 |
| |
| QG123500 | Glycohyocholic acid
CAS# 32747-08-3
M.F.: C26H43NO6
M.W.: 465.62 |
| |
| QE2620110 | Ezetimibe Impurity 110
CAS# NA
M.F.: C26H27F2NO4
M.W.: 455.49 |
| |
| QL131102 | Malic Acid Impurity 2
CAS# NA
M.F.: C8H8O8
M.W.: 232.14 |
| |
| QR131220 | Ramelteon Impurity T
CAS# 896736-21-3
M.F.: C16H21NO3
M.W.: 275.34 |
| |
| QA164826 | Axitinib Impurity 26
CAS# NA
M.F.: C15H12IN3O3S
M.W.: 441.24 |
| |
| QN140415 | Nintedanib Impurity 15
CAS# 1168152-07-5
M.F.: C20H17NO5
M.W.: 351.35 |
| |
| QF211704 | Fluphenazine dihydrochloride EP Impurity F
CAS# NA
M.F.: C31H44F3N5O3S
M.W.: 623.77 |
| |
| QF211703 | Fluphenazine dihydrochloride EP Impurity D
CAS# NA
M.F.: C36H34F6N4S2
M.W.: 700.80 |
| |
| QF211702 | Fluphenazine dihydrochloride EP Impurity C
CAS# NA
M.F.: C35H32F6N4OS2
M.W.: 702.78 |
| |
| QC-M151404 | Monooctyl Maleate
CAS# 2370-71-0
M.F.: C12H20O4
M.W.: 228.28 |
| |
| QF211701 | Fluphenazine dihydrochloride EP Impurity B;
Fluphenazine S,S-dioxide
CAS# 1476-79-5
M.F.: C22H26F3N3O3S
M.W.: 469.52 |
| |
| QB051321 | Bempedoic acid Impurity 21
CAS# NA
M.F.: C21H40O5
M.W.: 372.54 |
| |
| QB051320 | Bempedoic acid Impurity 20
CAS# NA
M.F.: C21H38O6
M.W.: 386.52 |
| |
| QB051319 | Bempedoic acid Impurity 19
CAS# 738606-64-9
M.F.: C23H44O5
M.W.: 400.59 |
| |
| QE202703 | Ethionamide EP Impurity D
CAS# 1531-18-6
M.F.: C8H8N2
M.W.: 132.16 |
| |
| QE191907 | Estradiol benzoate EP Impurity H
CAS# NA
M.F.: C27H30O4
M.W.: 418.52 |
| |
| QE191906 | Estradiol benzoate EP Impurity G;Estrone benzoate
CAS# NA
M.F.: C25H26O3
M.W.: 374.47 |
| |
| QE191905 | Estradiol benzoate EP Impurity F
CAS# NA
M.F.: C25H26O3
M.W.: 374.47 |
| |
| QE191904 | Estradiol benzoate EP Impurity E
CAS# NA
M.F.: C25H28O3
M.W.: 376.49 |
| |
| QE191903 | Estradiol benzoate EP Impurity D
CAS# NA
M.F.: C25H28O3
M.W.: 376.49 |
| |
| QE191902 | Estradiol benzoate EP Impurity C
CAS# NA
M.F.: C32H32O4
M.W.: 480.59 |
| |
| QE191901 | Estradiol benzoate EP Impurity B
CAS# NA
M.F.: C26H30O3
M.W.: 390.51 |
| |
| QE191900 | Estradiol benzoate
CAS# 50-50-0
M.F.: C25H28O3
M.W.: 376.49 |
| |
| QE182051 | Erythromycin estolate EP Impurity G
CAS# NA
M.F.: C39H69NO14
M.W.: 775.96 |
| |
| QA261962 | Azilsartan Impurity 62
CAS# NA
M.F.: C32H28N4O8
M.W.: 596.59 |
| |
| QT142428 | Tranexamic Acid Impurity 28
CAS# NA
M.F.: C24H41N3O4
M.W.: 435.60 |
| |
| QC083100 | Chlorophyll a
CAS# 479-61-8
M.F.: C55H72MgN4O5
M.W.: 893.50 |
| |
| QG042410 | Gadoxetate Disodium Impurity I
CAS# NA
M.F.: C23H28GdN3Na2O11
M.W.: 725.71 |
| |
| QG042409 | Gadoxetate Disodium Impurity H
CAS# NA
M.F.: C23H28GdN3Na2O11
M.W.: 725.71 |
| |
| QG011209 | Galantamine hydrobromide Impurity 9
CAS# 134332-50-6
M.F.: C17H21NO4
M.W.: 303.35 |
| |
| QI191646 | Isoproterenol Impurity 46
CAS# NA
M.F.: C11H15NO3
M.W.: 209.24 |
| |
| QI191645 | Isoproterenol Impurity 45
CAS# NA
M.F.: C12H16O4
M.W.: 224.25 |
| |
| QI182066 | Ibrutinib Impurity 66
CAS# NA
M.F.: C16H13NO5
M.W.: 299.28 |
| |
| QI182064 | Ibrutinib Impurity 64
CAS# NA
M.F.: C16H11NO4
M.W.: 281.26 |
| |
| QI150201 | Isochlorogenic acid C
CAS# 57378-72-0
M.F.: C25H24O12
M.W.: 516.45 |
| |
| QB041437 | Budesonide Impurity 37
CAS# NA
M.F.: C23H28O7
M.W.: 416.46 |
| |
| QS052500 | Senkyunolide A
CAS# 63038-10-8
M.F.: C12H16O2
M.W.: 192.25 |
| |
| QG052700 | Genipin 1-gentiobioside
CAS# 29307-60-6
M.F.: C23H34O15
M.W.: 550.51 |
| |
| QD161503 | Dipotassium clorazepate EP Impurity C
CAS# NA
M.F.: C18H15ClN2O3
M.W.: 342.78 |
| |
| QN051519 | Neostigmine bromide Impurity 19
CAS# NA
M.F.: C6H7NO2
M.W.: 125.13 |
| |
| QD061400 | Diphenoxylate hydrochloride
CAS# 3810-80-8
M.F.: C30H32N2O2.HCl
M.W.: 452.59 36.46 |
| |
| QI132068 | Imatinib Impurity 68
CAS# NA
M.F.: C16H13N5O2
M.W.: 307.31 |
| |
| QD162476 | Dapoxetine Impurity 76
CAS# NA
M.F.: C18H17ClO2
M.W.: 300.78 |
| |
| QP812556 | Paclitaxel Impurity 56
CAS# NA
M.F.: C58H58Cl3NO17
M.W.: 1147.44 |
| |
| QD091006 | Dicloxacillin sodium Impurity 6
CAS# NA
M.F.: C27H27Cl2N5O7S2
M.W.: 668.57 |
| |
| QD098107 | Difloxacin hydrochloride trihydrate EP Impurity G
CAS# NA
M.F.: C16H8ClF2NO3
M.W.: 335.69 |
| |
| QD098105 | Difloxacin hydrochloride trihydrate EP Impurity F
CAS# NA
M.F.: C27H23F3N4O2
M.W.: 492.49 |
| |
| QD098104 | Difloxacin hydrochloride trihydrate EP Impurity E
CAS# NA
M.F.: C21H19ClFN3O3
M.W.: 415.85 |
| |
| QS0602104 | Sofosbuvir Impurity 104
CAS# 874638-98-9
M.F.: C17H18FN3O5
M.W.: 363.34 |
| |
| QU130505 | Umeclidinium bromide Impurity 5
CAS# NA
M.F.: C44H54Br2N2O3
M.W.: 818.72 |
| |
| QV307795 | Vitamin K1 Impurity 95
CAS# NA
M.F.: C31H46O3
M.W.: 466.70 |
| |
| QV307794 | Vitamin K1 Impurity 94
CAS# 85955-78-8
M.F.: C31H46O3
M.W.: 466.70 |
| |
| QD091005 | Dicloxacillin sodium Impurity 5
CAS# NA
M.F.: C32H27Cl4N5O9S
M.W.: 799.46 |
| |
| QO240209 | Oxybutynin hydrochloride Impurity 9
CAS# NA
M.F.: C11H14O3
M.W.: 194.23 |
| |
| QO240208 | Oxybutynin hydrochloride Impurity 8
CAS# NA
M.F.: C26H38O
M.W.: 366.58 |
| |
| QO240207 | Oxybutynin hydrochloride Impurity 7
CAS# NA
M.F.: C26H40O2
M.W.: 384.59 |
| |
| QC016100 | Caronic anhydride
CAS# 67911-21-1
M.F.: C7H8O3
M.W.: 140.14 |
| |
| QV091220 | Vilanterol Impurity 20
CAS# 2762285-55-0
M.F.: C48H64Cl4N2O9
M.W.: 954.84 |
| |
| QV091215 | Vilanterol Impurity 15
CAS# NA
M.F.: C24H33Cl2NO5
M.W.: 486.43 |
| |
| QV091212 | Vilanterol Impurity 12
CAS# NA
M.F.: C36H53Cl2NO15
M.W.: 810.71 |
| |
| QC052001 | Cetrorelix Impurity 1
CAS# NA
M.F.: C69H91ClN16O13
M.W.: 1388.01 |
| |
| QD098103 | Difloxacin hydrochloride trihydrate EP Impurity D
CAS# NA
M.F.: C21H19ClFN3O3
M.W.: 415.85 |
| |
| QE201937 | Sacubitril Impurity 37
CAS# NA
M.F.: C25H31NO4
M.W.: 409.52 |
| |
| QV307793 | Vitamin K1 Impurity 93
CAS# NA
M.F.: C31H46O3
M.W.: 466.70 |
| |
| QA182003 | Arotinolol Impurity 3
CAS# NA
M.F.: C15H20N2O3S3
M.W.: 372.53 |
| |
| QO121509 | Olodaterol Impurity 9
CAS# NA
M.F.: C17H16ClNO4
M.W.: 333.77 |
| |
| QO121508 | Olodaterol Impurity 8
CAS# 869478-13-7
M.F.: C28H32N2O5
M.W.: 476.56 |
| |
| QL051926 | Levosimendan Impurity 26
CAS# NA
M.F.: C11H14N2O2
M.W.: 206.24 |
| |
| QD030466 | Diclofenac sodium Impurity 66
CAS# NA
M.F.: C14H9Cl3NNaO2
M.W.: 352.58 |
| |
| QD030465 | Diclofenac sodium Impurity 65
CAS# NA
M.F.: C14H8Cl3NO
M.W.: 312.58 |
| |
| QD152603 | Deoxycholic acid Impurity 3
CAS# NA
M.F.: C26H44O5
M.W.: 436.62 |
| |
| QD152602 | Deoxycholic acid Impurity 2
CAS# NA
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QD152601 | Deoxycholic acid Impurity 1
CAS# 24637-46-5
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QF140607 | 2-Chloro Fenofibric Acid
CAS# 61024-31-5
M.F.: C17H15ClO4
M.W.: 318.75 |
| |
| QC132666 | Cefmetazole sodium Impurity 66
CAS# NA
M.F.: C13H16N6O5S3
M.W.: 432.50 |
| |
| QC132665 | Cefmetazole sodium Impurity 65
CAS# NA
M.F.: C26H25ClN6O5S2
M.W.: 601.10 |
| |
| QC132664 | Cefmetazole sodium Impurity 64
CAS# NA
M.F.: C26H26N6O5S3
M.W.: 598.72 |
| |
| QC132663 | Cefmetazole sodium Impurity 63
CAS# NA
M.F.: C28H27N7O5S3
M.W.: 637.75 |
| |
| QC132662 | Cefmetazole sodium Impurity 62
CAS# NA
M.F.: C24H22N6O3S3
M.W.: 538.66 |
| |
| QE1316173 | Empagliflozin Impurity 173
CAS# NA
M.F.: C17H17ClO4
M.W.: 320.77 |
| |
| QA060307 | Alfacalcidol Impurity 7
CAS# 160796-62-3
M.F.: C27H44O4S
M.W.: 464.70 |
| |
| QF181952 | Furosemide Impurity 52
CAS# NA
M.F.: C16H18ClNO6S
M.W.: 387.84 |
| |
| QS040688 | Sildenafil Impurity 88
CAS# NA
M.F.: C5H12N2O
M.W.: 116.16 |
| |
| QC152900 | Cortisone acetate;
Hydrocortisone acetate EP Impurity D
CAS# 50-04-4
M.F.: C23H30O6
M.W.: 402.48 |
| |
| QB011223 | Baclofen Impurity 23
CAS# NA
M.F.: C9H13ClN2
M.W.: 184.67 |
| |
| QC123602 | Clodronate disodium EP Impurity D
CAS# 87591-00-2
M.F.: CH5ClO6P2
M.W.: 210.45 |
| |
| QC123601 | Clodronate disodium EP Impurity A
CAS# 134757-52-1
M.F.: C4H10Cl2O6P2
M.W.: 286.97 |
| |
| QC123600 | Clodronate disodium tetrahydrate
CAS# NA
M.F.: CH2Cl2Na2O6P2.4H2O
M.W.: 288.86 72.06 |
| |
| QS061431 | Safinamide Impurity 5
CAS# NA
M.F.: C17H17FN2O2
M.W.: 300.33 |
| |
| QD030464 | Diclofenac sodium Impurity 64
CAS# NA
M.F.: C28H16Cl4N2O2
M.W.: 554.25 |
| |
| QR0718100 | Regorafenib Impurity 100
CAS# NA
M.F.: C8H8FNO2
M.W.: 169.15 |
| |
| QR071891 | Regorafenib Impurity 91
CAS# NA
M.F.: C20H19N5O4
M.W.: 393.40 |
| |
| QR071887 | Regorafenib Impurity 87
CAS# NA
M.F.: C12H8ClFN2O2
M.W.: 266.66 |
| |
| QR071882 | Regorafenib Impurity 82
CAS# NA
M.F.: C13H13N3O3
M.W.: 259.26 |
| |
| QR071881 | Regorafenib Impurity 81
CAS# NA
M.F.: C12H11FN2O2
M.W.: 234.23 |
| |
| QA130242 | Ambroxol Impurity 42
CAS# NA
M.F.: C19H22Br2N2O3
M.W.: 486.20 |
| |
| QC050514 | Ceftibuten Impurity 14
CAS# 36923-21-4
M.F.: C20H18N2O3S
M.W.: 366.43 |
| |
| QC050504 | Ceftibuten Impurity 4
CAS# NA
M.F.: C20H22N2O4S
M.W.: 386.46 |
| |
| QB211309 | Bumetanide Impurity 9
CAS# NA
M.F.: C7H5ClN2O6S
M.W.: 280.64 |
| |
| QC082811 | Chlormadinone acetate EP Impurity L
CAS# NA
M.F.: C23H31ClO4
M.W.: 406.94 |
| |
| QC082810 | Chlormadinone acetate EP Impurity K
CAS# NA
M.F.: C23H30O4
M.W.: 370.48 |
| |
| QC082809 | Chlormadinone acetate EP Impurity J;
Chlormadinone
CAS# 1961-77-9
M.F.: C21H27ClO3
M.W.: 362.89 |
| |
| QC082808 | Chlormadinone acetate EP Impurity I
CAS# NA
M.F.: C25H35ClO4
M.W.: 435.00 |
| |
| QC082807 | Chlormadinone acetate EP Impurity H
CAS# 1054-64-4
M.F.: C24H34O4
M.W.: 386.52 |
| |
| QC082806 | Chlormadinone acetate EP Impurity F
CAS# NA
M.F.: C24H34O4
M.W.: 386.52 |
| |
| QC082805 | Chlormadinone acetate EP Impurity E
CAS# 15251-04-4
M.F.: C23H29BrO4
M.W.: 449.38 |
| |
| QC050503 | Ceftibuten Impurity 3
CAS# NA
M.F.: C13H12N2O4S
M.W.: 292.31 |
| |
| QC082803 | Chlormadinone acetate EP Impurity C
CAS# NA
M.F.: C24H33ClO4
M.W.: 420.97 |
| |
| QC082802 | Chlormadinone acetate EP Impurity B
CAS# NA
M.F.: C23H26BrClO4
M.W.: 481.81 |
| |
| QO131909 | Olmesartan Medoxomil Impurity 9
CAS# NA
M.F.: C53H54N12O8
M.W.: 987.07 |
| |
| QR242227 | Roxatidine Impurity 27
CAS# NA
M.F.: C10H19ClN2O3
M.W.: 250.72 |
| |
| QF210660 | Flurbiprofen Impurity 60
CAS# NA
M.F.: C9H9FN2O4
M.W.: 228.18 |
| |
| QF210659 | Flurbiprofen Impurity 59
CAS# NA
M.F.: C14H17FN2O6
M.W.: 328.29 |
| |
| QF210657 | Flurbiprofen Impurity 57
CAS# NA
M.F.: C19H20O5
M.W.: 328.36 |
| |
| QT1406191 | Tenofovir Impurity 191
CAS# NA
M.F.: C53H80N15O26P3
M.W.: 1436.21 |
| |
| QP092707 | Pinaverium Bromide Impurity 7
CAS# 38284-47-8;53330-19-1(HCl salt)
M.F.: C17H31NO2
M.W.: 281.43 |
| |
| QD161408 | Dexpanthenol Impurity 8
CAS# 18679-90-8
M.F.: C10H19NO5
M.W.: 233.26 |
| |
| QD161407 | L-Panthenol
CAS# 74561-18-5
M.F.: C9H19NO4
M.W.: 205.25 |
| |
| QC082902 | Chloramphenicol palmitate EP Impurity B
CAS# NA
M.F.: C43H72Cl2N2O7
M.W.: 799.95 |
| |
| QC082901 | Chloramphenicol palmitate EP Impurity A
CAS# NA
M.F.: C27H42Cl2N2O6
M.W.: 561.54 |
| |
| QC082900 | Chloramphenicol palmitate
CAS# 530-43-8
M.F.: C27H42Cl2N2O6
M.W.: 561.54 |
| |
| QC052903 | Cefapirin sodium EP Impurity C
CAS# NA
M.F.: C15H15N3O4S2
M.W.: 365.43 |
| |
| QC052902 | Cefapirin sodium EP Impurity B
CAS# 104557-24-6(Na salt)
M.F.: C15H15N3O5S2
M.W.: 381.43 |
| |
| QC052901 | Cefapirin sodium EP Impurity A
CAS# NA
M.F.: C15H13N3O4S2
M.W.: 363.41 |
| |
| QD150423 | Dronedarone Impurity 23
CAS# NA
M.F.: C19H16ClNO5
M.W.: 373.79 |
| |
| QC180200 | Carbasalate calcium
CAS# 5749-67-7
M.F.: C18H14CaO8.CH4N2O
M.W.: 398.38 60.06 |
| |
| QH042506 | Hydrocortisone Acetate EP Impurity F;
epi-Hydrocortisone Acetate
CAS# 1250-97-1
M.F.: C23H32O6
M.W.: 404.50 |
| |
| QP0203100 | Palbociclib Impurity 100
CAS# NA
M.F.: C13H13Cl2N3O
M.W.: 298.17 |
| |
| QP020398 | Palbociclib Impurity 98
CAS# 119285-07-3
M.F.: C14H22N4O2
M.W.: 278.35 |
| |
| QI071837 | Iguratimod Impurity 37
CAS# NA
M.F.: C18H19NO6S
M.W.: 377.41 |
| |
| QF150901 | Calcium Folinate Hydrate EP Impurity E
CAS# 4349-43-3
M.F.: C15H16N6O4
M.W.: 344.33 |
| |
| QP081844 | Phloroglucinol Impurity 44
CAS# 23957-21-3
M.F.: C8H10BrNO2
M.W.: 232.07 |
| |
| QI192271 | Isavuconazole Impurity 71
CAS# NA
M.F.: C50H55ClF2N10O10S
M.W.: 1061.55 |
| |
| QB200109 | Betamethasone Dipropionate EP Impurity I
CAS# 80163-83-3
M.F.: C28H39FO7
M.W.: 506.60 |
| |
| QD0207102 | Dabigatran Etexilate Impurity 102
CAS# 1900865-84-0
M.F.: C16H12N4O
M.W.: 276.29 |
| |
| QD0207101 | Dabigatran Etexilate Impurity 101
CAS# 18358-63-9
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QS0102106 | Salbutamol Impurity 106
CAS# NA
M.F.: C22H31NO6
M.W.: 405.48 |
| |
| QS0102105 | Salbutamol Impurity 105
CAS# 1888806-75-4
M.F.: C8H9BrO2
M.W.: 217.06 |
| |
| QS010298 | Salbutamol Impurity 98
CAS# 1044764-21-7
M.F.: C9H11NO3
M.W.: 181.19 |
| |
| QM200315 | Metoclopramide Impurity 15
CAS# 3761-48-6
M.F.: C14H23N3O2
M.W.: 265.35 |
| |
| QT011415 | Tandospirone Impurity 15
CAS# NA
M.F.: C13H18BrNO2
M.W.: 300.19 |
| |
| QM131931 | 21-Acetyloxy Deschloromometasone Furoate
CAS# 83897-05-6
M.F.: C29H33ClO8
M.W.: 545.02 |
| |
| QI091635 | Ipratropium Bromide Impurity 35
CAS# NA
M.F.: C11H19NO2
M.W.: 197.27 |
| |
| QF130427 | Famotidine Impurity 27
CAS# NA
M.F.: C9H15N7O2S3
M.W.: 349.46 |
| |
| QI192901 | Gambogic acid
CAS# 2752-65-0
M.F.: C38H44O8
M.W.: 628.75 |
| |
| QI192267 | Isavuconazole Impurity 67
CAS# NA
M.F.: C15H23N3O4
M.W.: 309.36 |
| |
| QD0207100 | Dabigatran Etexilate Impurity 100
CAS# NA
M.F.: C18H22N4O3
M.W.: 342.39 |
| |
| QD020799 | Dabigatran Etexilate Impurity 99
CAS# NA
M.F.: C18H22N4O3
M.W.: 342.39 |
| |
| QD020798 | Dabigatran Etexilate Impurity 98
CAS# NA
M.F.: C27H28N6O4
M.W.: 500.55 |
| |
| QI191643 | Isoproterenol Impurity 43
CAS# 3868-81-3
M.F.: C12H19NO3.HCl
M.W.: 225.28 36.46 |
| |
| QC-C250351 | cyclohexylmethanol;Benzyl alcohol EP Impurity B
CAS# 100-49-2
M.F.: C7H14O
M.W.: 114.19 |
| |
| QP053100 | Pelargonidin chloride
CAS# 134-04-3
M.F.: C15H11ClO5
M.W.: 306.70 |
| |
| QT130611 | Tamoxifen Citrate Impurity 11
CAS# NA
M.F.: C28H35NO2
M.W.: 417.58 |
| |
| QA260406 | Ricinoleic acid
CAS# 141-22-0
M.F.: C18H34O3
M.W.: 298.46 |
| |
| QR457048 | Rocuronium bromide Impurity 48;Androsterone
CAS# 53-41-8
M.F.: C19H30O2
M.W.: 290.44 |
| |
| QB053406 | Benzydamine Hydrochloride EP Impurity F
CAS# 87453-75-6
M.F.: C12H18N2O2
M.W.: 222.28 |
| |
| QB053405 | Benzydamine Hydrochloride EP Impurity E
CAS# 52413-42-0;85284-06-6(HCl salt)
M.F.: C19H23N3O
M.W.: 309.41 |
| |
| QB053404 | Benzydamine Hydrochloride EP Impurity D
CAS# 1337966-15-0
M.F.: C23H32N4O
M.W.: 380.53 |
| |
| QB053403 | Benzydamine Hydrochloride EP Impurity C
CAS# 2215-63-6
M.F.: C14H12N2O
M.W.: 224.26 |
| |
| QB053402 | Benzydamine Hydrochloride EP Impurity B
CAS# 1797879-37-8;2196183-71-6(HCl salt)
M.F.: C26H29N3O
M.W.: 399.53 |
| |
| QB053401 | Benzydamine Hydrochloride EP Impurity A
CAS# 87453-76-7;2196185-65-4(HCl salt)
M.F.: C19H24N2O2
M.W.: 312.41 |
| |
| QB053400 | Benzydamine Hydrochloride
CAS# 132-69-4
M.F.: C19H23N3O.HCl
M.W.: 309.41 36.46 |
| |
| QC065303 | 1-Caffeoylquinic acid
CAS# 1241-87-8
M.F.: C16H18O9
M.W.: 354.31 |
| |
| QI142503 | Indocyanine Green Impurity 3
CAS# NA
M.F.: C44H50N2O6S2
M.W.: 767.01 |
| |
| QI142502 | Indocyanine Green Impurity 2
CAS# NA
M.F.: C44H50N2O6S2
M.W.: 767.01 |
| |
| QI142501 | Indocyanine Green N-Oxide
CAS# NA
M.F.: C43H47N2NaO7S2
M.W.: 790.96 |
| |
| QI142500 | Indocyanine Green
CAS# 3599-32-4
M.F.: C43H47N2NaO6S2
M.W.: 774.96 |
| |
| QP090324 | Sodium Picosulfate Impurity 24
CAS# NA
M.F.: C19H17NO3
M.W.: 307.34 |
| |
| QL010320 | L-Alanine Isopropyl Ester Lactose Adduct
CAS# NA
M.F.: C18H33NO12
M.W.: 455.45 |
| |
| QL091673 | Lipoic Acid Impurity 73
CAS# NA
M.F.: C10H18O2S3
M.W.: 266.44 |
| |
| QZ151210 | Zoledronic acid Impurity 10
CAS# 239065-60-2
M.F.: C8H12N2O2
M.W.: 168.19 |
| |
| QI192900 | Isogambogic acid
CAS# 149655-52-7
M.F.: C38H44O8
M.W.: 628.75 |
| |
| QE161700 | Epigambogic acid
CAS# 887606-04-4
M.F.: C38H44O8
M.W.: 628.75 |
| |
| QG010200 | Gambogenic acid
CAS# 173932-75-7
M.F.: C38H46O8
M.W.: 630.77 |
| |
| QM154300 | Morellic acid
CAS# 5304-71-2
M.F.: C33H36O8
M.W.: 560.63 |
| |
| QF123702 | Florfenicol Impurity 2
CAS# NA
M.F.: C12H14Cl2FNO4S
M.W.: 358.21 |
| |
| QT161894 | Topiroxostat Impurity 94
CAS# NA
M.F.: C8H5N5O
M.W.: 187.16 |
| |
| QP160533 | Prednisone EP Impurity K
CAS# 7738-93-4
M.F.: C19H22O3
M.W.: 298.38 |
| |
| QI192265 | Isavuconazole Impurity 65
CAS# NA
M.F.: C40H43ClF2N8O7S
M.W.: 853.33 |
| |
| QA261960 | Azilsartan Impurity 60
CAS# 91526-16-8
M.F.: C12H12O6S
M.W.: 284.29 |
| |
| QD242615 | Doxazosin Impurity 15
CAS# 60547-96-8
M.F.: C10H12N4O2
M.W.: 220.23 |
| |
| QS040687 | Sildenafil Impurity 87
CAS# 501120-38-3
M.F.: C17H22N4O3
M.W.: 330.38 |
| |
| QD141647 | Donepezil Impurity 47
CAS# NA
M.F.: C24H29NO3.HCl
M.W.: 379.49 36.46 |
| |
| QC150900 | Colistin sulfate
CAS# 1264-72-8
M.F.: C53H100N16O13.5/2H2SO4+C52H98N16O13.5/2H2SO4
M.W.: 1169.46 245.20+1155.43 245.20 |
| |
| QP090323 | Sodium Picosulfate Impurity 23
CAS# NA
M.F.: C22H19NO4
M.W.: 361.39 |
| |
| QP090322 | Sodium Picosulfate Impurity 22
CAS# NA
M.F.: C22H19NO4
M.W.: 361.39 |
| |
| QV011232 | Valproic Acid Impurity 32
CAS# NA
M.F.: C15H28O4
M.W.: 272.38 |
| |
| QV011231 | Valproic Acid Impurity 31
CAS# NA
M.F.: C14H26O4
M.W.: 258.35 |
| |
| QC-H042405 | Butyl parahydroxybenzoate;
Propyl Parahydroxybenzoate EP Impurity D;
Sodium ethyl parahydroxybenzoate EP Impurity D
CAS# 94-26-8
M.F.: C11H14O3
M.W.: 194.23 |
| |
| QG011208 | N-Nitroso Galantamine EP Impurity E
CAS# NA
M.F.: C16H18N2O4
M.W.: 302.33 |
| |
| QO131908 | Olmesartan Medoxomil Impurity 8
CAS# NA
M.F.: C49H53ClN8O10
M.W.: 949.45 |
| |
| QM122507 | Melatonin Impurity 7
CAS# 188397-16-2 (keton form), 229018-17-1 (enol form)
M.F.: C13H16N2O3
M.W.: 248.28 |
| |
| QO260765 | Ozagrel Impurity 65
CAS# 67688-89-5(HCl salt)
M.F.: C10H11NO2
M.W.: 177.20 |
| |
| QA0702108 | Argatroban Impurity 108
CAS# NA
M.F.: C15H28N6O5
M.W.: 372.42 |
| |
| QS041920 | Sodium Valproate Impurity 20
CAS# 258264-00-5
M.F.: C11H20O4
M.W.: 216.27 |
| |
| QI091634 | Ipratropium Bromide Impurity 34
CAS# NA
M.F.: C20H28BrNO2
M.W.: 394.35 |
| |
| QP182712 | Piribedil Impurity 12
CAS# 1580471-72-2
M.F.: C8H8Cl2O2
M.W.: 207.05 |
| |
| QP182707 | Piribedil Impurity 7
CAS# 55436-41-4
M.F.: C20H22N2O4
M.W.: 354.40 |
| |
| QP182706 | Piribedil Impurity 6
CAS# 443694-35-7
M.F.: C12H18N2O2
M.W.: 222.28 |
| |
| QP182704 | Piribedil Impurity 4
CAS# NA
M.F.: C7H7ClO2
M.W.: 158.58 |
| |
| QR210601 | Rufinamide USP Related Compound A
CAS# 106308-41-2
M.F.: C10H9FN4O
M.W.: 220.20 |
| |
| QB010437 | Bazedoxifene Acetate Impurity 37
CAS# NA
M.F.: C44H46N2O3
M.W.: 650.85 |
| |
| QR152439 | Roxadustat Impurity 39
CAS# NA
M.F.: C22H22N2O5
M.W.: 394.42 |
| |
| QI192251 | Isavuconazole Impurity 51
CAS# 2069200-13-9
M.F.: C13H12F2N4O
M.W.: 278.26 |
| |
| QO121828 | Olprinone Impurity 28
CAS# NA
M.F.: C12H14N2O
M.W.: 202.25 |
| |
| QM031632 | Mycophenolic Acid Impurity 32
CAS# NA
M.F.: C23H32O11
M.W.: 484.49 |
| |
| QV200107 | Vitamin A Impurity 7
CAS# 34356-30-4
M.F.: C36H60O2
M.W.: 524.86 |
| |
| QV041424 | Vardenafil Impurity 24
CAS# NA
M.F.: C17H19ClN4O2
M.W.: 346.81 |
| |
| QT260400 | Trazodone hydrochloride
CAS# 25332-39-2
M.F.: C19H22ClN5O.HCl
M.W.: 371.86 36.46 |
| |
| QT1406183 | Tenofovir Impurity 183
CAS# NA
M.F.: C33H49N6O15P
M.W.: 800.75 |
| |
| QU190449 | Deoxycholic Acid Ethyl Ester
CAS# 69519-35-3
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QD150211 | Dobutamine Impurity 11
CAS# 69617-84-1
M.F.: C10H14O2
M.W.: 166.22 |
| |
| QC-H052419 | Hexadecanedioic acid
CAS# 505-54-4
M.F.: C16H30O4
M.W.: 286.41 |
| |
| QP092706 | Pinaverium Bromide Impurity 6
CAS# 135964-95-3
M.F.: C26H41Br2NO4
M.W.: 591.42 |
| |
| QP092705 | Pinaverium Bromide Impurity 5
CAS# 1970218-70-2
M.F.: C26H41Br2NO4
M.W.: 591.42 |
| |
| QC061914 | Ceftaroline Fosamil Impurity N
CAS# 1286218-68-5
M.F.: C44H40N16O15P2S8
M.W.: 1351.35 |
| |
| QC061913 | Ceftaroline Fosamil Impurity M
CAS# 1277090-04-6
M.F.: C28H35N12O10PS4
M.W.: 858.89 |
| |
| QC061912 | Ceftaroline Fosamil
CAS# 229016-73-3
M.F.: C22H21N8O8PS4
M.W.: 684.68 |
| |
| QC061911 | Ceftaroline Fosamil Impurity K
CAS# 1286218-64-1
M.F.: C22H22N8O11P2S4
M.W.: 764.66 |
| |
| QE161249 | Epalrestat Impurity 23
CAS# 15289-56-2
M.F.: C13H11NOS2
M.W.: 261.36 |
| |
| QL252028 | Lysine Impurity 28;
DL-Lysine acetylsalicylate EP Impurity C
CAS# NA
M.F.: C12H26N4O3
M.W.: 274.36 |
| |
| QZ121623 | Zolpidem tartrate Impurity 23
CAS# NA
M.F.: C19H25N3O
M.W.: 311.42 |
| |
| QG211205 | Sodium Gualenate Impurity 5
CAS# NA
M.F.: C5H8N2O2
M.W.: 128.13 |
| |
| QD020797 | Dabigatran Etexilate Impurity 97
CAS# 1307233-94-8
M.F.: C20H21ClN4O3
M.W.: 400.86 |
| |
| QD241358 | Dexamethasone Impurity 58
CAS# 6762-51-2
M.F.: C22H27FO4
M.W.: 374.45 |
| |
| QI591816 | Imidacloprid Impurity 16
CAS# 380912-09-4
M.F.: C9H10ClN5O3
M.W.: 271.66 |
| |
| QC-M052504 | methyl 2-amino-3-bromobenzoate
CAS# 104670-74-8
M.F.: C8H8BrNO2
M.W.: 230.06 |
| |
| QL032002 | Lactitol monohydrate EP Impurity B;Lactulitol
CAS# 53796-37-5
M.F.: C12H24O11
M.W.: 344.31 |
| |
| QA163003 | Apremilast Impurity W
CAS# 253168-94-4
M.F.: C12H19NO4S
M.W.: 273.35 |
| |
| QL091672 | Lipoic Acid Impurity 46
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QN151863 | Noradrenaline (Norepinephrine) Impurity 63
CAS# NA
M.F.: C9H13NO6S
M.W.: 263.27 |
| |
| QD160701 | Dapagliflozin Impurity A
CAS# 1807632-95-6
M.F.: C21H25BrO6
M.W.: 453.32 |
| |
| QP091326 | Pimavanserin Impurity 26
CAS# NA
M.F.: C25H34FN3O2
M.W.: 427.55 |
| |
| QP180458 | Perindopril EP Impurity X
CAS# NA
M.F.: C19H32N2O5
M.W.: 368.47 |
| |
| QP180453 | Perindopril EP Impurity Q
CAS# NA
M.F.: C19H32N2O5
M.W.: 368.47 |
| |
| QD090710 | Diclazuril Impurity 10
CAS# 103317-59-5
M.F.: C14H7Cl3N2O2
M.W.: 341.58 |
| |
| QP261639 | Pazopanib Impurity 39
CAS# NA
M.F.: C34H34N12O2S
M.W.: 674.78 |
| |
| QP181679 | Pramipexole Impurity 79
CAS# 106006-83-1
M.F.: C7H11N3S
M.W.: 169.25 |
| |
| QC120453 | Clindamycin Pentadecanoate
CAS# 1123211-67-5
M.F.: C33H61ClN2O6S
M.W.: 649.37 |
| |
| QG270101 | GCTA Impurity 1
CAS# NA
M.F.: C29H27N3O5S2
M.W.: 561.67 |
| |
| QC042024 | Cefditoren pivoxil Impurity 24
CAS# NA
M.F.: C19H17N6NaO5S3
M.W.: 528.56 |
| |
| QT180126 | Travoprost Impurity 26
CAS# NA
M.F.: C24H30O4Si
M.W.: 410.58 |
| |
| QC012311 | Carteolol Impurity 11
CAS# NA
M.F.: C9H8BrNO2
M.W.: 242.07 |
| |
| QC042023 | Cefditoren pivoxil Impurity 23
CAS# NA
M.F.: C50H56N12O14S6
M.W.: 1241.44 |
| |
| QC042022 | Cefditoren pivoxil Impurity 22
CAS# 878002-85-8
M.F.: C51H56N12O14S6
M.W.: 1253.45 |
| |
| QI191641 | Isoproterenol Impurity 15
CAS# NA
M.F.: C11H17NO3
M.W.: 211.26 |
| |
| QR152436 | Roxadustat Impurity 36
CAS# 1455091-04-9
M.F.: C15H13ClO3
M.W.: 276.71 |
| |
| QT031241 | Tacrolimus Impurity 41
CAS# NA
M.F.: C46H75NO13
M.W.: 850.09 |
| |
| QH251400 | Sodium Hyaluronate
CAS# 9067-32-7
M.F.: (C14H20NNaO11)n
M.W.: NA |
| |
| QK201841 | Ketorolac Impurity 41
CAS# NA
M.F.: C17H17NO3
M.W.: 283.32 |
| |
| QA200118 | Atazanavir EP Impurity H
CAS# NA
M.F.: C38H52N6O7
M.W.: 704.86 |
| |
| QH150918 | Hyoscine Butylbromide EP Impurity H
CAS# NA
M.F.: C21H32BrNO3
M.W.: 426.39 |
| |
| QA200116 | Atazanavir EP Impurity F
CAS# 1332981-14-2
M.F.: C38H52N6O7
M.W.: 704.86 |
| |
| QV091208 | Vilanterol Impurity 8
CAS# 452340-96-4
M.F.: C13H15NO4
M.W.: 249.26 |
| |
| QP090321 | Sodium Picosulfate Impurity 21
CAS# NA
M.F.: C18H13NNa2O8S2
M.W.: 481.41 |
| |
| QA164183 | Avanafil Impurity 57
CAS# NA
M.F.: C40H43Cl2N11O6
M.W.: 844.75 |
| |
| QF122046 | Fluticasone Furoate EP Impurity I
CAS# NA
M.F.: C27H29F3O6S
M.W.: 538.58 |
| |
| QB051318 | Bempedoic acid Impurity 18
CAS# NA
M.F.: C38H70O9
M.W.: 670.96 |
| |
| QT201625 | Tiotropium bromide Impurity 25
CAS# 3141-26-2
M.F.: C4H2Br2S
M.W.: 241.93 |
| |
| QT201624 | Tiotropium bromide Impurity 24
CAS# 3140-93-0
M.F.: C4H2Br2S
M.W.: 241.93 |
| |
| QT201623 | Tiotropium bromide Impurity 23
CAS# 3141-27-3
M.F.: C4H2Br2S
M.W.: 241.93 |
| |
| QT201622 | Tiotropium bromide Impurity 22
CAS# 3140-92-9
M.F.: C4H2Br2S
M.W.: 241.93 |
| |
| QU190447 | Ursodeoxycholic Acid Impurity 47
CAS# 2393-61-5
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QR051224 | Relugolix Impurity 24
CAS# NA
M.F.: C30H28F2N6O5S
M.W.: 622.64 |
| |
| QF121936 | Fulvestrant Impurity 36
CAS# NA
M.F.: C5H5F5I2O3S
M.W.: 493.96 |
| |
| QO162023 | Olopatadine Impurity 23
CAS# NA
M.F.: C20H21NO2 HCl
M.W.: 307.39 36.46 |
| |
| QU190446 | Ursodeoxycholic Acid Impurity 46
CAS# 71883-64-2
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190445 | Ursodeoxycholic Acid Impurity 45
CAS# 14772-92-0
M.F.: C25H40O5
M.W.: 420.58 |
| |
| QB211400 | Butenafine
CAS# 101828-21-1
M.F.: C23H27N
M.W.: 317.47 |
| |
| QU190443 | Ursodeoxycholic Acid Impurity 43
CAS# 108266-90-6
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190442 | Ursodeoxycholic Acid Impurity 42
CAS# 67008-26-8
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QU190441 | Ursodeoxycholic Acid Impurity 41
CAS# 110107-03-4
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QD030459 | Diclofenac sodium Impurity 59
CAS# NA
M.F.: C15H11Cl2NO
M.W.: 292.16 |
| |
| QC061357 | Cefotiam Impurity 57
CAS# NA
M.F.: C36H44N18O7S6
M.W.: 1033.24 |
| |
| QU190438 | 12-Ketolithocholic acid
CAS# 5130-29-0
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QU190437 | 3-Hydroxy-7,12-diketocholanoic acid
CAS# 517-33-9
M.F.: C24H36O5
M.W.: 404.54 |
| |
| QS067647 | Salicylic Acid Impurity 47
CAS# NA
M.F.: C7H4NNaO4
M.W.: 189.10 |
| |
| QS067646 | Salicylic Acid Impurity 46
CAS# 1172605-63-8(free base)
M.F.: C7H4NNaO4
M.W.: 189.10 |
| |
| QA131255 | Amlodipine Impurity 55
CAS# 140171-49-9
M.F.: C29H29ClN2O7
M.W.: 553.00 |
| |
| QO022033 | Obeticholic Acid Impurity 33
CAS# NA
M.F.: C35H52O5Si
M.W.: 580.87 |
| |
| QN051819 | Neratinib Impurity 19
CAS# 20629-35-0
M.F.: C4H5BrO2
M.W.: 164.99 |
| |
| QD053401 | Delfaprazine Impurity 1
CAS# 791026-42-1
M.F.: C17H19ClN2
M.W.: 286.80 |
| |
| QR1922137 | Rosuvastatin Impurity 137
CAS# NA
M.F.: C13H15NO5S2
M.W.: 329.39 |
| |
| QR1922134 | Rosuvastatin Impurity 134
CAS# NA
M.F.: C20H27NO5S2
M.W.: 425.56 |
| |
| QR1922133 | Rosuvastatin Impurity 133
CAS# 325471-28-1
M.F.: C10H19ClO4
M.W.: 238.71 |
| |
| QR1922131 | Rosuvastatin Impurity 131
CAS# NA
M.F.: C13H15NO4S2
M.W.: 313.39 |
| |
| QR1922130 | Rosuvastatin Impurity 130
CAS# NA
M.F.: C16H19NO4S2
M.W.: 353.46 |
| |
| QC022655 | Cabozantinib Impurity 55
CAS# 1355031-15-0
M.F.: C16H14N2O3
M.W.: 282.29 |
| |
| QT011409 | Tandospirone Impurity 9
CAS# NA
M.F.: C21H27N5O3
M.W.: 397.47 |
| |
| QG122201 | Glutamic Acid Impurity 1
CAS# 3929-61-1
M.F.: C10H16N2O7
M.W.: 276.24 |
| |
| QT180685 | Tirofiban Impurity 85
CAS# NA
M.F.: C12H17Cl2N
M.W.: 246.18 |
| |
| QO242801 | Oxonic Acid Impurity 1
CAS# 60301-55-5
M.F.: C3H3N3O2
M.W.: 113.07 |
| |
| QP1903174 | Posaconazole Impurity 174
CAS# NA
M.F.: C24H31N5O3
M.W.: 437.53 |
| |
| QA261950 | Azilsartan Impurity 50
CAS# NA
M.F.: C29H23N3O6
M.W.: 509.51 |
| |
| QA261949 | Azilsartan Impurity 49
CAS# NA
M.F.: C27H22N4O7
M.W.: 514.49 |
| |
| QZ010600 | Zafirlukast
CAS# 107753-78-6
M.F.: C31H33N3O6S
M.W.: 575.68 |
| |
| QB011216 | Baclofen Impurity 16
CAS# NA
M.F.: C20H20Cl2N2O2
M.W.: 391.29 |
| |
| QB011212 | Baclofen Impurity 12
CAS# NA
M.F.: C20H22Cl2N2O3
M.W.: 409.31 |
| |
| QS212600 | Sulfadimethoxine
CAS# 122-11-2
M.F.: C12H14N4O4S
M.W.: 310.33 |
| |
| QM201826 | Metaraminol Impurity 26
CAS# 1075-61-2;54779-56-5(HCl salt)
M.F.: C9H13NO
M.W.: 151.21 |
| |
| QL091671 | Lipoic Acid Impurity 45
CAS# NA
M.F.: C12H20N2OS2
M.W.: 272.43 |
| |
| QA161884 | Aprepitant Impurity 84
CAS# NA
M.F.: C21H19F6NO3
M.W.: 447.37 |
| |
| QP160628 | Propofol Impurity 28
CAS# NA
M.F.: C13H18O3
M.W.: 222.28 |
| |
| QT0307195 | Ticagrelor Impurity 195
CAS# 1345413-20-8(free base)
M.F.: C9H9F2N C8H8O3
M.W.: 169.17 152.15 |
| |
| QV011230 | Valproic Acid Impurity 4
CAS# NA
M.F.: C6H12O2
M.W.: 116.16 |
| |
| QL091670 | Lipoic Acid Impurity 44
CAS# NA
M.F.: C10H18O2S
M.W.: 202.31 |
| |
| QF120322 | Folic Acid Impurity 22
CAS# 1148179-25-2
M.F.: C21H25N7O7
M.W.: 487.47 |
| |
| QP160625 | Propofol Impurity 25
CAS# NA
M.F.: C26H34O5
M.W.: 426.55 |
| |
| QE2003111 | Entecavir Impurity 111
CAS# NA
M.F.: C51H47N5O4
M.W.: 793.95 |
| |
| QE1316157 | Empagliflozin Impurity 157
CAS# NA
M.F.: C17H17BrO2
M.W.: 333.22 |
| |
| QM142414 | Minoxidil Impurity 14
CAS# NA
M.F.: C4H5ClN4O
M.W.: 160.56 |
| |
| QO1920129 | Oseltamivir Impurity 129
CAS# NA
M.F.: C24H42N2O3
M.W.: 406.60 |
| |
| QO1920128 | Oseltamivir Impurity 128
CAS# NA
M.F.: C24H42N2O3
M.W.: 406.60 |
| |
| QT142427 | Tranexamic Acid Impurity 27
CAS# NA
M.F.: C8H7Cl2NO
M.W.: 204.05 |
| |
| QO201567 | Vortioxetine Impurity 41
CAS# 1025895-66-2
M.F.: C17H19NS
M.W.: 269.40 |
| |
| QO201566 | Vortioxetine Impurity 40
CAS# 62755-64-0
M.F.: C16H18N2O
M.W.: 254.33 |
| |
| QO022026 | Obeticholic Acid Impurity 26
CAS# 4185-00-6
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QU190436 | Ursodeoxycholic Acid Impurity 36
CAS# 77059-13-3
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QM200508 | Methylene Blue Impurity 8
CAS# 823802-43-3
M.F.: C12H7N3O4S
M.W.: 289.27 |
| |
| QM200507 | Methylene Blue Impurity 7
CAS# 860443-88-5
M.F.: C12H5N5O8S
M.W.: 379.26 |
| |
| QM200506 | Methylene Blue Impurity 6
CAS# 1747-87-1
M.F.: C12H8N2O2S
M.W.: 244.27 |
| |
| QM200505 | Methylene Blue Impurity 5
CAS# 1628-76-8
M.F.: C12H8N2O2S
M.W.: 244.27 |
| |
| QM200504 | Methylene Blue Impurity 4
CAS# 1628-77-9
M.F.: C12H8N2O2S
M.W.: 244.27 |
| |
| QM200503 | Methylene Blue Impurity 3
CAS# 77529-65-8
M.F.: C12H6N4O6S
M.W.: 334.26 |
| |
| QM200502 | Methylene Blue Impurity 2
CAS# NA
M.F.: C12H7N3O4S
M.W.: 289.27 |
| |
| QM200501 | Methylene Blue Impurity 1
CAS# 1628-78-0
M.F.: C12H7N3O4S
M.W.: 289.27 |
| |
| QR152434 | Roxadustat Impurity 34
CAS# 1421312-34-6
M.F.: C18H15NO4
M.W.: 309.32 |
| |
| QP160622 | Propofol Impurity 22
CAS# 2005-09-6
M.F.: C19H22O2
M.W.: 282.38 |
| |
| QS040675 | Sildenafil Impurity 75
CAS# 17243-13-9
M.F.: C7H5ClO5S
M.W.: 236.63 |
| |
| QM092609 | Mizolastine Impurity 9
CAS# 935860-12-1
M.F.: C25H27FN6O
M.W.: 446.52 |
| |
| QC182585 | Canagliflozin Impurity 85
CAS# NA
M.F.: C24H25FO7S
M.W.: 476.51 |
| |
| QP011408 | Pantothenic acid calcium Impurity 8
CAS# NA
M.F.: C18H32CaN2O10
M.W.: 476.53 |
| |
| QP011407 | Pantothenic acid calcium Impurity 7
CAS# NA
M.F.: C10H17NO5
M.W.: 231.25 |
| |
| QA220139 | Avatrombopag Impurity 39
CAS# NA
M.F.: C29H34Cl2N6O4S2
M.W.: 665.65 |
| |
| QT082000 | L-Threonic Acid
CAS# 7306-96-9;70753-61-6(Ca salt)
M.F.: C4H8O5
M.W.: 136.10 |
| |
| QT201621 | Tiotropium bromide Impurity 21
CAS# NA
M.F.: C19H21ClINO3S2
M.W.: 537.86 |
| |
| QE2620104 | Ezetimibe Impurity 104
CAS# 2280081-72-1
M.F.: C39H47FN2O5Si2
M.W.: 698.97 |
| |
| QP182254 | Peramivir Impurity 54
CAS# NA
M.F.: C16H28N2O5
M.W.: 328.40 |
| |
| QR1922123 | Rosuvastatin Impurity 123
CAS# NA
M.F.: C22H28FN3O6S
M.W.: 481.54 |
| |
| QM071204 | Miglitol Impurity 4
CAS# NA
M.F.: C8H11NO2
M.W.: 153.18 |
| |
| QP1903161 | Posaconazole Impurity 161
CAS# 1185745-03-2
M.F.: C34H45N5O5
M.W.: 603.75 |
| |
| QP1903158 | Posaconazole Impurity 158
CAS# NA
M.F.: C16H19N3O
M.W.: 269.34 |
| |
| QN022228 | Nebivolol Impurity 28
CAS# NA
M.F.: C20H37N
M.W.: 291.51 |
| |
| QD241355 | Dexamethasone Impurity 55
CAS# 1188271-71-7(aldehyde form)
M.F.: C22H29FO5.C22H27FO4
M.W.: 392.47 374.45 |
| |
| QB051317 | Bempedoic acid Impurity 17
CAS# 2570179-40-5
M.F.: C25H48O6
M.W.: 444.65 |
| |
| QE191330 | Esmolol Impurity 30
CAS# 495-78-3
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QE191328 | Esmolol Impurity 28
CAS# 22367-76-6
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QE191325 | Esmolol Impurity 25
CAS# NA
M.F.: C28H39NO8
M.W.: 517.61 |
| |
| QL091669 | Lipoic Acid Impurity 43
CAS# NA
M.F.: C10H20O2S2
M.W.: 236.39 |
| |
| QL091668 | Lipoic Acid Impurity 42
CAS# NA
M.F.: C10H18O2S
M.W.: 202.31 |
| |
| QL091667 | Lipoic Acid Impurity 41
CAS# NA
M.F.: C16H26O5S4
M.W.: 426.63 |
| |
| QV091206 | Vilanterol Impurity 6
CAS# NA
M.F.: C24H31Cl2NO5
M.W.: 484.41 |
| |
| QP051207 | Penicillin Impurity 7
CAS# NA
M.F.: C16H18N2O6S
M.W.: 366.39 |
| |
| QA661222 | Ampicillin Impurity 22
CAS# NA
M.F.: C24H33N3O5S
M.W.: 475.60 |
| |
| QI131200 | Imiprothrin
CAS# 72963-72-5
M.F.: C17H22N2O4
M.W.: 318.37 |
| |
| QN022225 | Nebivolol Impurity 25
CAS# 1346562-35-3
M.F.: C22H21F2NO4
M.W.: 401.40 |
| |
| QL051301 | Folinic Acid Impurity 1
CAS# 4349-41-1
M.F.: C15H18N6O3
M.W.: 330.34 |
| |
| QB180961 | Brivaracetam Impurity 35
CAS# NA
M.F.: C11H21BrN2O2
M.W.: 293.20 |
| |
| QV180395 | Voriconazole Impurity 69
CAS# NA
M.F.: C16H13BrF3N5O
M.W.: 428.21 |
| |
| QV180394 | Voriconazole Impurity 68
CAS# NA
M.F.: C16H14F3N5O2
M.W.: 365.31 |
| |
| QT0307194 | Ticagrelor Impurity 194
CAS# 2204313-65-3
M.F.: C17H27ClN4O6S
M.W.: 450.94 |
| |
| QM151700 | Metopimazine Acid
CAS# 18182-00-8
M.F.: C22H26N2O4S2
M.W.: 446.58 |
| |
| QL241688 | Loxoprofen Impurity 62
CAS# NA
M.F.: C22H26O5
M.W.: 370.44 |
| |
| QD050128 | Dexrazoxane Impurity 28
CAS# NA
M.F.: C11H15N4O4
M.W.: 267.26 |
| |
| QS111677 | Sitafloxacin Impurity 51
CAS# 185225-84-7
M.F.: C7H8O3S C3H6FN
M.W.: 172.20 75.08 |
| |
| QP140303 | Pancuronium bromide EP Impurity C
CAS# 15500-65-9
M.F.: C31H56Br2N2O2
M.W.: 648.60 |
| |
| QP140302 | Pancuronium bromide EP Impurity B
CAS# 41261-71-6;43021-44-9(cation form)
M.F.: C33H58Br2N2O3
M.W.: 690.63 |
| |
| QP140301 | Pancuronium bromide EP Impurity A
CAS# 27115-86-2
M.F.: C33H58Br2N2O3
M.W.: 690.63 |
| |
| QI192108 | Isoflurane Impurity 8
CAS# NA
M.F.: C5H5F7O2
M.W.: 230.08 |
| |
| QZ151209 | Zoledronic acid Impurity 9
CAS# 1313885-85-6
M.F.: C6H12N2O7P2
M.W.: 286.12 |
| |
| QZ151208 | Zoledronic acid Impurity 8
CAS# 118054-52-7
M.F.: C6H12N2O7P2
M.W.: 286.12 |
| |
| QL091666 | Lipoic Acid Impurity 40
CAS# 100386-08-1
M.F.: C12H24O2S2
M.W.: 264.45 |
| |
| QT202001 | Tetrahydrobiopterin Impurity 1
CAS# NA
M.F.: C813CH15N215N3O3 2C2HF3O2
M.W.: 245.22 228.04 |
| |
| QF151600 | Fosphenytoin Disodium Salt
CAS# 92134-98-0;93390-81-9 (free base)
M.F.: C16H13N2Na2O6P
M.W.: 406.24 |
| |
| QD121842 | Desloratadine Impurity 42
CAS# 119410-05-8
M.F.: C19H19ClN2O
M.W.: 326.82 |
| |
| QV180393 | Voriconazole Impurity 67
CAS# NA
M.F.: C22H18ClF4N7O
M.W.: 507.87 |
| |
| QL252024 | DL-Lysine acetylsalicylate EP Impurity K
CAS# NA
M.F.: C15H20N2O5
M.W.: 308.33 |
| |
| QL252023 | DL-Lysine acetylsalicylate EP Impurity I
CAS# NA
M.F.: C15H20N2O5
M.W.: 308.33 |
| |
| QL252022 | Lysine aspirin Impurity 22
CAS# NA
M.F.: C15H20N2O5
M.W.: 308.33 |
| |
| QL252021 | DL-Lysine acetylsalicylate EP Impurity J
CAS# NA
M.F.: C13H18N2O4
M.W.: 266.29 |
| |
| QT120217 | Tulobuterol Impurity 17
CAS# NA
M.F.: C12H18ClNO
M.W.: 227.73 |
| |
| QT120207 | Tulobuterol Impurity 7
CAS# 133662-20-1
M.F.: C8H7ClO2
M.W.: 170.59 |
| |
| QD030457 | Diclofenac sodium Impurity 57
CAS# 304884-75-1
M.F.: C14H11Cl2NO
M.W.: 280.15 |
| |
| QE262097 | Ezetimibe Impurity 97
CAS# NA
M.F.: C39H46F2N2O5Si2
M.W.: 716.96 |
| |
| QT031884 | Vitamin E Impurity 84
CAS# NA
M.F.: C32H54O3
M.W.: 486.77 |
| |
| QT031882 | Vitamin E Impurity 82
CAS# NA
M.F.: C31H52O3
M.W.: 472.74 |
| |
| QP051304 | Perampanel Impurity 4
CAS# 380918-51-4
M.F.: C22H16N2O
M.W.: 324.38 |
| |
| QE262090 | Ezetimibe Impurity 90
CAS# NA
M.F.: C39H46F2N2O5Si2
M.W.: 716.96 |
| |
| QA162978 | Apremilast Impurity 78
CAS# NA
M.F.: C16H10N2O7
M.W.: 342.26 |
| |
| QA162975 | Apremilast Impurity 75
CAS# NA
M.F.: C16H12N2O8
M.W.: 360.28 |
| |
| QI182053 | Ibrutinib Impurity 53
CAS# NA
M.F.: C27H28N6O3
M.W.: 484.55 |
| |
| QR201422 | Ritonavir EP Impurity S
CAS# NA
M.F.: C52H61N7O8S2
M.W.: 976.21 |
| |
| QF122922 | Fluocinolone acetonide Impurity 22
CAS# NA
M.F.: C26H32ClFO7
M.W.: 510.98 |
| |
| QP156534 | Progesterone Impurity 34
CAS# 88128-62-5
M.F.: C23H36O4
M.W.: 376.53 |
| |
| QR1922118 | Rosuvastatin Impurity 118
CAS# 122549-26-2
M.F.: C14H15FO3
M.W.: 250.27 |
| |
| QN152710 | Norethindrone Impurity 10
CAS# 1670-34-4
M.F.: C20H26O2
M.W.: 298.42 |
| |
| QM202425 | Methotrexate Impurity 25
CAS# NA
M.F.: C4H5N6
M.W.: 137.12 |
| |
| QA200370 | Atracurium besilate EP Impurity K
CAS# NA
M.F.: C54H74N2O12
M.W.: 943.17 |
| |
| QA200369 | Atracurium besilate EP Impurity I
CAS# NA
M.F.: C54H74N2O12
M.W.: 943.17 |
| |
| QA200368 | Atracurium besilate EP Impurity H
CAS# NA
M.F.: C54H74N2O12
M.W.: 943.17 |
| |
| QA200366 | Atracurium besilate EP Impurity F
CAS# NA
M.F.: C22H30NO4
M.W.: 372.48 |
| |
| QA200365 | Atracurium besilate EP Impurity E
CAS# NA
M.F.: C24H32NO6
M.W.: 430.51 |
| |
| QA200364 | Atracurium besilate EP Impurity D
CAS# NA
M.F.: C29H42NO7
M.W.: 516.65 |
| |
| QA200363 | Atracurium besilate EP Impurity C
CAS# NA
M.F.: C32H44NO8
M.W.: 570.69 |
| |
| QA200362 | Atracurium besilate EP Impurity B
CAS# NA
M.F.: C51H66N2O12
M.W.: 899.08 |
| |
| QA200361 | Atracurium besilate EP Impurity A
CAS# NA
M.F.: C52H69N2O12
M.W.: 914.11 |
| |
| QS011234 | Salmeterol Impurity 8
CAS# 934842-69-0
M.F.: C32H43NO4
M.W.: 505.69 |
| |
| QT0307192 | Ticagrelor Impurity 192
CAS# NA
M.F.: C14H14Cl2N6O5S2
M.W.: 481.33 |
| |
| QP090320 | Sodium Picosulfate Impurity 20
CAS# NA
M.F.: C20H19NO8S2
M.W.: 465.50 |
| |
| QA060306 | Alfacalcidol Impurity 6
CAS# NA
M.F.: C33H58O2Si
M.W.: 514.90 |
| |
| QI091633 | Ipratropium Bromide Impurity 33
CAS# 3967-53-1
M.F.: C10H12O3
M.W.: 180.20 |
| |
| QI091632 | Ipratropium Bromide Impurity 32
CAS# 59216-85-2
M.F.: C9H8O3
M.W.: 164.16 |
| |
| QI091631 | Ipratropium Bromide Impurity 31
CAS# 54108-62-2
M.F.: C16H14O3
M.W.: 254.28 |
| |
| QS200779 | Sitagliptin Impurity 79
CAS# NA
M.F.: C16H13F6N5O2
M.W.: 421.30 |
| |
| QA011538 | Anastrozole Impurity 38
CAS# 1301724-97-9
M.F.: C19H21N3O2
M.W.: 323.39 |
| |
| QE1316132 | Empagliflozin Impurity 132
CAS# NA
M.F.: C23H27BrO7
M.W.: 495.36 |
| |
| QL130629 | Lamivudine Impurity 29
CAS# NA
M.F.: C23H33N8O10PS
M.W.: 644.59 |
| |
| QI151621 | R-Iopamidol
CAS# 88375-91-1
M.F.: C17H22I3N3O8
M.W.: 777.09 |
| |
| QA1624202 | Apixaban Impurity 202
CAS# NA
M.F.: C27H30N4O5
M.W.: 490.55 |
| |
| QF181944 | Furosemide Impurity 44
CAS# NA
M.F.: C15H16ClNO6S
M.W.: 373.81 |
| |
| QN151856 | Noradrenaline (Norepinephrine) Impurity 56
CAS# 14309-96-7
M.F.: C8H9NO3
M.W.: 167.16 |
| |
| QP012100 | Pasireotide
CAS# 396091-73-9
M.F.: C58H66N10O9
M.W.: 1047.21 |
| |
| QA1624197 | Apixaban Impurity 197
CAS# NA
M.F.: C25H28N6O4
M.W.: 476.53 |
| |
| QA1624196 | Apixaban Impurity 196
CAS# NA
M.F.: C27H31N5O5
M.W.: 505.57 |
| |
| QA1624194 | Apixaban Impurity 194
CAS# NA
M.F.: C38H38N6O6
M.W.: 674.74 |
| |
| QA1624193 | Apixaban Impurity 193
CAS# NA
M.F.: C29H34N6O5
M.W.: 546.62 |
| |
| QL201554 | Letrozole Impurity 54
CAS# NA
M.F.: C17H11N5O
M.W.: 301.30 |
| |
| QL201553 | Letrozole Impurity 53
CAS# NA
M.F.: C17H11N5O2
M.W.: 317.30 |
| |
| QI131800 | Imidapril
CAS# 89371-37-9
M.F.: C20H27N3O6
M.W.: 405.44 |
| |
| QR457047 | Rocuronium bromide Impurity 47
CAS# NA
M.F.: C32H53BrN2O4
M.W.: 609.68 |
| |
| QE191817 | Estradiol Valerate EP Impurity G
CAS# 1313382-25-0
M.F.: C23H30O3
M.W.: 354.48 |
| |
| QF122043 | Fluticasone Impurity 43
CAS# NA
M.F.: C52H54F4O12S3
M.W.: 1043.17 |
| |
| QT161890 | Topiroxostat Impurity 64
CAS# NA
M.F.: C13H8N6O2
M.W.: 280.24 |
| |
| QM031631 | Mycophenolic Acid Impurity 31
CAS# 344562-78-3
M.F.: C23H30O11
M.W.: 482.48 |
| |
| QL151433 | Lornoxicam Impurity 33
CAS# NA
M.F.: C9H12ClNO6S2
M.W.: 329.78 |
| |
| QM132040 | Memantine Impurity 40
CAS# NA
M.F.: C16H26N2O2
M.W.: 278.39 |
| |
| QF022490 | Febuxostat Impurity 64
CAS# 923942-36-3
M.F.: C20H24N2O3S
M.W.: 372.48 |
| |
| QF022489 | Febuxostat Impurity 63
CAS# 1312815-36-3
M.F.: C20H25NO4S
M.W.: 375.48 |
| |
| QI192022 | Irbesartan Impurity 22
CAS# NA
M.F.: C25H27N3O
M.W.: 385.50 |
| |
| QM154258 | Mirabegron Impurity 32
CAS# NA
M.F.: C24H22N2O6
M.W.: 434.44 |
| |
| QG122538 | Glycopyrrolate Impurity 38
CAS# NA
M.F.: C5H13NO2
M.W.: 119.16 |
| |
| QG122535 | Glycopyrrolate Impurity 35
CAS# NA
M.F.: C5H9NO2
M.W.: 115.13 |
| |
| QG122533 | Glycopyrrolate Impurity 33
CAS# NA
M.F.: C5H7NO3
M.W.: 129.11 |
| |
| QF120320 | Folic Acid Impurity 20
CAS# 5959-18-2
M.F.: C12H14N2O5
M.W.: 266.25 |
| |
| QK201837 | Ketorolac Impurity 37
CAS# 111930-01-9
M.F.: C15H13NO4
M.W.: 271.27 |
| |
| QF132033 | Formoterol Impurity 33
CAS# NA
M.F.: C20H26N2O4
M.W.: 358.43 |
| |
| QS060295 | Sofosbuvir Impurity 95
CAS# NA
M.F.: C10H13FN2O5
M.W.: 260.22 |
| |
| QS060294 | Sofosbuvir Impurity 94
CAS# NA
M.F.: C24H21FN2O7
M.W.: 468.43 |
| |
| QD012010 | Daprodustat Impurity 10
CAS# NA
M.F.: C18H27N3O4
M.W.: 349.42 |
| |
| QD053300 | Doxacurium chloride
CAS# 106819-53-8
M.F.: C56H78Cl2N2O16
M.W.: 1106.13 |
| |
| QO240111 | Oxacillin sodium Impurity 11
CAS# NA
M.F.: C19H19N3O5S
M.W.: 401.44 |
| |
| QE1316129 | Empagliflozin Impurity 129
CAS# NA
M.F.: C20H25ClO3Si
M.W.: 376.95 |
| |
| QE120134 | Elagolix Impurity 34
CAS# 7143-01-3
M.F.: C2H6O5S2
M.W.: 174.20 |
| |
| QE120133 | Elagolix Impurity 33
CAS# 117049-14-6
M.F.: C13H19NO3
M.W.: 237.29 |
| |
| QE120131 | Elagolix Impurity 31
CAS# 20989-17-7
M.F.: C8H11NO
M.W.: 137.18 |
| |
| QE120127 | Elagolix Impurity 27
CAS# 830346-47-9
M.F.: C13H10F4N2O2
M.W.: 302.22 |
| |
| QP180450 | Perindopril Impurity 50
CAS# 145513-33-3(free base)
M.F.: C19H32N2O5 C4H11N
M.W.: 368.47 73.14 |
| |
| QS200777 | Sitagliptin Impurity 77
CAS# 1253056-01-7
M.F.: C16H14F6N4O2
M.W.: 408.30 |
| |
| QR182452 | Brexpiprazole Impurity 52
CAS# 15116-41-3
M.F.: C16H15NO2
M.W.: 253.30 |
| |
| QA200105 | Atazanavir Impurity 5
CAS# 156474-21-4
M.F.: C15H21NO3
M.W.: 263.33 |
| |
| QT183200 | Triclabendazole
CAS# 68786-66-3
M.F.: C14H9Cl3N2OS
M.W.: 359.66 |
| |
| QT092401 | Tixocortol pivalate
CAS# 55560-96-8
M.F.: C26H38O5S
M.W.: 462.64 |
| |
| QF122430 | Fluoxetine Impurity 30
CAS# NA
M.F.: C9H9IO
M.W.: 260.07 |
| |
| QF122429 | Fluoxetine Impurity 29
CAS# 62872-58-6
M.F.: C9H11IO
M.W.: 262.09 |
| |
| QA132449 | Amoxicillin Impurity 23
CAS# NA
M.F.: C31H40N6O9S2
M.W.: 704.81 |
| |
| QA1624179 | Apixaban Impurity 179
CAS# NA
M.F.: C27H29ClN4O5
M.W.: 525.00 |
| |
| QC551819 | Clenbuterol Impurity 19
CAS# 37159-31-2
M.F.: C12H19ClN2O
M.W.: 242.75 |
| |
| QT0307191 | Ticagrelor Impurity 191
CAS# NA
M.F.: C7H10N2O3S
M.W.: 202.23 |
| |
| QO022025 | Obeticholic Acid Impurity 25
CAS# 1516887-33-4
M.F.: C26H40O4
M.W.: 416.59 |
| |
| QP092700 | Pinaverium Bromide
CAS# 53251-94-8
M.F.: C26H41Br2NO4
M.W.: 591.42 |
| |
| QP092704 | Pinaverium Bromide Impurity 4
CAS# 1235355-01-7
M.F.: C26H39Br2NO4
M.W.: 589.40 |
| |
| QP092703 | Pinaverium Bromide Impurity 3
CAS# 1126385-20-3
M.F.: C9H11BrO
M.W.: 215.09 |
| |
| QP092702 | Pinaverium Bromide Impurity 2
CAS# 53207-00-4
M.F.: C9H10Br2O2
M.W.: 309.98 |
| |
| QP092701 | Pinaverium Bromide Impurity 1
CAS# 54370-00-2
M.F.: C9H11BrO3
M.W.: 247.09 |
| |
| QO1920112 | Oseltamivir Impurity 112
CAS# NA
M.F.: C11H17N3O5
M.W.: 271.27 |
| |
| QO1920110 | Oseltamivir Impurity 110
CAS# NA
M.F.: C11H16N4O4
M.W.: 268.27 |
| |
| QA1624171 | Apixaban Impurity 171
CAS# NA
M.F.: C25H33Cl2N3O4
M.W.: 510.45 |
| |
| QA1624168 | Apixaban Impurity 168
CAS# NA
M.F.: C19H28N4O3
M.W.: 360.45 |
| |
| QA1624166 | Apixaban Impurity 166
CAS# NA
M.F.: C19H26N4O5
M.W.: 390.43 |
| |
| QR152425 | Roxadustat Impurity 25
CAS# 1455091-10-7
M.F.: C17H13NO4
M.W.: 295.29 |
| |
| QG140957 | Ganciclovir Impurity 57
CAS# NA
M.F.: C15H21N5O8
M.W.: 399.36 |
| |
| QT142426 | Tranexamic Acid Impurity 26
CAS# 2375016-71-8
M.F.: C8H13ClO2
M.W.: 176.64 |
| |
| QA022600 | Abeprazan
CAS# 1902954-60-2
M.F.: C19H17F3N2O3S
M.W.: 410.41 |
| |
| QS011232 | Salmeterol Impurity 6
CAS# 2262385-84-0
M.F.: C9H9BrO3
M.W.: 245.07 |
| |
| QT012000 | Tartronic acid
CAS# 80-69-3
M.F.: C3H4O5
M.W.: 120.06 |
| |
| QI162000 | Isomaltohexaonic acid
CAS# 534-74-7
M.F.: C12H22O12
M.W.: 358.30 |
| |
| QM120200 | Maltobionic acid
CAS# 534-42-9
M.F.: C12H22O12
M.W.: 358.30 |
| |
| QT0307190 | Ticagrelor Impurity 190
CAS# NA
M.F.: C26H31F2N7O5S
M.W.: 591.63 |
| |
| QI120114 | Ilaprazole Impurity 14
CAS# 1018229-53-2
M.F.: C11H9N3O
M.W.: 199.21 |
| |
| QF132032 | Formoterol Impurity 32
CAS# NA
M.F.: C20H26N2O4
M.W.: 358.43 |
| |
| QG140954 | Ganciclovir Impurity 54
CAS# 108436-61-9
M.F.: C18H21N5O5
M.W.: 387.39 |
| |
| QI120113 | Ilaprazole Impurity 13
CAS# 86604-74-2;124473-12-7(free base)
M.F.: C8H10ClNO HCl
M.W.: 171.62 36.46 |
| |
| QI210658 | Ibuprofen Impurity 32
CAS# 4397-53-9
M.F.: C14H12O2
M.W.: 212.24 |
| |
| QI222040 | Itraconazole Impurity 40
CAS# 219923-93-0
M.F.: C18H22N4O2
M.W.: 326.39 |
| |
| QI041553 | Indobufen Impurity 27
CAS# NA
M.F.: C18H17NO5
M.W.: 327.33 |
| |
| QI041551 | Indobufen Impurity 25
CAS# 1093759-05-7
M.F.: C14H13NO4
M.W.: 259.26 |
| |
| QS091106 | Shikimic Acid Impurity 6
CAS# 171963-37-4
M.F.: C7H10O5
M.W.: 174.15 |
| |
| QS091105 | Shikimic Acid Impurity 5
CAS# NA
M.F.: C7H10O5
M.W.: 174.15 |
| |
| QS091104 | Shikimic Acid Impurity 4
CAS# 21967-35-1
M.F.: C7H10O5
M.W.: 174.15 |
| |
| QS091103 | Shikimic Acid Impurity 3
CAS# 10191-00-1
M.F.: C7H10O5
M.W.: 174.15 |
| |
| QA220370 | Avibactam Impurity 44
CAS# NA
M.F.: C17H19N
M.W.: 237.34 |
| |
| QA220368 | Avibactam Impurity 42
CAS# NA
M.F.: C27H36N6O5
M.W.: 524.61 |
| |
| QC061738 | Cefoperazone Impurity 12
CAS# NA
M.F.: C24H25N9O8S2
M.W.: 631.64 |
| |
| QR182450 | Brexpiprazole Impurity 50
CAS# NA
M.F.: C33H31N3O2S2
M.W.: 565.75 |
| |
| QD261615 | Diazepam Impurity 15
CAS# 25759-97-1
M.F.: C20H14Cl2N2O
M.W.: 369.24 |
| |
| QD030451 | Diclofenac sodium Impurity 51
CAS# 95093-56-4
M.F.: C17H17Cl2NO3
M.W.: 354.23 |
| |
| QC022649 | Cabozantinib Impurity 49
CAS# NA
M.F.: C28H24FN3O5
M.W.: 501.51 |
| |
| QC022648 | Cabozantinib Impurity 48
CAS# NA
M.F.: C28H26FN3O6
M.W.: 519.52 |
| |
| QA130240 | Ambroxol Impurity 40
CAS# NA
M.F.: C13H16Br2N2O3
M.W.: 408.09 |
| |
| QA260501 | Dehydro Azelnidipine
CAS# 918659-10-6
M.F.: C33H32N4O6
M.W.: 580.63 |
| |
| QI071800 | Iguratimod
CAS# 123663-49-0
M.F.: C17H14N2O6S
M.W.: 374.37 |
| |
| QN202112 | Netupitant Impurity 12
CAS# NA
M.F.: C11H8F6O2
M.W.: 286.17 |
| |
| QC080304 | Cholic Acid Impurity 4
CAS# NA
M.F.: C25H40O5
M.W.: 420.58 |
| |
| QC080303 | Cholic Acid Impurity 3
CAS# NA
M.F.: C25H42O5
M.W.: 422.60 |
| |
| QR021649 | Rabeprazole Impurity 49
CAS# 117977-19-2
M.F.: C13H19NO4
M.W.: 253.29 |
| |
| QL201548 | Letrozole Impurity 48
CAS# 143030-54-0
M.F.: C16H11BrN4
M.W.: 339.19 |
| |
| QA161908 | Acetylsalicylic Acid Impurity 8
CAS# 15540-79-1
M.F.: C8H7NO5
M.W.: 197.14 |
| |
| QS041919 | Sodium Valproate Impurity 19
CAS# 3274-28-0
M.F.: C9H18O2
M.W.: 158.24 |
| |
| QR457046 | Rocuronium bromide Impurity 46
CAS# NA
M.F.: C23H37NO2
M.W.: 359.55 |
| |
| QR457045 | Rocuronium bromide Impurity 45
CAS# NA
M.F.: C23H37NO2
M.W.: 359.55 |
| |
| QR457044 | Rocuronium bromide Impurity 44
CAS# 2102929-98-4
M.F.: C23H37NO2
M.W.: 359.55 |
| |
| QR457043 | Rocuronium bromide Impurity 43
CAS# NA
M.F.: C21H30O3
M.W.: 330.46 |
| |
| QR457042 | Rocuronium bromide Impurity 42
CAS# 212505-49-2
M.F.: C21H30O3
M.W.: 330.46 |
| |
| QR457041 | Rocuronium bromide Impurity 41
CAS# NA
M.F.: C21H30O4
M.W.: 346.46 |
| |
| QR457040 | Rocuronium bromide Impurity 40
CAS# NA
M.F.: C21H30O4
M.W.: 346.46 |
| |
| QR457039 | Rocuronium bromide Impurity 39
CAS# NA
M.F.: C21H30O2
M.W.: 314.46 |
| |
| QG123301 | Glycodeoxycholic Acid Ethyl Ester
CAS# 70779-06-5
M.F.: C28H47NO5
M.W.: 477.68 |
| |
| QG121502 | Glycocholic Acid Ethyl Ester
CAS# 517904-33-5
M.F.: C28H47NO6
M.W.: 493.68 |
| |
| QV180388 | Voriconazole Nitroso Impurity 4
CAS# NA
M.F.: C10H9F2N5O2
M.W.: 269.21 |
| |
| QV180386 | Voriconazole Nitroso Impurity 3
CAS# NA
M.F.: C2H3N5O
M.W.: 113.08 |
| |
| QO1920101 | Oseltamivir Impurity 101
CAS# NA
M.F.: C13H18N4O5
M.W.: 310.31 |
| |
| QV307786 | Vitamin K1 Impurity 86
CAS# NA
M.F.: C31H46O3
M.W.: 466.70 |
| |
| QP082902 | Calcium Phenylpyruvate Impurity 2
CAS# NA
M.F.: C17H14N2O3
M.W.: 294.30 |
| |
| QP082901 | Calcium Phenylpyruvate Impurity 1
CAS# NA
M.F.: C18H13NO4
M.W.: 307.30 |
| |
| QD030444 | Diclofenac sodium Impurity 44
CAS# NA
M.F.: C28H23NO4
M.W.: 437.49 |
| |
| QL151427 | Lornoxicam Impurity 27
CAS# NA
M.F.: C10H11Cl2NO6S2
M.W.: 376.23 |
| |
| QL151425 | Lornoxicam Impurity 25
CAS# NA
M.F.: C7H7Cl2NO4S2
M.W.: 304.17 |
| |
| QT1406175 | Tenofovir Impurity 175
CAS# 50615-40-2
M.F.: C8H10ClN5
M.W.: 211.65 |
| |
| QF122602 | Flutrimazole EP Impurity B
CAS# 128092-72-8
M.F.: C19H14F2O
M.W.: 296.31 |
| |
| QM092208 | Mivacurium chloride Impurity 8
CAS# 38561-68-1
M.F.: C8H12O4
M.W.: 172.18 |
| |
| QD122041 | Dolutegravir Impurity 41
CAS# 1309560-49-3
M.F.: C20H19F2N3O5
M.W.: 419.38 |
| |
| QC082801 | Chlormadinone acetate EP Impurity A
CAS# 2477-73-8
M.F.: C23H31ClO4
M.W.: 406.94 |
| |
| QN131129 | Nifuratel impurity 29
CAS# NA
M.F.: C5H10N2O2S
M.W.: 162.21 |
| |
| QC120103 | Clavulanic Acid Impurity 3
CAS# 92632-79-6
M.F.: C4H9NO2 HCl
M.W.: 103.12 36.46 |
| |
| QA262011 | Azathioprine Impurity 11;
Mercaptopurine EP Impurity C
CAS# 90947-51-6
M.F.: C10H6N8S
M.W.: 270.27 |
| |
| QV122220 | Valaciclovir Impurity 20;Adenine;
Mercaptopurine EP Impurity B
CAS# 73-24-5
M.F.: C5H5N5
M.W.: 135.13 |
| |
| QE1316124 | Empagliflozin Impurity 124
CAS# 915095-90-8
M.F.: C17H16BrClO2
M.W.: 367.66 |
| |
| QG123400 | Glycolithocholic acid
CAS# 474-74-8
M.F.: C26H43NO4
M.W.: 433.62 |
| |
| QR182448 | Brexpiprazole Impurity 48
CAS# 6855-48-7
M.F.: C8H7NO2
M.W.: 149.15 |
| |
| QR182447 | Brexpiprazole Impurity 47
CAS# 22246-84-0
M.F.: C10H11NO2
M.W.: 177.20 |
| |
| QR182446 | Brexpiprazole Impurity 46
CAS# NA
M.F.: C26H28ClN3O2S
M.W.: 482.04 |
| |
| QD030440 | Diclofenac sodium Impurity 40
CAS# 320777-08-0
M.F.: C14H12ClNO2
M.W.: 261.70 |
| |
| QM202421 | Methotrexate Impurity 21
CAS# 82778-08-3
M.F.: C7H7ClN6 HCl
M.W.: 210.62 36.46 |
| |
| QB052512 | Benzylpenicillin sodium CP Impurity L
CAS# NA
M.F.: C26H29N3O7S
M.W.: 527.59 |
| |
| QB052510 | Benzylpenicillin sodium CP Impurity J
CAS# NA
M.F.: C17H20N2O6S
M.W.: 380.42 |
| |
| QB052509 | Benzylpenicillin sodium CP Impurity I
CAS# NA
M.F.: C16H18N2O4S
M.W.: 334.39 |
| |
| QB052508 | Benzylpenicillin sodium CP Impurity H
CAS# 500-98-1
M.F.: C10H11NO3
M.W.: 193.20 |
| |
| QK200318 | Ketoconazole Impurity 18
CAS# 2234-16-4
M.F.: C8H6Cl2O
M.W.: 189.04 |
| |
| QG131815 | Gimeracil Impurity 15
CAS# 1379260-15-7
M.F.: C6H6ClNO2
M.W.: 159.57 |
| |
| QH041815 | Cholesterol Impurity 15
CAS# 15073-00-4
M.F.: C28H48O
M.W.: 400.68 |
| |
| QE042245 | Edaravone Impurity 19
CAS# NA
M.F.: C27H30N4O4
M.W.: 474.55 |
| |
| QC042020 | Cefditoren pivoxil Impurity 20
CAS# NA
M.F.: C31H40N6O10S3
M.W.: 752.88 |
| |
| QC042018 | Cefditoren pivoxil Impurity 18
CAS# NA
M.F.: C33H36N6O8S3
M.W.: 740.87 |
| |
| QC042017 | Cefditoren pivoxil Impurity 17
CAS# 145904-68-3
M.F.: C19H18N6O5S3
M.W.: 506.58 |
| |
| QR052002 | 9-cis-4-Hydroxyretinoic acid
CAS# 150737-17-0
M.F.: C20H28O3
M.W.: 316.43 |
| |
| QM031630 | Mycophenolic Acid Impurity 30
CAS# 27979-57-3
M.F.: C9H8O4
M.W.: 180.16 |
| |
| QR022238 | Ribavirin Impurity 12
CAS# 61849-90-9
M.F.: C13H18O9
M.W.: 318.28 |
| |
| QG211202 | Sodium Gualenate Impurity 2
CAS# 6223-36-5
M.F.: C17H22O3S
M.W.: 306.42 |
| |
| QG211201 | Sodium Gualenate Impurity 1
CAS# 93914-28-4
M.F.: C15H17NaO3S
M.W.: 300.35 |
| |
| QG211200 | Sodium Gualenate
CAS# 6223-35-4
M.F.: C15H17NaO3S
M.W.: 300.35 |
| |
| QV307785 | Vitamin B6 Impurity 85
CAS# 90005-85-9
M.F.: C8H9NO3 HCl
M.W.: 167.16 36.46 |
| |
| QV307784 | Vitamin B6 Impurity 84
CAS# NA
M.F.: C16H20N2O5
M.W.: 320.34 |
| |
| QV307783 | Vitamin B6 Impurity 83
CAS# 2726926-28-7
M.F.: C16H20N2O5
M.W.: 320.34 |
| |
| QV307782 | Vitamin B6 Impurity 82
CAS# NA
M.F.: C16H20N2O5
M.W.: 320.34 |
| |
| QV307781 | Vitamin B6 Impurity 81
CAS# NA
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QV307780 | Vitamin B6 Impurity 80
CAS# NA
M.F.: C12H17NO3
M.W.: 223.27 |
| |
| QV307779 | Vitamin B6 Impurity 79
CAS# 1385767-86-1
M.F.: C12H17NO3
M.W.: 223.27 |
| |
| QV307778 | Vitamin B6 Impurity 78
CAS# NA
M.F.: C14H21NO3
M.W.: 251.32 |
| |
| QC065302 | Chlorogenic acid Impurity 2
CAS# NA
M.F.: C16H16O9
M.W.: 352.29 |
| |
| QV307777 | Vitamin K1 Impurity 77
CAS# NA
M.F.: C31H46O2
M.W.: 450.71 |
| |
| QO022024 | Obeticholic Acid Impurity 24
CAS# 1831863-02-5
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QO022023 | Tauro-Obeticholic Acid-d5
CAS# NA
M.F.: C28H44D5NO6S
M.W.: 532.79 |
| |
| QO022022 | Tauro-Obeticholic Acid
CAS# 863239-61-6
M.F.: C28H49NO6S
M.W.: 527.76 |
| |
| QO022021 | Glyco-Obeticholic Acid-d5
CAS# NA
M.F.: C28H42D5NO5
M.W.: 482.71 |
| |
| QO022020 | Glyco-Obeticholic Acid
CAS# 863239-60-5
M.F.: C28H47NO5
M.W.: 477.68 |
| |
| QO022019 | Obeticholic Acid-d5
CAS# 1992000-80-2
M.F.: C26H39D5O4
M.W.: 425.66 |
| |
| QA056342 | Agomelatine Impurity 42
CAS# 178677-39-9
M.F.: C15H19NO2
M.W.: 245.32 |
| |
| QT131212 | Timolol Maleate Impurity 12
CAS# 158636-96-5
M.F.: C13H24N4O3S
M.W.: 316.42 |
| |
| QW011820 | Warfarin sodium Impurity 20
CAS# NA
M.F.: C18H18O3
M.W.: 282.33 |
| |
| QA131245 | Amlodipine Impurity 45
CAS# 130161-00-1
M.F.: C18H18ClNO4
M.W.: 347.79 |
| |
| QI091630 | Ipratropium Bromide Impurity 30
CAS# NA
M.F.: C19H25NO3
M.W.: 315.41 |
| |
| QP180449 | Perindopril Impurity 49
CAS# 145513-93-5
M.F.: C9H15NO2
M.W.: 169.22 |
| |
| QM201820 | Metaraminol Impurity 20
CAS# NA
M.F.: C24H25NO4
M.W.: 391.46 |
| |
| QR122411 | Raloxifene Impurity 11
CAS# 2008-75-5
M.F.: C7H14ClN HCl
M.W.: 147.65 36.46 |
| |
| QP1903129 | Posaconazole Impurity 129
CAS# NA
M.F.: C22H20F2INO4
M.W.: 527.30 |
| |
| QA020415 | Albendazole Impurity 15
CAS# 95384-59-1
M.F.: C14H14N2O
M.W.: 226.27 |
| |
| QR051209 | Relugolix Impurity 9
CAS# NA
M.F.: C31H30F2N8O7S
M.W.: 696.68 |
| |
| QR051208 | Relugolix Impurity 8
CAS# NA
M.F.: C54H46F4N12O6S2
M.W.: 1099.14 |
| |
| QP082202 | Phenprocoumon, (S)-
CAS# 3770-63-6
M.F.: C18H16O3
M.W.: 280.32 |
| |
| QS211704 | Sulindac Impurity 4
CAS# 61849-35-2
M.F.: C20H17FO3S
M.W.: 356.41 |
| |
| QZ151207 | Zoledronic acid Impurity 7
CAS# NA
M.F.: C5H8N2O6P2
M.W.: 254.07 |
| |
| QC160765 | Clopidogrel Impurity 39
CAS# NA
M.F.: C15H14O5S
M.W.: 306.33 |
| |
| QP180787 | Pregabalin Impurity 87
CAS# NA
M.F.: C8H17NO3
M.W.: 175.23 |
| |
| QS040669 | Sildenafil Impurity 69
CAS# 1446089-83-3
M.F.: C32H38N6O3
M.W.: 554.68 |
| |
| QP160520 | Prednisolone Acetate EP Impurity E
CAS# 4380-55-6
M.F.: C23H28O5
M.W.: 384.47 |
| |
| QP160519 | Prednisolone Acetate EP Impurity D
CAS# 20423-99-8
M.F.: C21H28O4
M.W.: 344.44 |
| |
| QP160518 | Prednisolone Acetate EP Impurity C
CAS# 98523-85-4
M.F.: C25H32O7
M.W.: 444.52 |
| |
| QT050704 | Tegafur Impurity 4
CAS# NA
M.F.: C10H14N2O4
M.W.: 226.23 |
| |
| QE201515 | Etodolac Impurity 15
CAS# 101901-08-0
M.F.: C17H21NO4
M.W.: 303.35 |
| |
| QR021644 | Rabeprazole Impurity 44
CAS# 1173655-69-0
M.F.: C11H17NO4
M.W.: 227.26 |
| |
| QF120319 | Folic Acid Impurity 19
CAS# NA
M.F.: C20H22ClN7O6
M.W.: 491.88 |
| |
| QV307775 | Vitamin K1 Impurity 75
CAS# 64236-23-3
M.F.: C31H48O2
M.W.: 452.71 |
| |
| QS075488 | Sugammadex Impurity 88
CAS# 131105-41-4
M.F.: C36H54I6O24
M.W.: 1632.23 |
| |
| QP1903120 | Posaconazole Impurity 120
CAS# NA
M.F.: C44H48F2N8O4
M.W.: 790.90 |
| |
| QV041415 | Vardenafil Impurity 15
CAS# NA
M.F.: C18H22N4O5S
M.W.: 406.46 |
| |
| QS200774 | Sitagliptin Impurity 74
CAS# NA
M.F.: C10H8F3NO2
M.W.: 231.17 |
| |
| QS200773 | Sitagliptin Impurity 73
CAS# 1256815-03-8
M.F.: C10H7F3O3
M.W.: 232.16 |
| |
| QS200772 | Sitagliptin Impurity 72
CAS# 1151240-88-8
M.F.: C12H11F3O3
M.W.: 260.21 |
| |
| QP131243 | Pomalidomide Impurity 17
CAS# NA
M.F.: C15H10N2O4
M.W.: 282.25 |
| |
| QP090319 | Sodium Picosulfate Impurity 19
CAS# NA
M.F.: C26H31NO8S2
M.W.: 549.66 |
| |
| QP090318 | Sodium Picosulfate Impurity 18
CAS# NA
M.F.: C22H23NO8S2
M.W.: 493.55 |
| |
| QC010100 | Controlled Substance
(Cannabidiolic acid)
CAS# 1244-58-2
M.F.: C22H30O4
M.W.: 358.47 |
| |
| QT142425 | Tranexamic Acid Impurity 25
CAS# 861518-79-8
M.F.: C16H13ClO4
M.W.: 304.73 |
| |
| QB121432 | Blonanserin Impurity 6
CAS# NA
M.F.: C25H35N3O
M.W.: 393.56 |
| |
| QM1602121 | Moxifloxacin Impurity 121
CAS# 1797982-51-4
M.F.: C16H16FNO5
M.W.: 321.30 |
| |
| QT052402 | Tenoxicam Impurity 2
CAS# 59337-92-7
M.F.: C6H5ClO4S2
M.W.: 240.68 |
| |
| QI140414 | Indometacin Impurity 14
CAS# 73301-01-6
M.F.: C10H11ClO4
M.W.: 230.64 |
| |
| QS132249 | Simvastatin EP Impurity M
CAS# 864357-87-9
M.F.: C27H44O6
M.W.: 464.63 |
| |
| QD030439 | Diclofenac sodium Impurity 39
CAS# 172494-87-0
M.F.: C13H11Cl2N
M.W.: 252.14 |
| |
| QD030438 | Diclofenac sodium Impurity 38
CAS# 127792-34-1
M.F.: C14H12ClNO2
M.W.: 261.70 |
| |
| QD030437 | Diclofenac sodium Impurity 37
CAS# NA
M.F.: C18H20Cl2N2O2
M.W.: 367.27 |
| |
| QS061426 | Safinamide Impurity Z
CAS# 1827614-91-4
M.F.: C18H20FNO3
M.W.: 317.35 |
| |
| QF122113 | Fluorouracil Impurity 13
CAS# 155-16-8
M.F.: C5H5FN2O2
M.W.: 144.10 |
| |
| QA150925 | Atomoxetine Impurity 25
CAS# 881995-46-6
M.F.: C16H19NO HCl
M.W.: 241.33 36.46 |
| |
| QP181674 | Pramipexole Impurity 74
CAS# 1001648-75-4
M.F.: C7H11N3OS
M.W.: 185.25 |
| |
| QS010262 | Salbutamol Impurity 36
CAS# NA
M.F.: C17H23NO4
M.W.: 305.37 |
| |
| QF130421 | Famotidine Impurity 21
CAS# 95853-46-6
M.F.: C3H7N3O2S
M.W.: 149.17 |
| |
| QP180784 | Pregabalin Impurity 84
CAS# 313651-25-1
M.F.: C9H19NO2
M.W.: 173.25 |
| |
| QV307774 | Vitamin K1 Impurity 74
CAS# 107759-10-4
M.F.: C31H48O4
M.W.: 484.71 |
| |
| QA190213 | Ascorbic Acid Impurity 13
CAS# NA
M.F.: C6H6O7
M.W.: 190.11 |
| |
| QD162006 | Daptomycin Impurity F
CAS# NA
M.F.: C72H103N17O27
M.W.: 1638.69 |
| |
| QM031629 | Mycophenolic Acid-13C-d3
CAS# NA
M.F.: C1613CH17D3O6
M.W.: 324.35 |
| |
| QM040140 | Midazolam Impurity 14
CAS# NA
M.F.: C23H18ClFN2O4
M.W.: 440.85 |
| |
| QB191626 | Bisoprolol Impurity 26
CAS# NA
M.F.: C19H33NO4
M.W.: 339.47 |
| |
| QB191625 | Bisoprolol Impurity 25
CAS# 2226263-67-6
M.F.: C15H22O4
M.W.: 266.33 |
| |
| QB191624 | Bisoprolol Impurity 24
CAS# NA
M.F.: C27H40O7
M.W.: 476.60 |
| |
| QA220362 | Avibactam Impurity 36
CAS# NA
M.F.: C9H21O3P
M.W.: 208.24 |
| |
| QA220361 | Avibactam Impurity 35
CAS# 18812-51-6
M.F.: C7H17O3P
M.W.: 180.18 |
| |
| QA220359 | Avibactam Impurity 33
CAS# NA
M.F.: C11H25O3P
M.W.: 236.29 |
| |
| QA220358 | Avibactam Impurity 32
CAS# NA
M.F.: C17H21O3P
M.W.: 304.32 |
| |
| QV180382 | Voriconazole Impurity 56
CAS# 2094735-34-7
M.F.: C10H10BrFN4O
M.W.: 301.12 |
| |
| QC180821 | Chlorphenamine Impurity 21
CAS# NA
M.F.: C17H20ClN3O
M.W.: 317.81 |
| |
| QA180607 | ArforMoterol Tartrate Impurity 7
CAS# NA
M.F.: C20H26N2O4
M.W.: 358.43 |
| |
| QG040238 | Gadobutrol Impurity 38
CAS# 112193-75-6
M.F.: C12H24N4O4
M.W.: 288.34 |
| |
| QG040237 | Gadobutrol Impurity 37
CAS# 170454-90-7
M.F.: C10H22N4O2
M.W.: 230.31 |
| |
| QF022487 | Febuxostat Impurity 61
CAS# 25984-63-8
M.F.: C7H7NOS
M.W.: 153.20 |
| |
| QP090317 | Sodium Picosulfate Impurity 17
CAS# 22945-62-6
M.F.: C12H9NO2
M.W.: 199.21 |
| |
| QP090316 | Sodium Picosulfate Impurity 16
CAS# 33077-70-2
M.F.: C12H9NO2
M.W.: 199.21 |
| |
| QB082440 | Bromhexine Impurity 14
CAS# NA
M.F.: C20H30Br2N2O5
M.W.: 538.27 |
| |
| QP052700 | Pemirolast
CAS# 69372-19-6
M.F.: C10H8N6O
M.W.: 228.21 |
| |
| QP132075 | Pemetrexed Impurity 49
CAS# 883553-87-5
M.F.: C25H28N6O9
M.W.: 556.52 |
| |
| QP1824108 | Parecoxib Sodium Impurity 82
CAS# 1448355-87-0
M.F.: C16H12ClNO
M.W.: 269.73 |
| |
| QF120210 | Flubendazole Impurity 10
CAS# NA
M.F.: C13H7ClFNO3
M.W.: 279.65 |
| |
| QF120209 | Flubendazole Impurity 9
CAS# NA
M.F.: C12H8F2OS
M.W.: 238.25 |
| |
| QS201223 | Sertraline Impurity 23
CAS# NA
M.F.: C17H17Cl2N
M.W.: 306.23 |
| |
| QP012200 | Parvine
CAS# 57103-51-2
M.F.: C18H13N3O
M.W.: 287.32 |
| |
| QI221800 | Ivermectin B1a
CAS# 71827-03-7
M.F.: C48H74O14
M.W.: 875.09 |
| |
| QM041849 | Minodronic Acid Impurity 23
CAS# 22418-77-5
M.F.: C4H4O3
M.W.: 100.07 |
| |
| QT180678 | Tirofiban Impurity 78
CAS# NA
M.F.: C21H34N2O5S
M.W.: 426.57 |
| |
| QT180676 | Tirofiban Impurity 76
CAS# NA
M.F.: C20H26N2O5S
M.W.: 406.50 |
| |
| QM041848 | Minodronic Acid Impurity 22
CAS# 1575-59-3
M.F.: C4H4O3
M.W.: 100.07 |
| |
| QD030435 | Diclofenac sodium Impurity 35
CAS# 69002-84-2
M.F.: C14H11Cl2NO3
M.W.: 312.15 |
| |
| QL091665 | Lipoic Acid Impurity39
CAS# 6718-96-3
M.F.: C16H28O4S4
M.W.: 412.65 |
| |
| QL091664 | Lipoic Acid Impurity 38
CAS# NA
M.F.: C16H28O4S4
M.W.: 412.65 |
| |
| QP081833 | Phloroglucinol Impurity 33
CAS# NA
M.F.: C18H14O9
M.W.: 374.30 |
| |
| QL053000 | Leucovorin
CAS# 58-05-9
M.F.: C20H23N7O7
M.W.: 473.44 |
| |
| QI200341 | Irinotecan-d10 HCl
CAS# 718612-62-5
M.F.: C33H28D10N4O6 HCl
M.W.: 596.74 36.46 |
| |
| QC162011 | Camptothecin Impurity 11
CAS# 718612-49-8
M.F.: C22H17D3N2O5
M.W.: 395.42 |
| |
| QA164180 | Avanafil Impurity 54
CAS# NA
M.F.: C28H30ClN9O3
M.W.: 576.05 |
| |
| QA164179 | Avanafil Impurity 53
CAS# 2520113-98-6
M.F.: C24H24ClN7O4
M.W.: 509.94 |
| |
| QA164173 | Avanafil Impurity 47
CAS# NA
M.F.: C18H19ClN4O5
M.W.: 406.82 |
| |
| QA164172 | Avanafil Impurity 46
CAS# NA
M.F.: C20H23ClN4O5
M.W.: 434.87 |
| |
| QA164170 | Avanafil Impurity 44
CAS# NA
M.F.: C18H19ClN4O5
M.W.: 406.82 |
| |
| QA164167 | Avanafil Impurity 41
CAS# 56633-75-1
M.F.: C6H11NO2
M.W.: 129.16 |
| |
| QA164165 | Avanafil Impurity 39
CAS# 1624833-89-1
M.F.: C19H19ClN6O4S
M.W.: 462.91 |
| |
| QA164164 | Avanafil Impurity 38
CAS# NA
M.F.: C14H14ClN3O5S
M.W.: 371.80 |
| |
| QA164163 | Avanafil Impurity 37
CAS# NA
M.F.: C14H14ClN3O4S
M.W.: 355.80 |
| |
| QA164160 | Avanafil Impurity 34
CAS# NA
M.F.: C26H22Cl2N6O7
M.W.: 601.39 |
| |
| QA164159 | Avanafil Impurity 33
CAS# NA
M.F.: C30H30Cl2N6O7
M.W.: 657.50 |
| |
| QA164158 | Avanafil Impurity 32
CAS# 330786-34-0
M.F.: C14H14ClN3O3S
M.W.: 339.80 |
| |
| QA164156 | Avanafil Impurity 30
CAS# NA
M.F.: C16H17Cl2N3O3S
M.W.: 402.30 |
| |
| QN151852 | Noradrenaline (Norepinephrine) Impurity 52
CAS# NA
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QN151851 | Noradrenaline (Norepinephrine) Impurity 51
CAS# 4779-94-6(HCl salt)
M.F.: C8H11NO2
M.W.: 153.18 |
| |
| QN151850 | Noradrenaline (Norepinephrine) Impurity 50
CAS# NA
M.F.: C8H11NO4
M.W.: 185.18 |
| |
| QN151849 | Noradrenaline (Norepinephrine) Impurity 49
CAS# NA
M.F.: C8H11NO4
M.W.: 185.18 |
| |
| QN151848 | Noradrenaline (Norepinephrine) Impurity 48
CAS# NA
M.F.: C8H11NO4
M.W.: 185.18 |
| |
| QN151847 | Noradrenaline (Norepinephrine) Impurity 47
CAS# NA
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QN151846 | Noradrenaline (Norepinephrine) Impurity 46
CAS# 94593-04-1
M.F.: C8H9NO3
M.W.: 167.16 |
| |
| QN151845 | Noradrenaline (Norepinephrine) Impurity 45
CAS# 117883-03-1
M.F.: C8H7NO3
M.W.: 165.15 |
| |
| QN151844 | Noradrenaline (Norepinephrine) Impurity 44
CAS# NA
M.F.: C8H7NO3
M.W.: 165.15 |
| |
| QN151843 | Noradrenaline (Norepinephrine) Impurity 43
CAS# NA
M.F.: C10H8Cl2O4
M.W.: 263.07 |
| |
| QN151842 | Noradrenaline (Norepinephrine) Impurity 42
CAS# NA
M.F.: C8H5ClO3
M.W.: 184.58 |
| |
| QS201218 | Sertraline Impurity 18
CAS# NA
M.F.: C17H17Cl2NO
M.W.: 322.23 |
| |
| QR052213 | Revefenacin Impurity 13
CAS# 90-41-5
M.F.: C12H11N
M.W.: 169.22 |
| |
| QB051316 | Bempedoic acid Impurity 16
CAS# 36635-61-7
M.F.: C9H9NO2S
M.W.: 195.24 |
| |
| QB051315 | Bempedoic acid Impurity 15
CAS# NA
M.F.: C18H18N2O4S2
M.W.: 390.48 |
| |
| QB051314 | Bempedoic acid Impurity 14
CAS# 36635-56-0
M.F.: C9H11NO3S
M.W.: 213.25 |
| |
| QB051313 | Bempedoic acid Impurity 13
CAS# NA
M.F.: C21H38O5
M.W.: 370.52 |
| |
| QB051312 | Bempedoic acid Impurity 12
CAS# NA
M.F.: C20H36O5
M.W.: 356.50 |
| |
| QB051311 | Bempedoic acid Impurity 11
CAS# NA
M.F.: C21H38O5
M.W.: 370.52 |
| |
| QB051310 | Bempedoic acid Impurity 10
CAS# 123469-92-1
M.F.: C11H21BrO2
M.W.: 265.19 |
| |
| QB051309 | Bempedoic acid Impurity 9
CAS# NA
M.F.: C12H22O3
M.W.: 214.30 |
| |
| QB051308 | Bempedoic acid Impurity 8
CAS# NA
M.F.: C20H29NO4S
M.W.: 379.51 |
| |
| QB051307 | Bempedoic acid Impurity 7
CAS# NA
M.F.: C17H32O4
M.W.: 300.43 |
| |
| QB051306 | Bempedoic acid Impurity 6
CAS# NA
M.F.: C11H21BrO2
M.W.: 265.19 |
| |
| QB051305 | Bempedoic acid Impurity 5
CAS# 413624-71-2
M.F.: C19H34O5
M.W.: 342.47 |
| |
| QB051304 | Bempedoic acid Impurity 4
CAS# 738606-43-4
M.F.: C23H42O5
M.W.: 398.58 |
| |
| QB051303 | Bempedoic acid Impurity 3
CAS# NA
M.F.: C31H49NO6S
M.W.: 563.79 |
| |
| QB051302 | Bempedoic acid Impurity 2
CAS# 2280838-78-8
M.F.: C11H22O3
M.W.: 202.29 |
| |
| QB051301 | Bempedoic acid Impurity 1
CAS# 7443-29-0
M.F.: C9H17BrO2
M.W.: 237.13 |
| |
| QV307772 | Vitamin K1 Impurity 72
CAS# NA
M.F.: C31H46O4
M.W.: 482.69 |
| |
| QV307770 | Vitamin K1 Impurity 70
CAS# 22399-39-9
M.F.: C13H10O3
M.W.: 214.22 |
| |
| QL151413 | Lornoxicam Impurity 13
CAS# 59804-27-2
M.F.: C7H9NO4S2
M.W.: 235.28 |
| |
| QL151412 | Lornoxicam Impurity 12
CAS# NA
M.F.: C6H5ClO5S2
M.W.: 256.68 |
| |
| QI191918 | Isosorbide Impurity 18
CAS# 100402-56-0;27299-12-3(free base)
M.F.: C6H12O5 C6H12O6
M.W.: 164.16 180.16 |
| |
| QI191917 | Isosorbide Impurity 17
CAS# 13042-38-1
M.F.: C10H14O6
M.W.: 230.21 |
| |
| QI191916 | Isosorbide Impurity 16
CAS# 65940-93-4
M.F.: C8H12O5
M.W.: 188.18 |
| |
| QL051510 | Calcium Levofolinate Impurity 10;
Calcium Folinate Hydrate EP Impurity B
CAS# 98814-60-9
M.F.: C21H23N7O8
M.W.: 501.45 |
| |
| QT0307174 | Ticagrelor Impurity 174
CAS# 3721-26-4
M.F.: C9H11N
M.W.: 133.19 |
| |
| QT1406157 | Tenofovir Impurity 157
CAS# NA
M.F.: C21H29N6O5P
M.W.: 476.47 |
| |
| QE200376 | Entacapone Impurity 76
CAS# 158693-01-7
M.F.: C10H7N3O5
M.W.: 249.18 |
| |
| QE200375 | Entacapone Impurity 75
CAS# NA
M.F.: C14H16N2O7
M.W.: 324.29 |
| |
| QP090315 | Sodium Picosulfate Impurity 15
CAS# NA
M.F.: C18H13NNa2O8S2
M.W.: 481.41 |
| |
| QA202298 | Atorvastatin EP Impurity J
CAS# NA
M.F.: C33H33FN2O4
M.W.: 540.62 |
| |
| QF012226 | Favipiravir Impurity 26
CAS# NA
M.F.: C5H2FN3O
M.W.: 139.09 |
| |
| QL162031 | Lapatinib Impurity 31
CAS# 202196-46-1
M.F.: C26H19N3O3
M.W.: 421.45 |
| |
| QI091629 | Ipratropium Bromide Impurity 29
CAS# 3423-23-2;94217-34-2(HCl salt)
M.F.: C10H19NO
M.W.: 169.26 |
| |
| QV200104 | Vitamin A epoxide
CAS# 512-39-0
M.F.: C20H30O2
M.W.: 302.45 |
| |
| QA122613 | Alprazolam Impurity 13
CAS# NA
M.F.: C15H13ClN4
M.W.: 284.74 |
| |
| QA122612 | Alprazolam Impurity 12
CAS# 5220-83-7
M.F.: C15H11ClN2O
M.W.: 270.71 |
| |
| QM031626 | Mycophenolate Impurity 26
CAS# NA
M.F.: C17H20O7
M.W.: 336.34 |
| |
| QT012800 | Taurocholic Acid Sodium Salt Hydrate
CAS# 345909-26-4; 81-24-3(free base);145-42-6(Na salt)
M.F.: C26H44NNaO7S XH2O
M.W.: 537.68 X18.02 |
| |
| QF120318 | Folic Acid Impurity 18
CAS# NA
M.F.: C7H7N5O2
M.W.: 193.16 |
| |
| QF120317 | Folic Acid Impurity 17
CAS# 948-60-7
M.F.: C7H5N5O3
M.W.: 207.15 |
| |
| QF120316 | Folic Acid Impurity 16
CAS# 708-75-8
M.F.: C7H7N5O
M.W.: 177.16 |
| |
| QD050120 | Dexrazoxane Impurity 20
CAS# NA
M.F.: C14H24N2O8
M.W.: 348.35 |
| |
| QE042849 | Edoxaban Impurity 49
CAS# NA
M.F.: C8H11IN2OS2
M.W.: 342.22 |
| |
| QT183100 | Trihydroxycoprostanic Acid
CAS# 547-98-8
M.F.: C27H46O5
M.W.: 450.65 |
| |
| QP020382 | Palbociclib Impurity 82
CAS# 1023594-50-4
M.F.: C14H22N4O2
M.W.: 278.35 |
| |
| QA1624147 | Apixaban Impurity 147
CAS# NA
M.F.: C27H28N4O5
M.W.: 488.54 |
| |
| QA1624146 | Apixaban Impurity 146
CAS# NA
M.F.: C25H25N5O4
M.W.: 459.50 |
| |
| QD160768 | Dapagliflozin Impurity 68
CAS# NA
M.F.: C10H20O6
M.W.: 236.26 |
| |
| QD160766 | Dapagliflozin Impurity 66
CAS# NA
M.F.: C15H14ClIO2
M.W.: 388.63 |
| |
| QS060287 | Sofosbuvir Impurity 87
CAS# NA
M.F.: C31H26FN3O7
M.W.: 571.55 |
| |
| QC242034 | Cefoxitin Impurity 34
CAS# NA
M.F.: C10H14N2O3S
M.W.: 242.29 |
| |
| QA142703 | Androstenediol Impurity 3
CAS# 68539-12-8
M.F.: C19H24O2
M.W.: 284.39 |
| |
| QF051805 | Ferulic acid Impurity 5
CAS# 32263-14-2
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QF051804 | Ferulic acid Impurity 4
CAS# 2931-90-0
M.F.: C9H8O4
M.W.: 180.16 |
| |
| QP184001 | Pregnanediol-3alpha-glucuronide
CAS# 1852-49-9
M.F.: C27H44O8
M.W.: 496.63 |
| |
| QO192071 | Oseltamivir Impurity 71
CAS# NA
M.F.: C22H32N2O6
M.W.: 420.50 |
| |
| QV050308 | Vecuronium Bromide Impurity 8
CAS# 13522-16-2
M.F.: C29H50N2O2
M.W.: 458.72 |
| |
| QV050307 | Vecuronium Bromide Impurity 7
CAS# 13522-14-0
M.F.: C29H48N2O2
M.W.: 456.70 |
| |
| QL091663 | Lipoic Acid Impurity 37
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QT180673 | Tirofiban Impurity 73
CAS# 10147-36-1
M.F.: C3H7ClO2S
M.W.: 142.60 |
| |
| QV010714 | Valganciclovir EP Impurity P
CAS# 897937-73-4
M.F.: C19H31N7O6
M.W.: 453.49 |
| |
| QP180781 | Pregabalin Impurity 81
CAS# NA
M.F.: C8H14N2O
M.W.: 154.21 |
| |
| QL091662 | Lipoic Acid Impurity 36
CAS# 188783-96-2
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091661 | Lipoic Acid Impurity 35
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091660 | Lipoic Acid Impurity 34
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091659 | Lipoic Acid Impurity 33
CAS# 188745-24-6
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091658 | Lipoic Acid Impurity 32
CAS# 119365-69-4
M.F.: C8H16O2S2
M.W.: 208.34 |
| |
| QK201632 | Ketoprofen Impurity 32
CAS# 1853132-06-5
M.F.: C26H32O3
M.W.: 392.53 |
| |
| QC0303106 | Cinacalcet Impurity 106
CAS# 217483-10-8
M.F.: C17H20O3S
M.W.: 304.40 |
| |
| QD182400 | Droxidopa
CAS# 23651-95-8
M.F.: C9H11NO5
M.W.: 213.19 |
| |
| QD050400 | Dehydrocholic acid
CAS# 81-23-2
M.F.: C24H34O5
M.W.: 402.52 |
| |
| QE161242 | Epalrestat Impurity 16
CAS# 1151944-57-8
M.F.: C12H9NO3S2
M.W.: 279.33 |
| |
| QC022023 | Cabazitaxel Impurity 23
CAS# NA
M.F.: C44H55NO14
M.W.: 821.91 |
| |
| QI201511 | Itopride Impurity K
CAS# 3943-77-9
M.F.: C11H14O4
M.W.: 210.23 |
| |
| QT180624 | Tirofiban Impurity X
CAS# NA
M.F.: C22H35ClN2O5S HCl
M.W.: 475.04 36.46 |
| |
| QU190432 | Ursodeoxycholic Acid Impurity 32
CAS# 108179-87-9
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190431 | Ursodeoxycholic Acid Impurity 31
CAS# 80434-32-8
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190430 | Ursodeoxycholic Acid Impurity 30
CAS# 2393-59-1
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190429 | Ursodeoxycholic Acid Impurity 29
CAS# 2393-58-0
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190428 | Ursodeoxycholic Acid Impurity 28
CAS# 6830-03-1
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190427 | Ursodeoxycholic Acid Impurity 27
CAS# 3338-16-7
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190426 | Ursodeoxycholic Acid Impurity 26
CAS# 570-62-7
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QC080302 | Cholic Acid Impurity 2
CAS# 566-24-5
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QC080301 | Cholic Acid Impurity 1
CAS# 89238-74-4
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QE201933 | Sacubitril Impurity 33
CAS# NA
M.F.: C25H33NO5
M.W.: 427.53 |
| |
| QS212500 | Suxamethonium chloride
CAS# 6101-15-1
M.F.: C14H34Cl2N2O6
M.W.: 397.34 |
| |
| QV307761 | Vitamin B6 Impurity 61
CAS# 58947-70-9
M.F.: C8H9NO3
M.W.: 167.16 |
| |
| QF051803 | Ferulic acid Impurity 3
CAS# 4475-29-0
M.F.: C11H10O6
M.W.: 238.19 |
| |
| QF051802 | trans-Ferulic acid
CAS# 537-98-4
M.F.: C10H10O4
M.W.: 194.18 |
| |
| QF051801 | Ferulic acid (cis)
CAS# 1014-83-1
M.F.: C10H10O4
M.W.: 194.18 |
| |
| QB131602 | Bimatoprost Impurity B
CAS# NA
M.F.: C25H37NO5
M.W.: 431.56 |
| |
| QB131601 | Bimatoprost
CAS# 155206-00-1
M.F.: C25H37NO4
M.W.: 415.57 |
| |
| QP1824106 | Parecoxib Sodium Impurity 80
CAS# 198470-82-5
M.F.: C20H20N2O4S
M.W.: 384.45 |
| |
| QL050325 | Lercanidipine Impurity 25
CAS# NA
M.F.: C23H35NOSi
M.W.: 369.62 |
| |
| QV220504 | Vedaprofen EP Impurity D
CAS# NA
M.F.: C19H22O2
M.W.: 282.38 |
| |
| QP261633 | Pazopanib Impurity 33
CAS# 1226500-00-0
M.F.: C28H30N4O2S
M.W.: 486.63 |
| |
| QP261630 | Pazopanib Impurity 30
CAS# 1036585-24-6
M.F.: C7H10N2O2S
M.W.: 186.23 |
| |
| QI091628 | Ipratropium Bromide Impurity 28
CAS# 30833-12-6
M.F.: C10H17NO3
M.W.: 199.25 |
| |
| QV220501 | Vedaprofen EP Impurity A
CAS# NA
M.F.: C20H24O2
M.W.: 296.40 |
| |
| QV220103 | Valnemulin hydrochloride EP Impurity C
CAS# NA
M.F.: C36H61N3O6S
M.W.: 663.95 |
| |
| QV220102 | Valnemulin hydrochloride EP Impurity B
CAS# NA
M.F.: C26H43NO4S
M.W.: 465.69 |
| |
| QV220101 | Valnemulin hydrochloride EP Impurity A
CAS# NA
M.F.: C31H52N2O6S
M.W.: 580.82 |
| |
| QV220100 | Valnemulin hydrochloride
CAS# 133868-46-9
M.F.: C31H53ClN2O5S
M.W.: 601.28 |
| |
| QU140400 | Undecylenic acid
CAS# 112-38-9
M.F.: C11H20O2
M.W.: 184.28 |
| |
| QT181007 | Trimipramine maleate EP Impurity G
CAS# NA
M.F.: C15H15N
M.W.: 209.29 |
| |
| QT181005 | Trimipramine maleate EP Impurity E
CAS# NA
M.F.: C25H37N3
M.W.: 379.58 |
| |
| QT181003 | Trimipramine maleate EP Impurity C
CAS# NA
M.F.: C20H24N2
M.W.: 292.42 |
| |
| QT181002 | Trimipramine maleate EP Impurity B
CAS# NA
M.F.: C19H24N2
M.W.: 280.41 |
| |
| QT181001 | Trimipramine maleate EP Impurity A
CAS# NA
M.F.: C20H26N2O
M.W.: 310.43 |
| |
| QT181000 | Trimipramine maleate
CAS# 521-78-8
M.F.: C24H30N2O4
M.W.: 410.51 |
| |
| QT011302 | Tramazoline hydrochloride monohydrate EP Impurity B
CAS# NA
M.F.: C30H38N6O2
M.W.: 514.66 |
| |
| QT011301 | Tramazoline hydrochloride monohydrate EP Impurity A
CAS# NA
M.F.: C13H13N3
M.W.: 211.26 |
| |
| QT011300 | Tramazoline hydrochloride monohydrate
CAS# 74195-73-6
M.F.: C13H20ClN3O
M.W.: 269.77 |
| |
| QT151700 | Tosylchloramide sodium
CAS# NA
M.F.: C7H13ClNNaO5S
M.W.: 281.69 |
| |
| QT151504 | Tolnaftate EP Impurity D
CAS# NA
M.F.: C8H11N
M.W.: 121.18 |
| |
| QT151502 | Tolnaftate EP Impurity B
CAS# 127084-74-6
M.F.: C21H14O2S
M.W.: 330.40 |
| |
| QT151403 | Tolfenamic acid EP Impurity C
CAS# NA
M.F.: C14H10ClNO
M.W.: 243.69 |
| |
| QT151402 | Tolfenamic acid EP Impurity B
CAS# 87-60-5
M.F.: C7H8ClN
M.W.: 141.60 |
| |
| QT151400 | Tolfenamic acid
CAS# 13710-19-5
M.F.: C14H12ClNO2
M.W.: 261.70 |
| |
| QT151303 | Tolbutamide EP Impurity C
CAS# NA
M.F.: C14H21N3O3S
M.W.: 311.40 |
| |
| QT090803 | Tioconazole EP Impurity C
CAS# 119386-76-4
M.F.: C16H12BrCl3N2OS
M.W.: 466.61 |
| |
| QT090801 | Tioconazole EP Impurity A
CAS# NA
M.F.: C16H14Cl2N2OS
M.W.: 353.27 |
| |
| QT090706 | Tiaprofenic acid EP Impurity F
CAS# NA
M.F.: C11H7BrOS
M.W.: 267.14 |
| |
| QT090705 | Tiaprofenic acid EP Impurity E
CAS# NA
M.F.: C7H8O2S
M.W.: 156.20 |
| |
| QT090703 | Tiaprofenic acid EP Impurity C
CAS# NA
M.F.: C14H12O3S
M.W.: 260.31 |
| |
| QT090702 | Tiaprofenic acid EP Impurity B
CAS# NA
M.F.: C13H10O2S
M.W.: 230.28 |
| |
| QT090701 | Tiaprofenic acid EP Impurity A
CAS# NA
M.F.: C13H12OS
M.W.: 216.30 |
| |
| QT090700 | Tiaprofenic acid
CAS# 33005-95-7
M.F.: C14H12O3S
M.W.: 260.31 |
| |
| QT090505 | Tianeptine sodium EP Impurity E
CAS# NA
M.F.: C28H37ClN2O6S
M.W.: 565.12 |
| |
| QT090504 | Tianeptine sodium EP Impurity D
CAS# NA
M.F.: C21H23ClN2O4S
M.W.: 434.94 |
| |
| QT090503 | Tianeptine sodium EP Impurity C
CAS# NA
M.F.: C14H10ClNO3S
M.W.: 307.75 |
| |
| QT090502 | Tianeptine sodium EP Impurity B
CAS# NA
M.F.: C23H29ClN2O4S
M.W.: 465.01 |
| |
| QT090501 | Tianeptine sodium EP Impurity A
CAS# NA
M.F.: C9H17BrO2
M.W.: 237.13 |
| |
| QT090500 | Tianeptine sodium
CAS# 30123-17-2;66981-73-5(free base)
M.F.: C21H24ClN2NaO4S
M.W.: 458.93 |
| |
| QA070278 | Argatroban Impurity 52
CAS# NA
M.F.: C24H38N6O5S
M.W.: 522.66 |
| |
| QT081604 | Thiopental sodium and sodium carbonate EP Impurity D
CAS# NA
M.F.: C11H20N2O3S
M.W.: 260.35 |
| |
| QT081603 | Thiopental sodium and sodium carbonate EP Impurity C
CAS# NA
M.F.: C11H18N2O2S
M.W.: 242.34 |
| |
| QT081601 | Thiopental sodium and sodium carbonate EP Impurity A
CAS# NA
M.F.: C9H14N2O2S
M.W.: 214.28 |
| |
| QT081600 | Thiopental sodium and sodium carbonate
CAS# NA
M.F.: C11H17N2NaO2S
M.W.: 264.32 |
| |
| QT052301 | Tetryzoline hydrochloride EP Impurity A
CAS# NA
M.F.: C11H11N
M.W.: 157.21 |
| |
| QT052300 | Tetryzoline hydrochloride
CAS# 522-48-5
M.F.: C13H17ClN2
M.W.: 236.74 |
| |
| QT052203 | Tetracaine hydrochloride EP Impurity C
CAS# 71839-12-8
M.F.: C12H17NO2
M.W.: 207.27 |
| |
| QT052202 | Tetracaine hydrochloride EP Impurity B
CAS# 4740-24-3
M.F.: C11H15NO2
M.W.: 193.24 |
| |
| QT052200 | Tetracaine hydrochloride
CAS# 136-47-0;94-24-6(free base)
M.F.: C15H25ClN2O2
M.W.: 300.82 |
| |
| QT052110 | Terfenadine EP Impurity J
CAS# NA
M.F.: C22H35NO3
M.W.: 361.52 |
| |
| QT052108 | Terfenadine EP Impurity H
CAS# NA
M.F.: C32H41NO
M.W.: 455.67 |
| |
| QT052104 | Terfenadine EP Impurity D
CAS# NA
M.F.: C32H39NO
M.W.: 453.66 |
| |
| QT052103 | Terfenadine EP Impurity C
CAS# NA
M.F.: C32H41NO3
M.W.: 487.67 |
| |
| QT052102 | Terfenadine EP Impurity B
CAS# NA
M.F.: C32H41NO
M.W.: 455.67 |
| |
| QM050610 | Mefenamic Acid Impurity 10
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
| |
| QT052101 | Terfenadine EP Impurity A
CAS# NA
M.F.: C32H39NO2
M.W.: 469.66 |
| |
| QT130107 | Temazepam EP Impurity G
CAS# 93329-92-1
M.F.: C17H15ClN2O2
M.W.: 314.77 |
| |
| QT130106 | Temazepam EP Impurity F
CAS# 3294-96-0
M.F.: C16H13ClN2O2
M.W.: 300.74 |
| |
| QT130105 | Controlled Substance
(Temazepam EP Impurity E)
CAS# 2888-64-4
M.F.: C16H13ClN2O2
M.W.: 300.74 |
| |
| QT130104 | Temazepam EP Impurity D
CAS# 17191-70-7
M.F.: C17H15ClN2O2
M.W.: 314.77 |
| |
| QT130102 | Controlled Substance
(Temazepam EP Impurity B)
CAS# 604-75-1
M.F.: C15H11ClN2O2
M.W.: 286.71 |
| |
| QS211703 | Sulindac EP Impurity C
CAS# 49627-27-2
M.F.: C20H17FO2S
M.W.: 340.41 |
| |
| QS211702 | Sulindac EP Impurity B
CAS# 59973-80-7
M.F.: C20H17FO4S
M.W.: 372.41 |
| |
| QS211701 | Sulindac EP Impurity A
CAS# 53933-60-1
M.F.: C20H17FO3S
M.W.: 356.41 |
| |
| QI192222 | Isavuconazole Impurity 22
CAS# NA
M.F.: C29H35ClF2N8O5S
M.W.: 681.15 |
| |
| QS211601 | Sulfinpyrazone EP Impurity A
CAS# NA
M.F.: C23H20N2O4S
M.W.: 420.48 |
| |
| QS211405 | Sulfadimidine EP Impurity E
CAS# 144-80-9
M.F.: C8H10N2O3S
M.W.: 214.24 |
| |
| QS211400 | Sulfadimidine
CAS# 57-68-1
M.F.: C12H14N4O2S
M.W.: 278.33 |
| |
| QS211205 | Sulfadiazine EP Impurity E
CAS# 127-74-2
M.F.: C12H12N4O3S
M.W.: 292.31 |
| |
| QS211201 | Sulfadiazine EP Impurity A
CAS# 109-12-6
M.F.: C4H5N3
M.W.: 95.10 |
| |
| QS531507 | Sucralose EP Impurity G
CAS# NA
M.F.: C12H18Cl2O8
M.W.: 361.17 |
| |
| QS531506 | Sucralose EP Impurity F
CAS# NA
M.F.: C12H20Cl2O9
M.W.: 379.19 |
| |
| QS531505 | Sucralose EP Impurity E
CAS# NA
M.F.: C12H20Cl2O9
M.W.: 379.19 |
| |
| QS531502 | Sucralose EP Impurity B
CAS# NA
M.F.: C12H19Cl3O8
M.W.: 397.63 |
| |
| QS201800 | Streptomycin sulfate
CAS# 3810-74-0;57-92-1(free base)
M.F.: C42H84N14O36S3
M.W.: 1457.38 |
| |
| QP1903103 | Posaconazole Impurity 103
CAS# 81445-44-5
M.F.: C10H12O2
M.W.: 164.20 |
| |
| QS201402 | Stanozolol EP Impurity B
CAS# NA
M.F.: C21H32O3
M.W.: 332.48 |
| |
| QS201400 | Stanozolol
CAS# 10418-03-8
M.F.: C21H32N2O
M.W.: 328.49 |
| |
| QS152004 | Sotalol hydrochloride EP Impurity D
CAS# 2724689-38-5;2724689-39-6(HCl salt)
M.F.: C12H20N2O3S
M.W.: 272.36 |
| |
| QS152003 | Sotalol hydrochloride EP Impurity C
CAS# 83922-54-7
M.F.: C8H9NO3S
M.W.: 199.23 |
| |
| QS152002 | Sotalol hydrochloride EP Impurity B
CAS# 60735-85-5;5576-49-8(HCl salt)
M.F.: C12H18N2O3S
M.W.: 270.35 |
| |
| QS152001 | Sotalol hydrochloride EP Impurity A
CAS# 16974-42-8;16974-44-0(HCl salt)
M.F.: C12H20N2O2S
M.W.: 256.36 |
| |
| QS152000 | Sotalol hydrochloride
CAS# 959-24-0;3930-20-9(free base);
366-80-3(2HCl salt);1350271-32-7(HBr salt)
M.F.: C12H21ClN2O3S
M.W.: 308.82 |
| |
| QC051400 | Cefalotin Sodium
CAS# 58-71-9
M.F.: C16H15N2NaO6S2
M.W.: 418.42 |
| |
| QS151100 | Sodium salicylate
CAS# 54-21-7
M.F.: C7H5NaO3
M.W.: 160.10 |
| |
| QS151000 | Sodium propionate
CAS# 137-40-6
M.F.: C3H5NaO2
M.W.: 96.06 |
| |
| QS150900 | Ethylparaben sodium;Sodium ethyl parahydroxybenzoate
CAS# 35285-68-8
M.F.: C9H9NaO3
M.W.: 188.16 |
| |
| QS150810 | Sodium caprylate EP Impurity J;
Caprylic acid EP Impurity J
CAS# NA
M.F.: C8H14O2
M.W.: 142.20 |
| |
| QS150809 | Sodium caprylate EP Impurity I;
Caprylic acid EP Impurity I
CAS# NA
M.F.: C11H22O2
M.W.: 170.29 |
| |
| QS150808 | Sodium caprylate EP Impurity H;
Caprylic acid EP Impurity H
CAS# 110-42-9
M.F.: C11H22O2
M.W.: 186.29 |
| |
| QS150807 | Sodium caprylate EP Impurity G;
Caprylic acid EP Impurity G
CAS# NA
M.F.: C10H20O2
M.W.: 172.26 |
| |
| QS150806 | Sodium caprylate EP Impurity F;
Caprylic acid EP Impurity F
CAS# 111-11-5
M.F.: C9H18O2
M.W.: 158.24 |
| |
| QS150804 | Sodium caprylate EP Impurity D;
Caprylic acid EP Impurity D;Decanoic acid
CAS# NA
M.F.: C10H20O2
M.W.: 172.26 |
| |
| QS150803 | Sodium caprylate EP Impurity C;
Caprylic acid EP Impurity C;Nonanoic acid
CAS# NA
M.F.: C9H18O2
M.W.: 158.24 |
| |
| QS150802 | Sodium caprylate EP Impurity B
CAS# NA
M.F.: C7H14O2
M.W.: 130.18 |
| |
| QS150801 | Sodium caprylate EP Impurity A
CAS# NA
M.F.: C6H12O2
M.W.: 116.16 |
| |
| QS150800 | Sodium caprylate
CAS# 1984-06-1
M.F.: C8H15NaO2
M.W.: 166.19 |
| |
| QS150701 | Sodium calcium edetate EP Impurity A
CAS# 139-13-9
M.F.: C6H9NO6
M.W.: 191.14 |
| |
| QS150700 | Sodium calcium edetate
CAS# 62-33-9
M.F.: C10H12CaN2Na2O8,xH2O
M.W.: 374.27,x18.02 |
| |
| QZ090300 | Zinc undecylenate
CAS# 557-08-4
M.F.: C22H38O4Zn
M.W.: 431.91 |
| |
| QZ091403 | Zinc acexamate EP Impurity C
CAS# 1888-91-1
M.F.: C8H13NO2
M.W.: 155.19 |
| |
| QZ091401 | Zinc acexamate EP Impurity A
CAS# NA
M.F.: C14H26N2O4
M.W.: 286.37 |
| |
| QZ091400 | Zinc acexamate
CAS# 70020-71-2
M.F.: C16H28N2O6Zn
M.W.: 409.78 |
| |
| QY151205 | Yohimbine hydrochloride EP Impurity E
CAS# NA
M.F.: C22H28N2O3
M.W.: 368.47 |
| |
| QS150600 | Sodium aminosalicylate dihydrate
CAS# 6018-19-5
M.F.: C7H10NNaO5
M.W.: 211.15 |
| |
| QS150502 | Sodium amidotrizoate EP Impurity B;
Amidotrizoic Acid EP Impurity B
CAS# NA
M.F.: C11H10I2N2O4
M.W.: 488.02 |
| |
| QS150500 | Sodium amidotrizoate
CAS# 737-31-5
M.F.: C11H8I3N2NaO4
M.W.: 635.90 |
| |
| QS150400 | Sodium alendronate trihydrate
CAS# 121268-17-5
M.F.: C4H18NNaO10P2
M.W.: 325.12 |
| |
| QS052000 | Sertaconazole nitrate
CAS# 99592-39-9
M.F.: C20H16Cl3N3O4S
M.W.: 500.78 |
| |
| QS051300 | Selenium disulfide
CAS# 7488-56-4
M.F.: S2Se
M.W.: 143.09 |
| |
| QS011708 | Saquinavir mesilate EP Impurity H
CAS# NA
M.F.: C38H47N5O5
M.W.: 653.81 |
| |
| QS011707 | Saquinavir mesilate EP Impurity G
CAS# NA
M.F.: C39H51N5O6
M.W.: 685.85 |
| |
| QS011706 | Saquinavir mesilate EP Impurity F
CAS# NA
M.F.: C38H48N6O4
M.W.: 652.83 |
| |
| QS011705 | Saquinavir mesilate EP Impurity E
CAS# NA
M.F.: C38H49N5O6
M.W.: 671.83 |
| |
| QS011704 | Saquinavir mesilate EP Impurity D
CAS# NA
M.F.: C38H50N6O5
M.W.: 670.84 |
| |
| QS011703 | Saquinavir mesilate EP Impurity C
CAS# NA
M.F.: C24H39N3O2
M.W.: 401.59 |
| |
| QS011702 | Saquinavir mesilate EP Impurity B
CAS# NA
M.F.: C16H17N3O4
M.W.: 315.32 |
| |
| QS011701 | Saquinavir mesilate EP Impurity A
CAS# NA
M.F.: C14H13N3O4
M.W.: 287.27 |
| |
| QS011700 | Saquinavir mesilate
CAS# 149845-06-7
M.F.: C39H54N6O8S
M.W.: 766.95 |
| |
| QS011230 | Salmeterol xinafoate
CAS# 94749-08-3;89365-50-4(free base)
M.F.: C36H45NO7
M.W.: 603.75 |
| |
| QS010410 | Saccharin sodium
CAS# 128-44-9
M.F.: C7H4NNaO3S
M.W.: 205.17 |
| |
| QR212203 | Rutoside trihydrate EP Impurity C;Quercetin
CAS# 117-39-5
M.F.: C15H10O7
M.W.: 302.24 |
| |
| QR212202 | Rutoside trihydrate EP Impurity B;
Nicotiflorin;Kaempferol-3-O-rutinoside
CAS# 17650-84-9
M.F.: C27H30O15
M.W.: 594.52 |
| |
| QR212201 | Rutoside trihydrate EP Impurity A
CAS# 21637-25-2
M.F.: C21H20O12
M.W.: 464.38 |
| |
| QR212200 | Rutoside trihydrate
CAS# 250249-75-3
M.F.: C27H36O19
M.W.: 664.56 |
| |
| QR091905 | Risedronate sodium 2.5-hydrate EP Impurity E
CAS# 75755-10-1
M.F.: C7H11NO6P2
M.W.: 267.11 |
| |
| QR091904 | Risedronate sodium 2.5-hydrate EP Impurity D
CAS# 501-81-5
M.F.: C7H7NO2
M.W.: 137.14 |
| |
| QR091903 | Risedronate sodium 2.5-hydrate EP Impurity C
CAS# 105462-25-7
M.F.: C7H11NO7P2
M.W.: 283.11 |
| |
| QR091902 | Risedronate sodium 2.5-hydrate EP Impurity B
CAS# 105462-23-5;1220806-40-5(monohydrate)
M.F.: C7H11NO7P2
M.W.: 283.11 |
| |
| QR091901 | Risedronate sodium 2.5-hydrate EP Impurity A
CAS# NA
M.F.: C14H18N2O12P4
M.W.: 530.19 |
| |
| QR091900 | Risedronate sodium 2.5-hydrate
CAS# 329003-65-8
M.F.: C7H10NNaO7P2,2½H2O
M.W.: 350.13 |
| |
| QM040139 | Midazolam Impurity 13
CAS# 60656-76-0
M.F.: C16H11ClFN3O3
M.W.: 347.73 |
| |
| QR091303 | Rilmenidine dihydrogen phosphate EP Impurity C
CAS# NA
M.F.: C17H26N2O
M.W.: 274.40 |
| |
| QR091302 | Rilmenidine dihydrogen phosphate EP Impurity B
CAS# NA
M.F.: C10H17ClN2O
M.W.: 216.71 |
| |
| QR091301 | Rilmenidine dihydrogen phosphate EP Impurity A
CAS# NA
M.F.: C10H18N2O2
M.W.: 198.26 |
| |
| QR091300 | Rilmenidine dihydrogen phosphate
CAS# 85409-38-7
M.F.: C10H19N2O5P
M.W.: 278.24 |
| |
| QR090705 | Rifabutin EP Impurity E
CAS# 100324-63-8
M.F.: C44H60N4O10
M.W.: 804.97 |
| |
| QR090704 | Rifabutin EP Impurity D
CAS# 62041-01-4
M.F.: C37H47N3O11
M.W.: 709.78 |
| |
| QR090702 | Rifabutin EP Impurity B
CAS# 51756-80-0
M.F.: C37H46N2O12
M.W.: 710.77 |
| |
| QR090701 | Rifabutin EP Impurity A
CAS# NA
M.F.: C9H17NO
M.W.: 155.24 |
| |
| QQ211403 | Quinidine sulfate EP Impurity C
CAS# NA
M.F.: C20H26N2O2
M.W.: 326.43 |
| |
| QQ211402 | Quinidine sulfate EP Impurity B
CAS# NA
M.F.: C19H22N2O
M.W.: 294.39 |
| |
| QQ211401 | Quinidine sulfate EP Impurity A
CAS# NA
M.F.: C20H24N2O2
M.W.: 324.42 |
| |
| QP252002 | Pyridostigmine bromide EP Impurity B
CAS# NA
M.F.: C6H8NO
M.W.: 110.13 |
| |
| QP252001 | Pyridostigmine bromide EP Impurity A
CAS# 51581-32-9
M.F.: C8H10N2O2
M.W.: 166.18 |
| |
| QP252000 | Pyridostigmine bromide
CAS# 101-26-8;155-97-5(cation form)
M.F.: C9H13BrN2O2
M.W.: 261.12 |
| |
| QP251903 | Pyrantel embonate EP Impurity C
CAS# NA
M.F.: C5H4OS
M.W.: 112.15 |
| |
| QP251902 | Pyrantel embonate EP Impurity B
CAS# NA
M.F.: C11H16N2OS
M.W.: 224.32 |
| |
| QP251901 | Pyrantel embonate EP Impurity A
CAS# 36700-38-6
M.F.: C11H14N2S
M.W.: 206.31 |
| |
| QP251900 | Pyrantel embonate
CAS# 22204-24-6
M.F.: C34H30N2O6S
M.W.: 594.68 |
| |
| QP152104 | Protirelin EP Impurity D
CAS# NA
M.F.: C16H21N5O5
M.W.: 363.37 |
| |
| QP152102 | Protirelin EP Impurity B
CAS# NA
M.F.: C16H22N6O4
M.W.: 362.38 |
| |
| QP152101 | Protirelin EP Impurity A
CAS# NA
M.F.: C16H22N6O4
M.W.: 362.38 |
| |
| QP151802 | Propyphenazone EP Impurity B
CAS# NA
M.F.: C14H18N2O
M.W.: 230.31 |
| |
| QP151800 | Propyphenazone
CAS# 479-92-5
M.F.: C14H18N2O
M.W.: 230.31 |
| |
| QP151700 | Propantheline bromide
CAS# 50-34-0
M.F.: C23H30BrNO3
M.W.: 448.39 |
| |
| QP151600 | Propacetamol hydrochloride
CAS# 66532-86-3
M.F.: C14H20N2O3.HCl
M.W.: 264.32 36.46 |
| |
| QP151501 | Promazine hydrochloride EP Impurity A
CAS# NA
M.F.: C17H20N2OS
M.W.: 300.42 |
| |
| QP150704 | Proguanil hydrochloride EP Impurity D
CAS# NA
M.F.: C8H19N5
M.W.: 185.27 |
| |
| QP150703 | Proguanil hydrochloride EP Impurity C
CAS# NA
M.F.: C14H13Cl2N5
M.W.: 322.19 |
| |
| QP150701 | Proguanil hydrochloride EP Impurity A
CAS# NA
M.F.: C5H10N4
M.W.: 126.16 |
| |
| QP150700 | Proguanil hydrochloride
CAS# 637-32-1
M.F.: C11H17Cl2N5
M.W.: 290.19 |
| |
| QP150300 | Prochlorperazine maleate
CAS# 84-02-6
M.F.: C28H32ClN3O8S
M.W.: 606.09 |
| |
| QP150204 | Probenecid EP Impurity D
CAS# 70190-76-0
M.F.: C15H23NO4S
M.W.: 313.41 |
| |
| QM050609 | Mefenamic Acid Impurity 9
CAS# NA
M.F.: C14H9ClO4
M.W.: 276.67 |
| |
| QP150203 | Probenecid EP Impurity C
CAS# NA
M.F.: C19H32N2O3S
M.W.: 368.53 |
| |
| QM050608 | Mefenamic Acid Impurity 8
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
| |
| QM050607 | Mefenamic Acid Impurity 7
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
| |
| QP150201 | Probenecid EP Impurity A
CAS# 636-78-2
M.F.: C7H6O5S
M.W.: 202.18 |
| |
| QP150200 | Probenecid
CAS# 57-66-9
M.F.: C13H19NO4S
M.W.: 285.36 |
| |
| QM050606 | Mefenamic Acid Impurity 6
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
| |
| QT211500 | Taurochenodeoxycholic Acid
CAS# 516-35-8;6009-98-9(Na salt)
M.F.: C26H45NO6S
M.W.: 499.70 |
| |
| QF012218 | Favipiravir Impurity 18
CAS# 2305633-62-7
M.F.: C5H2BrN3O
M.W.: 199.99 |
| |
| QT0307166 | Ticagrelor Impurity 166
CAS# 187666-88-2
M.F.: C7H10N2O2S
M.W.: 186.23 |
| |
| QC031612 | Cefcapene pivoxil Impurity 12
CAS# NA
M.F.: C22H27N5O8S2
M.W.: 553.61 |
| |
| QC031611 | Cefcapene pivoxil Impurity 11
CAS# 105889-80-3
M.F.: C28H37N5O10S2
M.W.: 667.75 |
| |
| QC031609 | Cefcapene pivoxil Impurity 9
CAS# NA
M.F.: C24H30N4O8S2
M.W.: 566.65 |
| |
| QC031608 | Cefcapene pivoxil Impurity 8
CAS# NA
M.F.: C22H28N4O7S2
M.W.: 524.61 |
| |
| QC031607 | Cefcapene pivoxil Impurity 7
CAS# NA
M.F.: C23H31N5O9S2
M.W.: 585.65 |
| |
| QC031606 | Cefcapene pivoxil Impurity 6
CAS# NA
M.F.: C23H29N5O9S2
M.W.: 583.63 |
| |
| QC031605 | Cefcapene pivoxil Impurity 5
CAS# NA
M.F.: C39H45N9O12S4
M.W.: 960.09 |
| |
| QC031604 | Cefcapene pivoxil Impurity 4
CAS# NA
M.F.: C17H19N5O6S2
M.W.: 453.49 |
| |
| QC031603 | Cefcapene pivoxil Impurity 3
CAS# NA
M.F.: C23H29N5O8S2
M.W.: 567.64 |
| |
| QC031602 | Cefcapene pivoxil Impurity 2
CAS# NA
M.F.: C23H29N5O8S2
M.W.: 567.64 |
| |
| QC031601 | Cefcapene pivoxil Impurity 1
CAS# NA
M.F.: C16H16N4O4S2
M.W.: 392.45 |
| |
| QC031600 | Cefcapene pivoxil
CAS# 105889-45-0;147816-23-7(HCl salt);
147816-24-8(H2O HCl salt)
M.F.: C23H29N5O8S2
M.W.: 567.64 |
| |
| QC250223 | Cytarabine Impurity 23
CAS# 6698-20-0
M.F.: C9H11N3O4
M.W.: 225.20 |
| |
| QT142424 | Tranexamic Acid Impurity 24
CAS# NA
M.F.: C16H28N2O3
M.W.: 296.41 |
| |
| QT142423 | Tranexamic Acid Impurity 23
CAS# NA
M.F.: C16H16N2O3
M.W.: 284.31 |
| |
| QT142422 | Tranexamic Acid Impurity 22
CAS# 98270-32-7
M.F.: C24H21NO6
M.W.: 419.43 |
| |
| QT142421 | Tranexamic Acid Impurity 21
CAS# 14900-61-9
M.F.: C16H15NO4
M.W.: 285.29 |
| |
| QT142420 | Tranexamic Acid Impurity 20
CAS# 179076-85-8
M.F.: C8H9NO3
M.W.: 167.16 |
| |
| QT142419 | Tranexamic Acid Impurity 19
CAS# 165530-43-8;549531-01-3(HCl salt)
M.F.: C8H8ClNO2
M.W.: 185.61 |
| |
| QT142418 | Tranexamic Acid Impurity 18
CAS# 100-21-0
M.F.: C8H6O4
M.W.: 166.13 |
| |
| QT142417 | Tranexamic Acid Impurity 17
CAS# 121-91-5
M.F.: C8H6O4
M.W.: 166.13 |
| |
| QT142416 | Tranexamic Acid Impurity 16
CAS# 85888-81-9
M.F.: C8H7ClO2
M.W.: 170.59 |
| |
| QT142415 | Tranexamic Acid Impurity 15
CAS# 31719-77-4
M.F.: C8H7ClO2
M.W.: 170.59 |
| |
| QT142414 | Tranexamic Acid Impurity 14
CAS# 5264-40-4
M.F.: C8H5Cl3O2
M.W.: 239.48 |
| |
| QT142413 | Tranexamic Acid Impurity 13
CAS# 5278-91-1
M.F.: C8H6Cl2O2
M.W.: 205.04 |
| |
| QT142412 | Tranexamic Acid Impurity 12
CAS# NA
M.F.: C8H6Cl2O2
M.W.: 205.04 |
| |
| QR1922104 | Rosuvastatin Impurity 104
CAS# NA
M.F.: C29H42FN3O7S
M.W.: 595.72 |
| |
| QP092302 | Pivmecillinam hydrochloride EP Impurity B
CAS# NA
M.F.: C21H35N3O6S
M.W.: 457.58 |
| |
| QP092301 | Pivmecillinam hydrochloride EP Impurity A
CAS# NA
M.F.: C14H22N2O5S
M.W.: 330.40 |
| |
| QP092203 | Pivampicillin EP Impurity C
CAS# NA
M.F.: C44H58N6O12S2
M.W.: 927.09 |
| |
| QP092002 | Piretanide EP Impurity B
CAS# NA
M.F.: C21H25N3O5S
M.W.: 431.51 |
| |
| QP091903 | Pirenzepine EP Impurity C
CAS# NA
M.F.: C19H21N5O2
M.W.: 351.40 |
| |
| QC182559 | Canagliflozin Impurity 59
CAS# NA
M.F.: C24H25FO6S
M.W.: 460.52 |
| |
| QL130621 | Lamivudine Impurity 21
CAS# 147027-10-9
M.F.: C18H27N3O4S
M.W.: 381.49 |
| |
| QP161510 | Piperazine hydrate
CAS# 142-63-2
M.F.: C4H22N2O6
M.W.: 194.23 |
| |
| QP131605 | Pimozide EP Impurity E
CAS# NA
M.F.: C28H29F2N3O2
M.W.: 477.55 |
| |
| QP131603 | Pimozide EP Impurity C
CAS# NA
M.F.: C28H29F2N3O
M.W.: 461.55 |
| |
| QP131602 | Pimozide EP Impurity B
CAS# NA
M.F.: C28H30FN3O
M.W.: 443.56 |
| |
| QA162971 | Apremilast Impurity 71
CAS# NA
M.F.: C21H24N2O8S
M.W.: 464.49 |
| |
| QP131501 | Pimobendan EP Impurity A
CAS# NA
M.F.: C19H18N2O4
M.W.: 338.36 |
| |
| QC012501 | Neochlorogenic acid
CAS# 906-33-2
M.F.: C16H18O9
M.W.: 354.31 |
| |
| QL051509 | Calcium Levofolinate Impurity 9
CAS# 2800-34-2
M.F.: C20H23N7O7
M.W.: 473.44 |
| |
| QR152418 | Roxadustat Nitroso Impurity 1
CAS# 20689-96-7
M.F.: C9H12N2O
M.W.: 164.20 |
| |
| QA180243 | Arbidol Impurity 43
CAS# 153633-07-9
M.F.: C16H21BrN2O3
M.W.: 369.25 |
| |
| QS010256 | Salbutamol Impurity 30
CAS# NA
M.F.: C13H22BNO3
M.W.: 251.13 |
| |
| QD241346 | Dexamethasone sodium phosphate EP Impurity C
CAS# NA
M.F.: C22H30FO8P
M.W.: 472.44 |
| |
| QI222037 | Itraconazole Impurity 37
CAS# NA
M.F.: C34H35Cl3N8O4
M.W.: 726.05 |
| |
| QB151435 | Bromfenac Impurity 9
CAS# 845276-75-7
M.F.: C13H10BrNO
M.W.: 276.13 |
| |
| QC061618 | Cefpodoxime Proxetil Impurity 18
CAS# NA
M.F.: C25H33N5O11S2
M.W.: 643.69 |
| |
| QT201620 | Tiotropium bromide Impurity 20
CAS# 1508-46-9
M.F.: C9H16BrNO2
M.W.: 250.13 |
| |
| QP091704 | Picotamide monohydrate EP Impurity D
CAS# NA
M.F.: C6H8N2
M.W.: 108.14 |
| |
| QP091703 | Picotamide monohydrate EP Impurity C
CAS# NA
M.F.: C15H14N2O4
M.W.: 286.28 |
| |
| QP091702 | Picotamide monohydrate EP Impurity B
CAS# NA
M.F.: C15H14N2O4
M.W.: 286.28 |
| |
| QP091700 | Picotamide monohydrate
CAS# NA
M.F.: C21H22N4O4
M.W.: 394.42 |
| |
| QP082600 | Physostigmine salicylate
CAS# 57-64-7
M.F.: C22H27N3O5
M.W.: 413.47 |
| |
| QP081605 | Pholcodine EP Impurity E
CAS# NA
M.F.: C23H30N2O5
M.W.: 414.49 |
| |
| QP081604 | Pholcodine EP Impurity D
CAS# NA
M.F.: C29H41N3O5
M.W.: 511.65 |
| |
| QP050809 | Pethidine EP Impurity I
CAS# NA
M.F.: C15H19NO2
M.W.: 245.32 |
| |
| QP050801 | Pethidine EP Impurity A
CAS# 774-52-7
M.F.: C12H17N
M.W.: 175.27 |
| |
| QP181701 | Perphenazine EP Impurity A
CAS# 10078-25-8
M.F.: C21H26ClN3O2S
M.W.: 419.97 |
| |
| QP050702 | Pergolide mesilate EP Impurity B
CAS# NA
M.F.: C19H26N2O2S
M.W.: 346.49 |
| |
| QR457038 | Rocuronium bromide Impurity 38
CAS# NA
M.F.: C32H53BrN2O5
M.W.: 625.68 |
| |
| QR457037 | Rocuronium bromide Impurity 37
CAS# 159325-45-8
M.F.: C23H35NO2
M.W.: 357.53 |
| |
| QR457036 | Rocuronium bromide Impurity 36
CAS# NA
M.F.: C23H36BrNO3
M.W.: 454.44 |
| |
| QR457035 | Rocuronium bromide Impurity 35
CAS# NA
M.F.: C23H37NO3
M.W.: 375.54 |
| |
| QR457034 | Rocuronium bromide Impurity 34
CAS# NA
M.F.: C19H28O2
M.W.: 288.42 |
| |
| QR457033 | Rocuronium bromide Impurity 33
CAS# 50588-22-2
M.F.: C21H30O4
M.W.: 346.46 |
| |
| QP051601 | Penbutolol sulfate EP Impurity A
CAS# NA
M.F.: C18H27NO2
M.W.: 289.41 |
| |
| QR457032 | Rocuronium bromide Impurity 32
CAS# 10429-07-9
M.F.: C26H36O4S
M.W.: 444.63 |
| |
| QT140206 | Trandolapril EP Impurity F
CAS# NA
M.F.: C24H34N2O5
M.W.: 430.54 |
| |
| QT140205 | Trandolapril EP Impurity E
CAS# 87679-71-8
M.F.: C22H30N2O5
M.W.: 402.48 |
| |
| QT140204 | Trandolapril EP Impurity D
CAS# 149881-40-3
M.F.: C24H32N2O4
M.W.: 412.52 |
| |
| QT140203 | Trandolapril EP Impurity C
CAS# NA
M.F.: C24H40N2O5
M.W.: 436.58 |
| |
| QT140202 | Trandolapril EP Impurity B
CAS# NA
M.F.: C25H36N2O5
M.W.: 444.56 |
| |
| QT140201 | Trandolapril EP Impurity A
CAS# 118194-41-5
M.F.: C23H32N2O5
M.W.: 416.51 |
| |
| QT010901 | Trapidil EP Impurity A
CAS# 2503-56-2
M.F.: C6H6N4O
M.W.: 150.14 |
| |
| QT040900 | Trehalose dihydrate
CAS# 6138-23-4
M.F.: C12H22O11,2H2O
M.W.: 342.30 36.03 |
| |
| QT041265 | Tadalafil Impurity 65
CAS# 1356345-67-9
M.F.: C23H23N3O4
M.W.: 405.45 |
| |
| QL091657 | Lipoic Acid Impurity 31
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091656 | Lipoic Acid Impurity 30
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QO240204 | Oxybutynin hydrochloride EP Impurity D
CAS# 4335-77-7
M.F.: C14H18O3
M.W.: 234.29 |
| |
| QO240202 | Oxybutynin hydrochloride EP Impurity B
CAS# 14943-53-4
M.F.: C22H25NO3
M.W.: 351.44 |
| |
| QT022103 | Tributyl Acetylcitrate EP Impurity C
CAS# NA
M.F.: C20H34O8
M.W.: 402.48 |
| |
| QT022102 | Tributyl Acetylcitrate EP Impurity B
CAS# 7568-58-3
M.F.: C18H30O6
M.W.: 342.43 |
| |
| QT022101 | Tributyl Acetylcitrate EP Impurity A
CAS# 77-94-1
M.F.: C18H32O7
M.W.: 360.44 |
| |
| QT022100 | Tributyl Acetylcitrate
CAS# 77-90-7
M.F.: C20H34O8
M.W.: 402.48 |
| |
| QO240200 | Oxybutynin hydrochloride
CAS# 1508-65-2
M.F.: C22H32ClNO3
M.W.: 393.95 |
| |
| QO241703 | Oxolinic acid EP Impurity C
CAS# NA
M.F.: C12H9NO5
M.W.: 247.20 |
| |
| QO241702 | Oxolinic acid EP Impurity B
CAS# NA
M.F.: C15H15NO5
M.W.: 289.28 |
| |
| QO241701 | Oxolinic acid EP Impurity A
CAS# NA
M.F.: C11H7NO5
M.W.: 233.18 |
| |
| QO241003 | Oxitropium bromide EP Impurity C
CAS# NA
M.F.: C19H26NO4
M.W.: 332.41 |
| |
| QO240504 | Oxeladin hydrogen citrate EP Impurity D
CAS# 18109-81-4(citrate salt)
M.F.: C18H29NO3
M.W.: 307.43 |
| |
| QO240502 | Oxeladin hydrogen citrate EP Impurity B
CAS# NA
M.F.: C12H16O2
M.W.: 192.25 |
| |
| QO242605 | Oxazepam EP Impurity E;
Chlordiazepoxide EP Impurity A
CAS# 963-39-3
M.F.: C15H11ClN2O2
M.W.: 286.71 |
| |
| QO242603 | Oxazepam EP Impurity C
CAS# 5958-05-4
M.F.: C15H9ClN2O
M.W.: 268.70 |
| |
| QO181606 | Orphenadrine citrate EP Impurity F
CAS# 19804-27-4
M.F.: C18H23NO
M.W.: 269.38 |
| |
| QO181605 | Orphenadrine citrate EP Impurity E
CAS# 21945-86-8
M.F.: C18H23NO
M.W.: 269.38 |
| |
| QO181604 | Orphenadrine citrate EP Impurity D
CAS# NA
M.F.: C17H21NO
M.W.: 255.35 |
| |
| QA130308 | Aminocaproic acid Impurity H
CAS# 4775-98-8
M.F.: C6H11NO
M.W.: 113.16 |
| |
| QO181603 | Orphenadrine citrate EP Impurity C
CAS# 17349-96-1;17752-32-8(HCl salt)
M.F.: C16H19NO
M.W.: 241.33 |
| |
| QA130307 | Aminocaproic acid Impurity G
CAS# 22993-71-1
M.F.: C12H20N2O
M.W.: 208.30 |
| |
| QO181602 | Orphenadrine citrate EP Impurity B
CAS# NA
M.F.: C14H12O
M.W.: 196.24 |
| |
| QA130306 | Aminocaproic acid Impurity F
CAS# NA
M.F.: C12H25NO7
M.W.: 295.33 |
| |
| QO181601 | Orphenadrine citrate EP Impurity A
CAS# NA
M.F.: C14H14O
M.W.: 198.26 |
| |
| QA130305 | Aminocaproic acid Impurity E
CAS# NA
M.F.: C12H19NO8 HCl
M.W.: 305.28 36.46 |
| |
| QA130304 | Aminocaproic acid Impurity D
CAS# 1675217-42-1
M.F.: C12H19NO8
M.W.: 305.28 |
| |
| QA130303 | Aminocaproic acid Impurity C
CAS# 5776-78-3
M.F.: C18H35N3O4
M.W.: 357.49 |
| |
| QP160619 | Propofol Impurity 19
CAS# 859034-02-9
M.F.: C10H12O3
M.W.: 180.20 |
| |
| QO180302 | Orciprenaline sulfate EP Impurity B
CAS# NA
M.F.: C11H15NO3
M.W.: 209.24 |
| |
| QO180301 | Orciprenaline sulfate EP Impurity A
CAS# NA
M.F.: C12H17NO3
M.W.: 223.27 |
| |
| QO180300 | Orciprenaline sulfate
CAS# 5874-97-5
M.F.: C11H17NO3.1/2H2SO4
M.W.: 211.26 49.04 |
| |
| QO180207 | Orbifloxacin EP Impurity G
CAS# NA
M.F.: C18H20F3N3O
M.W.: 351.37 |
| |
| QO180206 | Orbifloxacin EP Impurity F
CAS# NA
M.F.: C13H7F4NO3
M.W.: 301.19 |
| |
| QO180204 | Orbifloxacin EP Impurity D
CAS# NA
M.F.: C19H21F2N3O4
M.W.: 393.38 |
| |
| QO180201 | Orbifloxacin EP Impurity A
CAS# NA
M.F.: C25H33F2N5O3
M.W.: 489.56 |
| |
| QN182007 | Nortriptyline hydrochloride EP Impurity G
CAS# 16234-88-1
M.F.: C22H25NO2
M.W.: 335.44 |
| |
| QT180209 | Tri-n-butyl Phosphate EP Impurity I
CAS# NA
M.F.: C20H45O5P
M.W.: 396.54 |
| |
| QT180208 | Tri-n-butyl Phosphate EP Impurity H
CAS# NA
M.F.: C13H29O4P
M.W.: 280.34 |
| |
| QT180207 | Tri-n-butyl Phosphate EP Impurity G
CAS# NA
M.F.: C12H27O4P
M.W.: 266.31 |
| |
| QT180206 | Tri-n-butyl Phosphate EP Impurity F
CAS# NA
M.F.: C11H25O4P
M.W.: 252.29 |
| |
| QT180205 | Tri-n-butyl Phosphate EP Impurity E
CAS# NA
M.F.: C10H23O4P
M.W.: 238.26 |
| |
| QT180204 | Tri-n-butyl Phosphate EP Impurity D
CAS# 7242-59-3
M.F.: C9H21O4P
M.W.: 224.23 |
| |
| QT180202 | Tri-n-butyl Phosphate EP Impurity B
CAS# 85391-11-3
M.F.: C4H11O4P
M.W.: 154.10 |
| |
| QT180201 | Tri-n-butyl Phosphate EP Impurity A
CAS# NA
M.F.: C8H19O4P
M.W.: 210.21 |
| |
| QT180200 | Tri-n-butyl Phosphate
CAS# 126-73-8
M.F.: C12H27O4P
M.W.: 266.31 |
| |
| QS040659 | Sildenafil Impurity 59
CAS# NA
M.F.: C24H26N4O5
M.W.: 450.49 |
| |
| QA190400 | Ascaridole
CAS# 512-85-6
M.F.: C10H16O2
M.W.: 168.23 |
| |
| QE200239 | Eltrombopag Impurity 13
CAS# 18048-64-1
M.F.: C12H14N2O
M.W.: 202.25 |
| |
| QA1624132 | Apixaban Impurity 132
CAS# NA
M.F.: C10H16Cl2O3
M.W.: 255.14 |
| |
| QR1922100 | Rosuvastatin Impurity 100
CAS# 1007871-86-4(Na salt)
M.F.: C22H28FN3O6S
M.W.: 481.54 |
| |
| QP132070 | Pemetrexed Impurity 44
CAS# NA
M.F.: C17H23N5O3
M.W.: 345.40 |
| |
| QM201814 | Metaraminol Impurity 14
CAS# 7619-17-2
M.F.: C9H13NO2
M.W.: 167.21 |
| |
| QG121802 | 18α-Glycyrrhizic Acid Ammonium Salt
CAS# 80287-34-9;83896-44-0(free base)
M.F.: C42H62O16 NH3
M.W.: 822.93 17.03 |
| |
| QL142664 | Linezolid Impurity 64
CAS# NA
M.F.: C22H25FN4O4
M.W.: 428.46 |
| |
| QL142662 | Linezolid Impurity 62
CAS# NA
M.F.: C22H25FN4O4
M.W.: 428.46 |
| |
| QT182104 | Triflusal EP Impurity D
CAS# NA
M.F.: C18H10F6O6
M.W.: 436.26 |
| |
| QT182103 | Triflusal EP Impurity C
CAS# NA
M.F.: C12H9F3O5
M.W.: 290.19 |
| |
| QT182102 | Triflusal EP Impurity B
CAS# 328-90-5
M.F.: C8H5F3O3
M.W.: 206.12 |
| |
| QT182101 | Triflusal EP Impurity A
CAS# NA
M.F.: C10H8O6
M.W.: 224.17 |
| |
| QN032012 | Nicotinic acid Impurity 12
CAS# 536-78-7
M.F.: C7H9N
M.W.: 107.15 |
| |
| QC042012 | Cefditoren pivoxil Impurity 12
CAS# NA
M.F.: C27H32N6O8S3
M.W.: 664.77 |
| |
| QC042009 | Cefditoren pivoxil Impurity 9
CAS# NA
M.F.: C19H17N6NaO5S3
M.W.: 528.56 |
| |
| QC042008 | Cefditoren pivoxil Impurity 8
CAS# NA
M.F.: C19H17N6NaO5S3
M.W.: 528.56 |
| |
| QC042007 | Cefditoren pivoxil Impurity 7
CAS# NA
M.F.: C13H13N3O3S2
M.W.: 323.39 |
| |
| QC042006 | Cefditoren pivoxil Impurity 6
CAS# NA
M.F.: C13H13N3O3S2
M.W.: 323.39 |
| |
| QA201615 | Atropine Impurity 15
CAS# 102312-28-7
M.F.: C9H18N2
M.W.: 154.25 |
| |
| QR161416 | Ropinirole Impurity 16
CAS# 1027600-42-5
M.F.: C17H26N2O2
M.W.: 290.40 |
| |
| QV041412 | Vardenafil Impurity 12
CAS# 1009013-42-6
M.F.: C19H25N5O4S
M.W.: 419.50 |
| |
| QT142411 | Tranexamic Acid Impurity 11
CAS# 4331-54-8
M.F.: C8H14O2
M.W.: 142.20 |
| |
| QS180102 | Strontium ranelate Impurity 2
CAS# NA
M.F.: C10H10N2O4S
M.W.: 254.26 |
| |
| QS180101 | Strontium ranelate Impurity 1
CAS# NA
M.F.: C11H10N2O6S
M.W.: 298.27 |
| |
| QD032048 | Docetaxel Impurity 48
CAS# 172018-16-5
M.F.: C29H36O10
M.W.: 544.59 |
| |
| QV192085 | Valsartan Impurity 85
CAS# NA
M.F.: C18H21NO2
M.W.: 283.36 |
| |
| QS200767 | Sitagliptin Impurity 67
CAS# 60470-15-7
M.F.: C12H16O3
M.W.: 208.25 |
| |
| QV140200 | Vinblastine Sulfate
CAS# 143-67-9
M.F.: C46H60N4O13S
M.W.: 909.05 |
| |
| QA201611 | Atropine Impurity 11
CAS# NA
M.F.: C8H15NO2
M.W.: 157.21 |
| |
| QT192053 | Telmisartan Impurity 27
CAS# 39627-24-2
M.F.: C14H13NO
M.W.: 211.26 |
| |
| QT0307165 | Ticagrelor Impurity 165
CAS# NA
M.F.: C9H9F2N
M.W.: 169.17 |
| |
| QP1824105 | Parecoxib Sodium Impurity 79
CAS# NA
M.F.: C19H18N2O4S
M.W.: 370.42 |
| |
| QL091655 | Lipoic Acid Impurity 29
CAS# 1700-12-5
M.F.: C10H18O6
M.W.: 234.25 |
| |
| QL091654 | Lipoic Acid Impurity 28
CAS# 91009-30-2
M.F.: C10H20O2S2
M.W.: 236.39 |
| |
| QL091653 | Lipoic Acid Impurity 27
CAS# 90435-60-2
M.F.: C8H15ClO3
M.W.: 194.66 |
| |
| QL091652 | Lipoic Acid Impurity 26
CAS# 74903-53-0
M.F.: C8H16O4
M.W.: 176.21 |
| |
| QL091651 | (S)-Lipoic acid
CAS# 1077-27-6
M.F.: C8H14O2S2
M.W.: 206.33 |
| |
| QL091650 | Lipoic Acid Impurity 24
CAS# 50628-92-7
M.F.: C10H16O3
M.W.: 184.23 |
| |
| QT090308 | Thioctic Acid Impurity 8
CAS# 1070-65-1
M.F.: C10H19ClO3
M.W.: 222.71 |
| |
| QT090307 | Thioctic Acid Impurity 7
CAS# 50628-91-6
M.F.: C10H17ClO3
M.W.: 220.69 |
| |
| QL151407 | Lornoxicam Impurity 7
CAS# 70415-50-8
M.F.: C9H8ClNO5S2
M.W.: 309.75 |
| |
| QA121900 | Allisartan Isoproxil
CAS# 947331-05-7
M.F.: C27H29ClN6O5
M.W.: 553.01 |
| |
| QA121905 | Allisartan Isoproxil Impurity 5
CAS# NA
M.F.: C28H27ClN6O8
M.W.: 611.00 |
| |
| QA121904 | Allisartan Isoproxil Impurity 4
CAS# NA
M.F.: C23H21ClN6O5
M.W.: 496.90 |
| |
| QA121903 | Allisartan Isoproxil Impurity 3
CAS# NA
M.F.: C25H25ClN6O5
M.W.: 524.96 |
| |
| QA152408 | Amphotericin B-13C6
CAS# 1397-89-3 (non-labelled)
M.F.: C4113C6H73NO17
M.W.: 930.03 |
| |
| QA152407 | Amphotericin B-13C6 Methyl Ester
CAS# 36148-89-7 (non-labelled)
M.F.: C4213C6H75NO17
M.W.: 944.06 |
| |
| QA152406 | Amphotericin B Methyl Ester
CAS# 36148-89-7
M.F.: C48H75NO17
M.W.: 938.11 |
| |
| QA152405 | Amphotericin B Impurity E
CAS# NA
M.F.: C48H73NO18
M.W.: 952.09 |
| |
| QA152403 | Amphotericin B EP Impurity C;
Amphotericin X2 (13-O-Ethyl Amphotericin B)
CAS# NA
M.F.: C49H77NO17
M.W.: 952.13 |
| |
| QA152402 | Amphotericin B EP Impurity B;
Amphotericin X1 (13-O-Methyl Amphotericin B)
CAS# 136135-57-4
M.F.: C48H75NO17
M.W.: 938.11 |
| |
| QA152401 | Amphotericin B EP Impurity A;Amphotericin A
CAS# 1405-32-9
M.F.: C47H75NO17
M.W.: 926.09 |
| |
| QC160324 | Capecitabine Impurity 24
CAS# NA
M.F.: C13H15FN2O7
M.W.: 330.27 |
| |
| QS010601 | Safflor Yellow A
CAS# 85532-77-0
M.F.: C27H30O15
M.W.: 594.52 |
| |
| QA030318 | Acetylcysteine Impurity 18
CAS# 20960-91-2
M.F.: C5H9NO6S
M.W.: 211.19 |
| |
| QT022009 | Terbutaline Impurity 9
CAS# NA
M.F.: C12H17NO4
M.W.: 239.27 |
| |
| QC051503 | Cefonicid Sodium Impurity 3
CAS# NA
M.F.: C2H4N4O3S2
M.W.: 196.21 |
| |
| QC182700 | Sodium Cromoglicate
CAS# 15826-37-6;16110-51-3(free base)
M.F.: C23H14Na2O11
M.W.: 512.33 |
| |
| QP080300 | Phytolaccagenic acid
CAS# 54928-05-1
M.F.: C31H48O6
M.W.: 516.71 |
| |
| QN151945 | Norflurane EP Impurity SS
CAS# 75-10-5
M.F.: CH2F2
M.W.: 52.02 |
| |
| QN151943 | Norflurane EP Impurity QQ
CAS# 75-46-7
M.F.: CHF3
M.W.: 70.01 |
| |
| QN151942 | Norflurane EP Impurity PP
CAS# 353-36-6
M.F.: C2H5F
M.W.: 48.06 |
| |
| QN151939 | Norflurane EP Impurity MM
CAS# 354-33-6
M.F.: C2HF5
M.W.: 120.02 |
| |
| QN151938 | Norflurane EP Impurity LL
CAS# 1645-83-6
M.F.: C3H2F4
M.W.: 114.04 |
| |
| QN151936 | Norflurane EP Impurity JJ
CAS# 75-38-7
M.F.: C2H2F2
M.W.: 64.03 |
| |
| QN151935 | Norflurane EP Impurity II
CAS# 359-11-5
M.F.: C2HF3
M.W.: 82.02 |
| |
| QN151933 | Norflurane EP Impurity GG
CAS# 75-45-6
M.F.: CHClF2
M.W.: 86.47 |
| |
| QN151930 | Norflurane EP Impurity DD
CAS# 354-25-6
M.F.: C2HClF4
M.W.: 136.48 |
| |
| QN151929 | Norflurane EP Impurity CC
CAS# 354-23-4
M.F.: C2HCl2F3
M.W.: 152.93 |
| |
| QN151927 | Norflurane EP Impurity AA
CAS# 2268-32-8
M.F.: C2H2ClF
M.W.: 80.49 |
| |
| QN151926 | Norflurane EP Impurity Z
CAS# 2268-31-7
M.F.: C2H2ClF
M.W.: 80.49 |
| |
| QN151925 | Norflurane EP Impurity Y
CAS# 359-04-6
M.F.: C2HClF2
M.W.: 98.48 |
| |
| QN151924 | Norflurane EP Impurity X
CAS# NA
M.F.: C2HCl2F
M.W.: 114.93 |
| |
| QN151920 | Norflurane EP Impurity T
CAS# 1516-64-9
M.F.: C4F8
M.W.: 200.03 |
| |
| QN151919 | Norflurane EP Impurity S
CAS# 1516-65-0
M.F.: C4F8
M.W.: 200.03 |
| |
| QN151918 | Norflurane EP Impurity R
CAS# 354-55-2
M.F.: C2BrF5
M.W.: 198.92 |
| |
| QN151917 | Norflurane EP Impurity Q
CAS# 76-18-6
M.F.: C3ClF7
M.W.: 204.47 |
| |
| QN151916 | Norflurane EP Impurity P
CAS# 75-72-9
M.F.: CClF3
M.W.: 104.46 |
| |
| QN151915 | Norflurane EP Impurity O
CAS# 353-59-3
M.F.: CBrClF2
M.W.: 165.36 |
| |
| QN151914 | Norflurane EP Impurity N
CAS# 76-15-3
M.F.: C2ClF5
M.W.: 154.47 |
| |
| QN151913 | Norflurane EP Impurity M
CAS# 374-07-2
M.F.: C2Cl2F4
M.W.: 170.92 |
| |
| QN151909 | Norflurane EP Impurity I
CAS# 677-21-4
M.F.: C3H3F3
M.W.: 96.05 |
| |
| QS091303 | Simethicone Impurity 3
CAS# 556-67-2
M.F.: C8H24O4Si4
M.W.: 296.62 |
| |
| QN151907 | Norflurane EP Impurity G
CAS# 359-10-4
M.F.: C2HClF2
M.W.: 98.48 |
| |
| QN151906 | Norflurane EP Impurity F
CAS# 79-35-6
M.F.: C2Cl2F2
M.W.: 132.92 |
| |
| QN151905 | Norflurane EP Impurity E
CAS# 75-37-6
M.F.: C2H4F2
M.W.: 66.05 |
| |
| QN151904 | Norflurane EP Impurity D
CAS# 420-46-2
M.F.: C2H3F3
M.W.: 84.04 |
| |
| QN151903 | Norflurane EP Impurity C
CAS# 359-35-3
M.F.: C2H2F4
M.W.: 102.03 |
| |
| QN151902 | Norflurane EP Impurity B
CAS# 2837-89-0
M.F.: C2HClF4
M.W.: 136.48 |
| |
| QN151900 | Controlled Substance
(Norflurane)
CAS# 811-97-2
M.F.: C2H2F4
M.W.: 102.03 |
| |
| QN151301 | Nomegestrol acetate EP Impurity A
CAS# NA
M.F.: C23H32O4
M.W.: 372.50 |
| |
| QN151300 | Nomegestrol acetate
CAS# 58652-20-3
M.F.: C23H30O4
M.W.: 370.48 |
| |
| QN092204 | Nitrazepam EP Impurity D
CAS# NA
M.F.: C23H15N3O6
M.W.: 429.38 |
| |
| QN092203 | Nitrazepam EP Impurity C
CAS# NA
M.F.: C15H11BrN2O4
M.W.: 363.16 |
| |
| QN092202 | Nitrazepam EP Impurity B
CAS# 1775-95-7
M.F.: C13H10N2O3
M.W.: 242.23 |
| |
| QN092201 | Nitrazepam EP Impurity A
CAS# 36020-93-6
M.F.: C15H11N3O3
M.W.: 281.27 |
| |
| QN091400 | Nimodipine
CAS# 66085-59-4
M.F.: C21H26N2O7
M.W.: 418.44 |
| |
| QN091304 | Nilutamide EP Impurity D
CAS# NA
M.F.: C15H8F6N4O5
M.W.: 438.24 |
| |
| QN091301 | Nilutamide EP Impurity A
CAS# NA
M.F.: C12H11F3N4O3
M.W.: 316.24 |
| |
| QN091300 | Nilutamide
CAS# 63612-50-0
M.F.: C12H10F3N3O4
M.W.: 317.22 |
| |
| QN092104 | Nifuroxazide EP Impurity D
CAS# NA
M.F.: C10H6N4O6
M.W.: 278.18 |
| |
| QI091627 | Ipratropium Bromide Impurity 27
CAS# 3423-25-4
M.F.: C10H19NO
M.W.: 169.26 |
| |
| QN092101 | Nifuroxazide EP Impurity A
CAS# NA
M.F.: C7H8N2O2
M.W.: 152.15 |
| |
| QN051607 | Neohesperidin-dihydrochalcone EP Impurity G
CAS# NA
M.F.: C16H16O6
M.W.: 304.29 |
| |
| QN090706 | Niflumic acid EP Impurity F
CAS# NA
M.F.: C14H11F3N2O2
M.W.: 296.24 |
| |
| QN090705 | Niflumic acid EP Impurity E
CAS# NA
M.F.: C13H9F3N2O2
M.W.: 282.22 |
| |
| QN090702 | Niflumic acid EP Impurity B
CAS# NA
M.F.: C13H9F3N2O2
M.W.: 282.22 |
| |
| QN090700 | Niflumic acid
CAS# 4394-00-7
M.F.: C13H9F3N2O2
M.W.: 282.22 |
| |
| QN051606 | Neohesperidin-dihydrochalcone EP Impurity F
CAS# NA
M.F.: C22H26O11
M.W.: 466.44 |
| |
| QN051605 | Neohesperidin-dihydrochalcone EP Impurity E
CAS# NA
M.F.: C28H36O15
M.W.: 612.58 |
| |
| QN011512 | Nandrolone decanoate EP Impurity L
CAS# NA
M.F.: C27H42O3
M.W.: 414.62 |
| |
| QN011511 | Nandrolone decanoate EP Impurity K
CAS# NA
M.F.: C26H40O3
M.W.: 400.59 |
| |
| QN011510 | Nandrolone decanoate EP Impurity J
CAS# NA
M.F.: C38H64O4
M.W.: 584.91 |
| |
| QN011509 | Nandrolone decanoate EP Impurity I
CAS# NA
M.F.: C30H48O3
M.W.: 456.70 |
| |
| QN011508 | Nandrolone decanoate EP Impurity H
CAS# NA
M.F.: C29H46O3
M.W.: 442.67 |
| |
| QN011507 | Nandrolone decanoate EP Impurity G
CAS# NA
M.F.: C28H42O3
M.W.: 426.63 |
| |
| QN011506 | Nandrolone decanoate EP Impurity F
CAS# NA
M.F.: C28H42O4
M.W.: 442.63 |
| |
| QN011505 | Nandrolone decanoate EP Impurity E
CAS# NA
M.F.: C28H44O4
M.W.: 444.65 |
| |
| QN011504 | Nandrolone decanoate EP Impurity D
CAS# 434-22-0
M.F.: C18H26O2
M.W.: 274.40 |
| |
| QN011503 | Nandrolone decanoate EP Impurity C
CAS# NA
M.F.: C30H52O4
M.W.: 476.73 |
| |
| QN011502 | Nandrolone decanoate EP Impurity B
CAS# NA
M.F.: C29H44O3
M.W.: 440.66 |
| |
| QN011501 | Nandrolone decanoate EP Impurity A
CAS# NA
M.F.: C28H46O3
M.W.: 430.66 |
| |
| QB201454 | Bortezomib Impurity 54
CAS# 514820-48-5
M.F.: C21H44BNO2Si2
M.W.: 409.56 |
| |
| QO192055 | Oseltamivir EP Impurity E
CAS# 208720-71-2;208720-78-9(HCl salt)
M.F.: C15H26N2O4
M.W.: 298.38 |
| |
| QN011500 | Nandrolone decanoate
CAS# 360-70-3
M.F.: C28H44O3
M.W.: 428.65 |
| |
| QP1824103 | Parecoxib Sodium Impurity 77
CAS# NA
M.F.: C16H13NO7S2
M.W.: 395.41 |
| |
| QP1824102 | Parecoxib Sodium Impurity 76
CAS# NA
M.F.: C16H13ClN2O3S
M.W.: 348.80 |
| |
| QA1624126 | Apixaban Impurity 126
CAS# 942142-51-0
M.F.: C26H41ClN4O5
M.W.: 525.08 |
| |
| QN011403 | Nalidixic acid EP Impurity C
CAS# 87-13-8
M.F.: C10H16O5
M.W.: 216.23 |
| |
| QN011402 | Nalidixic acid EP Impurity B
CAS# NA
M.F.: C12H12N2O3
M.W.: 232.24 |
| |
| QN011401 | Nalidixic acid EP Impurity A
CAS# NA
M.F.: C6H8N2
M.W.: 108.14 |
| |
| QN011400 | Nalidixic acid
CAS# 389-08-2
M.F.: C12H12N2O3
M.W.: 232.24 |
| |
| QT260423 | Trazodone hydrochloride Impurity W
CAS# 55290-67-0
M.F.: C19H24ClN5O3
M.W.: 405.88 |
| |
| QN012006 | Naftidrofuryl hydrogen oxalate EP Impurity F
CAS# NA
M.F.: C24H33NO3
M.W.: 383.52 |
| |
| QN012005 | Naftidrofuryl hydrogen oxalate EP Impurity E
CAS# NA
M.F.: C24H29NO3
M.W.: 379.49 |
| |
| QN012004 | Naftidrofuryl hydrogen oxalate EP Impurity D
CAS# NA
M.F.: C13H25NO3
M.W.: 243.34 |
| |
| QN012003 | Naftidrofuryl hydrogen oxalate EP Impurity C
CAS# NA
M.F.: C30H33NO2
M.W.: 439.59 |
| |
| QN012002 | Naftidrofuryl hydrogen oxalate EP Impurity B
CAS# NA
M.F.: C20H24O3
M.W.: 312.40 |
| |
| QN012001 | Naftidrofuryl hydrogen oxalate EP Impurity A
CAS# NA
M.F.: C18H20O3
M.W.: 284.35 |
| |
| QN012000 | Naftidrofuryl hydrogen oxalate
CAS# 3200-06-4
M.F.: C26H35NO7
M.W.: 473.56 |
| |
| QN010407 | Nadolol EP Impurity G
CAS# NA
M.F.: C17H27NO2
M.W.: 277.40 |
| |
| QN010406 | Nadolol EP Impurity F
CAS# NA
M.F.: C17H23NO2
M.W.: 273.37 |
| |
| QN010405 | Nadolol EP Impurity E
CAS# NA
M.F.: C17H26INO4
M.W.: 435.30 |
| |
| QN010404 | Nadolol EP Impurity D
CAS# NA
M.F.: C30H43NO8
M.W.: 545.66 |
| |
| QN010403 | Nadolol EP Impurity C
CAS# NA
M.F.: C23H28O7
M.W.: 416.46 |
| |
| QN010402 | Nadolol EP Impurity B
CAS# NA
M.F.: C14H20O5
M.W.: 268.31 |
| |
| QN010401 | Nadolol EP Impurity A
CAS# NA
M.F.: C13H18O5
M.W.: 254.28 |
| |
| QN010205 | Nabumetone EP Impurity E
CAS# NA
M.F.: C27H26O3
M.W.: 398.49 |
| |
| QN010204 | Nabumetone EP Impurity D
CAS# 127053-22-9
M.F.: C15H14O2
M.W.: 226.27 |
| |
| QN010203 | Nabumetone EP Impurity C
CAS# NA
M.F.: C15H18O2
M.W.: 230.30 |
| |
| QN010202 | Nabumetone EP Impurity B
CAS# NA
M.F.: C18H18O2
M.W.: 266.33 |
| |
| QM251502 | myo-Inositol EP Impurity B
CAS# NA
M.F.: C3H8O3
M.W.: 92.09 |
| |
| QB052804 | Benzocaine EP Impurity D
CAS# 87-25-2
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QT012700 | Taurohyodeoxycholic acid
CAS# 2958-04-5;38411-85-7(Na salt)
M.F.: C26H45NO6S
M.W.: 499.70 |
| |
| QH252400 | Hyodeoxycholic acid
CAS# 83-49-8
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QM152503 | Moxonidine EP Impurity C
CAS# NA
M.F.: C9H13N5O2
M.W.: 223.23 |
| |
| QM152501 | Moxonidine EP Impurity A
CAS# NA
M.F.: C8H9Cl2N5
M.W.: 246.10 |
| |
| QM180105 | Morantel hydrogen tartrate EP Impurity E
CAS# NA
M.F.: C6H6OS
M.W.: 126.18 |
| |
| QM180104 | Morantel hydrogen tartrate EP Impurity D
CAS# NA
M.F.: C12H18N2OS
M.W.: 238.35 |
| |
| QM180103 | Morantel hydrogen tartrate EP Impurity C;
Pyrantel embonate EP Impurity D
CAS# 4271-96-9
M.F.: C6H12N2
M.W.: 112.17 |
| |
| QM180102 | Morantel hydrogen tartrate EP Impurity B
CAS# NA
M.F.: C12H16N2S
M.W.: 220.33 |
| |
| QM180101 | Morantel hydrogen tartrate EP Impurity A
CAS# NA
M.F.: C12H16N2S
M.W.: 220.33 |
| |
| QM180100 | Morantel hydrogen tartrate
CAS# 26155-31-7
M.F.: C16H22N2O6S
M.W.: 370.42 |
| |
| QM091406 | Mianserin hydrochloride EP Impurity F
CAS# NA
M.F.: C24H24N2
M.W.: 340.46 |
| |
| QM091404 | Mianserin hydrochloride EP Impurity D
CAS# NA
M.F.: C24H26N2O
M.W.: 358.48 |
| |
| QM091402 | Mianserin hydrochloride EP Impurity B
CAS# NA
M.F.: C18H20N2O3S
M.W.: 344.43 |
| |
| QM091400 | Mianserin hydrochloride
CAS# 21535-47-7
M.F.: C18H21ClN2
M.W.: 300.83 |
| |
| QM052702 | Metixene hydrochloride EP Impurity B
CAS# NA
M.F.: C13H8OS
M.W.: 212.27 |
| |
| QM052701 | Metixene hydrochloride EP Impurity A
CAS# NA
M.F.: C13H10S
M.W.: 198.28 |
| |
| QM052700 | Metixene hydrochloride
CAS# 7081-40-5
M.F.: C20H26ClNOS
M.W.: 363.94 |
| |
| QM052600 | Methylrosanilinium chloride
CAS# 548-62-9
M.F.: C25H30ClN3
M.W.: 407.98 |
| |
| QM052306 | Methylphenidate hydrochloride EP Impurity F
CAS# 7251-52-7
M.F.: C13H12N2O
M.W.: 212.25 |
| |
| QM052305 | Methylphenidate hydrochloride EP Impurity E
CAS# NA
M.F.: C15H21NO2
M.W.: 247.33 |
| |
| QM052304 | Methylphenidate hydrochloride EP Impurity D
CAS# NA
M.F.: C13H18N2O
M.W.: 218.29 |
| |
| QM052303 | Methylphenidate hydrochloride EP Impurity C
CAS# NA
M.F.: C13H18N2O
M.W.: 218.29 |
| |
| QM052302 | Methylphenidate hydrochloride EP Impurity B
CAS# NA
M.F.: C14H19NO2
M.W.: 233.31 |
| |
| QM052301 | Methylphenidate hydrochloride EP Impurity A
CAS# NA
M.F.: C13H17NO2
M.W.: 219.28 |
| |
| QM052300 | Controlled Substance
(Methylphenidate hydrochloride)
CAS# 298-59-9
M.F.: C14H20ClNO2
M.W.: 269.77 |
| |
| QS060281 | Sofosbuvir Impurity 81
CAS# 2524-64-3
M.F.: C12H10ClO3P
M.W.: 268.63 |
| |
| QM052209 | Methylergometrine maleate EP Impurity I
CAS# 724767-21-9
M.F.: C20H25N3O2
M.W.: 339.43 |
| |
| QM052208 | Methylergometrine maleate EP Impurity H
CAS# 29477-88-1
M.F.: C20H25N3O2
M.W.: 339.43 |
| |
| QM052207 | Methylergometrine maleate EP Impurity G
CAS# 361-37-5
M.F.: C21H27N3O2
M.W.: 353.46 |
| |
| QM052206 | Methylergometrine maleate EP Impurity F
CAS# 479-00-5
M.F.: C19H23N3O2
M.W.: 325.40 |
| |
| QM052205 | Methylergometrine maleate EP Impurity E
CAS# 2889-26-1
M.F.: C16H17N3O
M.W.: 267.33 |
| |
| QM052204 | Methylergometrine maleate EP Impurity D
CAS# NA
M.F.: C19H23N3O2
M.W.: 325.40 |
| |
| QM052203 | Methylergometrine maleate EP Impurity C
CAS# 478-94-4
M.F.: C16H17N3O
M.W.: 267.33 |
| |
| QM052202 | Methylergometrine maleate EP Impurity B
CAS# 478-95-5
M.F.: C16H16N2O2
M.W.: 268.31 |
| |
| QM052201 | Methylergometrine maleate EP Impurity A
CAS# NA
M.F.: C16H16N2O2
M.W.: 268.31 |
| |
| QM052200 | Methylergometrine maleate
CAS# 57432-61-8;113-42-8(free base)
M.F.: C24H29N3O6
M.W.: 455.50 |
| |
| QM052104 | Methyldopa EP Impurity D
CAS# NA
M.F.: C10H13NO4
M.W.: 211.21 |
| |
| QM052103 | Methyldopa EP Impurity C
CAS# NA
M.F.: C12H17NO4
M.W.: 239.27 |
| |
| QM052101 | Methyldopa EP Impurity A
CAS# 6739-31-7
M.F.: C11H15NO4
M.W.: 225.24 |
| |
| QM200213 | Metacresol EP Impurity M
CAS# 697-82-5
M.F.: C9H12O
M.W.: 136.19 |
| |
| QM200212 | Metacresol EP Impurity L
CAS# 95-65-8
M.F.: C8H10O
M.W.: 122.16 |
| |
| QM200211 | Metacresol EP Impurity K
CAS# 123-07-9
M.F.: C8H10O
M.W.: 122.16 |
| |
| QM200210 | Metacresol EP Impurity J
CAS# 108-68-9
M.F.: C8H10O
M.W.: 122.16 |
| |
| QM200209 | Metacresol EP Impurity I
CAS# 526-75-0
M.F.: C8H10O
M.W.: 122.16 |
| |
| QM200208 | Metacresol EP Impurity H
CAS# NA
M.F.: C9H12O
M.W.: 136.19 |
| |
| QM200206 | Metacresol EP Impurity F
CAS# NA
M.F.: C8H10O
M.W.: 122.16 |
| |
| QM200205 | Metacresol EP Impurity E
CAS# 90-00-6
M.F.: C8H10O
M.W.: 122.16 |
| |
| QM192002 | Mesterolone EP Impurity B
CAS# NA
M.F.: C20H34O2
M.W.: 306.48 |
| |
| QM051905 | Mesna EP Impurity E
CAS# 1391054-56-0
M.F.: C5H9N5O3S2
M.W.: 251.29 |
| |
| QM051904 | Mesna EP Impurity D
CAS# 45127-11-5;16208-51-8(2Na salt)
M.F.: C4H10O6S4
M.W.: 282.38 |
| |
| QM051903 | Mesna EP Impurity C
CAS# 69536-71-6
M.F.: C4H8O4S2
M.W.: 184.23 |
| |
| QM051902 | Mesna EP Impurity B
CAS# 1391053-66-9
M.F.: C4H10N4O3S2
M.W.: 226.28 |
| |
| QM051901 | Mesna EP Impurity A
CAS# 25985-57-3
M.F.: C3H8N2O3S2
M.W.: 184.24 |
| |
| QM051801 | Mercaptopurine EP Impurity A;
Hypoxanthine
CAS# 68-94-0
M.F.: C5H4N4O
M.W.: 136.11 |
| |
| QM162503 | Mepyramine maleate EP Impurity C;
Tenoxicam EP Impurity A
CAS# 504-29-0
M.F.: C5H6N2
M.W.: 94.11 |
| |
| QM162501 | Mepyramine maleate EP Impurity A
CAS# NA
M.F.: C13H14N2O
M.W.: 214.26 |
| |
| QM162500 | Mepyramine maleate
CAS# 59-33-6
M.F.: C21H27N3O5
M.W.: 401.46 |
| |
| QM011806 | Marbofloxacin EP Impurity F
CAS# NA
M.F.: C17H19FN4O5
M.W.: 378.35 |
| |
| QM011804 | Marbofloxacin EP Impurity D
CAS# NA
M.F.: C16H19FN4O4
M.W.: 350.34 |
| |
| QM011803 | Marbofloxacin EP Impurity C
CAS# NA
M.F.: C16H18F2N4O3
M.W.: 352.34 |
| |
| QM011802 | Marbofloxacin EP Impurity B
CAS# NA
M.F.: C12H8F2N2O4
M.W.: 282.20 |
| |
| QM011801 | Marbofloxacin EP Impurity A
CAS# NA
M.F.: C11H8F2N2O4
M.W.: 270.19 |
| |
| QM011605 | Maprotiline hydrochloride EP Impurity E
CAS# NA
M.F.: C21H25N
M.W.: 291.43 |
| |
| QM011604 | Maprotiline hydrochloride EP Impurity D
CAS# NA
M.F.: C20H21N
M.W.: 275.39 |
| |
| QM011603 | Maprotiline hydrochloride EP Impurity C
CAS# NA
M.F.: C19H21N
M.W.: 263.38 |
| |
| QM011602 | Maprotiline hydrochloride EP Impurity B
CAS# NA
M.F.: C39H41N
M.W.: 523.75 |
| |
| QM011601 | Maprotiline hydrochloride EP Impurity A
CAS# NA
M.F.: C19H16O
M.W.: 260.33 |
| |
| QM011600 | Maprotiline hydrochloride
CAS# 10347-81-6
M.F.: C20H24ClN
M.W.: 313.86 |
| |
| QM120903 | Malathion EP Impurity C
CAS# NA
M.F.: C9H17O6PS2
M.W.: 316.33 |
| |
| QM120902 | Malathion EP Impurity B
CAS# NA
M.F.: C10H19O7PS
M.W.: 314.29 |
| |
| QM120901 | Malathion EP Impurity A
CAS# NA
M.F.: C10H19O6PS2
M.W.: 330.36 |
| |
| QP090402 | Magnesium pidolate EP Impurity B
CAS# 29227-92-7
M.F.: C10H14N2O6
M.W.: 258.23 |
| |
| QP090400 | Magnesium pidolate
CAS# 62003-27-4
M.F.: C10H12MgN2O6
M.W.: 280.52 |
| |
| QL252004 | Lysine acetate EP Impurity D;Valine
CAS# 72-18-4
M.F.: C5H11NO2
M.W.: 117.15 |
| |
| QL252000 | Lysine acetate
CAS# 57282-49-2;56-87-1(free base)
M.F.: C8H18N2O4
M.W.: 206.24 |
| |
| QL251403 | Lynestrenol EP Impurity C
CAS# NA
M.F.: C20H30O
M.W.: 286.45 |
| |
| QL251402 | Lynestrenol EP Impurity B
CAS# NA
M.F.: C20H28O
M.W.: 284.44 |
| |
| QL251401 | Lynestrenol EP Impurity A
CAS# NA
M.F.: C20H28O
M.W.: 284.44 |
| |
| QL251307 | Lymecycline EP Impurity G
CAS# NA
M.F.: C22H23ClN2O8
M.W.: 478.88 |
| |
| QL120608 | Lufenuron EP Impurity H
CAS# NA
M.F.: C19H8Cl4F12N2O3
M.W.: 682.07 |
| |
| QL120607 | Lufenuron EP Impurity G
CAS# NA
M.F.: C21H12Cl2F2N2O5
M.W.: 481.23 |
| |
| QL120606 | Lufenuron EP Impurity F
CAS# NA
M.F.: C17H9Cl2F7N2O3
M.W.: 493.16 |
| |
| QL120605 | Lufenuron EP Impurity E
CAS# NA
M.F.: C17H8Cl3F7N2O3
M.W.: 527.60 |
| |
| QL120604 | Lufenuron EP Impurity D
CAS# NA
M.F.: C17H9ClF8N2O3
M.W.: 476.71 |
| |
| QL120603 | Lufenuron EP Impurity C
CAS# NA
M.F.: C17H9ClF8N2O3
M.W.: 476.71 |
| |
| QL120602 | Lufenuron EP Impurity B
CAS# NA
M.F.: C14H8Cl2F2N2O3
M.W.: 361.13 |
| |
| QL120601 | Lufenuron EP Impurity A
CAS# NA
M.F.: C7H5F2NO
M.W.: 157.12 |
| |
| QL120600 | Lufenuron
CAS# 103055-07-8
M.F.: C17H8Cl2F8N2O3
M.W.: 511.15 |
| |
| QI091626 | Ipratropium Bromide Impurity 26
CAS# NA
M.F.: C20H30BrNO4
M.W.: 428.36 |
| |
| QI091625 | Ipratropium Bromide Impurity 25
CAS# NA
M.F.: C20H30BrNO4
M.W.: 428.36 |
| |
| QI091624 | Ipratropium Bromide Impurity 24
CAS# NA
M.F.: C20H30BrNO4
M.W.: 428.36 |
| |
| QM154250 | Mirabegron Impurity 24
CAS# NA
M.F.: C9H10N2O5S
M.W.: 258.25 |
| |
| QL161418 | Lopinavir EP Impurity R
CAS# NA
M.F.: C47H58N4O7
M.W.: 790.99 |
| |
| QL161416 | Lopinavir EP Impurity P
CAS# NA
M.F.: C37H48N4O5
M.W.: 628.80 |
| |
| QL161415 | Lopinavir EP Impurity O
CAS# NA
M.F.: C46H62N6O7
M.W.: 811.02 |
| |
| QL161414 | Lopinavir EP Impurity N
CAS# NA
M.F.: C38H50N4O5
M.W.: 642.83 |
| |
| QL161413 | Lopinavir EP Impurity M
CAS# NA
M.F.: C38H50N4O5
M.W.: 642.83 |
| |
| QL161412 | Lopinavir EP Impurity L
CAS# NA
M.F.: C22H26N2O4
M.W.: 382.45 |
| |
| QL161411 | Lopinavir EP Impurity K
CAS# NA
M.F.: C37H48N4O5
M.W.: 628.80 |
| |
| QL161410 | Lopinavir EP Impurity J
CAS# NA
M.F.: C37H48N4O5
M.W.: 628.80 |
| |
| QL161409 | Lopinavir EP Impurity I
CAS# NA
M.F.: C37H48N4O5
M.W.: 628.80 |
| |
| QL161408 | Lopinavir EP Impurity H
CAS# NA
M.F.: C29H32N2O4
M.W.: 472.58 |
| |
| QL161407 | Lopinavir EP Impurity G
CAS# NA
M.F.: C30H36N2O4
M.W.: 488.62 |
| |
| QL161405 | Lopinavir EP Impurity E
CAS# NA
M.F.: C28H34N2O3
M.W.: 446.58 |
| |
| QL161403 | Lopinavir EP Impurity C
CAS# NA
M.F.: C36H52N6O5
M.W.: 648.84 |
| |
| QL161402 | Lopinavir EP Impurity B
CAS# NA
M.F.: C28H38N4O4
M.W.: 494.63 |
| |
| QL161401 | Lopinavir EP Impurity A
CAS# NA
M.F.: C27H38N4O3
M.W.: 466.62 |
| |
| QL052706 | Levomethadone hydrochloride EP Impurity F
CAS# NA
M.F.: C12H15NO6S
M.W.: 301.32 |
| |
| QL052701 | Levomethadone hydrochloride EP Impurity A
CAS# NA
M.F.: C21H27NO
M.W.: 309.45 |
| |
| QL052700 | Levomethadone hydrochloride
CAS# 5967-73-7
M.F.: C21H28ClNO
M.W.: 345.91 |
| |
| QL052600 | Levomepromazine hydrochloride
CAS# 1236-99-3;7104-38-3(maleate)
M.F.: C19H25ClN2OS
M.W.: 364.93 |
| |
| QL052503 | Levodropropizine EP Impurity C
CAS# NA
M.F.: C3H6O2
M.W.: 74.08 |
| |
| QL052502 | Levodropropizine EP Impurity B
CAS# 92-54-6;153121-53-0(HBr salt)
M.F.: C10H14N2
M.W.: 162.23 |
| |
| QL052501 | Levodropropizine EP Impurity A
CAS# NA
M.F.: C13H20N2O2
M.W.: 236.31 |
| |
| QL052500 | Levodropropizine
CAS# 99291-25-5
M.F.: C13H20N2O2
M.W.: 236.31 |
| |
| QL052412 | Levocabastine hydrochloride EP Impurity L
CAS# NA
M.F.: C26H29FN2O3
M.W.: 436.52 |
| |
| QL052411 | Levocabastine hydrochloride EP Impurity K
CAS# NA
M.F.: C25H24FN2
M.W.: 371.47 |
| |
| QL052410 | Levocabastine hydrochloride EP Impurity J
CAS# NA
M.F.: C26H29FN2O3
M.W.: 436.52 |
| |
| QL052409 | Levocabastine hydrochloride EP Impurity I
CAS# NA
M.F.: C26H29FN2O2
M.W.: 420.52 |
| |
| QL052408 | Levocabastine hydrochloride EP Impurity H
CAS# NA
M.F.: C13H12FNO
M.W.: 217.24 |
| |
| QL052407 | Levocabastine hydrochloride EP Impurity G
CAS# NA
M.F.: C26H31FN2O3
M.W.: 438.53 |
| |
| QL052406 | Levocabastine hydrochloride EP Impurity F
CAS# NA
M.F.: C13H17NO2
M.W.: 219.28 |
| |
| QL052405 | Levocabastine hydrochloride EP Impurity E
CAS# NA
M.F.: C26H29FN2O2
M.W.: 420.52 |
| |
| QL052404 | Levocabastine hydrochloride EP Impurity D
CAS# NA
M.F.: C25H27FN2O2
M.W.: 406.49 |
| |
| QL052403 | Levocabastine hydrochloride EP Impurity C
CAS# NA
M.F.: C26H29FN2O2
M.W.: 420.52 |
| |
| QL052402 | Levocabastine hydrochloride EP Impurity B
CAS# NA
M.F.: C26H29FN2O2
M.W.: 420.52 |
| |
| QL052401 | Levocabastine hydrochloride EP Impurity A
CAS# NA
M.F.: C26H30N2O2
M.W.: 402.53 |
| |
| QL052400 | Levocabastine hydrochloride
CAS# 79547-78-7;79516-68-0(free base)
M.F.: C26H30ClFN2O2
M.W.: 456.98 |
| |
| QL052305 | Levamisole EP Impurity E
CAS# 32190-36-6
M.F.: C22H26N4O2S2
M.W.: 442.60 |
| |
| QL052304 | Levamisole EP Impurity D
CAS# 4335-28-8;4335-29-9(HCl salt)
M.F.: C11H10N2S
M.W.: 202.28 |
| |
| QL052303 | Levamisole EP Impurity C
CAS# 32190-33-3
M.F.: C11H14N2OS
M.W.: 222.31 |
| |
| QL052301 | Levamisole EP Impurity A
CAS# 32190-34-4
M.F.: C11H14N2OS
M.W.: 222.31 |
| |
| QL052300 | Levamisole
CAS# 14769-73-4
M.F.: C11H12N2S
M.W.: 204.29 |
| |
| QK201505 | Ketobemidone hydrochloride EP Impurity E
CAS# NA
M.F.: C13H16N2O
M.W.: 216.28 |
| |
| QK201504 | Ketobemidone hydrochloride EP Impurity D
CAS# NA
M.F.: C16H23NO2
M.W.: 261.36 |
| |
| QK201503 | Ketobemidone hydrochloride EP Impurity C
CAS# NA
M.F.: C14H19NO2
M.W.: 233.31 |
| |
| QK201502 | Ketobemidone hydrochloride EP Impurity B
CAS# NA
M.F.: C14H19NO2
M.W.: 233.31 |
| |
| QK201501 | Ketobemidone hydrochloride EP Impurity A
CAS# NA
M.F.: C15H21NO3
M.W.: 263.33 |
| |
| QK201500 | Ketobemidone hydrochloride
CAS# 5965-49-1
M.F.: C15H22ClNO2
M.W.: 283.79 |
| |
| QJ151911 | Josamycin EP Impurity K
CAS# NA
M.F.: C40H65NO15
M.W.: 799.94 |
| |
| QJ151910 | Josamycin EP Impurity J
CAS# NA
M.F.: C43H71NO15
M.W.: 842.02 |
| |
| QJ151909 | Josamycin EP Impurity I
CAS# NA
M.F.: C38H63NO14
M.W.: 757.91 |
| |
| QJ151908 | Josamycin EP Impurity H
CAS# NA
M.F.: C40H67NO14
M.W.: 785.96 |
| |
| QJ151907 | Josamycin EP Impurity G
CAS# NA
M.F.: C37H61NO14
M.W.: 743.88 |
| |
| QJ151906 | Josamycin EP Impurity F
CAS# NA
M.F.: C35H59NO13
M.W.: 701.84 |
| |
| QJ151905 | Josamycin EP Impurity E
CAS# NA
M.F.: C43H71NO15
M.W.: 842.02 |
| |
| QJ151904 | Josamycin EP Impurity D
CAS# NA
M.F.: C42H69NO15
M.W.: 827.99 |
| |
| QJ151902 | Josamycin EP Impurity B
CAS# NA
M.F.: C42H71NO15
M.W.: 830.01 |
| |
| QJ151901 | Josamycin EP Impurity A
CAS# NA
M.F.: C41H67NO15
M.W.: 813.97 |
| |
| QI191705 | Isopropyl alcohol EP Impurity E
CAS# 67-56-1
M.F.: CH4O
M.W.: 32.04 |
| |
| QI191704 | Isopropyl alcohol EP Impurity D
CAS# NA
M.F.: C4H10O
M.W.: 74.12 |
| |
| QA165127 | Azithromycin Impurity 27
CAS# 67342-52-3
M.F.: C10H13NO3S
M.W.: 227.28 |
| |
| QI191701 | Isopropyl alcohol EP Impurity A
CAS# NA
M.F.: C3H6O
M.W.: 58.08 |
| |
| QI191700 | Isopropyl alcohol
CAS# 67-63-0
M.F.: C3H8O
M.W.: 60.10 |
| |
| QI152408 | Ioxaglic acid EP Impurity H
CAS# NA
M.F.: C35H28I9N7O13
M.W.: 1896.78 |
| |
| QI152407 | Ioxaglic acid EP Impurity G
CAS# NA
M.F.: C26H23I6N5O9
M.W.: 1310.92 |
| |
| QI152405 | Ioxaglic acid EP Impurity E
CAS# NA
M.F.: C36H31I9N8O12
M.W.: 1909.82 |
| |
| QI152404 | Ioxaglic acid EP Impurity D
CAS# NA
M.F.: C25H23I6N5O8
M.W.: 1282.91 |
| |
| QI152402 | Ioxaglic acid EP Impurity B
CAS# NA
M.F.: C24H22I5N5O8
M.W.: 1142.98 |
| |
| QI152401 | Ioxaglic acid EP Impurity A
CAS# NA
M.F.: C10H9I3N2O4
M.W.: 601.90 |
| |
| QI152400 | Ioxaglic acid
CAS# 59017-64-0
M.F.: C24H21I6N5O8
M.W.: 1268.88 |
| |
| QI152110 | Iotrolan EP Impurity J
CAS# NA
M.F.: C49H64I6N6O18
M.W.: 1786.49 |
| |
| QI152109 | Iotrolan EP Impurity I
CAS# NA
M.F.: C46H60I6N6O18
M.W.: 1746.42 |
| |
| QI152108 | Iotrolan EP Impurity H
CAS# NA
M.F.: C43H56I6N6O18
M.W.: 1706.36 |
| |
| QI152107 | Iotrolan EP Impurity G
CAS# NA
M.F.: C21H8Cl4I6N2O6
M.W.: 1287.54 |
| |
| QI152106 | Iotrolan EP Impurity F
CAS# NA
M.F.: C21H12I6N2O10
M.W.: 1213.75 |
| |
| QI152105 | Iotrolan EP Impurity E
CAS# NA
M.F.: C17H24I3N3O8
M.W.: 779.10 |
| |
| QI152104 | Iotrolan EP Impurity D
CAS# NA
M.F.: C33H39I6N5O16
M.W.: 1523.11 |
| |
| QI152103 | Iotrolan EP Impurity C
CAS# NA
M.F.: C20H26I3N3O11
M.W.: 865.15 |
| |
| QI152102 | Iotrolan EP Impurity B
CAS# NA
M.F.: C19H26I3N3O9
M.W.: 821.14 |
| |
| QI152101 | Iotrolan EP Impurity A
CAS# NA
M.F.: C40H52I6N6O18
M.W.: 1666.30 |
| |
| QI152100 | Iotrolan
CAS# 79770-24-4
M.F.: C37H48I6N6O18
M.W.: 1626.23 |
| |
| QI160100 | Iopanoic acid
CAS# NA
M.F.: C11H12I3NO2
M.W.: 570.93 |
| |
| QI140505 | Indinavir sulfate EP Impurity E
CAS# NA
M.F.: C51H65N5O7
M.W.: 860.09 |
| |
| QI140504 | Indinavir sulfate EP Impurity D
CAS# NA
M.F.: C27H36N4O3
M.W.: 464.60 |
| |
| QI140503 | Indinavir sulfate EP Impurity C
CAS# NA
M.F.: C36H47N5O4
M.W.: 613.79 |
| |
| QI140502 | Indinavir sulfate EP Impurity B
CAS# NA
M.F.: C30H42N4O4
M.W.: 522.68 |
| |
| QI140501 | Indinavir sulfate EP Impurity A
CAS# NA
M.F.: C9H11NO
M.W.: 149.19 |
| |
| QI140500 | Indinavir sulfate
CAS# 157810-81-6
M.F.: C38H55N5O9S
M.W.: 757.94 |
| |
| QI131003 | Imipramine hydrochloride EP Impurity C
CAS# NA
M.F.: C18H20N2O
M.W.: 280.36 |
| |
| QI131002 | Imipramine hydrochloride EP Impurity B
CAS# NA
M.F.: C19H22N2
M.W.: 278.39 |
| |
| QI131001 | Imipramine hydrochloride EP Impurity A
CAS# NA
M.F.: C18H22N2
M.W.: 266.38 |
| |
| QI131000 | Imipramine hydrochloride
CAS# 113-52-0
M.F.: C19H25ClN2
M.W.: 316.87 |
| |
| QI061506 | Ifosfamide EP Impurity F
CAS# NA
M.F.: C5H10Cl2NO2P
M.W.: 218.02 |
| |
| QI061505 | Ifosfamide EP Impurity E
CAS# 42453-19-0
M.F.: C5H11Cl2N
M.W.: 156.05 |
| |
| QI061503 | Ifosfamide EP Impurity C;
Carmustine EP Impurity B
CAS# 689-98-5;870-24-6(HCl salt)
M.F.: C2H6ClN
M.W.: 79.53 |
| |
| QI061502 | Ifosfamide EP Impurity B
CAS# 241482-18-8
M.F.: C10H24Cl2N2O7P2
M.W.: 417.16 |
| |
| QI061501 | Ifosfamide EP Impurity A
CAS# 22608-58-8
M.F.: C5H13ClNO4P
M.W.: 217.59 |
| |
| QI041700 | Idoxuridine
CAS# 54-42-2
M.F.: C9H11IN2O5
M.W.: 354.10 |
| |
| QH250601 | Hydroxyethyl salicylate EP Impurity A
CAS# NA
M.F.: C7H6O3
M.W.: 138.12 |
| |
| QH250600 | Hydroxyethyl salicylate
CAS# 87-28-5
M.F.: C9H10O4
M.W.: 182.17 |
| |
| QH250504 | Hydromorphone hydrochloride EP Impurity D
CAS# NA
M.F.: C17H21NO3
M.W.: 287.35 |
| |
| QH250502 | Hydromorphone hydrochloride EP Impurity B
CAS# NA
M.F.: C17H19NO4
M.W.: 301.34 |
| |
| QH250501 | Hydromorphone hydrochloride EP Impurity A
CAS# NA
M.F.: C34H36N2O6
M.W.: 568.66 |
| |
| QH250500 | Hydromorphone hydrochloride
CAS# 71-68-1
M.F.: C17H20ClNO3
M.W.: 321.80 |
| |
| QH151401 | Homatropine hydrobromide EP Impurity A
CAS# NA
M.F.: C16H19NO3
M.W.: 273.33 |
| |
| QH151400 | Homatropine hydrobromide;
Homatropine methylbromide EP Impurity B
CAS# 51-56-9
M.F.: C16H21NO3.HBr
M.W.: 275.34 80.91 |
| |
| QH091900 | Histamine dihydrochloride
CAS# 56-92-8
M.F.: C5H11Cl2N3
M.W.: 184.07 |
| |
| QH052604 | Hexylresorcinol EP Impurity D
CAS# NA
M.F.: C12H16O3
M.W.: 208.25 |
| |
| QH052603 | Hexylresorcinol EP Impurity C
CAS# NA
M.F.: C11H16O2
M.W.: 180.24 |
| |
| QH052504 | Hexetidine EP Impurity D
CAS# 81-04-9
M.F.: C10H8O6S2
M.W.: 288.30 |
| |
| QH052503 | Hexetidine EP Impurity C
CAS# NA
M.F.: C22H45N3
M.W.: 351.61 |
| |
| QH052502 | Hexetidine EP Impurity B
CAS# NA
M.F.: C20H45N3
M.W.: 327.59 |
| |
| QT150201 | Deoxystreptamine-kanosaminide
CAS# 20744-51-8
M.F.: C12H25N3O7
M.W.: 323.34 |
| |
| QH051601 | Heptaminol hydrochloride EP Impurity A
CAS# NA
M.F.: C8H17N
M.W.: 127.23 |
| |
| QH051600 | Heptaminol hydrochloride
CAS# 543-15-7
M.F.: C8H20ClNO
M.W.: 181.7 |
| |
| QH011309 | Halothane EP Impurity I
CAS# NA
M.F.: C2BrCl2F3
M.W.: 231.83 |
| |
| QH011307 | Halothane EP Impurity G
CAS# NA
M.F.: C2BrClF2
M.W.: 177.38 |
| |
| QH011304 | Halothane EP Impurity D
CAS# NA
M.F.: C4HBrF6
M.W.: 242.95 |
| |
| QH011303 | Halothane EP Impurity C
CAS# NA
M.F.: C8Cl4F12
M.W.: 465.88 |
| |
| QH011302 | Halothane EP Impurity B
CAS# NA
M.F.: C8H2Cl2F12
M.W.: 396.99 |
| |
| QH121503 | Halofantrine hydrochloride EP Impurity C
CAS# NA
M.F.: C16H9Cl2F3O
M.W.: 345.14 |
| |
| QH121502 | Halofantrine hydrochloride EP Impurity B
CAS# NA
M.F.: C26H31ClF3NO
M.W.: 465.98 |
| |
| QH121501 | Halofantrine hydrochloride EP Impurity A
CAS# NA
M.F.: C26H31ClF3NO
M.W.: 465.98 |
| |
| QH121500 | Halofantrine hydrochloride
CAS# 36167-63-2
M.F.: C26H31Cl3F3NO
M.W.: 536.88 |
| |
| QG210300 | Guanethidine monosulfate
CAS# 645-43-2
M.F.: C10H24N4O4S
M.W.: 296.39 |
| |
| QG210208 | Guaiacol EP Impurity H
CAS# NA
M.F.: C7H8O2
M.W.: 124.14 |
| |
| QG210207 | Guaiacol EP Impurity G
CAS# 150-76-5
M.F.: C7H8O2
M.W.: 124.14 |
| |
| QG210206 | Guaiacol EP Impurity F
CAS# NA
M.F.: C8H10O2
M.W.: 138.16 |
| |
| QG210203 | Guaiacol EP Impurity C
CAS# 91-16-7
M.F.: C8H10O2
M.W.: 138.16 |
| |
| QG210202 | Guaiacol EP Impurity B
CAS# 108-95-2
M.F.: C6H6O
M.W.: 94.11 |
| |
| QG180900 | Griseofulvin
CAS# 126-07-8
M.F.: C17H17ClO6
M.W.: 352.77 |
| |
| QG122200 | Glutamic acid; Lysine acetate EP Impurity B; Pemetrexed Impurity M; Asparagine EP Impurity B;Magnesium pidolate EP Impurity A;Aspartic acid EP Impurity C;Alanine EP Impurity B
CAS# 56-86-0
M.F.: C5H9NO4
M.W.: 147.13 |
| |
| QG011206 | Galantamine hydrobromide EP Impurity F
CAS# 60384-53-4
M.F.: C17H21NO3
M.W.: 287.35 |
| |
| QG011205 | Galantamine hydrobromide EP Impurity E
CAS# 41303-74-6
M.F.: C16H19NO3
M.W.: 273.33 |
| |
| QG011204 | Galantamine hydrobromide EP Impurity D
CAS# 664995-65-7
M.F.: C17H19NO2
M.W.: 269.34 |
| |
| QG011203 | Galantamine hydrobromide EP Impurity C;
Dihydro Galantamine
CAS# 21133-52-8
M.F.: C17H23NO3
M.W.: 289.37 |
| |
| QG011201 | Galantamine hydrobromide EP Impurity A
CAS# 510-77-0
M.F.: C17H19NO3
M.W.: 285.34 |
| |
| QG011200 | Galantamine hydrobromide
CAS# 1953-04-4;357-70-0(free base)
M.F.: C17H22BrNO3
M.W.: 368.27 |
| |
| QF180107 | Framycetin sulfate EP Impurity G;Neomycin sulfate EP Impurity G;Neomycin B-LP
CAS# 54617-40-2
M.F.: C25H48N6O14
M.W.: 656.68 |
| |
| QF180106 | Framycetin sulfate EP Impurity F;Neomycin sulfate EP Impurity F
CAS# 51795-47-2
M.F.: C23H45N5O14
M.W.: 615.63 |
| |
| QF180105 | Framycetin sulfate EP Impurity E;
Neomycin sulfate EP Impurity E
CAS# 7542-37-2;1263-89-4(xH2SO4 salt)
M.F.: C23H45N5O14
M.W.: 615.63 |
| |
| QF180104 | Framycetin sulfate EP Impurity D;Neomycin sulfate EP Impurity D
CAS# 534-47-4
M.F.: C12H25N3O7
M.W.: 323.34 |
| |
| QF180103 | Framycetin sulfate EP Impurity C; Neomycin C;Neomycin sulfate EP Impurity C
CAS# 66-86-4
M.F.: C23H46N6O13
M.W.: 614.64 |
| |
| QF180102 | Framycetin sulfate EP Impurity B;Neomycin sulfate EP Impurity B
CAS# NA
M.F.: C14H28N4O7
M.W.: 364.39 |
| |
| QF180101 | Framycetin sulfate EP Impurity A;Neomycin sulfate EP Impurity A
CAS# 3947-65-7
M.F.: C12H26N4O6
M.W.: 322.36 |
| |
| QF180100 | Framycetin sulfate
CAS# NA
M.F.: C23H46N6O13
M.W.: 614.64 |
| |
| QF151904 | Foscarnet sodium hexahydrate EP Impurity D
CAS# 1474-78-8
M.F.: C7H15O5P
M.W.: 210.16 |
| |
| QF151902 | Foscarnet sodium hexahydrate EP Impurity B
CAS# 55920-24-6
M.F.: C3H5Na2O5P
M.W.: 198.02 |
| |
| QF151903 | Foscarnet sodium hexahydrate EP Impurity C
CAS# 72304-94-0
M.F.: C5H10NaO5P
M.W.: 204.09 |
| |
| QF151901 | Foscarnet sodium hexahydrate EP Impurity A
CAS# 72305-00-1
M.F.: C3H5Na2O5P
M.W.: 198.02 |
| |
| QF151900 | Foscarnet sodium hexahydrate
CAS# 34156-56-4
M.F.: CH12Na3O11P
M.W.: 300.04 |
| |
| QF123303 | Fluspirilene EP Impurity C
CAS# NA
M.F.: C30H33F2N3O2
M.W.: 505.60 |
| |
| QF123302 | Fluspirilene EP Impurity B
CAS# NA
M.F.: C29H31F2N3O
M.W.: 475.57 |
| |
| QF123203 | Flurazepam monohydrochloride EP Impurity C
CAS# NA
M.F.: C17H14ClFN2O2
M.W.: 332.76 |
| |
| QF123202 | Flurazepam monohydrochloride EP Impurity B
CAS# NA
M.F.: C15H10ClFN2O
M.W.: 288.70 |
| |
| QF123201 | Flurazepam monohydrochloride EP Impurity A
CAS# NA
M.F.: C19H22ClFN2O
M.W.: 348.84 |
| |
| QF123200 | Flurazepam monohydrochloride
CAS# 36105-20-1
M.F.: C21H24Cl2FN3O
M.W.: 424.34 |
| |
| QF211607 | Fluphenazine decanoate EP Impurity G;
Fluphenazine enantate EP Impurity G;
fluphenazine dodecanoate
CAS# NA
M.F.: C34H48F3N3O2S
M.W.: 619.82 |
| |
| QF211606 | Fluphenazine decanoate EP Impurity F;
Fluphenazine enantate EP Impurity F;
Fluphenazine undecanoate
CAS# NA
M.F.: C33H46F3N3O2S
M.W.: 605.80 |
| |
| QF211604 | Fluphenazine decanoate EP Impurity D;
Fluphenazine enantate EP Impurity D;
Fluphenazine octanoate
CAS# NA
M.F.: C30H40F3N3O2S
M.W.: 563.72 |
| |
| QF211605 | Fluphenazine decanoate EP Impurity E;
Fluphenazine enantate EP Impurity E;
Fluphenazine nonanoate
CAS# NA
M.F.: C31H42F3N3O2S
M.W.: 577.74 |
| |
| QF211603 | Fluphenazine decanoate EP Impurity C;
Fluphenazine enantate
CAS# 2746-81-8
M.F.: C29H38F3N3O2S
M.W.: 549.69 |
| |
| QF211602 | Fluphenazine decanoate EP Impurity B;
Fluphenazine enantate EP Impurity B;
Fluphenazine
CAS# 146-56-5(2HCl salt)
M.F.: C22H26F3N3OS
M.W.: 437.52 |
| |
| QF211601 | Fluphenazine decanoate EP Impurity A;
Fluphenazine dihydrochloride EP Impurity A;
Fluphenazine enantate EP Impurity A;
Fluphenazine S-oxide
CAS# 1674-76-6
M.F.: C22H26F3N3O2S
M.W.: 453.52 |
| |
| QF211600 | Fluphenazine decanoate;
Fluphenazine enantate EP Impurity C
CAS# 5002-47-1
M.F.: C32H44F3N3O2S
M.W.: 591.77 |
| |
| QF211504 | Fluocortolone pivalate EP Impurity D
CAS# NA
M.F.: C27H39FO5
M.W.: 462.59 |
| |
| QF211503 | Fluocortolone pivalate EP Impurity C
CAS# NA
M.F.: C27H35FO5
M.W.: 458.56 |
| |
| QF211502 | Fluocortolone pivalate EP Impurity B
CAS# NA
M.F.: C27H38O7
M.W.: 474.59 |
| |
| QF211501 | Fluocortolone pivalate EP Impurity A
CAS# 152-97-6
M.F.: C22H29FO4
M.W.: 376.46 |
| |
| QF211500 | Fluocortolone pivalate
CAS# 29205-06-9
M.F.: C27H37FO5
M.W.: 460.58 |
| |
| QF211404 | Flunixin meglumine EP Impurity D
CAS# NA
M.F.: C16H15F3N2O2
M.W.: 324.30 |
| |
| QF211403 | Flunixin meglumine EP Impurity C
CAS# NA
M.F.: C8H8ClNO2
M.W.: 185.61 |
| |
| QF211402 | Flunixin meglumine EP Impurity B
CAS# NA
M.F.: C8H8F3N
M.W.: 175.15 |
| |
| QF211400 | Flunixin meglumine
CAS# 42461-84-7
M.F.: C21H28F3N3O7
M.W.: 491.46 |
| |
| QM092207 | Mivacurium chloride Impurity 7
CAS# NA
M.F.: C58H80Cl2N2O14
M.W.: 1100.17 |
| |
| QM092206 | Mivacurium chloride Impurity 6
CAS# NA
M.F.: C58H80Cl2N2O14
M.W.: 1100.17 |
| |
| QM092205 | Mivacurium chloride Impurity 5
CAS# NA
M.F.: C58H80Cl2N2O14
M.W.: 1100.17 |
| |
| QM092204 | Mivacurium chloride Impurity 4
CAS# NA
M.F.: C25H36ClNO6
M.W.: 482.01 |
| |
| QM092203 | Mivacurium chloride Impurity 3
CAS# 107740-64-7
M.F.: C25H36ClNO6
M.W.: 482.01 |
| |
| QM092202 | Mivacurium chloride Impurity 2
CAS# NA
M.F.: C33H46ClNO9
M.W.: 636.17 |
| |
| QM092201 | Mivacurium chloride Impurity 1
CAS# NA
M.F.: C33H46ClNO9
M.W.: 636.17 |
| |
| QF122304 | Flunitrazepam EP Impurity D
CAS# NA
M.F.: C14H11FN2O3
M.W.: 274.25 |
| |
| QF122303 | Flunitrazepam EP Impurity C
CAS# NA
M.F.: C16H12FN3O3
M.W.: 313.28 |
| |
| QF122302 | Flunitrazepam EP Impurity B
CAS# NA
M.F.: C15H10FN3O3
M.W.: 299.26 |
| |
| QF121704 | Flumetasone pivalate EP Impurity D
CAS# NA
M.F.: C27H36ClFO6
M.W.: 511.02 |
| |
| QF121703 | Flumetasone pivalate EP Impurity C
CAS# 1926-94-9
M.F.: C27H37FO6
M.W.: 476.58 |
| |
| QF121702 | Flumetasone pivalate EP Impurity B
CAS# NA
M.F.: C24H30F2O6
M.W.: 452.49 |
| |
| QF121701 | Flumetasone pivalate EP Impurity A
CAS# 2135-17-3
M.F.: C22H28F2O5
M.W.: 410.45 |
| |
| QF121700 | Flumetasone pivalate
CAS# 2002-29-1
M.F.: C27H36F2O6
M.W.: 494.57 |
| |
| QF120805 | Flecainide acetate EP Impurity E
CAS# NA
M.F.: C17H14F6N2O3
M.W.: 408.30 |
| |
| QF120804 | Flecainide acetate EP Impurity D
CAS# NA
M.F.: C11H8F6O4
M.W.: 318.17 |
| |
| QF120803 | Flecainide acetate EP Impurity C
CAS# NA
M.F.: C17H20F6N2O4
M.W.: 430.34 |
| |
| QF120802 | Flecainide acetate EP Impurity B
CAS# NA
M.F.: C6H14N2
M.W.: 114.19 |
| |
| QF120801 | Flecainide acetate EP Impurity A
CAS# NA
M.F.: C17H18F6N2O2
M.W.: 396.33 |
| |
| QF120800 | Flecainide acetate
CAS# 54143-56-5
M.F.: C19H24F6N2O5
M.W.: 474.39 |
| |
| QF120703 | Flavoxate hydrochloride EP Impurity C
CAS# NA
M.F.: C20H18O4
M.W.: 322.35 |
| |
| QF120702 | Flavoxate hydrochloride EP Impurity B
CAS# NA
M.F.: C19H16O4
M.W.: 308.33 |
| |
| QF120701 | Flavoxate hydrochloride EP Impurity A
CAS# NA
M.F.: C17H12O4
M.W.: 280.27 |
| |
| QF120700 | Flavoxate hydrochloride
CAS# 3717-88-2
M.F.: C24H26ClNO4
M.W.: 427.92 |
| |
| QF051900 | Ferrous fumarate
CAS# 141-01-5
M.F.: C4H2FeO4
M.W.: 169.9 |
| |
| QF052003 | Fenticonazole nitrate EP Impurity C
CAS# NA
M.F.: C24H20Cl2N2O3S
M.W.: 487.40 |
| |
| QF052002 | Fenticonazole nitrate EP Impurity B
CAS# NA
M.F.: C24H20Cl2N2O2S
M.W.: 471.40 |
| |
| QF052001 | Fenticonazole nitrate EP Impurity A;
Tioconazole EP Impurity D;
Isoconazole EP Impurity B
CAS# NA
M.F.: C11H10Cl2N2O
M.W.: 257.12 |
| |
| QF052000 | Fenticonazole nitrate
CAS# 73151-29-8
M.F.: C24H21Cl2N3O4S
M.W.: 518.41 |
| |
| QF051603 | Fenoterol hydrobromide EP Impurity C
CAS# NA
M.F.: C18H23NO4
M.W.: 317.38 |
| |
| QF051602 | Fenoterol hydrobromide EP Impurity B
CAS# NA
M.F.: C17H19NO4
M.W.: 301.34 |
| |
| QF051601 | Fenoterol hydrobromide EP Impurity A
CAS# NA
M.F.: C17H21NO4
M.W.: 303.35 |
| |
| QF051600 | Fenoterol hydrobromide
CAS# 1944-12-3
M.F.: C17H22BrNO4
M.W.: 384.26 |
| |
| QF051504 | Fenbufen EP Impurity D
CAS# NA
M.F.: C16H14O4
M.W.: 270.28 |
| |
| QF051502 | Fenbufen EP Impurity B
CAS# NA
M.F.: C16H12O3
M.W.: 252.26 |
| |
| QF051201 | Felbinac EP Impurity A
CAS# NA
M.F.: C14H12O2
M.W.: 196.24 |
| |
| QF051200 | Felbinac
CAS# 5728-52-9
M.F.: C14H12O2
M.W.: 212.24 |
| |
| QE151617 | Etoposide EP Impurity Q
CAS# NA
M.F.: C21H16O7
M.W.: 380.35 |
| |
| QE151616 | Etoposide EP Impurity P
CAS# NA
M.F.: C21H16O8
M.W.: 396.35 |
| |
| QE151614 | Etoposide EP Impurity N
CAS# NA
M.F.: C50H50O20
M.W.: 970.92 |
| |
| QE151612 | Etoposide EP Impurity L
CAS# NA
M.F.: C21H20O8
M.W.: 400.38 |
| |
| QE151609 | Etoposide EP Impurity I
CAS# NA
M.F.: C30H34O13
M.W.: 602.58 |
| |
| QE151608 | Etoposide EP Impurity H
CAS# NA
M.F.: C23H24O8
M.W.: 428.43 |
| |
| QE151607 | Etoposide EP Impurity G
CAS# NA
M.F.: C39H38O17
M.W.: 778.71 |
| |
| QE151606 | Etoposide EP Impurity F
CAS# NA
M.F.: C37H38O15
M.W.: 722.69 |
| |
| QE151604 | Etoposide EP Impurity D
CAS# 23363-35-1
M.F.: C27H30O13
M.W.: 562.52 |
| |
| QE151603 | Etoposide EP Impurity C
CAS# 100007-53-2
M.F.: C29H32O13
M.W.: 588.56 |
| |
| QE151602 | Etoposide EP Impurity B
CAS# 100007-56-5
M.F.: C29H32O13
M.W.: 588.56 |
| |
| QE151601 | Etoposide EP Impurity A
CAS# 124151-67-3
M.F.: C37H38O15
M.W.: 722.69 |
| |
| QE202006 | Etilefrine hydrochloride EP Impurity F
CAS# NA
M.F.: C9H13N
M.W.: 135.21 |
| |
| QE202005 | Etilefrine hydrochloride EP Impurity E
CAS# NA
M.F.: C8H8O2
M.W.: 136.15 |
| |
| QE202004 | Etilefrine hydrochloride EP Impurity D
CAS# NA
M.F.: C17H19NO2
M.W.: 269.34 |
| |
| QE202003 | Etilefrine hydrochloride EP Impurity C
CAS# NA
M.F.: C8H11NO2
M.W.: 153.18 |
| |
| QE202002 | Etilefrine hydrochloride EP Impurity B;
Phenylephrine
CAS# 1477-63-0;154-86-9(HCl salt)
M.F.: C9H13NO2
M.W.: 167.21 |
| |
| QE202001 | Etilefrine hydrochloride EP Impurity A
CAS# 22510-12-9
M.F.: C10H13NO2
M.W.: 179.22 |
| |
| QE202000 | Etilefrine hydrochloride
CAS# 943-17-9
M.F.: C10H16ClNO2
M.W.: 217.69 |
| |
| QE201100 | Etidronate disodium
CAS# 7414-83-7
M.F.: C2H6Na2O7P2
M.W.: 249.99 |
| |
| QE052001 | Ethosuximide EP Impurity A
CAS# NA
M.F.: C7H12O4
M.W.: 160.17 |
| |
| QE052000 | Ethosuximide
CAS# 77-67-8
M.F.: C7H11NO2
M.W.: 141.17 |
| |
| QE201003 | Ethacridine lactate monohydrate EP Impurity C
CAS# NA
M.F.: C17H18N2O3
M.W.: 298.34 |
| |
| QE201002 | Ethacridine lactate monohydrate EP Impurity B
CAS# NA
M.F.: C15H13ClN2O
M.W.: 272.73 |
| |
| QE201001 | Ethacridine lactate monohydrate EP Impurity A
CAS# NA
M.F.: C15H14N2O2
M.W.: 254.28 |
| |
| QE201000 | Ethacridine lactate monohydrate
CAS# 6402-23-9
M.F.: C18H23N3O5
M.W.: 361.39 |
| |
| QE201701 | Etamsylate EP Impurity A
CAS# NA
M.F.: C6H6O2
M.W.: 110.11 |
| |
| QE011803 | Etacrynic acid EP Impurity C
CAS# NA
M.F.: C26H24Cl4O8
M.W.: 606.28 |
| |
| QE011802 | Etacrynic acid EP Impurity B
CAS# NA
M.F.: C13H13Cl3O4
M.W.: 339.60 |
| |
| QE011801 | Etacrynic acid EP Impurity A
CAS# NA
M.F.: C12H12Cl2O4
M.W.: 291.13 |
| |
| QE011800 | Etacrynic acid
CAS# 58-54-8
M.F.: C13H12Cl2O4
M.W.: 303.14 |
| |
| QE191104 | Esketamine hydrochloride EP Impurity D
CAS# NA
M.F.: C13H16ClNO
M.W.: 237.73 |
| |
| QE191103 | Esketamine hydrochloride EP Impurity C
CAS# 90717-17-2
M.F.: C12H13ClO2
M.W.: 224.68 |
| |
| QE191102 | Esketamine hydrochloride EP Impurity B
CAS# NA
M.F.: C12H13ClO2
M.W.: 224.68 |
| |
| QE191101 | Esketamine hydrochloride EP Impurity A
CAS# NA
M.F.: C13H16ClNO
M.W.: 237.73 |
| |
| QE191100 | Esketamine hydrochloride
CAS# 33795-24-3
M.F.: C13H17Cl2NO
M.W.: 274.19 |
| |
| QE051903 | Ergotamine tartrate EP Impurity C
CAS# NA
M.F.: C34H37N5O5
M.W.: 595.69 |
| |
| QE051902 | Ergotamine tartrate EP Impurity B
CAS# NA
M.F.: C33H35N5O5
M.W.: 581.66 |
| |
| QE051901 | Ergotamine tartrate EP Impurity A
CAS# NA
M.F.: C33H35N5O6
M.W.: 597.66 |
| |
| QE051900 | Ergotamine tartrate
CAS# 379-79-3
M.F.: C70H76N10O16
M.W.: 1313.41 |
| |
| QE091807 | Epirubicin hydrochloride EP Impurity G;
Epirubicin dimer
CAS# 1046827-43-3
M.F.: C54H58N2O22
M.W.: 1087.04 |
| |
| QE091806 | Epirubicin hydrochloride EP Impurity F
CAS# 56390-08-0(HCl salt)
M.F.: C27H29NO10
M.W.: 527.52 |
| |
| QL142269 | Lenvatinib Impurity 69
CAS# 108-43-0
M.F.: C6H5ClO
M.W.: 128.56 |
| |
| QE091805 | Epirubicin hydrochloride EP Impurity E
CAS# NA
M.F.: C27H31NO10
M.W.: 529.54 |
| |
| QE091803 | Epirubicin hydrochloride EP Impurity C;Daunorubicin EP Impurity D
CAS# NA
M.F.: C27H29NO11
M.W.: 543.52 |
| |
| QE091802 | Epirubicin hydrochloride EP Impurity B;
Daunorubicin EP Impurity A
CAS# 21794-55-8
M.F.: C21H18O8
M.W.: 398.36 |
| |
| QE091800 | Epirubicin hydrochloride
CAS# 56390-09-1;56420-45-2(free base)
M.F.: C27H30ClNO11
M.W.: 579.98 |
| |
| QV180379 | Voriconazole Impurity 53
CAS# NA
M.F.: C8H14N4
M.W.: 166.22 |
| |
| QE140906 | Enilconazole EP Impurity F
CAS# NA
M.F.: C14H14Cl2N2O
M.W.: 297.18 |
| |
| QE140904 | Enilconazole EP Impurity D
CAS# NA
M.F.: C15H17Cl2NO2
M.W.: 314.21 |
| |
| QE140903 | Enilconazole EP Impurity C
CAS# NA
M.F.: C12H13Cl2NO2
M.W.: 274.14 |
| |
| QE140902 | Enilconazole EP Impurity B
CAS# NA
M.F.: C14H17Cl2NO
M.W.: 286.2 |
| |
| QE140901 | Enilconazole EP Impurity A
CAS# NA
M.F.: C11H13Cl2NO
M.W.: 246.13 |
| |
| QE130400 | Emedastine difumarate
CAS# 87233-62-3;87233-61-2(free base)
M.F.: C17H26N4O.2C4H4O4
M.W.: 302.42 232.14 |
| |
| QE041800 | Edrophonium chloride
CAS# 116-38-1
M.F.: C10H16ClNO
M.W.: 201.69 |
| |
| QE040601 | Edetic acid EP Impurity A
CAS# NA
M.F.: C6H9NO6
M.W.: 191.14 |
| |
| QE040600 | Edetic acid
CAS# 60-00-4
M.F.: C10H16N2O8
M.W.: 292.24 |
| |
| QD250403 | Dydrogesterone EP Impurity C
CAS# 246038-13-1
M.F.: C21H28O2
M.W.: 312.45 |
| |
| QD250401 | Dydrogesterone EP Impurity A
CAS# 23035-53-2
M.F.: C21H26O2
M.W.: 310.43 |
| |
| QD250400 | Dydrogesterone
CAS# 152-62-5
M.F.: C21H28O2
M.W.: 312.45 |
| |
| QD181710 | Drospirenone EP Impurity K
CAS# 889652-31-7
M.F.: C24H30O3
M.W.: 366.49 |
| |
| QD181709 | Drospirenone EP Impurity I
CAS# 2896199-04-3
M.F.: C24H32O3
M.W.: 368.51 |
| |
| QD181708 | Drospirenone EP Impurity H
CAS# 932388-89-1
M.F.: C24H31ClO3
M.W.: 402.95 |
| |
| QD181707 | Drospirenone EP Impurity G
CAS# 932388-90-4
M.F.: C24H31ClO3
M.W.: 402.95 |
| |
| QD181704 | Drospirenone EP Impurity D
CAS# 67372-69-4
M.F.: C23H28O3
M.W.: 352.47 |
| |
| QD181703 | Drospirenone EP Impurity C
CAS# 116298-21-6
M.F.: C21H26O2
M.W.: 310.43 |
| |
| QD181702 | Drospirenone EP Impurity B
CAS# NA
M.F.: C24H32O4
M.W.: 384.51 |
| |
| QD181701 | Drospirenone EP Impurity A
CAS# 67372-68-3
M.F.: C23H30O3
M.W.: 354.48 |
| |
| QD240102 | Doxapram hydrochloride EP Impurity B
CAS# 1688-76-2
M.F.: C22H28N2O2
M.W.: 352.47 |
| |
| QD240101 | Doxapram hydrochloride EP Impurity A
CAS# 3192-64-1
M.F.: C20H22ClNO
M.W.: 327.85 |
| |
| QD240100 | Doxapram hydrochloride
CAS# 7081-53-0
M.F.: C24H33ClN2O3
M.W.: 432.98 |
| |
| QD152005 | Dosulepin hydrochloride EP Impurity E
CAS# NA
M.F.: C19H21NS
M.W.: 295.44 |
| |
| QD152004 | Dosulepin hydrochloride EP Impurity D
CAS# NA
M.F.: C19H21NO2S
M.W.: 327.44 |
| |
| QD152003 | Dosulepin hydrochloride EP Impurity C
CAS# NA
M.F.: C19H23NOS
M.W.: 313.46 |
| |
| QD152002 | Dosulepin hydrochloride EP Impurity B
CAS# 1531-77-7
M.F.: C14H10OS
M.W.: 226.29 |
| |
| QD152001 | Dosulepin hydrochloride EP Impurity A
CAS# NA
M.F.: C19H21NOS
M.W.: 311.44 |
| |
| QD152000 | Dosulepin hydrochloride
CAS# 897-15-4
M.F.: C19H22ClNS
M.W.: 331.9 |
| |
| QD150701 | Dodecyl gallate EP Impurity A;
Octyl gallate EP Impurity A
CAS# 149-91-7;5995-86-8(monohydrate)
M.F.: C7H6O5
M.W.: 170.12 |
| |
| QD150700 | Dodecyl gallate
CAS# 1166-52-5
M.F.: C19H30O5
M.W.: 338.44 |
| |
| QD092104 | Disopyramide EP Impurity D
CAS# NA
M.F.: C13H10N2
M.W.: 194.23 |
| |
| QD092103 | Disopyramide EP Impurity C
CAS# NA
M.F.: C18H23N3O
M.W.: 297.39 |
| |
| QD092102 | Disopyramide EP Impurity B
CAS# NA
M.F.: C20H28N2
M.W.: 296.45 |
| |
| QD092101 | Disopyramide EP Impurity A
CAS# NA
M.F.: C21H27N3
M.W.: 321.46 |
| |
| QD161502 | Controlled Substance
(Dipotassium clorazepate EP Impurity B)
CAS# 1088-11-5
M.F.: C15H11ClN2O
M.W.: 270.71 |
| |
| QD161500 | Dipotassium clorazepate
CAS# 57109-90-7
M.F.: C16H11ClK2N2O4
M.W.: 408.92 |
| |
| QD141706 | Dinoprostone EP Impurity F
CAS# 26441-05-4
M.F.: C20H30O5
M.W.: 350.45 |
| |
| QD141704 | Dinoprostone EP Impurity D
CAS# 13345-50-1
M.F.: C20H30O4
M.W.: 334.45 |
| |
| QD141702 | Dinoprostone EP Impurity B
CAS# 27415-25-4
M.F.: C20H32O5
M.W.: 352.47 |
| |
| QD141701 | Dinoprostone EP Impurity A
CAS# 38873-82-4
M.F.: C20H32O5
M.W.: 352.47 |
| |
| QD141700 | Dinoprostone;Alprostadil EP Impurity G
CAS# 363-24-6
M.F.: C20H32O5
M.W.: 352.47 |
| |
| QD141504 | Dinoprost trometamol EP Impurity D
CAS# NA
M.F.: C20H34O5
M.W.: 354.48 |
| |
| QD141502 | Dinoprost trometamol EP Impurity B
CAS# 37658-84-7
M.F.: C20H34O5
M.W.: 354.48 |
| |
| QD141501 | Dinoprost trometamol EP Impurity A
CAS# 36150-01-3
M.F.: C20H34O5
M.W.: 354.48 |
| |
| QD141500 | Dinoprost trometamol
CAS# 38562-01-5;551-11-1(free base)
M.F.: C24H45NO8
M.W.: 475.62 |
| |
| QD131900 | Dimethyl sulfoxide
CAS# 67-68-5
M.F.: C2H6OS
M.W.: 78.13 |
| |
| QD093303 | Dihydrotachysterol EP Impurity C
CAS# NA
M.F.: C28H48O
M.W.: 400.68 |
| |
| QD093302 | Dihydrotachysterol EP Impurity B
CAS# NA
M.F.: C28H46O
M.W.: 398.66 |
| |
| QD093301 | Dihydrotachysterol EP Impurity A
CAS# NA
M.F.: C28H46O
M.W.: 398.66 |
| |
| QD093300 | Dihydrotachysterol
CAS# 67-96-9
M.F.: C28H46O
M.W.: 398.66 |
| |
| QD093205 | Dihydroergotamine mesilate EP Impurity E
CAS# NA
M.F.: C35H41N5O5
M.W.: 611.73 |
| |
| QD093204 | Dihydroergotamine mesilate EP Impurity D
CAS# NA
M.F.: C33H37N5O5
M.W.: 583.68 |
| |
| QD093203 | Dihydroergotamine mesilate EP Impurity C
CAS# NA
M.F.: C33H37N5O6
M.W.: 599.68 |
| |
| QD093201 | Dihydroergotamine mesilate EP Impurity A
CAS# NA
M.F.: C33H35N5O5
M.W.: 581.66 |
| |
| QD093200 | Dihydroergotamine mesilate
CAS# 6190-39-2
M.F.: C34H41N5O8S
M.W.: 679.78 |
| |
| QD093112 | Dihydroergocristine mesilate EP Impurity L
CAS# NA
M.F.: C35H41N5O6
M.W.: 627.73 |
| |
| QD093111 | Dihydroergocristine mesilate EP Impurity K;
Ergotamine tartrate EP Impurity D
CAS# NA
M.F.: C35H39N5O5
M.W.: 609.71 |
| |
| QD093110 | Dihydroergocristine mesilate EP Impurity J
CAS# NA
M.F.: C36H43N5O5
M.W.: 625.76 |
| |
| QD093109 | Dihydroergocristine mesilate EP Impurity I
CAS# NA
M.F.: C32H43N5O5
M.W.: 577.71 |
| |
| QD093108 | Dihydroergocristine mesilate EP Impurity H
CAS# NA
M.F.: C32H43N5O5
M.W.: 577.71 |
| |
| QD093107 | Dihydroergocristine mesilate EP Impurity G;
Dihydroergotamine mesilate EP Impurity B
CAS# NA
M.F.: C34H39N5O5
M.W.: 597.70 |
| |
| QD093106 | Dihydroergocristine mesilate EP Impurity F
CAS# NA
M.F.: C31H41N5O5
M.W.: 563.69 |
| |
| QD093105 | Dihydroergocristine mesilate EP Impurity E
CAS# NA
M.F.: C33H37N5O5
M.W.: 583.68 |
| |
| QD093104 | Dihydroergocristine mesilate EP Impurity D
CAS# NA
M.F.: C29H37N5O5
M.W.: 535.63 |
| |
| QD093102 | Dihydroergocristine mesilate EP Impurity B
CAS# NA
M.F.: C16H19N3O
M.W.: 269.34 |
| |
| QD093101 | Dihydroergocristine mesilate EP Impurity A
CAS# NA
M.F.: C16H19N3O
M.W.: 269.34 |
| |
| QD093100 | Dihydroergocristine mesilate
CAS# 24730-10-7
M.F.: C36H45N5O8S
M.W.: 707.84 |
| |
| QD093004 | Dihydrocodeine hydrogen tartrate EP Impurity D
CAS# NA
M.F.: C19H25NO3
M.W.: 315.41 |
| |
| QD093003 | Dihydrocodeine hydrogen tartrate EP Impurity C;
Oxycodone hydrochloride EP Impurity E
CAS# NA
M.F.: C18H21NO3
M.W.: 299.36 |
| |
| QD093002 | Dihydrocodeine hydrogen tartrate EP Impurity B
CAS# NA
M.F.: C17H19NO3
M.W.: 285.34 |
| |
| QD093000 | Dihydrocodeine hydrogen tartrate
CAS# 5965-13-9
M.F.: C22H29NO9
M.W.: 451.47 |
| |
| QD052200 | Diethylstilbestrol
CAS# 56-53-1
M.F.: C18H20O2
M.W.: 268.35 |
| |
| QD091100 | Diethylcarbamazine citrate
CAS# 1642-54-2
M.F.: C16H29N3O8
M.W.: 391.42 |
| |
| QD091004 | Dicloxacillin sodium EP Impurity D
CAS# 3919-76-4
M.F.: C11H7Cl2NO3
M.W.: 272.08 |
| |
| QD091003 | Dicloxacillin sodium EP Impurity C
CAS# 551-16-6
M.F.: C8H12N2O3S
M.W.: 216.26 |
| |
| QD091002 | Dicloxacillin sodium EP Impurity B
CAS# NA
M.F.: C18H19Cl2N3O4S
M.W.: 444.33 |
| |
| QD091001 | Dicloxacillin sodium EP Impurity A
CAS# 2088415-70-5
M.F.: C19H19Cl2N3O6S
M.W.: 488.34 |
| |
| QD091000 | Dicloxacillin sodium
CAS# 13412-64-1;3116-76-5(free base)
M.F.: C19H18Cl2N3NaO6S
M.W.: 510.32 |
| |
| QD090707 | Diclazuril EP Impurity G
CAS# NA
M.F.: C22H17Cl3N4O4
M.W.: 507.75 |
| |
| QD090706 | Diclazuril EP Impurity F
CAS# NA
M.F.: C16H10Cl3N3O2
M.W.: 382.63 |
| |
| QD090705 | Diclazuril EP Impurity E
CAS# NA
M.F.: C14H9Cl3N2
M.W.: 311.59 |
| |
| QD090704 | Diclazuril EP Impurity D
CAS# NA
M.F.: C16H8Cl3N3O3
M.W.: 396.61 |
| |
| QD090703 | Diclazuril EP Impurity C
CAS# NA
M.F.: C18H10Cl3N5O3
M.W.: 450.66 |
| |
| QD090702 | Diclazuril EP Impurity B
CAS# NA
M.F.: C17H10Cl2N4O3
M.W.: 389.19 |
| |
| QD090701 | Diclazuril EP Impurity A
CAS# NA
M.F.: C18H9Cl3N4O4
M.W.: 451.65 |
| |
| QD090202 | Dibrompropamidine diisetionate EP Impurity B
CAS# NA
M.F.: C17H19BrN4O2
M.W.: 391.26 |
| |
| QD090201 | Dibrompropamidine diisetionate EP Impurity A
CAS# NA
M.F.: C17H17Br2N3O3
M.W.: 471.14 |
| |
| QD090200 | Dibrompropamidine diisetionate
CAS# 614-87-9
M.F.: C21H30Br2N4O10S2
M.W.: 722.42 |
| |
| QD052906 | Dextropropoxyphene hydrochloride EP Impurity F
CAS# NA
M.F.: C13H18O
M.W.: 190.28 |
| |
| QD052904 | Dextropropoxyphene hydrochloride EP Impurity D
CAS# NA
M.F.: C22H29NO2
M.W.: 339.47 |
| |
| QD052903 | Dextropropoxyphene hydrochloride EP Impurity C
CAS# NA
M.F.: C23H31NO2
M.W.: 353.50 |
| |
| QD052902 | Dextropropoxyphene hydrochloride EP Impurity B
CAS# NA
M.F.: C21H27NO2
M.W.: 325.44 |
| |
| QD052901 | Dextropropoxyphene hydrochloride EP Impurity A
CAS# NA
M.F.: C19H25NO
M.W.: 283.41 |
| |
| QD052900 | Dextropropoxyphene hydrochloride
CAS# 1639-60-7
M.F.: C22H30ClNO2
M.W.: 375.93 |
| |
| QD052800 | Dextromoramide tartrate
CAS# 2922-44-3
M.F.: C29H38N2O8
M.W.: 542.62 |
| |
| QD052602 | Dexchlorpheniramine maleate EP Impurity B
CAS# 32188-09-3
M.F.: C16H19ClN2
M.W.: 274.79 |
| |
| QD052601 | Dexchlorpheniramine maleate EP Impurity A
CAS# NA
M.F.: C16H20N2
M.W.: 240.34 |
| |
| QD052600 | Dexchlorpheniramine maleate
CAS# 2438-32-6
M.F.: C20H23ClN2O4
M.W.: 390.86 |
| |
| QD191500 | Desoxycortone acetate
CAS# 56-47-3
M.F.: C23H32O4
M.W.: 372.5 |
| |
| QD051600 | Desipramine hydrochloride
CAS# 58-28-6
M.F.: C18H23ClN2
M.W.: 302.84 |
| |
| QD052108 | Desflurane EP Impurity H
CAS# 67-64-1
M.F.: C3H6O
M.W.: 58.08 |
| |
| QD052103 | Desflurane EP Impurity C
CAS# 75-43-4
M.F.: CHCl2F
M.W.: 102.92 |
| |
| QD052102 | Desflurane EP Impurity B
CAS# NA
M.F.: C3H2ClF5O
M.W.: 184.49 |
| |
| QD052101 | Desflurane EP Impurity A
CAS# NA
M.F.: C4H2F8O
M.W.: 218.05 |
| |
| QD051305 | Dembrexine hydrochloride monohydrate EP Impurity E
CAS# 118-79-6
M.F.: C6H3Br3O
M.W.: 330.80 |
| |
| QD051704 | Deptropine citrate EP Impurity D
CAS# NA
M.F.: C22H25NO
M.W.: 319.44 |
| |
| QD051703 | Deptropine citrate EP Impurity C;
Nortriptyline hydrochloride EP Impurity I;
Amitriptyline EP Impurity G
CAS# 1210-34-0
M.F.: C15H14O
M.W.: 210.27 |
| |
| QD051702 | Deptropine citrate EP Impurity B
CAS# NA
M.F.: C23H27NO
M.W.: 333.47 |
| |
| QD051700 | Deptropine citrate
CAS# 2169-75-7
M.F.: C29H35NO8
M.W.: 525.59 |
| |
| QD051303 | Dembrexine hydrochloride monohydrate EP Impurity C
CAS# NA
M.F.: C7H4Br2O2
M.W.: 279.91 |
| |
| QD051302 | Dembrexine hydrochloride monohydrate EP Impurity B
CAS# NA
M.F.: C13H17Br2NO2
M.W.: 379.09 |
| |
| QD051301 | Dembrexine hydrochloride monohydrate EP Impurity A
CAS# NA
M.F.: C13H15Br2NO2
M.W.: 377.07 |
| |
| QD051300 | Dembrexine hydrochloride monohydrate
CAS# 52702-51-9
M.F.: C13H20Br2ClNO3
M.W.: 433.56 |
| |
| QD010303 | Dacarbazine EP Impurity C
CAS# 1314929-56-0
M.F.: C4H5N5O
M.W.: 139.12 |
| |
| QC251710 | Cyproterone acetate EP Impurity J
CAS# 15423-97-9
M.F.: C24H30O5
M.W.: 398.49 |
| |
| QC251709 | Cyproterone acetate EP Impurity I;
Chlormadinone acetate EP Impurity D
CAS# 13698-49-2
M.F.: C23H27ClO4
M.W.: 402.91 |
| |
| QC251708 | Cyproterone acetate EP Impurity H
CAS# 2668-74-8
M.F.: C23H30O4
M.W.: 370.48 |
| |
| QC251707 | Cyproterone acetate EP Impurity G
CAS# 23814-84-8
M.F.: C24H31ClO5
M.W.: 434.95 |
| |
| QC251706 | Cyproterone acetate EP Impurity F
CAS# 2098-66-0
M.F.: C22H27ClO3
M.W.: 374.90 |
| |
| QC251705 | Cyproterone acetate EP Impurity E
CAS# 17184-05-3
M.F.: C24H30O5
M.W.: 398.49 |
| |
| QC251704 | Cyproterone acetate EP Impurity D
CAS# NA
M.F.: C24H31ClO5
M.W.: 434.95 |
| |
| QC251703 | Cyproterone acetate EP Impurity C
CAS# 17183-98-1
M.F.: C24H30Cl2O4
M.W.: 453.4 |
| |
| QC251702 | Cyproterone acetate EP Impurity B
CAS# NA
M.F.: C25H32O5
M.W.: 412.52 |
| |
| QC251701 | Cyproterone acetate EP Impurity A
CAS# 2701-50-0
M.F.: C24H30O4
M.W.: 382.49 |
| |
| QC251700 | Cyproterone acetate
CAS# 427-51-0
M.F.: C24H29ClO4
M.W.: 416.94 |
| |
| QC250503 | Cyclopentolate hydrochloride EP Impurity C
CAS# 36882-00-5;113079-81-5(HCl salt)
M.F.: C12H17NO2
M.W.: 207.27 |
| |
| QC250501 | Cyclopentolate hydrochloride EP Impurity A
CAS# NA
M.F.: C13H16O3
M.W.: 220.26 |
| |
| QC250500 | Cyclopentolate hydrochloride
CAS# 5870-29-1
M.F.: C17H26ClNO3
M.W.: 327.85 |
| |
| QC250402 | Cyclizine hydrochloride EP Impurity B
CAS# 91-01-0
M.F.: C13H12O
M.W.: 184.23 |
| |
| QC250400 | Cyclizine hydrochloride
CAS# 305-25-3;82-92-8(free base)
M.F.: C18H23ClN2
M.W.: 302.84 |
| |
| QM041847 | Minodronic Acid Impurity 21
CAS# NA
M.F.: C18H14N4O3
M.W.: 334.33 |
| |
| QM041846 | Minodronic Acid Impurity 20
CAS# NA
M.F.: C9H7ClN2O
M.W.: 194.62 |
| |
| QM041845 | Minodronic Acid Impurity 19
CAS# NA
M.F.: C9H12N2O8P2
M.W.: 338.15 |
| |
| QC030203 | Cocaine hydrochloride EP Impurity C
CAS# NA
M.F.: C38H46N2O8
M.W.: 658.78 |
| |
| QC030202 | Cocaine hydrochloride EP Impurity B
CAS# NA
M.F.: C38H46N2O8
M.W.: 658.78 |
| |
| QC030201 | Cocaine hydrochloride EP Impurity A
CAS# NA
M.F.: C19H23NO4
M.W.: 329.39 |
| |
| QC030200 | Cocaine hydrochloride
CAS# 53-21-4
M.F.: C17H22ClNO4
M.W.: 339.81 |
| |
| QC152010 | Closantel sodium dihydrate EP Impurity J
CAS# NA
M.F.: C44H27Cl3I4N4O4
M.W.: 1289.69 |
| |
| QC152009 | Closantel sodium dihydrate EP Impurity I
CAS# NA
M.F.: C22H15Cl2IN2O2
M.W.: 537.18 |
| |
| QC152008 | Closantel sodium dihydrate EP Impurity H
CAS# NA
M.F.: C23H17Cl2I2NO4
M.W.: 696.10 |
| |
| QC152007 | Closantel sodium dihydrate EP Impurity G
CAS# NA
M.F.: C23H18Cl2I2N2O3
M.W.: 695.12 |
| |
| QC152006 | Closantel sodium dihydrate EP Impurity F
CAS# NA
M.F.: C21H13Cl2I2NO3
M.W.: 652.05 |
| |
| QC152005 | Closantel sodium dihydrate EP Impurity E
CAS# NA
M.F.: C22H14Cl3IN2O2
M.W.: 571.62 |
| |
| QC152004 | Closantel sodium dihydrate EP Impurity D
CAS# NA
M.F.: C22H16Cl2I2N2O3
M.W.: 681.09 |
| |
| QC152003 | Closantel sodium dihydrate EP Impurity C
CAS# NA
M.F.: C22H15Cl2I2NO4
M.W.: 682.07 |
| |
| QC152002 | Closantel sodium dihydrate EP Impurity B
CAS# NA
M.F.: C15H12Cl2N2
M.W.: 291.18 |
| |
| QC152001 | Closantel sodium dihydrate EP Impurity A
CAS# NA
M.F.: C7H4I2O3
M.W.: 389.91 |
| |
| QC152000 | Closantel sodium dihydrate
CAS# 61438-64-0
M.F.: C22H17Cl2I2N2NaO4
M.W.: 721.09 |
| |
| QC151608 | Clopamide EP Impurity H
CAS# NA
M.F.: C17H25ClN4O3S
M.W.: 400.92 |
| |
| QC151607 | Clopamide EP Impurity G
CAS# NA
M.F.: C13H18ClN3O3S
M.W.: 331.82 |
| |
| QC151601 | Clopamide EP Impurity A
CAS# NA
M.F.: C14H20ClN3O3S
M.W.: 345.84 |
| |
| QC151502 | Clonazepam EP Impurity B
CAS# 55198-89-5
M.F.: C15H10ClN3O3
M.W.: 315.71 |
| |
| QC151306 | Clomifene citrate EP Impurity F
CAS# 47648-28-2
M.F.: C26H27Cl2NO
M.W.: 440.40 |
| |
| QC151305 | Clomifene citrate EP Impurity E
CAS# 117884-82-9
M.F.: C26H27Cl2NO
M.W.: 440.40 |
| |
| QC151304 | Clomifene citrate EP Impurity D
CAS# 1391054-64-0
M.F.: C38H46N2O3
M.W.: 578.78 |
| |
| QC151303 | Clomifene citrate EP Impurity C
CAS# 5635-70-1(HCl salt)
M.F.: C26H29NO2
M.W.: 387.51 |
| |
| QC151302 | Clomifene citrate EP Impurity B
CAS# 796-77-0
M.F.: C19H23NO2
M.W.: 297.39 |
| |
| QC151301 | Clomifene citrate EP Impurity A
CAS# 19957-52-9;74056-26-1(HCl salt)
M.F.: C26H29NO
M.W.: 371.51 |
| |
| QC151300 | Clomifene citrate
CAS# 50-41-9
M.F.: C32H36ClNO8
M.W.: 598.08 |
| |
| QC150509 | Clobetasone butyrate EP Impurity I
CAS# NA
M.F.: C26H32ClFO5
M.W.: 478.98 |
| |
| QC150508 | Clobetasone butyrate EP Impurity H
CAS# NA
M.F.: C25H30ClFO5
M.W.: 464.95 |
| |
| QC150507 | Clobetasone butyrate EP Impurity G
CAS# NA
M.F.: C29H37FO7
M.W.: 516.6 |
| |
| QC150506 | Clobetasone butyrate EP Impurity F
CAS# NA
M.F.: C26H32ClFO5
M.W.: 478.98 |
| |
| QC150505 | Clobetasone butyrate EP Impurity E
CAS# NA
M.F.: C26H34ClFO5
M.W.: 481 |
| |
| QC150504 | Clobetasone butyrate EP Impurity D
CAS# NA
M.F.: C26H31BrClFO5
M.W.: 557.88 |
| |
| QC150503 | Clobetasone butyrate EP Impurity C
CAS# NA
M.F.: C26H34ClFO5
M.W.: 481 |
| |
| QC150501 | Clobetasone butyrate EP Impurity A
CAS# NA
M.F.: C22H26ClFO4
M.W.: 408.89 |
| |
| QC150500 | Clobetasone butyrate
CAS# 25122-57-0
M.F.: C26H32ClFO
M.W.: 478.98 |
| |
| QC150406 | Clobazam EP Impurity F
CAS# NA
M.F.: C17H17ClN2O3
M.W.: 332.78 |
| |
| QC150405 | Clobazam EP Impurity E
CAS# 75524-13-9
M.F.: C15H15ClN2O
M.W.: 274.75 |
| |
| QC150404 | Clobazam EP Impurity D
CAS# 2092997-47-0
M.F.: C18H17ClN2O2
M.W.: 328.79 |
| |
| QC150403 | Clobazam EP Impurity C
CAS# 22316-16-1
M.F.: C17H15ClN2O2
M.W.: 314.77 |
| |
| QC150402 | Clobazam EP Impurity B
CAS# 22316-24-1
M.F.: C16H14N2O2
M.W.: 266.29 |
| |
| QC150401 | Clobazam EP Impurity A
CAS# 22316-55-8
M.F.: C15H11ClN2O2
M.W.: 286.71 |
| |
| QC121103 | Clioquinol EP Impurity C
CAS# NA
M.F.: C9H5I2NO
M.W.: 396.95 |
| |
| QC121102 | Clioquinol EP Impurity B
CAS# NA
M.F.: C9H5Cl2NO
M.W.: 214.05 |
| |
| QC121101 | Clioquinol EP Impurity A
CAS# NA
M.F.: C9H6ClNO
M.W.: 179.6 |
| |
| QC121003 | Clebopride malate EP Impurity C
CAS# NA
M.F.: C20H25N3O2
M.W.: 339.43 |
| |
| QC121002 | Clebopride malate EP Impurity B
CAS# 50541-93-0
M.F.: C12H18N2
M.W.: 190.28 |
| |
| QC121001 | Clebopride malate EP Impurity A
CAS# 7206-70-4
M.F.: C8H8ClNO3
M.W.: 201.61 |
| |
| QC121000 | Clebopride malate
CAS# 57645-91-7
M.F.: C24H30ClN3O7
M.W.: 507.96 |
| |
| QC122609 | Clazuril EP Impurity I
CAS# NA
M.F.: C16H12Cl2N4O
M.W.: 347.2 |
| |
| QC122608 | Clazuril EP Impurity H
CAS# NA
M.F.: C34H19Cl3N8O4
M.W.: 709.92 |
| |
| QC122607 | Clazuril EP Impurity G
CAS# NA
M.F.: C16H9Cl2N3O3
M.W.: 362.17 |
| |
| QC122606 | Clazuril EP Impurity F
CAS# NA
M.F.: C20H14Cl2N4O4
M.W.: 445.26 |
| |
| QP032015 | Procaterol Impurity 15
CAS# NA
M.F.: C16H22N2O3 HCl
M.W.: 290.36 36.46 |
| |
| QC122605 | Clazuril EP Impurity E
CAS# NA
M.F.: C19H12Cl2N4O4
M.W.: 431.23 |
| |
| QC122604 | Clazuril EP Impurity D
CAS# NA
M.F.: C20H15Cl2N5O3
M.W.: 444.27 |
| |
| QC122603 | Clazuril EP Impurity C
CAS# NA
M.F.: C17H12Cl2N4O3
M.W.: 391.21 |
| |
| QC122602 | Clazuril EP Impurity B
CAS# NA
M.F.: C18H11Cl2N5O3
M.W.: 416.22 |
| |
| QC122601 | Clazuril EP Impurity A
CAS# NA
M.F.: C17H11Cl2N3O4
M.W.: 392.19 |
| |
| QC091204 | Cilazapril EP Impurity D
CAS# NA
M.F.: C22H31N3O5
M.W.: 417.50 |
| |
| QC091203 | Cilazapril EP Impurity C
CAS# NA
M.F.: C24H35N3O5
M.W.: 445.55 |
| |
| QC091202 | Cilazapril EP Impurity B
CAS# NA
M.F.: C20H27N3O5
M.W.: 389.45 |
| |
| QC091201 | Cilazapril EP Impurity A
CAS# NA
M.F.: C26H39N3O5
M.W.: 473.60 |
| |
| QC090403 | Ciclesonide EP Impurity C
CAS# NA
M.F.: C32H42O7
M.W.: 538.67 |
| |
| QC090402 | Ciclesonide EP Impurity B
CAS# 161115-59-9
M.F.: C28H38O6
M.W.: 470.60 |
| |
| QC090401 | Ciclesonide EP Impurity A
CAS# 141845-81-0
M.F.: C32H44O7
M.W.: 540.69 |
| |
| QN151841 | Noradrenaline (Norepinephrine) Impurity 41
CAS# 2947-04-8
M.F.: C9H13NO3
M.W.: 183.20 |
| |
| QC182212 | Chlortetracycline EP Impurity L
CAS# NA
M.F.: C22H21ClN2O7
M.W.: 460.86 |
| |
| QC182211 | Chlortetracycline EP Impurity K
CAS# NA
M.F.: C22H21ClN2O7
M.W.: 460.86 |
| |
| QC182210 | Chlortetracycline EP Impurity J;
Lymecycline EP Impurity C
CAS# NA
M.F.: C22H22N2O7
M.W.: 426.42 |
| |
| QC182209 | Chlortetracycline EP Impurity I;
Lymecycline EP Impurity D
CAS# NA
M.F.: C22H22N2O7
M.W.: 426.42 |
| |
| QC182208 | Chlortetracycline EP Impurity H
CAS# NA
M.F.: C23H24ClNO8
M.W.: 477.89 |
| |
| QC182207 | Chlortetracycline EP Impurity G
CAS# NA
M.F.: C22H23ClN2O8
M.W.: 478.88 |
| |
| QC182206 | Chlortetracycline EP Impurity F
CAS# NA
M.F.: C22H23ClN2O8
M.W.: 478.88 |
| |
| QC182205 | Chlortetracycline EP Impurity E;
Demeclocycline EP Impurity B
CAS# 14206-59-8
M.F.: C21H21ClN2O8
M.W.: 464.85 |
| |
| QC182204 | Chlortetracycline EP Impurity D;
Lymecycline EP Impurity A;
Tetracycline EP Impurity A;
4-Epitetracycline
CAS# 79-85-6;23313-80-6(HCl salt)
M.F.: C22H24N2O8
M.W.: 444.43 |
| |
| QC182203 | Chlortetracycline EP Impurity C;
Demeclocycline EP Impurity C
CAS# NA
M.F.: C21H22N2O8
M.W.: 430.41 |
| |
| QC121701 | Chlorhexidine EP Impurity A
CAS# 152504-08-0
M.F.: C16H24ClN9
M.W.: 377.88 |
| |
| QT131211 | Timolol Maleate Impurity 11
CAS# 1391068-18-0
M.F.: C19H31N7O4S2
M.W.: 485.62 |
| |
| QC121714 | Chlorhexidine EP Impurity N
CAS# 152504-10-4
M.F.: C15H25ClN8
M.W.: 352.87 |
| |
| QC121708 | Chlorhexidine EP Impurity H
CAS# NA
M.F.: C30H47Cl2N15
M.W.: 688.70 |
| |
| QC121705 | Chlorhexidine EP Impurity E
CAS# 45964-97-4;14279-91-5(HCl salt)
M.F.: C7H8ClN3
M.W.: 169.61 |
| |
| QC051309 | Celiprolol EP Impurity I
CAS# NA
M.F.: C15H22N2O3
M.W.: 278.35 |
| |
| QC051308 | Celiprolol EP Impurity H
CAS# NA
M.F.: C16H23BrN2O4
M.W.: 387.27 |
| |
| QC051307 | Celiprolol EP Impurity G
CAS# NA
M.F.: C16H22N2O4
M.W.: 306.36 |
| |
| QC051306 | Celiprolol EP Impurity F
CAS# NA
M.F.: C13H18N2O3
M.W.: 250.29 |
| |
| QC051304 | Celiprolol EP Impurity D
CAS# NA
M.F.: C20H33N3O4
M.W.: 379.49 |
| |
| QC051303 | Celiprolol EP Impurity C
CAS# NA
M.F.: C20H33N3O4
M.W.: 379.49 |
| |
| QC051301 | Celiprolol EP Impurity A
CAS# NA
M.F.: C15H24N2O3
M.W.: 280.36 |
| |
| QC012305 | Carteolol EP Impurity E
CAS# 56660-90-3
M.F.: C21H22N2O5
M.W.: 382.41 |
| |
| QC012304 | Carteolol EP Impurity D
CAS# 51781-13-6
M.F.: C12H14ClNO3
M.W.: 255.70 |
| |
| QC012303 | Carteolol EP Impurity C
CAS# 51781-14-7
M.F.: C12H13NO3
M.W.: 219.24 |
| |
| QC012302 | Carteolol EP Impurity B
CAS# 30389-33-4
M.F.: C9H9NO2
M.W.: 163.17 |
| |
| QC011705 | Carprofen EP Impurity E
CAS# NA
M.F.: C12H8ClN
M.W.: 201.65 |
| |
| QB051300 | Bempedoic acid
CAS# 738606-46-7
M.F.: C19H36O5
M.W.: 344.49 |
| |
| QC012809 | Camphor EP Impurity I
CAS# NA
M.F.: C10H18O
M.W.: 154.25 |
| |
| QC012804 | Camphor EP Impurity D
CAS# NA
M.F.: C10H18O
M.W.: 154.25 |
| |
| QC012803 | Camphor EP Impurity C
CAS# NA
M.F.: C10H16
M.W.: 136.23 |
| |
| QC012704 | Cabergoline EP Impurity D
CAS# 85329-86-8
M.F.: C23H32N4O
M.W.: 380.53 |
| |
| QC012703 | Cabergoline EP Impurity C
CAS# 126554-50-5
M.F.: C29H42N6O3
M.W.: 522.68 |
| |
| QC012702 | Cabergoline EP Impurity B
CAS# 166533-36-4
M.F.: C26H37N5O2
M.W.: 451.60 |
| |
| QC012701 | Cabergoline EP Impurity A
CAS# 81409-74-7
M.F.: C18H20N2O2
M.W.: 296.36 |
| |
| QB211610 | Buprenorphine EP Impurity J
CAS# NA
M.F.: C29H39NO4
M.W.: 465.62 |
| |
| QB211609 | Buprenorphine EP Impurity I
CAS# NA
M.F.: C28H37NO3
M.W.: 435.60 |
| |
| QN122033 | 6α-N-methylnaltrexamine
CAS# 102919-85-7
M.F.: C21H28N2O3
M.W.: 356.46 |
| |
| QB211608 | Buprenorphine EP Impurity H
CAS# NA
M.F.: C29H43NO4
M.W.: 469.66 |
| |
| QB211607 | Buprenorphine EP Impurity G
CAS# NA
M.F.: C58H80N2O8
M.W.: 933.26 |
| |
| QB211606 | Buprenorphine EP Impurity F
CAS# NA
M.F.: C29H39NO3
M.W.: 449.62 |
| |
| QB211605 | Buprenorphine EP Impurity E
CAS# NA
M.F.: C28H39NO4
M.W.: 453.61 |
| |
| QB211604 | Buprenorphine EP Impurity D
CAS# NA
M.F.: C30H43NO4
M.W.: 481.67 |
| |
| QB211603 | Buprenorphine EP Impurity C
CAS# NA
M.F.: C27H36N2O4
M.W.: 452.59 |
| |
| QB211602 | Buprenorphine EP Impurity B
CAS# NA
M.F.: C25H35NO4
M.W.: 413.55 |
| |
| QB211601 | Buprenorphine EP Impurity A
CAS# NA
M.F.: C29H41NO4
M.W.: 467.64 |
| |
| QB210503 | Bufexamac EP Impurity C
CAS# NA
M.F.: C16H24O3
M.W.: 264.36 |
| |
| QB210502 | Bufexamac EP Impurity B
CAS# NA
M.F.: C13H18O3
M.W.: 222.28 |
| |
| QB210501 | Bufexamac EP Impurity A
CAS# NA
M.F.: C12H16O3
M.W.: 208.25 |
| |
| QB182002 | Brotizolam EP Impurity B
CAS# NA
M.F.: C14H8BrClN4S
M.W.: 379.66 |
| |
| QB052202 | Betadex EP Impurity B;Alfadex EP Impurity B
CAS# 17465-86-0
M.F.: C48H80O40
M.W.: 1297.12 |
| |
| QB052201 | Betadex EP Impurity A
CAS# 10016-20-3
M.F.: C36H60O30
M.W.: 972.84 |
| |
| QB052700 | Benzyl benzoate
CAS# 120-51-4
M.F.: C14H12O2
M.W.: 212.24 |
| |
| QA181007 | Articaine EP Impurity G
CAS# NA
M.F.: C14H22N2O3S
M.W.: 298.4 |
| |
| QA181006 | Articaine EP Impurity F
CAS# NA
M.F.: C15H25N3O2S
M.W.: 311.44 |
| |
| QA181002 | Articaine EP Impurity B
CAS# 114176-52-2
M.F.: C12H18N2O3S
M.W.: 270.35 |
| |
| QA142601 | Antazoline hydrochloride EP Impurity A
CAS# NA
M.F.: C17H21N3O
M.W.: 283.37 |
| |
| QF120315 | Folic Acid Impurity 15
CAS# 712-29-8
M.F.: C7H7N5O2
M.W.: 193.16 |
| |
| QF120314 | Folic Acid Impurity 14
CAS# 873397-19-4
M.F.: C7H6ClN5O
M.W.: 211.61 |
| |
| QA142600 | Antazoline hydrochloride
CAS# 2508-72-7
M.F.: C17H20ClN3
M.W.: 301.81 |
| |
| QF122020 | Fluticasone Impurity 20;
Fluticasone Furoate EP Impurity F
CAS# NA
M.F.: C29H34F2O7
M.W.: 532.57 |
| |
| QN150300 | Neomycin sulfate
CAS# 1405-10-3
M.F.: C23H46N6O13.xH2SO4
M.W.: 614.64 x(98.08) |
| |
| QM091903 | Misoprostol EP Impurity C
CAS# NA
M.F.: C22H36O4
M.W.: 364.52 |
| |
| QM050105 | Metamizole sodium EP Impurity E
CAS# 117-38-4;129-89-5(Na salt)
M.F.: C12H15N3O4S
M.W.: 297.33 |
| |
| QM050104 | Metamizole sodium EP Impurity D
CAS# 58-15-1
M.F.: C13H17N3O
M.W.: 231.29 |
| |
| QM050103 | Metamizole sodium EP Impurity C
CAS# 519-98-2;856307-27-2(HCl salt)
M.F.: C12H15N3O
M.W.: 217.27 |
| |
| QM050102 | Metamizole sodium EP Impurity B
CAS# 83-07-8
M.F.: C11H13N3O
M.W.: 203.24 |
| |
| QV307760 | Vitamin B12;Cyanocobalamin
CAS# 68-19-9
M.F.: C63H88CoN14O14P
M.W.: 1355.37 |
| |
| QA130302 | Aminocaproic acid Impurity B
CAS# NA
M.F.: C8H11F2NO3
M.W.: 207.17 |
| |
| QL241678 | Loxoprofen Impurity 52
CAS# NA
M.F.: C18H24O5
M.W.: 320.38 |
| |
| QZ151206 | Zoledronic acid Impurity 6
CAS# 1627731-61-6;2043362-88-3(chloride)
M.F.: C7H16N2O14P4
M.W.: 476.10 |
| |
| QA141501 | Aminoglutethimide EP Impurity A
CAS# NA
M.F.: C13H16N2O2
M.W.: 232.28 |
| |
| QC162639 | Cefprozil Impurity 13
CAS# NA
M.F.: C36H36N6O9S2
M.W.: 760.84 |
| |
| QM140437 | Metronidazole Nitroso Impurity 5
CAS# NA
M.F.: C4H5N3O
M.W.: 111.10 |
| |
| QA120604 | Alfentanil EP Impurity D
CAS# NA
M.F.: C20H30N6O3
M.W.: 402.49 |
| |
| QA120600 | Alfentanil hydrochloride
CAS# 69049-06-5
M.F.: C21H33ClN6O3
M.W.: 452.98 |
| |
| QC123102 | Clemastine EP Impurity B
CAS# NA
M.F.: C21H26ClNO
M.W.: 343.89 |
| |
| QA031228 | Aciclovir Impurity 28
CAS# NA
M.F.: C9H13N5O4
M.W.: 255.23 |
| |
| QA161854 | Aprepitant Impurity 54
CAS# NA
M.F.: C3H6ClN3O2
M.W.: 151.55 |
| |
| QP082701 | Pheniramine maleate EP Impurity A
CAS# 101-82-6
M.F.: C12H11N
M.W.: 169.22 |
| |
| QA142001 | Antipyrine Impurity 1;Metamizole sodium EP Impurity A
CAS# 1672-58-8
M.F.: C12H13N3O2
M.W.: 231.25 |
| |
| QC181504 | Cromolyn Sodium Impurity 4;
Sodium Cromoglicate EP Impurity A
CAS# 699-83-2
M.F.: C8H8O3
M.W.: 152.15 |
| |
| QF120313 | D-Folic Acid
CAS# 65165-91-5
M.F.: C19H19N7O6
M.W.: 441.40 |
| |
| QT031856 | all-rac-alpha-Tocopherol EP Impurity C
CAS# 90510-39-7
M.F.: C30H52O2
M.W.: 444.73 |
| |
| QV307758 | Vitamin B6 Impurity 58
CAS# 19203-53-3
M.F.: C16H20N2O5
M.W.: 320.34 |
| |
| QV307757 | Vitamin B6 Impurity 57
CAS# 18436-47-0
M.F.: C16H20N2O5
M.W.: 320.34 |
| |
| QB180926 | Brivaracetam Impurity Z
CAS# 22530-99-0
M.F.: C8H14O2
M.W.: 142.20 |
| |
| QP080508 | Phenytoin Sodium impurity 8
CAS# 56079-91-5
M.F.: C15H11N3O4
M.W.: 297.27 |
| |
| QP080507 | Phenytoin Sodium impurity 7
CAS# 1189192-83-3
M.F.: C15H10N4O6
M.W.: 342.26 |
| |
| QP080506 | Phenytoin Sodium EP Impurity F
CAS# 51169-17-6
M.F.: C16H14N2O2
M.W.: 266.29 |
| |
| QP080505 | Phenytoin Sodium EP Impurity E
CAS# 6802-95-5
M.F.: C15H14N2O3
M.W.: 270.28 |
| |
| QP080511 | Phenytoin Sodium impurity 11
CAS# 36898-62-1
M.F.: C14H10N2O6
M.W.: 302.24 |
| |
| QP080510 | Phenytoin Sodium impurity 10
CAS# 61693-07-0
M.F.: C14H11NO4
M.W.: 257.24 |
| |
| QM041844 | Minodronic Acid Impurity 18
CAS# NA
M.F.: C8H6N2O2
M.W.: 162.15 |
| |
| QR160731 | Repaglinide Impurity 5
CAS# NA
M.F.: C18H24O7
M.W.: 352.38 |
| |
| QB050101 | Betaxolol EP Impurity A
CAS# 67193-95-7
M.F.: C14H23NO2
M.W.: 237.34 |
| |
| QA190212 | Ascorbic Acid Impurity 12
CAS# 3445-22-5
M.F.: C6H8O7
M.W.: 192.12 |
| |
| QL091649 | Lipoic Acid Impurity 23
CAS# 940-69-2
M.F.: C8H15NOS2
M.W.: 205.34 |
| |
| QM041843 | Minodronic Acid Impurity 17
CAS# NA
M.F.: C9H9N2O4P
M.W.: 240.15 |
| |
| QM041842 | Minodronic Acid Impurity 16
CAS# NA
M.F.: C14H12N4O
M.W.: 252.27 |
| |
| QM041841 | Minodronic Acid Impurity 15
CAS# 4437-06-3
M.F.: C4H4O3
M.W.: 100.07 |
| |
| QM041840 | Minodronic Acid Impurity 14
CAS# 653599-20-3
M.F.: C9H8N2O3
M.W.: 192.17 |
| |
| QM041839 | Minodronic Acid Impurity 13
CAS# 1507308-67-9
M.F.: C9H7ClN2O2
M.W.: 210.62 |
| |
| QM041838 | Minodronic Acid Impurity 12
CAS# NA
M.F.: C9H11ClN2O7P2
M.W.: 356.59 |
| |
| QL091648 | Lipoic Acid Impurity 22
CAS# 25636-58-2
M.F.: C8H14O2S
M.W.: 174.26 |
| |
| QM041837 | Minodronic Acid Impurity 11
CAS# 17745-04-9
M.F.: C9H8N2O2
M.W.: 176.17 |
| |
| QA130502 | Aminolevulinic Acid Related Compound B
CAS# 109258-71-1
M.F.: C14H13NO5
M.W.: 275.26 |
| |
| QA130501 | Aminolevulinic Acid Related Compound A
CAS# 77479-02-8
M.F.: C10H12N2O4
M.W.: 224.21 |
| |
| QA130500 | Aminolevulinic Acid Hydrochloride
CAS# 5451-09-2;106-60-5(free base)
M.F.: C5H9NO3 HCl
M.W.: 131.13 36.46 |
| |
| QC051206 | Ceftezole Sodium Impurity 6
CAS# NA
M.F.: C12H11N9O4S3
M.W.: 441.47 |
| |
| QC051205 | Ceftezole Sodium Impurity 5
CAS# NA
M.F.: C13H12N8O4S3
M.W.: 440.48 |
| |
| QC051204 | Ceftezole Sodium Impurity 4
CAS# NA
M.F.: C13H13N9O3S3
M.W.: 439.50 |
| |
| QC051203 | Ceftezole Sodium Impurity 3
CAS# NA
M.F.: C13H14N8O5S3
M.W.: 458.50 |
| |
| QC051202 | Ceftezole Sodium Impurity 2
CAS# NA
M.F.: C13H12N8O4S3
M.W.: 440.48 |
| |
| QC051201 | Ceftezole Sodium Impurity 1
CAS# NA
M.F.: C13H12N8O5S3
M.W.: 456.48 |
| |
| QE120119 | Elagolix Impurity 19
CAS# NA
M.F.: C28H21F5N2O4
M.W.: 544.47 |
| |
| QE120116 | Elagolix Impurity 16
CAS# NA
M.F.: C40H44F5N3O7
M.W.: 773.79 |
| |
| QC061910 | Ceftaroline Fosamil Impurity J
CAS# NA
M.F.: C29H26N2O7S2
M.W.: 578.66 |
| |
| QC061909 | Ceftaroline Fosamil Impurity I
CAS# NA
M.F.: C28H24N2O5S
M.W.: 500.57 |
| |
| QC061908 | Ceftaroline Fosamil Impurity H
CAS# NA
M.F.: C16H14N4O3S3
M.W.: 406.50 |
| |
| QU190425 | Ursodeoxycholic Acid Impurity 25
CAS# NA
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QP180437 | Perindopril Impurity 37
CAS# 82864-25-3
M.F.: C11H19NO2 HCl
M.W.: 197.27 36.46 |
| |
| QT011500 | Tauroursodeoxycholic Acid
CAS# 14605-22-2
M.F.: C26H45NO6S
M.W.: 499.70 |
| |
| QL091647 | Lipoic Acid Impurity 21
CAS# NA
M.F.: C9H16O2S2
M.W.: 220.35 |
| |
| QL091646 | Lipoic Acid Impurity 20
CAS# NA
M.F.: C4H6O2S2
M.W.: 150.22 |
| |
| QL091645 | Lipoic Acid Impurity 19
CAS# NA
M.F.: C6H10O3S2
M.W.: 194.27 |
| |
| QL091644 | Lipoic Acid Impurity 18
CAS# NA
M.F.: C6H10O2S2
M.W.: 178.27 |
| |
| QL091643 | Lipoic Acid Impurity 17
CAS# NA
M.F.: C9H16O2S2
M.W.: 220.35 |
| |
| QL091642 | Lipoic Acid Impurity 16
CAS# NA
M.F.: C9H16O2S2
M.W.: 220.35 |
| |
| QL091641 | Lipoic Acid Impurity 15
CAS# 1071-71-2
M.F.: C8H13ClO3
M.W.: 192.64 |
| |
| QA130405 | Amidotrizoic Acid EP Impurity E
CAS# NA
M.F.: C13H11I3N2O5
M.W.: 655.95 |
| |
| QA130404 | Amidotrizoic Acid EP Impurity D
CAS# NA
M.F.: C11H8I4N2O4
M.W.: 739.81 |
| |
| QA130403 | Amidotrizoic Acid EP Impurity C
CAS# NA
M.F.: C11H10I2N2O4
M.W.: 488.02 |
| |
| QA130401 | Amidotrizoic Acid EP Impurity A;
Sodium amidotrizoate EP Impurity A
CAS# NA
M.F.: C9H7I3N2O3
M.W.: 571.88 |
| |
| QA130400 | Amidotrizoic Acid
CAS# 117-96-4
M.F.: C11H9I3N2O4
M.W.: 613.91 |
| |
| QA041601 | Adipic acid EP Impurity A
CAS# 110-94-1
M.F.: C5H8O4
M.W.: 132.11 |
| |
| QA180228 | Arbidol Impurity 28
CAS# NA
M.F.: C20H21BrN2O3S
M.W.: 449.36 |
| |
| QI091600 | Ipratropium bromide monohydrate
CAS# 66985-17-9
M.F.: C20H30BrNO3 H2O
M.W.: 412.36 18.02 |
| |
| QT181400 | Treprostinil
CAS# 81846-19-7;289480-64-4(Na salt)
M.F.: C23H34O5
M.W.: 390.51 |
| |
| QP072040 | Pioglitazone hydrochloride Impurity 40
CAS# NA
M.F.: C19H20N2O2S
M.W.: 340.44 |
| |
| QN050904 | Netilmicin sulfate EP Impurity D
CAS# NA
M.F.: C23H45N5O7
M.W.: 503.63 |
| |
| QA200345 | Cisatracurium Besylate Impurity 45
CAS# NA
M.F.: C65H82N2O18S2
M.W.: 1243.48 |
| |
| QH121617 | Haloperidol Impurity 17
CAS# NA
M.F.: C31H32ClF2NO3
M.W.: 540.04 |
| |
| QA200344 | Atracurium besylate
CAS# 64228-81-5
M.F.: C65H82N2O18S2
M.W.: 1243.48 |
| |
| QS052003 | Sertaconazole nitrate EP Impurity C
CAS# 142181-53-1
M.F.: C9H7ClOS
M.W.: 198.67 |
| |
| QS052002 | Sertaconazole nitrate EP Impurity B
CAS# 17512-61-7
M.F.: C9H6BrClS
M.W.: 261.57 |
| |
| QC042005 | Cefditoren pivoxil Impurity 5
CAS# NA
M.F.: C28H33N7O7S3
M.W.: 675.80 |
| |
| QC042004 | Cefditoren pivoxil Impurity 4
CAS# NA
M.F.: C25H28N6O7S3
M.W.: 620.72 |
| |
| QB050415 | Bedaquiline Fumarate Impurity 15
CAS# 861709-47-9
M.F.: C31H29BrN2O2
M.W.: 541.48 |
| |
| QI091623 | Ipratropium Bromide Impurity 23
CAS# NA
M.F.: C20H30BrNO3
M.W.: 412.36 |
| |
| QI091622 | Ipratropium Bromide Impurity 22
CAS# NA
M.F.: C19H27NO3
M.W.: 317.42 |
| |
| QZ151205 | Zoledronic acid Impurity 5
CAS# 1334703-07-9
M.F.: C11H17ClN2O4
M.W.: 276.72 |
| |
| QZ151204 | Zoledronic acid Impurity 4
CAS# 117255-11-5;805228-36-8(chloride)
M.F.: C7H8N2O4
M.W.: 184.15 |
| |
| QZ151203 | Zoledronic acid Impurity 3
CAS# 1627731-60-5
M.F.: C7H12N2O9P2
M.W.: 330.13 |
| |
| QZ151202 | Zoledronic acid Impurity 2
CAS# NA
M.F.: C10H16N4O12P4
M.W.: 508.15 |
| |
| QZ151201 | Zoledronic acid Impurity 1;
Zoledronic acid EP Impurity B
CAS# 1632236-60-2;2043362-88-3(Cl salt)
M.F.: C7H17N2O14P4
M.W.: 477.11 |
| |
| QN151836 | Noradrenaline (Norepinephrine) Impurity 36
CAS# 50988-14-2
M.F.: C9H11NO3
M.W.: 181.19 |
| |
| QN151835 | Noradrenaline (Norepinephrine) Impurity 35
CAS# NA
M.F.: C9H13NO4
M.W.: 199.20 |
| |
| QN151834 | Noradrenaline (Norepinephrine) Impurity 34
CAS# NA
M.F.: C9H13NO4
M.W.: 199.20 |
| |
| QN151833 | Noradrenaline (Norepinephrine) Impurity 33
CAS# 21213-89-8
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QN151832 | Noradrenaline (Norepinephrine) Impurity 32
CAS# 554-99-4
M.F.: C10H15NO3
M.W.: 197.23 |
| |
| QN151831 | Noradrenaline (Norepinephrine) Impurity 31
CAS# 2947-02-6;74571-90-7(HCl salt)
M.F.: C10H15NO3
M.W.: 197.23 |
| |
| QN151830 | Noradrenaline (Norepinephrine) Impurity 30
CAS# NA
M.F.: C17H21NO6
M.W.: 335.35 |
| |
| QN151829 | Noradrenaline (Norepinephrine) Impurity 29
CAS# NA
M.F.: C17H17NO6
M.W.: 331.32 |
| |
| QN151828 | Noradrenaline (Norepinephrine) Impurity 28
CAS# 150-05-0
M.F.: C9H13NO3
M.W.: 183.20 |
| |
| QN151827 | Noradrenaline (Norepinephrine) Impurity 27
CAS# 1197-09-7
M.F.: C8H8O3
M.W.: 152.15 |
| |
| QN151826 | Noradrenaline (Norepinephrine) Impurity 26
CAS# 373360-12-4
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QN151825 | Noradrenaline (Norepinephrine) Impurity 25
CAS# 73660-93-2
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QN151824 | Noradrenaline (Norepinephrine) Impurity 24
CAS# 1891319-98-4
M.F.: C8H9NO3
M.W.: 167.16 |
| |
| QN151823 | Noradrenaline (Norepinephrine) Impurity 23
CAS# NA
M.F.: C8H9NO4
M.W.: 183.16 |
| |
| QN151822 | Noradrenaline (Norepinephrine) Impurity 22
CAS# NA
M.F.: C8H6Cl2O3
M.W.: 221.04 |
| |
| QN151821 | Noradrenaline (Norepinephrine) Impurity 21
CAS# 29477-54-1
M.F.: C8H8O4
M.W.: 168.15 |
| |
| QN151820 | Noradrenaline (Norepinephrine) Impurity 20
CAS# 408328-15-4
M.F.: C8H8O4
M.W.: 168.15 |
| |
| QN151819 | Noradrenaline (Norepinephrine) Impurity 19
CAS# 60912-82-5
M.F.: C8H7ClO3
M.W.: 186.59 |
| |
| QN151818 | Noradrenaline (Norepinephrine) Impurity 18
CAS# 490-90-4
M.F.: C8H5NO3
M.W.: 163.13 |
| |
| QN151817 | Noradrenaline (Norepinephrine) Impurity 17
CAS# 490-89-1
M.F.: C8H7NO3
M.W.: 165.15 |
| |
| QN151816 | Noradrenaline (Norepinephrine) Impurity 16
CAS# 3198-07-0(HCl salt)
M.F.: C10H15NO3
M.W.: 197.23 |
| |
| QN151815 | Noradrenaline (Norepinephrine) Impurity 15
CAS# 132261-26-8
M.F.: C8H12N2O2
M.W.: 168.19 |
| |
| QN151814 | Noradrenaline (Norepinephrine) Impurity 14
CAS# 3805-00-3(HCl salt)
M.F.: C10H15NO3
M.W.: 197.23 |
| |
| QN151813 | Noradrenaline (Norepinephrine) Impurity 13
CAS# 5530-29-0
M.F.: C8H9ClO3
M.W.: 188.61 |
| |
| QN151812 | Noradrenaline (Norepinephrine) Impurity 12
CAS# 28822-73-3
M.F.: C8H10O4
M.W.: 170.16 |
| |
| QN151811 | Noradrenaline (Norepinephrine) Impurity 11
CAS# NA
M.F.: C16H19NO6
M.W.: 321.33 |
| |
| QN151809 | Noradrenaline (Norepinephrine) Impurity 9
CAS# 872266-28-9
M.F.: C16H15NO6
M.W.: 317.29 |
| |
| QG122109 | Glucaric acid
CAS# 87-73-0;5793-89-5(Calcium salt tetrahydrate)
M.F.: C6H10O8
M.W.: 210.14 |
| |
| QM050501 | Methylene violet
CAS# 2516-05-4
M.F.: C14H12N2OS
M.W.: 256.32 |
| |
| QC071209 | Carglumic Acid Impurity 9
CAS# NA
M.F.: C6H8N2O4
M.W.: 172.14 |
| |
| QC071208 | Carglumic Acid Impurity 8
CAS# 5624-26-0
M.F.: C6H8N2O4
M.W.: 172.14 |
| |
| QC071207 | Carglumic Acid Impurity 7
CAS# 17027-50-8
M.F.: C6H8N2O4
M.W.: 172.14 |
| |
| QC071206 | Carglumic Acid Impurity 6
CAS# 2380660-24-0
M.F.: C6H8N2O4
M.W.: 172.14 |
| |
| QA032104 | Aclidinium bromide Impurity 4
CAS# NA
M.F.: C26H30BrNO4S2
M.W.: 564.55 |
| |
| QP132613 | Promethazine Impurity 13
CAS# 1207-71-2
M.F.: C12H9NOS
M.W.: 215.27 |
| |
| QM201244 | Montelukast Impurity 18
CAS# 1152185-58-4
M.F.: C35H36ClNO4S
M.W.: 602.18 |
| |
| QA200343 | Atracurium Besylate Impurity 43
CAS# 91950-41-3
M.F.: C10H14O3S
M.W.: 214.28 |
| |
| QA040638 | Adefovir Impurity 12
CAS# NA
M.F.: C32H52N5O18P
M.W.: 825.75 |
| |
| QM131925 | Mometasone Furoate Impurity 25
CAS# 134429-33-7
M.F.: C27H30Cl2O7
M.W.: 537.43 |
| |
| QM131924 | Mometasone Furoate Impurity 24
CAS# 1404070-67-2
M.F.: C26H28Cl2O6
M.W.: 507.40 |
| |
| QM131923 | Mometasone Furoate Impurity 23
CAS# NA
M.F.: C28H32Cl2O6
M.W.: 535.46 |
| |
| QM131922 | Mometasone Furoate Impurity 22
CAS# NA
M.F.: C27H28Cl2O6
M.W.: 519.41 |
| |
| QM131921 | Mometasone Furoate Impurity 21
CAS# NA
M.F.: C26H29ClO7
M.W.: 488.96 |
| |
| QM131920 | Mometasone Furoate EP Impurity T
CAS# NA
M.F.: C27H29Cl3O6
M.W.: 555.87 |
| |
| QM131918 | Mometasone Furoate EP Impurity R
CAS# 1370190-08-1
M.F.: C28H33ClO9S
M.W.: 581.07 |
| |
| QM131917 | Mometasone Furoate EP Impurity Q
CAS# 83881-08-7
M.F.: C22H27ClO4
M.W.: 390.90 |
| |
| QM131916 | Mometasone Furoate EP Impurity P
CAS# NA
M.F.: C27H31ClO7
M.W.: 502.98 |
| |
| QM131915 | Mometasone Furoate EP Impurity O
CAS# 24916-91-4
M.F.: C24H31ClO6
M.W.: 450.95 |
| |
| QM131913 | Mometasone Furoate EP Impurity M
CAS# 57780-86-6
M.F.: C22H29ClO4
M.W.: 392.92 |
| |
| QM131910 | Mometasone Furoate EP Impurity J
CAS# NA
M.F.: C28H32Cl2O6
M.W.: 535.46 |
| |
| QK161827 | Kyprolis Impurity 27
CAS# NA
M.F.: C37H47N3O6
M.W.: 629.79 |
| |
| QA032103 | Aclidinium bromide Impurity 3
CAS# 320346-75-6
M.F.: C25H28BrNO4S2
M.W.: 550.53 |
| |
| QA032102 | Aclidinium bromide Impurity 2
CAS# 1708930-15-7
M.F.: C16H24BrNO2
M.W.: 342.27 |
| |
| QA032101 | Aclidinium bromide Impurity 1
CAS# 588-63-6
M.F.: C9H11BrO
M.W.: 215.09 |
| |
| QA032100 | Aclidinium bromide
CAS# 320345-99-1
M.F.: C26H30BrNO4S2
M.W.: 564.55 |
| |
| QL010317 | Memantine Lactose Adduct
CAS# 1159637-28-1
M.F.: C24H41NO10
M.W.: 503.58 |
| |
| QC022000 | Cabazitaxel
CAS# 183133-96-2;1426815-65-7(acetone)
M.F.: C45H57NO14
M.W.: 835.93 |
| |
| QC071205 | Carglumic Acid Impurity 5
CAS# 1009553-88-1
M.F.: C6H8N2O4
M.W.: 172.14 |
| |
| QI091621 | Ipratropium Bromide Impurity 21
CAS# NA
M.F.: C19H27NO3
M.W.: 317.42 |
| |
| QV200101 | Vitamin A EP Impurity A
CAS# NA
M.F.: C40H60O2/C44H64O4
M.W.: 572.90/ 656.98 |
| |
| QV200103 | Vitamin A EP Impurity C
CAS# 16729-22-9
M.F.: C20H30O
M.W.: 286.45 |
| |
| QV200102 | Vitamin A EP Impurity B
CAS# 144407-18-1
M.F.: C20H28
M.W.: 268.44 |
| |
| QT182702 | Tramadol EP Impurity B
CAS# 66170-32-9(HCl salt)
M.F.: C16H23NO
M.W.: 245.36 |
| |
| QF122414 | Fluoxetine Impurity 14
CAS# NA
M.F.: C39H58F3NO5
M.W.: 677.88 |
| |
| QF120312 | Folic Acid EP Impurity H
CAS# 2366274-27-1
M.F.: C31H31N9O10
M.W.: 689.63 |
| |
| QF120311 | Folic Acid EP Impurity G
CAS# 2734707-85-6
M.F.: C19H19N7O6
M.W.: 441.40 |
| |
| QG121800 | Glycyrrhizic Acid
CAS# 1405-86-3
M.F.: C42H62O16
M.W.: 822.93 |
| |
| QC030354 | Cinacalcet Impurity 54
CAS# 3751-48-2
M.F.: C10H12O2
M.W.: 164.20 |
| |
| QL091640 | Lipoic Acid Impurity 14
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091639 | Lipoic Acid Impurity 13
CAS# 41443-60-1
M.F.: C8H14Cl2O2
M.W.: 213.10 |
| |
| QT181919 | Torasemide Impurity 19
CAS# 33263-44-4
M.F.: C5H3Cl2NO2S
M.W.: 212.05 |
| |
| QC-M011202 | Malic acid;
Aspartic acid EP Impurity A
CAS# 6915-15-7;617-48-1
M.F.: C4H6O5
M.W.: 134.09 |
| |
| QU190421 | Ursodeoxycholic Acid Impurity 21
CAS# NA
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QT070501 | Tigecycline EP Impurity A
CAS# 1422262-97-2
M.F.: C29H39N5O8
M.W.: 585.65 |
| |
| QL051508 | Calcium Levofolinate EP Impurity H
CAS# 73951-54-9
M.F.: C20H23N7O7
M.W.: 473.44 |
| |
| QL051507 | Calcium Levofolinate EP Impurity G;
Calcium Folinate Hydrate EP Impurity G
CAS# 4033-27-6
M.F.: C19H21N7O6
M.W.: 443.41 |
| |
| QL051506 | Calcium Levofolinate EP Impurity F;
Calcium Folinate Hydrate EP Impurity F
CAS# 28459-40-7
M.F.: C20H21N7O7
M.W.: 471.42 |
| |
| QL051504 | Calcium Levofolinate EP Impurity D;
Calcium Folinate Hydrate EP Impurity D
CAS# 134-05-4
M.F.: C20H19N7O7
M.W.: 469.41 |
| |
| QL051503 | Calcium Levofolinate EP Impurity C;
Calcium Folinate Hydrate EP Impurity C;
Folic acid
CAS# 59-30-3
M.F.: C19H19N7O6
M.W.: 441.40 |
| |
| QL051502 | Calcium Levofolinate EP Impurity B
CAS# NA
M.F.: C21H23N7O8
M.W.: 501.45 |
| |
| QL051500 | Calcium Levofolinate
CAS# 80433-71-2
M.F.: C20H21CaN7O7
M.W.: 511.50 |
| |
| QL051515 | Calcium levofolinate Impurity 15
CAS# 26560-38-3;134-35-0 (free base)
M.F.: C20H23CaN7O6
M.W.: 497.52 |
| |
| QE262041 | Ezetimibe Impurity 41
CAS# 163222-32-0
M.F.: C31H27F2NO3
M.W.: 499.55 |
| |
| QL051505 | Calcium levofolinate EP Impurity E
CAS# 944737-05-7
M.F.: C15H16N6O4
M.W.: 344.33 |
| |
| QF122908 | Fluocinolone acetonide EP Impurity H;
Triamcinolone acetonide
CAS# 76-25-5
M.F.: C24H31FO6
M.W.: 434.50 |
| |
| QL091638 | Lipoic Acid Impurity 12
CAS# 2114407-78-0
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091637 | Lipoic Acid Impurity 11
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091636 | Lipoic Acid Impurity 10
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091635 | Lipoic Acid Impurity 9
CAS# NA
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QV011228 | 4-Hydroxy Valproic Acid Sodium Salt
CAS# 1216888-06-0
M.F.: C8H15NaO3
M.W.: 182.19 |
| |
| QS210300 | Sucrose
CAS# 57-50-1
M.F.: C12H22O11
M.W.: 342.30 |
| |
| QD061807 | Deferasirox Impurity 7
CAS# 1395346-29-8
M.F.: C23H17N3O6
M.W.: 431.40 |
| |
| QO132066 | Olmesartan Impurity 66
CAS# NA
M.F.: C45H44N6O3
M.W.: 716.87 |
| |
| QT090306 | Thioctic Acid Impurity 6
CAS# NA
M.F.: C8H14O2S3
M.W.: 238.39 |
| |
| QT090305 | Thioctic Acid EP Impurity B
CAS# NA
M.F.: H2O[C8H14OS2]n
M.W.: 18.02[190.33]n |
| |
| QW011803 | Warfarin sodium EP Impurity C
CAS# 1896-62-4
M.F.: C10H10O
M.W.: 146.19 |
| |
| QW011800 | Warfarin sodium
CAS# 129-06-6;81-81-2(free base)
M.F.: C19H15NaO4
M.W.: 330.31 |
| |
| QA180603 | ArforMoterol Tartrate Impurity 3
CAS# 477552-94-6
M.F.: C9H11NO3
M.W.: 181.19 |
| |
| QO240110 | Oxacillin sodium monohydrate EP Impurity J;
Ozolamide of 6-APA dimer
CAS# NA
M.F.: C27H31N5O8S2
M.W.: 617.69 |
| |
| QO240109 | Oxacillin sodium monohydrate EP Impurity I
CAS# NA
M.F.: C27H29N5O7S2
M.W.: 599.68 |
| |
| QO240107 | Oxacillin sodium monohydrate EP Impurity G
CAS# NA
M.F.: C19H18ClN3O5S
M.W.: 435.88 |
| |
| QO240106 | Oxacillin sodium monohydrate EP Impurity F
CAS# 5053-35-0
M.F.: C19H19N3O4S2
M.W.: 417.50 |
| |
| QO240105 | Oxacillin sodium monohydrate EP Impurity E;
Cloxacillin
CAS# 61-72-3;7081-44-9(Na salt monohydrate)
M.F.: C19H18ClN3O5S
M.W.: 435.88 |
| |
| QO240103 | Oxacillin sodium monohydrate EP Impurity C
CAS# 1136-45-4
M.F.: C11H9NO3
M.W.: 203.19 |
| |
| QF120310 | Folic Acid Impurity 10;
Calcium levofolinate EP Impurity I
CAS# 31690-11-6
M.F.: C20H23N7O6
M.W.: 457.44 |
| |
| QF120309 | Folic Acid EP Impurity G
CAS# 2734707-85-6
M.F.: C19H19N7O6
M.W.: 441.40 |
| |
| QF061311 | Fosfomycin Trometamol Impurity 11
CAS# 26017-03-8
M.F.: C3H7O4P
M.W.: 138.06 |
| |
| QF061310 | Fosfomycin Trometamol Impurity 10
CAS# 45629-00-3
M.F.: C3H7O4P
M.W.: 138.06 |
| |
| QF061304 | Fosfomycin Trometamol EP Impurity D
CAS# 1262243-12-8
M.F.: C10H25NO11P2
M.W.: 397.25 |
| |
| QF061303 | Fosfomycin Trometamol EP Impurity C
CAS# 23001-39-0;114252-50-5(Barium Salt)
M.F.: C4H12NO6P
M.W.: 201.11 |
| |
| QF061302 | Fosfomycin Trometamol EP Impurity B
CAS# 1262243-11-7
M.F.: C7H18NO7P
M.W.: 259.19 |
| |
| QF061301 | Fosfomycin Trometamol EP Impurity A
CAS# 84954-80-3
M.F.: C3H9O5P
M.W.: 156.07 |
| |
| QM051500 | Methocarbamol
CAS# 532-03-6
M.F.: C11H15NO5
M.W.: 241.24 |
| |
| QD150305 | Docusate sodium Impurity 5
CAS# NA
M.F.: C14H25NaO7S
M.W.: 360.40 |
| |
| QD150304 | Docusate sodium Impurity 4
CAS# NA
M.F.: C14H25NaO7S
M.W.: 360.40 |
| |
| QD150303 | Docusate sodium Impurity 3
CAS# 86878-53-7
M.F.: C12H20Na2O7S
M.W.: 354.33 |
| |
| QD150302 | Docusate sodium Impurity 2
CAS# 115960-17-3
M.F.: C12H21NaO7S
M.W.: 332.35 |
| |
| QL091634 | Lipoic Acid Impurity 8
CAS# NA
M.F.: C20H37NO6S4 C4H11NO3
M.W.: 515.77 121.14 |
| |
| QH251200 | Hyocholic acid
CAS# 547-75-1
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QC-S210301 | succinic acid;
Adipic acid EP Impurity B;
Aspartic acid EP Impurity E
CAS# 110-15-6
M.F.: C4H6O4
M.W.: 118.09 |
| |
| QM160284 | Moxifloxacin Impurity 84
CAS# NA
M.F.: C21H24FN3O7
M.W.: 449.43 |
| |
| QC-P160500 | Pteroic acid
CAS# 119-24-4
M.F.: C14H12N6O3
M.W.: 312.28 |
| |
| QT031853 | α-Tocopherol;
all-rac-α-Tocopherol
CAS# 10191-41-0
M.F.: C29H50O2
M.W.: 430.71 |
| |
| QP082500 | Vitamin K1 (Phytonadione)
CAS# 84-80-0
M.F.: C31H46O2
M.W.: 450.70 |
| |
| QT131204 | Timolol Maleate EP Impurity D
CAS# 30165-97-0
M.F.: C6H9N3O2S
M.W.: 187.22 |
| |
| QF120308 | 10-Formyl-7,8-dihydro Folic Acid Disodium Salt
CAS# 28459-40-7(free base)
M.F.: C20H19N7Na2O7
M.W.: 515.39 |
| |
| QF120307 | Folic Acid Impurity 7
CAS# NA
M.F.: C31H31N9O10
M.W.: 689.63 |
| |
| QC-A180701 | L-Arginine; Lysine acetate EP Impurity F
CAS# 74-79-3;1119-34-2(HCl salt)
M.F.: C6H14N4O2
M.W.: 174.20 |
| |
| QE201208 | Estriol EP Impurity H;
16alpha-Hydroxyestrone
CAS# 566-76-7
M.F.: C18H22O3
M.W.: 286.37 |
| |
| QL091633 | Lipoic Acid Impurity 7
CAS# NA
M.F.: C16H28O6S4
M.W.: 444.65 |
| |
| QV011201 | Valproic Acid Ethyl Ester
CAS# 17022-31-0
M.F.: C10H20O2
M.W.: 172.26 |
| |
| QD032012 | Docetaxel Impurity 12
CAS# 151636-78-1
M.F.: C49H55Cl6NO18
M.W.: 1158.67 |
| |
| QT142409 | Tranexamic Acid Impurity 9
CAS# 70795-45-8
M.F.: C8H18N2
M.W.: 142.24 |
| |
| QT142408 | Tranexamic Acid Impurity 8
CAS# NA
M.F.: C9H17NO2
M.W.: 171.24 |
| |
| QT142407 | Tranexamic Acid EP Impurity E
CAS# 82755-59-7
M.F.: C16H28N2O3
M.W.: 296.41 |
| |
| QT142406 | Tranexamic Acid Impurity 6
CAS# 13064-83-0
M.F.: C8H14O2
M.W.: 142.20 |
| |
| QC-A080301 | D-Glucose;Trehalose dihydrate EP Impurity A
CAS# 50-99-7;5996-10-1(monohydrate)
M.F.: C6H12O6
M.W.: 180.16 |
| |
| QP050400 | Peonidin Chloride
CAS# 134-01-0
M.F.: C16H13ClO6
M.W.: 336.72 |
| |
| QI020101 | Ibandronic acid Impurity 1
CAS# 128202-57-3(free base)
M.F.: C4H12NNaO7P2
M.W.: 271.08 |
| |
| QT090304 | (R)-alpha-Thioctic Acid
CAS# 1200-22-2
M.F.: C8H14O2S2
M.W.: 206.33 |
| |
| QM050605 | Mefenamic Acid EP Impurity E
CAS# 4869-11-8
M.F.: C14H15N
M.W.: 197.28 |
| |
| QM050602 | Mefenamic Acid EP Impurity B
CAS# 21122-68-9
M.F.: C23H24N2O
M.W.: 344.45 |
| |
| QM050601 | Mefenamic Acid EP Impurity A
CAS# 87-59-2
M.F.: C8H11N
M.W.: 121.18 |
| |
| QM050600 | Mefenamic Acid
CAS# 61-68-7
M.F.: C15H15NO2
M.W.: 241.29 |
| |
| QF211900 | Fusidic Acid
CAS# 6990-06-3
M.F.: C31H48O6
M.W.: 516.71 |
| |
| QD190640 | Doxofylline Impurity 14
CAS# NA
M.F.: C13H20N4O6
M.W.: 328.32 |
| |
| QM011412 | Mandelic acid 12
CAS# 51019-43-3
M.F.: C10H10O4
M.W.: 194.18 |
| |
| QM011411 | Mandelic acid 11
CAS# 29169-64-0
M.F.: C9H7ClO3
M.W.: 198.60 |
| |
| QM011410 | Mandelic acid 10
CAS# 29169-63-9
M.F.: C9H8O4
M.W.: 180.16 |
| |
| QP011406 | DL-Pantothenic acid calcium salt
CAS# 6381-63-1
M.F.: C18H32CaN2O10
M.W.: 476.53 |
| |
| QC-D091307 | Calcium Pantothenate EP Impurity B;
Dexpanthenol EP Impurity B;
Pantoic acid
CAS# 1112-33-0;60979-68-2(Na salt)
M.F.: C6H12O4
M.W.: 148.16 |
| |
| QP051401 | Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)
CAS# 6683-19-8
M.F.: C73H108O12
M.W.: 1177.63 |
| |
| QE120100 | Elagolix Sodium
CAS# 832720-36-2
M.F.: C32H29F5N3NaO5
M.W.: 653.57 |
| |
| QZ151200 | Zoledronic acid hydrate
CAS# 165800-06-6;118072-93-8(free base)
M.F.: C5H12N2O8P2
M.W.: 290.10 |
| |
| QS151800 | Sorbitan Monolaurate
CAS# 1338-39-2
M.F.: C18H34O6
M.W.: 346.46 |
| |
| QF161401 | Hydroxy-Fipronil
CAS# NA
M.F.: C11H5Cl2F3N4O
M.W.: 337.08 |
| |
| QA161907 | Acetylsalicylic Acid Impurity 7
CAS# 2708578-72-5
M.F.: C16H12O6
M.W.: 300.26 |
| |
| QC551804 | Clenbuterol EP Impurity D
CAS# 99-92-3
M.F.: C8H9NO
M.W.: 135.16 |
| |
| QC062804 | Cefetamet Pivoxyl Impurity 4
CAS# NA
M.F.: C41H50N10O14S4
M.W.: 1035.15 |
| |
| QC062803 | Cefetamet Pivoxyl Impurity 3
CAS# NA
M.F.: C25H33N5O8S2
M.W.: 595.69 |
| |
| QC062802 | Cefetamet Pivoxyl Impurity 2
CAS# NA
M.F.: C20H25N5O7S2
M.W.: 511.57 |
| |
| QC062801 | Cefetamet Pivoxyl Impurity 1
CAS# NA
M.F.: C21H27N5O8S2
M.W.: 541.60 |
| |
| QF121200 | Flucloxacillin sodium
CAS# 1847-24-1
M.F.: C19H16ClFN3NaO5S
M.W.: 475.85 |
| |
| QF121205 | Flucloxacillin sodium EP Impurity E
CAS# NA
M.F.: C27H27ClFN5O7S2
M.W.: 652.11 |
| |
| QF121204 | Flucloxacillin sodium EP Impurity D
CAS# 3919-74-2
M.F.: C11H7ClFNO3
M.W.: 255.63 |
| |
| QF121202 | Flucloxacillin sodium EP Impurity B
CAS# NA
M.F.: C18H19ClFN3O4S
M.W.: 427.88 |
| |
| QF121201 | Flucloxacillin sodium EP Impurity A
CAS# 68728-50-7(2Na salt)
M.F.: C19H19ClFN3O6S
M.W.: 471.89 |
| |
| QT150900 | Tropicamide
CAS# 1508-75-4
M.F.: C17H20N2O2
M.W.: 284.35 |
| |
| QA201500 | Atovaquone
CAS# 95233-18-4
M.F.: C22H19ClO3
M.W.: 366.84 |
| |
| QE161236 | Epalrestat Impurity 10
CAS# NA
M.F.: C17H17NO3S2
M.W.: 347.45 |
| |
| QC071200 | Carglumic Acid
CAS# 1188-38-1
M.F.: C6H10N2O5
M.W.: 190.15 |
| |
| QT140405 | Tinidazole Impurity 5
CAS# 110-77-0
M.F.: C4H10OS
M.W.: 106.19 |
| |
| QF211904 | Fusidic Acid EP Impurity D;
Sodium Fusidate EP Impurity D
CAS# NA
M.F.: C31H48O7
M.W.: 532.71 |
| |
| QF211903 | Fusidic Acid EP Impurity C;
Sodium Fusidate EP Impurity C
CAS# NA
M.F.: C31H48O7
M.W.: 532.71 |
| |
| QF211902 | Fusidic Acid EP Impurity B;
Sodium Fusidate EP Impurity B
CAS# NA
M.F.: C31H48O7
M.W.: 532.71 |
| |
| QF211906 | Fusidic Acid EP Impurity F;
Sodium Fusidate EP Impurity F
CAS# NA
M.F.: C31H46O7
M.W.: 530.69 |
| |
| QF211905 | Fusidic Acid EP Impurity E;
Sodium Fusidate EP Impurity E
CAS# NA
M.F.: C31H48O7
M.W.: 532.71 |
| |
| QF211901 | Fusidic Acid EP Impurity A;
Sodium Fusidate EP Impurity A
CAS# 80445-74-5
M.F.: C31H50O8
M.W.: 550.72 |
| |
| QF211911 | Fusidic Acid EP Impurity K;
Sodium Fusidate EP Impurity K
CAS# 4701-54-6
M.F.: C29H44O4
M.W.: 456.66 |
| |
| QF211910 | Fusidic Acid EP Impurity J;
Sodium Fusidate EP Impurity J
CAS# 13011-12-6
M.F.: C29H44O4
M.W.: 456.66 |
| |
| QF211915 | Fusidic Acid EP Impurity O;
Sodium Fusidate EP Impurity O
CAS# 55601-53-1(Na salt)
M.F.: C29H46O5
M.W.: 474.67 |
| |
| QF211913 | Fusidic Acid EP Impurity M;
Sodium Fusidate EP Impurity M
CAS# 1013937-16-0
M.F.: C31H48O5
M.W.: 500.71 |
| |
| QF211912 | Fusidic Acid EP Impurity L;
Sodium Fusidate EP Impurity L
CAS# 74048-41-2
M.F.: C31H46O5
M.W.: 498.69 |
| |
| QF211909 | Fusidic Acid EP Impurity I;
Sodium Fusidate EP Impurity I;
16-epi-Deacetylfusidic acid
CAS# 5951-83-7
M.F.: C29H46O5
M.W.: 474.67 |
| |
| QF211908 | Fusidic Acid EP Impurity H;
Sodium Fusidate EP Impurity H
CAS# 16711-91-4
M.F.: C31H46O6
M.W.: 514.69 |
| |
| QF211907 | Fusidic Acid EP Impurity G;
Sodium Fusidate EP Impurity G
CAS# 4680-37-9
M.F.: C31H46O6
M.W.: 514.69 |
| |
| QE182012 | Erythromycin EP Impurity L;3″-N-demethyl-3″-N-formyl Erythromycin A
CAS# 127955-44-6
M.F.: C37H65NO14
M.W.: 747.91 |
| |
| QS075425 | Mono-ethyl-ester-Sugammadex
CAS# NA
M.F.: C74H109Na7O48S8
M.W.: 2184.08 |
| |
| QL091632 | Lipoic Acid Impurity 6
CAS# NA
M.F.: C8H14O4S2
M.W.: 238.32 |
| |
| QE202512 | Estradiol Hemihydrate EP Impurity B;
Ethinylestradiol EP Impurity L;
Estriol EP Impurity J
CAS# 57-91-0
M.F.: C18H24O2
M.W.: 272.38 |
| |
| QD090530 | Dienogest 17-Epi Impurity
CAS# NA
M.F.: C20H25NO2
M.W.: 311.42 |
| |
| QA221805 | Alverine Citrate EP Impurity E
CAS# NA
M.F.: C27H33N
M.W.: 371.56 |
| |
| QA221804 | Alverine Citrate EP Impurity D
CAS# NA
M.F.: C20H33N
M.W.: 287.48 |
| |
| QA221803 | Alverine Citrate EP Impurity C
CAS# NA
M.F.: C11H17N
M.W.: 163.26 |
| |
| QA221802 | Alverine Citrate EP Impurity B
CAS# 122-97-4
M.F.: C9H12O
M.W.: 136.19 |
| |
| QA221801 | Alverine Citrate EP Impurity A
CAS# NA
M.F.: C9H11Cl
M.W.: 154.64 |
| |
| QA190208 | Ascorbic Acid EP Impurity H;
Sodium Ascorbate EP Impurity H
CAS# 122046-79-1
M.F.: C7H8O7
M.W.: 204.13 |
| |
| QA190207 | Ascorbic Acid EP Impurity G;
Sodium Ascorbate EP Impurity G
CAS# 66757-69-5
M.F.: C6H6O7
M.W.: 190.11 |
| |
| QA190204 | Ascorbic Acid EP Impurity D;
Sodium Ascorbate EP Impurity D
CAS# 3031-98-9
M.F.: C7H12O7
M.W.: 208.17 |
| |
| QA190203 | Ascorbic Acid EP Impurity C;
Sodium Ascorbate EP Impurity C
CAS# 526-98-7
M.F.: C6H10O7
M.W.: 194.14 |
| |
| QA190200 | Ascorbic Acid
CAS# 50-81-7
M.F.: C6H8O6
M.W.: 176.12 |
| |
| QA161900 | Acetylsalicylic Acid
CAS# 50-78-2
M.F.: C9H8O4
M.W.: 180.16 |
| |
| QB200108 | Betamethasone Dipropionate EP Impurity H
CAS# 2575516-37-7
M.F.: C28H36BrFO7
M.W.: 583.48 |
| |
| QB200107 | Betamethasone Dipropionate EP Impurity G
CAS# 1186048-33-8
M.F.: C31H41FO8
M.W.: 560.65 |
| |
| QB200106 | Betamethasone Dipropionate EP Impurity F;
Beclometasone Dipropionate EP Impurity J
CAS# 66917-44-0
M.F.: C28H36O7
M.W.: 484.58 |
| |
| QB200105 | Betamethasone Dipropionate EP Impurity E;
Beclometasone Dipropionate
CAS# 5534-09-8
M.F.: C28H37ClO7
M.W.: 521.04 |
| |
| QB200104 | Betamethasone Dipropionate EP Impurity D
CAS# 5514-81-8
M.F.: C27H35FO7
M.W.: 490.56 |
| |
| QB200103 | Betamethasone Dipropionate EP Impurity C;
Clobetasol Propionate EP Impurity K;
Betamethasone 21-propionate
CAS# 75883-07-7
M.F.: C25H33FO6
M.W.: 448.52 |
| |
| QB200101 | Betamethasone Dipropionate EP Impurity A;
Dexamethasone EP Impurity B;
Betamethasone Acetate EP Impurity A;
Betamethasone valerate EP Impurity A;
Betamethasone
CAS# 378-44-9
M.F.: C22H29FO5
M.W.: 392.46 |
| |
| QI121604 | Iloperidone Impurity 4
CAS# NA
M.F.: C12H14Cl2FNO
M.W.: 278.15 |
| |
| QS160904 | Spironolactone EP Impurity D
CAS# NA
M.F.: C24H32O4S2
M.W.: 448.64 |
| |
| QT120842 | Trelagliptin Impurity 16
CAS# 1485536-93-3
M.F.: C8H4Br2FN
M.W.: 292.93 |
| |
| QG031906 | Glucosamine Impurity 6; Ascorbic Acid EP
Impurity A;Sodium Ascorbate EP Impurity A
CAS# 98-01-1
M.F.: C5H4O2
M.W.: 96.08 |
| |
| QR182424 | Brexpiprazole Impurity 24
CAS# 98327-87-8
M.F.: C44H32P2
M.W.: 622.67 |
| |
| QC015905 | Cladribine EP Impurity E
CAS# NA
M.F.: C5H10O4
M.W.: 134.13 |
| |
| QL131101 | Malic Acid Impurity 1
CAS# 1800467-68-8
M.F.: C8H10O9
M.W.: 250.16 |
| |
| QF121403 | Flunarizine EP Impurity C
CAS# 90830-31-2
M.F.: C26H26F2N2
M.W.: 404.49 |
| |
| QP011405 | Calcium Pantothenate EP Impurity H
CAS# NA
M.F.: C10H17NO5
M.W.: 231.25 |
| |
| QP011404 | Calcium Pantothenate EP Impurity G
CAS# 2140-53-6
M.F.: C6H12N2O3
M.W.: 160.17 |
| |
| QP011403 | Calcium Pantothenate EP Impurity F
CAS# 505-47-5
M.F.: C6H11NO4
M.W.: 161.16 |
| |
| QP011402 | Calcium Pantothenate EP Impurity E
CAS# 897045-90-8
M.F.: C12H22N2O6
M.W.: 290.31 |
| |
| QP011401 | Calcium Pantothenate EP Impurity D;Methyl Pantothenate
CAS# 50692-78-9
M.F.: C10H19NO5
M.W.: 233.26 |
| |
| QA181625 | Aripiprazole Impurity 25
CAS# 710339-49-4
M.F.: C12H16BrNO
M.W.: 270.17 |
| |
| QT181501 | Trospium EP Impurity A
CAS# 76-93-7
M.F.: C14H12O3
M.W.: 228.24 |
| |
| QC-E200808 | ethyl 4-hydroxybenzoate;
Propyl Parahydroxybenzoate EP Impurity C;
Butyl parahydroxybenzoate EP Impurity C
CAS# 120-47-8
M.F.: C9H10O3
M.W.: 166.17 |
| |
| QC-M052004 | methyl 4-hydroxybenzoate;
Propyl Parahydroxybenzoate EP Impurity B;
Nifuroxazide EP Impurity B;
Sodium ethyl parahydroxybenzoate EP Impurity B;
Butyl parahydroxybenzoate EP Impurity B
CAS# 99-76-3
M.F.: C8H8O3
M.W.: 152.15 |
| |
| QE191307 | Esmolol Isopropyl Amide Analog HCl
CAS# NA
M.F.: C18H28N2O3.HCl
M.W.: 320.43 36.46 |
| |
| QE191306 | N-Ethyl Esmolol HCl
CAS# 2469273-97-8(free base)
M.F.: C15H23NO4.HCl
M.W.: 281.35 36.46 |
| |
| QE191305 | Esmolol Acid HCl
CAS# 83356-60-9
M.F.: C15H23NO4.HCl
M.W.: 281.35 36.46 |
| |
| QF121902 | Fulvestrant Impurity 2
CAS# NA
M.F.: C32H47F5O2S
M.W.: 590.77 |
| |
| QT081811 | N-Carbobenzoxy-D-threonine
CAS# 80384-27-6
M.F.: C12H15NO5
M.W.: 253.25 |
| |
| QF191413 | Fosinopril EP Impurity N
CAS# NA
M.F.: C41H63N2O8P
M.W.: 742.92 |
| |
| QF191410 | Fosinopril EP Impurity B
CAS# NA
M.F.: C30H46NO7P
M.W.: 563.66 |
| |
| QF191409 | Fosinopril EP Impurity H
CAS# NA
M.F.: C30H46NO7P
M.W.: 563.66 |
| |
| QA220327 | Avibactam Impurity 1
CAS# 2306254-34-0;2413365-40-7(oxalate salt)
M.F.: C15H22N2O3
M.W.: 278.35 |
| |
| QH151600 | Homopiperazine
CAS# 505-66-8
M.F.: C5H12N2
M.W.: 100.16 |
| |
| QF120306 | Folic Acid EP Impurity F
CAS# 1391194-56-1
M.F.: C7H6ClN5O
M.W.: 211.61 |
| |
| QF120302 | Folic Acid EP Impurity B
CAS# 1004-75-7;35011-47-3(H2SO4 salt)
M.F.: C4H7N5O
M.W.: 141.13 |
| |
| QP251800 | Pyrazolam
CAS# 39243-02-2
M.F.: C16H12BrN5
M.W.: 354.20 |
| |
| QF141929 | Finasteride Impurity 3
CAS# NA
M.F.: C23H36N2O2
M.W.: 372.54 |
| |
| QC242015 | Cefoxitin Impurity 15
CAS# NA
M.F.: C16H16N3NaO8S2
M.W.: 465.43 |
| |
| QD090508 | Dienogest EP Impurity H
CAS# 16669-06-0
M.F.: C20H25NO2
M.W.: 311.42 |
| |
| QD090505 | Dienogest EP Impurity E
CAS# 102193-41-9
M.F.: C22H31NO3
M.W.: 357.49 |
| |
| QD090504 | Dienogest EP Impurity D
CAS# 190662-30-7
M.F.: C22H29NO3
M.W.: 355.47 |
| |
| QD090503 | Dienogest EP Impurity C
CAS# 106111-42-6
M.F.: C20H25NO2
M.W.: 311.42 |
| |
| QI151612 | Iopamidol EPImpurity F
CAS# 1869069-71-5
M.F.: C16H20I3N3O6
M.W.: 731.06 |
| |
| QI151601 | Iopamidol EP Impurity A
CAS# 60166-98-5
M.F.: C14H18I3N3O6
M.W.: 705.02 |
| |
| QK201820 | Ketorolac EP Impurity H
CAS# 80965-09-9
M.F.: C16H15NO3
M.W.: 269.30 |
| |
| QL141249 | Lenalidomide Impurity 49
CAS# 827026-44-8
M.F.: C13H14N4O5
M.W.: 306.27 |
| |
| QN032011 | Nicotinic acid Impurity 11
CAS# 33545-23-2
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QL130601 | Lamivudine EP Impurity A
CAS# NA
M.F.: C8H9N3O4S
M.W.: 243.24 |
| |
| QM202413 | Methotrexate EP Impurity K;
Folic Acid EP Impurity A;
Calcium Levofolinate EP Impurity A;
Calcium Folinate Hydrate EP Impurity A
CAS# 4271-30-1
M.F.: C12H14N2O5
M.W.: 266.25 |
| |
| QM202410 | Methotrexate
CAS# 59-05-2
M.F.: C20H22N8O5
M.W.: 454.44 |
| |
| QN032010 | Nicotinic acid Impurity 10
CAS# 13362-26-0
M.F.: C8H10N2O2
M.W.: 166.18 |
| |
| QN032009 | Nicotinic acid EP Impurity I
CAS# 940-06-7
M.F.: C5H3N3O4
M.W.: 169.10 |
| |
| QN032008 | Nicotinic acid EP Impurity H
CAS# 2530-26-9
M.F.: C5H4N2O2
M.W.: 124.10 |
| |
| QN032006 | Nicotinic acid EP Impurity F
CAS# 2047-49-6
M.F.: C6H4N2O4
M.W.: 168.11 |
| |
| QN032004 | Nicotinic acid EP Impurity D
CAS# 100-26-5
M.F.: C7H5NO4
M.W.: 167.12 |
| |
| QN032003 | Nicotinic acid EP Impurity C
CAS# 104-90-5;2024-89-7(HCl salt)
M.F.: C8H11N
M.W.: 121.18 |
| |
| QN032002 | Nicotinic acid EP Impurity B
CAS# 1802-30-8
M.F.: C12H8N2O4
M.W.: 244.20 |
| |
| QN032001 | Nicotinic acid EP Impurity A
CAS# 3222-47-7
M.F.: C7H7NO2
M.W.: 137.14 |
| |
| QL091631 | Lipoic Acid Impurity 5
CAS# 17370-41-1
M.F.: C8H14O4S2
M.W.: 238.32 |
| |
| QP141200 | Phenylephrine
CAS# 59-42-7;61-76-7(HCl salt)
M.F.: C9H13NO2
M.W.: 167.21 |
| |
| QT161835 | Topiroxostat Impurity 9
CAS# 2044708-04-3
M.F.: C7H10N6O
M.W.: 194.19 |
| |
| QR131617 | Ramipril EP Impurity N
CAS# 129939-63-5
M.F.: C23H32N2O5
M.W.: 416.51 |
| |
| QS210209 | Sulbactam Impurity 9;Penicillanic acid
CAS# 87-53-6
M.F.: C8H11NO3S
M.W.: 201.24 |
| |
| QS061900 | Sulfasalazine
CAS# 599-79-1
M.F.: C18H14N4O5S
M.W.: 398.39 |
| |
| QD030422 | Diclofenac Impurity V
CAS# NA
M.F.: C26H35Cl2NO2
M.W.: 464.47 |
| |
| QG121501 | Glycocholic Acid
CAS# 475-31-0;863-57-0(Na salt);
338950-81-5(xH2O Na salt)
M.F.: C26H43NO6
M.W.: 465.62 |
| |
| QS122501 | Silybin A
CAS# 22888-70-6
M.F.: C25H22O10
M.W.: 482.44 |
| |
| QC120210 | Clobetasol Propionate EP Impurity J
CAS# 1486466-31-2
M.F.: C25H30ClFO4
M.W.: 448.95 |
| |
| QC120206 | Clobetasol Propionate EP Impurity F
CAS# 2412496-00-3
M.F.: C22H27FO4
M.W.: 374.45 |
| |
| QC120205 | Clobetasol Propionate EP Impurity E
CAS# NA
M.F.: C25H33ClO4
M.W.: 432.98 |
| |
| QC120204 | Clobetasol Propionate EP Impurity D
CAS# 25120-99-4
M.F.: C25H34ClFO5
M.W.: 468.99 |
| |
| QC120203 | Clobetasol Propionate EP Impurity C
CAS# 25122-52-5
M.F.: C25H32ClFO5
M.W.: 466.97 |
| |
| QC120202 | Clobetasol Propionate EP Impurity B
CAS# 1356190-17-4
M.F.: C22H26ClFO3
M.W.: 392.89 |
| |
| QC120209 | Clobetasol Propionate EP Impurity I
CAS# 15423-80-0
M.F.: C26H35FO8S
M.W.: 526.61 |
| |
| QC120208 | Clobetasol Propionate EP Impurity H
CAS# 4351-48-8
M.F.: C25H33FO5
M.W.: 432.52 |
| |
| QC120201 | Clobetasol Propionate EP Impurity A;
Betamethasone 17-propionate
CAS# 5534-13-4
M.F.: C25H33FO6
M.W.: 448.52 |
| |
| QC120200 | Clobetasol Propionate
CAS# 25122-46-7
M.F.: C25H32ClFO5
M.W.: 466.97 |
| |
| QC221213 | Clavulanate Potassium EP Impurity M
CAS# 3033-62-3
M.F.: C8H20N2O
M.W.: 160.26 |
| |
| QC221212 | Clavulanate Potassium EP Impurity L
CAS# 4013-94-9
M.F.: C8H20N2
M.W.: 144.26 |
| |
| QC221211 | Clavulanate Potassium EP Impurity K
CAS# 107-45-9
M.F.: C8H19N
M.W.: 129.24 |
| |
| QC221215 | Clavulanate Potassium EP Impurity J
CAS# 110-18-9;7677-21-6(2HCl salt)
M.F.: C6H16N2
M.W.: 116.20 |
| |
| QC221208 | Clavulanate Potassium EP Impurity H
CAS# 75-64-9
M.F.: C4H11N
M.W.: 73.14 |
| |
| QU190400 | Ursodeoxycholic Acid;Chenodeoxycholic acid EP Impurity A
CAS# 128-13-2
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QH120311 | Halcinonide Impurity K
CAS# NA
M.F.: C21H28ClFO5
M.W.: 414.90 |
| |
| QI221205 | Isoniazid Impurity E
CAS# 31599-25-4
M.F.: C12H10N6
M.W.: 238.25 |
| |
| QI221204 | Isoniazid Impurity D
CAS# 4329-75-3
M.F.: C12H10N4O2
M.W.: 242.23 |
| |
| QI221202 | Isoniazid EP Impurity D
CAS# 553-53-7
M.F.: C6H7N3O
M.W.: 137.14 |
| |
| QR022221 | Ribavirin Impurity U;Ascorbic Acid EP Impurity E;Sodium Ascorbate EP Impurity E;Oxaliplatin EP Impurity A
CAS# 144-62-7
M.F.: C2H2O4
M.W.: 90.03 |
| |
| QV011227 | Valproic Acid Impurity 1
CAS# 624-24-8
M.F.: C6H12O2
M.W.: 116.16 |
| |
| QV011200 | Valproic Acid;
Sodium caprylate EP Impurity E;
Caprylic acid EP Impurity E
CAS# 99-66-1
M.F.: C8H16O2
M.W.: 144.21 |
| |
| QN201800 | Nitrogen Mustard
CAS# 55-86-7
M.F.: C5H12Cl3N
M.W.: 192.51 |
| |
| QE122031 | Erlotinib Impurity 5
CAS# NA
M.F.: C22H23N3O5
M.W.: 409.44 |
| |
| QE122030 | Erlotinib Impurity 4
CAS# NA
M.F.: C22H25N3O6
M.W.: 427.45 |
| |
| QA132006 | Amantadine EP Impurity B
CAS# NA
M.F.: C12H19NO
M.W.: 193.29 |
| |
| QA132005 | Amantadine EP Impurity A
CAS# 935-56-8
M.F.: C10H15Cl
M.W.: 170.68 |
| |
| QC062727 | Cefazolin Impurity 1
CAS# 2416213-67-5
M.F.: C18H20N4O8S2
M.W.: 484.50 |
| |
| QP201642 | Pantoprazole Impurity 16
CAS# 72830-08-1
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QT140695 | Tenofovir Impurity 95
CAS# 108-23-6
M.F.: C4H7ClO2
M.W.: 122.55 |
| |
| QT140694 | Tenofovir Impurity 94
CAS# 133217-92-2
M.F.: C6H12ClNO2
M.W.: 165.62 |
| |
| QT140692 | Tenofovir Impurity 92
CAS# NA
M.F.: C5H8Cl2O3
M.W.: 187.02 |
| |
| QT140669 | Tenofovir Impurity 69
CAS# 6482-34-4
M.F.: C7H14O3
M.W.: 146.18 |
| |
| QT140668 | Tenofovir Impurity 68
CAS# 35273-90-6
M.F.: C5H9ClO3
M.W.: 152.58 |
| |
| QT140667 | Tenofovir Impurity 67
CAS# 35179-98-7
M.F.: C4H7ClO3
M.W.: 138.55 |
| |
| QT140662 | Tenofovir Impurity 62
CAS# 3084-40-0
M.F.: C5H13O4P
M.W.: 168.13 |
| |
| QT140661 | Tenofovir Impurity 61
CAS# 762-04-9
M.F.: C4H11O3P
M.W.: 138.10 |
| |
| QT140609 | Tenofovir Impurity H
CAS# NA
M.F.: C11H17N5O2
M.W.: 251.28 |
| |
| QE131610 | Empagliflozin Impurity J
CAS# NA
M.F.: C18H17ClO4
M.W.: 332.78 |
| |
| QP020338 | Palbociclib Impurity 12
CAS# NA
M.F.: C44H52Br2N14O2
M.W.: 968.78 |
| |
| QP020337 | Palbociclib Impurity 11
CAS# NA
M.F.: C13H14BrN3O2
M.W.: 324.17 |
| |
| QP020336 | Palbociclib Impurity 10
CAS# 851067-56-6
M.F.: C22H26BrN7O
M.W.: 484.39 |
| |
| QP020334 | Palbociclib Impurity 8
CAS# NA
M.F.: C15H17N3O3
M.W.: 287.31 |
| |
| QP020333 | Palbociclib Impurity 7
CAS# NA
M.F.: C13H13Br2N3O
M.W.: 387.07 |
| |
| QP020332 | Palbociclib Impurity 6
CAS# 1244949-62-9
M.F.: C11H14ClN3O
M.W.: 239.70 |
| |
| QG210101 | Guanfacine Impurity A
CAS# NA
M.F.: C17H13Cl4N3O2
M.W.: 433.12 |
| |
| QR010310 | Racecadotril Impurity J;
Benzalkonium chloride EP Impurity C
CAS# 100-44-7
M.F.: C7H7Cl
M.W.: 126.58 |
| |
| QA070208 | Argatroban Impurity H
CAS# NA
M.F.: C23H36N6O5S
M.W.: 508.63 |
| |
| QA070206 | Argatroban Impurity F
CAS# 74874-09-2
M.F.: C25H35N7O7S
M.W.: 577.65 |
| |
| QO022018 | Obeticholic Acid Impurity R
CAS# 10538-59-7
M.F.: C25H40O4
M.W.: 404.58 |
| |
| QO022017 | Obeticholic Acid Impurity Q
CAS# NA
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QB161617 | Bupropion Impurity Q
CAS# 119802-69-6
M.F.: C9H10ClNO
M.W.: 183.63 |
| |
| QF022461 | Febuxostat Impurity 35
CAS# NA
M.F.: C15H18N2O2S
M.W.: 290.38 |
| |
| QF022459 | Febuxostat Impurity 33
CAS# NA
M.F.: C17H18N2O3S
M.W.: 330.40 |
| |
| QF022458 | Febuxostat Impurity 32
CAS# 2418591-43-0
M.F.: C16H16N2O3S
M.W.: 316.37 |
| |
| QF022457 | Febuxostat Impurity 31
CAS# NA
M.F.: C18H20N2O3S
M.W.: 344.43 |
| |
| QF022456 | Febuxostat Impurity 30
CAS# NA
M.F.: C18H20N2O3S
M.W.: 344.43 |
| |
| QF022454 | Febuxostat Impurity 28
CAS# NA
M.F.: C15H17NO2S
M.W.: 275.37 |
| |
| QF022453 | Febuxostat Impurity 27
CAS# NA
M.F.: C15H18N2O2S
M.W.: 290.38 |
| |
| QF022450 | Febuxostat Impurity 24
CAS# 1350352-70-3
M.F.: C16H18N2O4S
M.W.: 334.39 |
| |
| QC201819 | Cetirizine Impurity 19
CAS# 1016-78-0
M.F.: C13H9ClO
M.W.: 216.66 |
| |
| QC132401 | Cefmenoxime Impurity 1
CAS# 84994-24-1
M.F.: C13H10N4O3S2
M.W.: 334.37 |
| |
| QO022014 | Obeticholic Acid Impurity N
CAS# NA
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QO022013 | Obeticholic Acid Impurity M
CAS# NA
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QO022012 | Obeticholic Acid Impurity L
CAS# NA
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QO022011 | Obeticholic Acid Impurity K
CAS# NA
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QO022010 | Obeticholic Acid Impurity J
CAS# NA
M.F.: C26H42O4
M.W.: 418.61 |
| |
| QO022009 | Obeticholic Acid Impurity I
CAS# 915038-26-5
M.F.: C26H42O4
M.W.: 418.61 |
| |
| QO022008 | Obeticholic Acid Impurity H
CAS# NA
M.F.: C26H40O4
M.W.: 416.59 |
| |
| QC061714 | Cefoperazone Impurity N
CAS# NA
M.F.: C23H25N5O8S2
M.W.: 563.60 |
| |
| QC061711 | Cefoperazone Impurity K
CAS# NA
M.F.: C25H29N9O9S2
M.W.: 663.68 |
| |
| QC061710 | Cefoperazone Impurity J
CAS# 24209-38-9
M.F.: C10H12N6O3S2
M.W.: 328.37 |
| |
| QC061709 | Cefoperazone Impurity I
CAS# NA
M.F.: C23H25N5O9S
M.W.: 547.54 |
| |
| QC140600 | Coniferyl ferulate
CAS# 63644-62-2
M.F.: C20H20O6
M.W.: 356.37 |
| |
| QP020331 | Palbociclib Impurity 5
CAS# 1082876-26-3
M.F.: C9H14N4
M.W.: 178.23 |
| |
| QG140905 | Ganciclovir EP Impurity E
CAS# 86357-09-7
M.F.: C9H13N5O4
M.W.: 255.23 |
| |
| QG140904 | Ganciclovir EP Impurity D
CAS# 1346598-14-8
M.F.: C10H15N5O5
M.W.: 285.26 |
| |
| QG140903 | Ganciclovir EP Impurity C;
Valganciclovir EP Impurity I
CAS# 108436-36-8
M.F.: C9H12ClN5O3
M.W.: 273.68 |
| |
| QG140902 | Ganciclovir EP Impurity B;
Valganciclovir EP Impurity J
CAS# 194159-18-7
M.F.: C12H17N5O5
M.W.: 311.29 |
| |
| QG140901 | Ganciclovir EP Impurity A
CAS# 1797982-93-4
M.F.: C9H10ClN5O2
M.W.: 255.66 |
| |
| QL191631 | Lansoprazole Impurity 5
CAS# 103577-61-3
M.F.: C9H10F3NO2
M.W.: 221.18 |
| |
| QD240907 | Dexmedetomidine Impurity 7
CAS# 2240179-65-9
M.F.: C23H28N2
M.W.: 332.48 |
| |
| QD240906 | Controlled Substance
(Dexmedetomidine Impurity 6)
CAS# 60907-90-6
M.F.: C10H14O
M.W.: 150.22 |
| |
| QL221518 | Levonorgestrel EP Impurity R
CAS# 2322-77-2
M.F.: C20H28O2
M.W.: 300.44 |
| |
| QL221517 | Levonorgestrel EP Impurity Q
CAS# 1038-28-4
M.F.: C20H30O2
M.W.: 302.45 |
| |
| QL221516 | Levonorgestrel EP Impurity P
CAS# 100021-05-4
M.F.: C21H28O2
M.W.: 312.45 |
| |
| QL221514 | Levonorgestrel EP Impurity N
CAS# 4222-96-2
M.F.: C19H26O2
M.W.: 286.41 |
| |
| QL221512 | Levonorgestrel EP Impurity L
CAS# 21800-83-9
M.F.: C19H26O2
M.W.: 286.41 |
| |
| QL221510 | Levonorgestrel EP Impurity J
CAS# 1175109-63-3
M.F.: C21H26O3
M.W.: 326.43 |
| |
| QL221509 | Levonorgestrel EP Impurity I
CAS# 20402-62-4;21508-50-9
M.F.: C21H28O3
M.W.: 328.45 |
| |
| QL221507 | Levonorgestrel EP Impurity G
CAS# 87585-03-3
M.F.: C21H28O3
M.W.: 328.45 |
| |
| QL221504 | Levonorgestrel EP Impurity D
CAS# 32419-58-2
M.F.: C21H30O
M.W.: 298.46 |
| |
| QL221503 | Levonorgestrel EP Impurity C
CAS# 1337972-89-0
M.F.: C23H28O
M.W.: 320.47 |
| |
| QL221502 | Levonorgestrel EP Impurity B
CAS# 19914-67-1
M.F.: C21H28O2
M.W.: 312.45 |
| |
| QA202262 | Atorvastatin Impurity 12
CAS# 196085-85-5
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QP202222 | Pitavastatin Impurity V
CAS# NA
M.F.: C50H46CaF2N2O8
M.W.: 880.98 |
| |
| QA164808 | Axitinib Impurity H
CAS# 1428728-83-9
M.F.: C44H36N8O2S2
M.W.: 772.94 |
| |
| QP812519 | Paclitaxel Impurity S
CAS# NA
M.F.: C47H51NO14
M.W.: 853.91 |
| |
| QG120309 | Gliclazide Impurity I
CAS# 38173-52-3
M.F.: C15H19N3O5S
M.W.: 353.39 |
| |
| QC-A130910 | 6-aminohexanoic acid; Aminocaproic acid;Zinc acexamate EP Impurity B
CAS# 60-32-2
M.F.: C6H13NO2
M.W.: 131.17 |
| |
| QC120424 | Clindamycin Phosphate EP Impurity B
CAS# 54887-31-9
M.F.: C17H32ClN2O8PS
M.W.: 490.94 |
| |
| QF120103 | Flutamide EP Impurity C
CAS# 13312-12-4
M.F.: C10H9F3N2O3
M.W.: 262.19 |
| |
| QA011404 | 7-ANCA Impurity D
CAS# NA
M.F.: C7H8N2O3S
M.W.: 200.22 |
| |
| QA011407 | 7-ANCA Impurity G
CAS# NA
M.F.: C14H14N4O5S2
M.W.: 382.41 |
| |
| QA011405 | 7-ANCA Impurity E
CAS# NA
M.F.: C6H8N2OS
M.W.: 156.21 |
| |
| QA011403 | 7-ANCA Impurity C
CAS# 68403-70-3
M.F.: C7H10N2O4S
M.W.: 218.23 |
| |
| QA011402 | 7-ANCA Impurity B
CAS# NA
M.F.: C7H8N2O4S
M.W.: 216.21 |
| |
| QA202250 | Atorvastatin Impurity Z
CAS# 196085-84-4
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QP201637 | Pantoprazole Sodium Impurity 11
CAS# NA
M.F.: C7H8ClNO2
M.W.: 173.60 |
| |
| QP201632 | Pantoprazole Sodium Impurity 6
CAS# NA
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QP201631 | Pantoprazole Sodium Impurity 5
CAS# NA
M.F.: C8H11NO3
M.W.: 169.18 |
| |
| QP201629 | Pantoprazole Sodium Impurity 3
CAS# NA
M.F.: C9H13NO3
M.W.: 183.20 |
| |
| QP201628 | Pantoprazole Sodium Impurity 2
CAS# 957470-59-6
M.F.: C24H24F2N4O6S
M.W.: 534.53 |
| |
| QP201627 | Pantoprazole Sodium Impurity 1
CAS# NA
M.F.: C16H15F2N3O3S
M.W.: 367.37 |
| |
| QP201626 | Pantoprazole Sodium Impurity Z
CAS# NA
M.F.: C15H11F2N3O5
M.W.: 351.26 |
| |
| QT120838 | Trelagliptin Impurity 12
CAS# 31737-09-4
M.F.: C5H5ClN2O2
M.W.: 160.56 |
| |
| QT120834 | Trelagliptin Impurity 8
CAS# 147754-12-9
M.F.: C8H6FN
M.W.: 135.14 |
| |
| QL142619 | Linezolid Impurity S
CAS# 5394-50-3
M.F.: C16H16N2O4
M.W.: 300.31 |
| |
| QE131609 | Empagliflozin Impurity I
CAS# NA
M.F.: C46H52Cl2O14
M.W.: 899.80 |
| |
| QC160802 | Cephalothin Impurity B;Cefalotin sodium EP Impurity A
CAS# 34691-02-6
M.F.: C14H14N2O4S2
M.W.: 338.40 |
| |
| QT251954 | Thymalfasin Impurity D-Ser9
CAS# NA
M.F.: C129H215O55N33
M.W.: 3108.34 |
| |
| QT251953 | Thymalfasin Impurity D-Ser8
CAS# NA
M.F.: C129H215O55N33
M.W.: 3108.34 |
| |
| QT251952 | Thymalfasin Impurity Des-Asn28
CAS# NA
M.F.: C125H209O53N31
M.W.: 2994.24 |
| |
| QT251946 | Thymalfasin Impurity Des-Val23
CAS# NA
M.F.: C124H206O54N32
M.W.: 3009.21 |
| |
| QC121204 | Cholecalciferol EP Impurity D;iso-Tachysterol 3
CAS# 22350-43-2
M.F.: C27H44O
M.W.: 384.64 |
| |
| QI192106 | Isoflurane EP Impurity F
CAS# NA
M.F.: C4H8
M.W.: 56.11 |
| |
| QI192105 | Isoflurane EP Impurity E
CAS# 32778-09-9
M.F.: C3Cl3F5O
M.W.: 253.38 |
| |
| QI192103 | Isoflurane EP Impurity C
CAS# 32778-08-8
M.F.: C3HCl2F5O
M.W.: 218.94 |
| |
| QI192100 | Isoflurane
CAS# 26675-46-7
M.F.: C3H2ClF5O
M.W.: 184.49 |
| |
| QC062111 | Ceftazidime Impurity 11
CAS# NA
M.F.: C22H24N6O8S2
M.W.: 564.59 |
| |
| QL191808 | Lesinurad Impurity H
CAS# NA
M.F.: C19H18BrN3O2S
M.W.: 432.33 |
| |
| QL191807 | Lesinurad Impurity G
CAS# NA
M.F.: C17H15N3O3S
M.W.: 341.38 |
| |
| QL191806 | Lesinurad Impurity F
CAS# NA
M.F.: C17H15N3O2S
M.W.: 325.38 |
| |
| QL191804 | Lesinurad Impurity D
CAS# NA
M.F.: C17H14ClN3O2S
M.W.: 359.83 |
| |
| QL191803 | Lesinurad Impurity C
CAS# NA
M.F.: C17H13Br2N3O2S
M.W.: 483.18 |
| |
| QL191802 | Lesinurad Impurity B
CAS# NA
M.F.: C17H14BrN3O4S
M.W.: 436.28 |
| |
| QC121203 | Cholecalciferol EP Impurity C;Lumisterol 3
CAS# 5226-01-7
M.F.: C27H44O
M.W.: 384.64 |
| |
| QB162227 | Bupivacaine N-Oxide
CAS# 1346597-81-6;1796927-05-3(HCl salt)
M.F.: C18H28N2O2
M.W.: 304.43 |
| |
| QT251941 | Thymalfasin Impurity Des-Glu18
CAS# NA
M.F.: C124H208O52N32
M.W.: 2979.22 |
| |
| QT251963 | Thymalfasin Impurity Des-Lys17
CAS# NA
M.F.: C123H203O54N31
M.W.: 2980.16 |
| |
| QT251924 | Thymalfasin Impurity Des-Thr13
CAS# NA
M.F.: C125H208O53N32
M.W.: 3007.23 |
| |
| QT251923 | Thymalfasin Impurity Des-Thr12
CAS# NA
M.F.: C125H208O53N32
M.W.: 3007.23 |
| |
| QT251914 | Thymalfasin Impurity Des-Asp2
CAS# NA
M.F.: C125H210O52N32
M.W.: 2993.25 |
| |
| QT251913 | Thymalfasin Impurity Des-Ser1
CAS# NA
M.F.: C126H210O53N32
M.W.: 3021.26 |
| |
| QD072406 | Digoxin EP Impurity F;Digoxigenin bisdigitoxoside
CAS# 5297-05-2
M.F.: C35H54O11
M.W.: 650.80 |
| |
| QD072404 | Digoxin EP Impurity D;Digoxigenin monodigitoxoside
CAS# 5352-63-6
M.F.: C29H44O8
M.W.: 520.65 |
| |
| QC182501 | Canagliflozin Impurity A
CAS# 842133-16-8
M.F.: C24H26O5S
M.W.: 426.53 |
| |
| QT041215 | Tadalafil Impurity O;Tryptophan;N-Acetyltryptophan EP Impurity A
CAS# 73-22-3
M.F.: C11H12N2O2
M.W.: 204.23 |
| |
| QF122106 | Fluorouracil EP Impurity F
CAS# 56177-80-1
M.F.: C6H7FN2O2
M.W.: 158.13 |
| |
| QF122105 | Fluorouracil EP Impurity E
CAS# 1820-81-1
M.F.: C4H3ClN2O2
M.W.: 146.53 |
| |
| QF122104 | Fluorouracil EP Impurity D
CAS# 6623-81-0
M.F.: C5H6N2O3
M.W.: 142.11 |
| |
| QF122102 | Fluorouracil EP Impurity B
CAS# 496-76-4
M.F.: C4H4N2O3
M.W.: 128.09 |
| |
| QF122101 | Fluorouracil EP Impurity A
CAS# 67-52-7
M.F.: C4H4N2O3
M.W.: 128.09 |
| |
| QL142617 | Linezolid Impurity 17
CAS# 15708-41-5
M.F.: C10H12FeN2NaO8
M.W.: 367.05 |
| |
| QI140410 | Indometacin EP Impurity J
CAS# 402849-25-6
M.F.: C33H27Cl2N3O5
M.W.: 616.49 |
| |
| QI140409 | Indometacin EP Impurity I
CAS# 16401-99-3
M.F.: C21H20ClNO4
M.W.: 385.84 |
| |
| QI140408 | Indometacin EP Impurity H
CAS# 1601-18-9
M.F.: C20H18ClNO4
M.W.: 371.81 |
| |
| QI140407 | Indometacin EP Impurity G
CAS# 402849-26-7
M.F.: C19H15Cl2NO4
M.W.: 392.23 |
| |
| QI140405 | Indometacin EP Impurity E
CAS# 807614-94-4
M.F.: C19H16ClNO4
M.W.: 357.79 |
| |
| QI140404 | Indometacin EP Impurity D
CAS# NA
M.F.: C19H16ClNO4
M.W.: 357.79 |
| |
| QI140402 | Indometacin EP Impurity B
CAS# 2882-15-7
M.F.: C12H13NO3
M.W.: 219.24 |
| |
| QL142221 | Lenvatinib Impurity U
CAS# NA
M.F.: C19H16ClN3O5
M.W.: 401.80 |
| |
| QL142220 | Lenvatinib Impurity T
CAS# 417719-51-8
M.F.: C18H15ClN4O4
M.W.: 386.79 |
| |
| QL142217 | Lenvatinib Impurity Q
CAS# 2110414-05-4
M.F.: C11H10N2O3
M.W.: 218.21 |
| |
| QL142216 | Lenvatinib Impurity P
CAS# 2143930-77-0
M.F.: C13H14N2O3
M.W.: 246.26 |
| |
| QL142215 | Lenvatinib Impurity O
CAS# 2143930-76-9
M.F.: C20H19ClN4O4
M.W.: 414.84 |
| |
| QL052013 | Levetiracetam Impurity M
CAS# NA
M.F.: C8H17N3O2
M.W.: 187.24 |
| |
| QP020323 | Palbociclib Impurity W
CAS# NA
M.F.: C27H34ClN7O3
M.W.: 540.06 |
| |
| QP020322 | Palbociclib Impurity V
CAS# NA
M.F.: C29H37N7O3
M.W.: 531.65 |
| |
| QP020321 | Palbociclib Impurity U
CAS# 2270982-31-3
M.F.: C28H37N7O2
M.W.: 503.64 |
| |
| QP020327 | Palbociclib Impurity 1
CAS# 2206135-30-8
M.F.: C41H55N11O5
M.W.: 781.95 |
| |
| QF121906 | Fulvestrant EP Impurity F;6-Keto Fulvestrant
CAS# NA
M.F.: C32H45F5O4S
M.W.: 620.75 |
| |
| QF121903 | Fulvestrant EP Impurity C
CAS# 2482852-42-4
M.F.: C41H65F5O4S2
M.W.: 781.07 |
| |
| QF121901 | Fulvestrant EP Impurity A
CAS# 407577-53-1
M.F.: C32H47F5O3S
M.W.: 606.77 |
| |
| QP020328 | Palbociclib Impurity 2
CAS# 2204863-06-7
M.F.: C24H29N7O
M.W.: 431.53 |
| |
| QC060504 | Cefradine EP Impurity D
CAS# NA
M.F.: C16H19N3O5S
M.W.: 365.40 |
| |
| QL040310 | Lidocaine EP Impurity J
CAS# 857570-37-7;1012864-23-1(HCl salt)
M.F.: C14H22N2O
M.W.: 234.34 |
| |
| QL040309 | Lidocaine EP Impurity I
CAS# 17289-53-1;17289-54-2(HCl salt)
M.F.: C14H22N2O
M.W.: 234.34 |
| |
| QL040307 | Lidocaine EP Impurity G
CAS# 42459-30-3;35891-87-3(HCl salt)
M.F.: C13H20N2O
M.W.: 220.31 |
| |
| QL040306 | Lidocaine EP Impurity F
CAS# 142713-08-4;857170-72-0(HCl salt)
M.F.: C14H22N2O
M.W.: 234.34 |
| |
| QA181620 | Aripiprazole Impurity 20
CAS# NA
M.F.: C18H27Cl3N2O
M.W.: 393.78 |
| |
| QL040305 | Lidocaine EP Impurity E
CAS# 745798-07-6;1135231-62-7(HCl salt)
M.F.: C20H25N3O2
M.W.: 339.43 |
| |
| QC-T180903 | 1H-1,2,4-triazol-3-amine;Trapidil EP Impurity B
CAS# 61-82-5
M.F.: C2H4N4
M.W.: 84.08 |
| |
| QC241308 | Cefixime Impurity H
CAS# 79349-82-9
M.F.: C9H10N2O3S
M.W.: 226.25 |
| |
| QA261230 | Azelastine EP Impurity D
CAS# 53242-88-9
M.F.: C15H11ClN2O
M.W.: 270.71 |
| |
| QG062006 | Gefitinib Impurity F
CAS# 1502829-45-9(free base)
M.F.: C29H40Cl4FN5O4
M.W.: 683.47 |
| |
| QL050310 | Lercanidipine Impurity J
CAS# NA
M.F.: C36H39N3O7
M.W.: 625.71 |
| |
| QI041628 | Indapamide EP Impurity B
CAS# 63968-75-2
M.F.: C16H14ClN3O3S
M.W.: 363.82 |
| |
| QS161808 | Sulpiride Impurity 8
CAS# NA
M.F.: C14H21N3O5S
M.W.: 343.4 |
| |
| QE131607 | Empagliflozin Impurity G
CAS# 1620758-33-9
M.F.: C23H27ClO7
M.W.: 450.91 |
| |
| QC-C081204 | 2-chlorobenzoic acid;Mesalazine EP
Impurity L;Mefenamic Acid EP Impurity C;
Tolfenamic acid EP Impurity A
CAS# 118-91-2
M.F.: C7H5ClO2
M.W.: 156.57 |
| |
| QC132637 | Cefmetazole Impurity 11
CAS# 56796-16-8
M.F.: C15H17N3O7S2
M.W.: 415.44 |
| |
| QA041430 | Adrenaline EP Impurity D
CAS# 317351-40-9
M.F.: C16H19NO3
M.W.: 273.33 |
| |
| QC062429 | Ceftriaxone Impurity 3
CAS# 6938-68-7
M.F.: C2H7N3S
M.W.: 105.16 |
| |
| QC162631 | Cefprozil Impurity 5
CAS# 1000980-59-5
M.F.: C18H19N3O5S
M.W.: 389.43 |
| |
| QG130333 | Gemcitabine EP Impurity C
CAS# 114248-23-6
M.F.: C9H10F2N2O5
M.W.: 264.18 |
| |
| QC201838 | (S)-Cetirizine
CAS# 130018-76-7;163837-48-7(2HCl salt)
M.F.: C21H25ClN2O3
M.W.: 388.89 |
| |
| QP151427 | Prostaglandin E1-d3
CAS# 745-65-3 (non-labelled)
M.F.: C20H31D3O5
M.W.: 357.50 |
| |
| QA161830 | Aprepitant Impurity 1
CAS# 638990-20-2
M.F.: C22H24N2O5
M.W.: 396.44 |
| |
| QL142631 | Linezolid Impurity 31
CAS# NA
M.F.: C21H29FN4O6
M.W.: 452.48 |
| |
| QA200331 | Cisatracurium Besylate EP Impurity K
CAS# NA
M.F.: C66H84N2O18S2
M.W.: 1257.51 |
| |
| QL221523 | Levonorgestrel EP Impurity W
CAS# 155683-59-3
M.F.: C21H24O2
M.W.: 308.41 |
| |
| QL221508 | Levonorgestrel EP Impurity H
CAS# 55555-97-0
M.F.: C21H28O3
M.W.: 328.45 |
| |
| QL221501 | Levonorgestrel EP Impurity A
CAS# 1260525-53-8
M.F.: C21H26O2
M.W.: 310.43 |
| |
| QA120715 | Alogliptin Impurity O
CAS# 655-63-0
M.F.: C8H5Br2N
M.W.: 274.94 |
| |
| QC081229 | Chlorpromazine EP Impurity D
CAS# 3953-65-9(HCl salt)
M.F.: C16H17ClN2S
M.W.: 304.84 |
| |
| QD240905 | Dexmedetomidine Impurity 5
CAS# 1021949-47-2
M.F.: C13H14N2
M.W.: 198.26 |
| |
| QF141911 | Finasteride Impurity K
CAS# NA
M.F.: C23H32N2O2
M.W.: 368.51 |
| |
| QE200335 | Entecavir Impurity 9
CAS# NA
M.F.: C15H19N5O5
M.W.: 349.34 |
| |
| QE200334 | Entecavir Impurity 8
CAS# NA
M.F.: C15H19N5O5
M.W.: 349.34 |
| |
| QE200333 | Entecavir Impurity 7
CAS# NA
M.F.: C15H19N5O5
M.W.: 349.34 |
| |
| QE200332 | Entecavir Impurity 6
CAS# NA
M.F.: C15H19N5O5
M.W.: 349.34 |
| |
| QT140623 | Tenofovir Impurity W
CAS# NA
M.F.: C13H23N5O8P2
M.W.: 439.30 |
| |
| QE151308 | Esomeprazole Impurity H
CAS# NA
M.F.: C8H7NO2S
M.W.: 181.21 |
| |
| QL140306 | Lincomycin Hydrochloride EP Impurity F
CAS# 14810-93-6
M.F.: C9H19NO5S
M.W.: 253.32 |
| |
| QL140303 | Lincomycin Hydrochloride EP impurity C
CAS# 14600-41-0
M.F.: C17H33ClN2O6S
M.W.: 428.97 |
| |
| QL140328 | Lincomycin B Hydrochloride
CAS# 11021-35-5;2520-24-3(free base)
M.F.: C17H32N2O6S.HCl
M.W.: 392.51 36.46 |
| |
| QL140327 | Lincomycin Hydrochloride EP Impurity A
CAS# NA
M.F.: C18H34N2O6S
M.W.: 406.54 |
| |
| QA120714 | Alogliptin Impurity N
CAS# NA
M.F.: C20H26N4O4
M.W.: 386.44 |
| |
| QL121929 | Lansoprazole Impurity 3
CAS# 1083100-27-9
M.F.: C25H22F6N4O2S
M.W.: 556.52 |
| |
| QV141677 | Vonoprazan Impurity 40
CAS# 1421640-34-7
M.F.: C6H7NO3S
M.W.: 173.19 |
| |
| QT120832 | Trelagliptin Impurity 6
CAS# 1938080-42-2
M.F.: C13H10FN3O3
M.W.: 275.24 |
| |
| QB031214 | Bicalutamide EP Impurity M
CAS# 151262-57-6
M.F.: C10H11FO5S
M.W.: 262.25 |
| |
| QO022030 | Obeticholic Acid
CAS# 459789-99-2
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QE151318 | Esomeprazole Impurity 9
CAS# 695-98-7
M.F.: C8H11N
M.W.: 121.18 |
| |
| QI040128 | Indacaterol Impurity 2
CAS# 435273-75-9
M.F.: C31H34N2O3
M.W.: 482.61 |
| |
| QC132634 | Cefmetazole Impurity 8;
7-MAC
CAS# 56610-72-1
M.F.: C24H24N6O4S2
M.W.: 524.62 |
| |
| QC132632 | Cefmetazole Impurity 6
CAS# NA
M.F.: C15H17N7O6S3
M.W.: 487.53 |
| |
| QC132633 | Cefmetazole Impurity 7
CAS# NA
M.F.: C15H19N7O6S3
M.W.: 489.55 |
| |
| QC-M200824 | Trelagliptin Impurity 24
CAS# NA
M.F.: C12H9BrClFN2O2
M.W.: 347.57 |
| |
| QA163000 | Apremilast Impurity T
CAS# 2096492-41-8
M.F.: C22H26N2O8S
M.W.: 478.52 |
| |
| QA162999 | Apremilast Impurity S
CAS# 1809170-71-5
M.F.: C22H26N2O8S
M.W.: 478.52 |
| |
| QG062003 | Gefitinib Impurity C
CAS# 199327-61-2
M.F.: C16H21N3O4
M.W.: 319.36 |
| |
| QT192019 | Telmisartan Impurity S
CAS# 4760-34-3
M.F.: C7H10N2
M.W.: 122.17 |
| |
| QA181630 | Aripiprazole EP Impurity D
CAS# 203395-82-8
M.F.: C23H28ClN3O2
M.W.: 413.95 |
| |
| QC121904 | Cilastatin EP Impurity D
CAS# 141-79-7
M.F.: C6H10O
M.W.: 98.14 |
| |
| QC062431 | Ceftriaxone Oxidation Impurity
CAS# NA
M.F.: C18H18N8O8S3
M.W.: 570.58 |
| |
| QE151325 | Esomeprazole Sodium Impurity 9
CAS# NA
M.F.: C26H30N4O3S
M.W.: 478.61 |
| |
| QC132628 | Cefmetazole Impurity 2
CAS# NA
M.F.: C15H16N7NaO6S3
M.W.: 509.52 |
| |
| QF181932 | Furosemide Impurity 6
CAS# 4795-29-3
M.F.: C5H11NO
M.W.: 101.15 |
| |
| QE262031 | Ezetimibe Impurity 5
CAS# 1612153-32-8
M.F.: C20H20FNO4
M.W.: 357.38 |
| |
| QT251910 | Des-Ser1-Asp15-Tal
CAS# NA
M.F.: C66H113N17O25
M.W.: 1544.74 |
| |
| QT251906 | Des-Ser1-Asp2-Tal
CAS# NA
M.F.: C120H203N31O49
M.W.: 2864.13 |
| |
| QT260227 | Tazobactam Impurity 1
CAS# 89789-07-1
M.F.: C23H22N4O5S
M.W.: 466.51 |
| |
| QF181931 | Furosemide Impurity 5
CAS# 98-00-0
M.F.: C5H6O2
M.W.: 98.10 |
| |
| QD180904 | Dirithromycin EP Impurity D
CAS# NA
M.F.: C41H76N2O14
M.W.: 821.05 |
| |
| QF181928 | Furosemide Impurity 2
CAS# 41332-59-6
M.F.: C7H4Cl2O5S
M.W.: 271.07 |
| |
| QL142630 | (R)-Linezolid
CAS# 872992-20-6
M.F.: C16H20FN3O4
M.W.: 337.35 |
| |
| QC120101 | Clavulanic Acid Imidazole Derivative-d3
CAS# NA
M.F.: C10H10D3N3O3
M.W.: 226.25 |
| |
| QT180630 | Tirofiban Impurity 4
CAS# NA
M.F.: C9H19NO2
M.W.: 173.25 |
| |
| QC-A140901 | Aniline;Mesalazine EP Impurity K;
Fentanyl EP Impurity F;
Sodium Cyclamate EP Impurity B;
Trimethoprim EP Impurity K;
4-Aminobenzoic acid EP Impurity C
CAS# 62-53-3;142-04-1(HCl salt)
M.F.: C6H7N
M.W.: 93.13 |
| |
| QI131602 | Imipenem EP Impurity B
CAS# 1197869-90-1
M.F.: C12H19N3O5S
M.W.: 317.36 |
| |
| QD190628 | Doxofylline Impurity 2
CAS# NA
M.F.: C10H14N4O5
M.W.: 270.24 |
| |
| QE200345 | Entecavir Impurity 45
CAS# 142217-81-0
M.F.: C26H27N5O3
M.W.: 457.52 |
| |
| QT090303 | Thioctic Acid Impurity C
CAS# 916746-61-7
M.F.: C12H23NO4S2
M.W.: 309.45 |
| |
| QP201618 | Pantoprazole Impurity R
CAS# 172282-50-7
M.F.: C7H8F2N2O
M.W.: 174.15 |
| |
| QP201617 | Pantoprazole Impurity Q
CAS# 97963-76-3
M.F.: C7H6F2N2O3
M.W.: 204.13 |
| |
| QD031232 | Daclatasvir Impurity 6
CAS# 1417333-58-4
M.F.: C40H50N8O6
M.W.: 738.88 |
| |
| QD031231 | Daclatasvir Impurity 5
CAS# 1009117-26-3
M.F.: C40H50N8O6
M.W.: 738.88 |
| |
| QL052229 | Levocetirizine Impurity 3
CAS# NA
M.F.: C21H25ClN2O3[C2H4]n
M.W.: 388.90[44.05]n |
| |
| QG121621 | Glipizide Impurity U
CAS# NA
M.F.: C14H20N2O6S
M.W.: 344.38 |
| |
| QG121619 | Glipizide Impurity S
CAS# NA
M.F.: C12H17N3O
M.W.: 219.28 |
| |
| QG121618 | Glipizide Impurity R
CAS# NA
M.F.: C8H8N2O4
M.W.: 196.16 |
| |
| QG121610 | Glipizide Impurity 1 HCl
CAS# 1428553-61-0;2015-16-9(free base)
M.F.: C15H23N3O3S.HCl
M.W.: 325.43 36.46 |
| |
| QB200102 | Betamethasone Dipropionate EP Impurity B
CAS# 5534-13-4
M.F.: C25H33FO6
M.W.: 448.52 |
| |
| QL121928 | Lansoprazole Impurity 2
CAS# NA
M.F.: C16H14F3N3O2
M.W.: 337.30 |
| |
| QL141239 | Linagliptin Impurity 39
CAS# 88203-04-7
M.F.: C10H10N2O
M.W.: 174.20 |
| |
| QA131501 | N-Desethyl Amodiaquine DiHCl
CAS# 79352-78-6(free base)
M.F.: C18H20Cl3N3O
M.W.: 400.73 |
| |
| QA181619 | Aripiprazole Impurity 19
CAS# 889443-20-3
M.F.: C13H17NO3
M.W.: 235.28 |
| |
| QD031229 | Daclatasvir Impurity 29
CAS# NA
M.F.: C29H32N6O3
M.W.: 512.60 |
| |
| QD130927 | Demiditraz Impurity 1
CAS# 944263-08-5
M.F.: C13H16N2
M.W.: 200.28 |
| |
| QC251927 | Cystine Impurity 1
CAS# 32854-09-4;1069-29-0(free base)
M.F.: C8H16N2O4S2.2HCl
M.W.: 268.35 72.92 |
| |
| QC120313 | Celecoxib Impurity M
CAS# 41472-49-5
M.F.: C10H14N2O3S
M.W.: 242.29 |
| |
| QG121629 | Glipizide Impurity 3
CAS# 933705-21-6
M.F.: C8H12N2O2S
M.W.: 200.26 |
| |
| QG121628 | Glipizide Impurity 2
CAS# 73631-58-0
M.F.: C8H11NO3S
M.W.: 201.24 |
| |
| QG121627 | Glipizide Impurity 1
CAS# 877-95-2
M.F.: C10H13NO
M.W.: 163.22 |
| |
| QA041404 | rac-Adrenaline EP Impurity D HCl
CAS# 1095714-91-2 (free base)
M.F.: C16H20ClNO3
M.W.: 309.79 |
| |
| QA041406 | rac-Adrenaline EP Impurity F
CAS# 26405-77-6
M.F.: C9H13NO5S
M.W.: 247.27 |
| |
| QP122412 | Plerixafor Impurity L
CAS# NA
M.F.: C70H90N8O12S6
M.W.: 1427.90 |
| |
| QP122411 | Plerixafor Impurity K
CAS# 104395-69-9
M.F.: C31H42N4O6S3
M.W.: 662.88 |
| |
| QC202627 | Ceftizoxime Impurity 1
CAS# NA
M.F.: C13H15N5O6S2
M.W.: 401.42 |
| |
| QD241305 | Dexamethasone Acetate EP Impurity E
CAS# 1524-94-3
M.F.: C24H33FO6
M.W.: 436.51 |
| |
| QT180629 | Tirofiban Impurity 3
CAS# NA
M.F.: C20H24N2O4
M.W.: 356.42 |
| |
| QG140927 | Ganciclovir EP Impurity H
CAS# 84222-50-4
M.F.: C9H13N5O4
M.W.: 255.23 |
| |
| QT142090 | Teneligliptin (2S,4R)-Isomer Impurity
CAS# 1404559-15-4
M.F.: C22H30N6OS
M.W.: 426.58 |
| |
| QO241810 | Oxiracetam Impurity J
CAS# NA
M.F.: C6H8N2O2
M.W.: 140.14 |
| |
| QL162007 | Lapatinib Impurity 7
CAS# 1026818-86-9
M.F.: C29H26ClFN4O4S
M.W.: 581.06 |
| |
| QL162003 | Lapatinib Impurity 3
CAS# 1360431-86-2
M.F.: C29H26ClFN4O5S
M.W.: 597.06 |
| |
| QL162002 | Lapatinib Impurity 2
CAS# 320337-48-2
M.F.: C26H19ClFN3O3
M.W.: 475.90 |
| |
| QG140909 | Ganciclovir EP Impurity I
CAS# 86357-20-2
M.F.: C15H21N5O6
M.W.: 367.36 |
| |
| QT060359 | Tofacitinib Impurity 33
CAS# NA
M.F.: C13H19N5
M.W.: 245.32 |
| |
| QP121827 | Palonosetron Impurity 27
CAS# 135729-78-1
M.F.: C18H24N2O
M.W.: 284.40 |
| |
| QC-M200805 | Bisoctrizole
CAS# 103597-45-1
M.F.: C41H50N6O2
M.W.: 658.87 |
| |
| QT132014 | Trimetazidine Impurity N
CAS# 69471-05-2
M.F.: C9H10O4
M.W.: 182.17 |
| |
| QH042401 | Hydroxychloroquine sulfate EP Impurity A
CAS# 1449223-88-4
M.F.: C18H26ClN3O2
M.W.: 351.87 |
| |
| QH042403 | Hydroxychloroquine sulfate EP Impurity C
CAS# 4298-15-1
M.F.: C16H22ClN3O
M.W.: 307.82 |
| |
| QT161828 | Topiroxostat Impurity 2
CAS# 38634-05-8
M.F.: C12H10N6
M.W.: 238.25 |
| |
| QC161306 | Cefepime EP Impurity F
CAS# NA
M.F.: C32H42N9O7S3
M.W.: 760.93 |
| |
| QC161302 | Cefepime EP Impurity B
CAS# NA
M.F.: C25H29N9O7S3
M.W.: 663.75 |
| |
| QC160732 | Clopidogrel Impurity 6
CAS# 212838-70-5
M.F.: C9H11Cl2NO2
M.W.: 236.10 |
| |
| QP182004 | Paracetamol EP Impurity D
CAS# 103-84-4
M.F.: C8H9NO
M.W.: 135.16 |
| |
| QC551801 | Clenbuterol EP Impurity A
CAS# 62909-66-4
M.F.: C7H5Cl2NO
M.W.: 190.03 |
| |
| QL091630 | Lipoic Acid Impurity 4
CAS# NA
M.F.: C8H14O4S2
M.W.: 238.32 |
| |
| QL091629 | Lipoic Acid Impurity 3
CAS# 108015-78-7
M.F.: C8H14O3S2
M.W.: 222.32 |
| |
| QL091628 | Lipoic Acid Impurity 2
CAS# 462-20-4
M.F.: C8H16O2S2
M.W.: 208.34 |
| |
| QL091600 | Lipoic Acid
CAS# 1077-28-7;2319-84-8(Na salt)
M.F.: C8H14O2S2
M.W.: 206.33 |
| |
| QT060372 | Tofacitinib Impurity 72
CAS# NA
M.F.: C16H20N6O
M.W.: 312.37 |
| |
| QC010606 | Caffeine EP Impurity F
CAS# 611-59-6
M.F.: C7H8N4O2
M.W.: 180.16 |
| |
| QA202267 | Atorvastatin Impurity 17
CAS# 425408-16-8
M.F.: C53H58ClFN4O9
M.W.: 949.50 |
| |
| QA202266 | Atorvastatin Impurity 16
CAS# 1821498-27-4
M.F.: C27H30FNO6
M.W.: 483.53 |
| |
| QT140657 | Tenofovir Impurity 31
CAS# NA
M.F.: C21H29N6O5P
M.W.: 476.47 |
| |
| QT201608 | Tiotropium Bromide EP Impurity H
CAS# 845870-40-8
M.F.: C9H16BrNO2
M.W.: 250.13 |
| |
| QI041529 | Indobufen Impurity 3
CAS# 21762-22-1
M.F.: C10H11NO4
M.W.: 209.20 |
| |
| QL141202 | Lenalidomide Impurity B
CAS# 1218910-61-2
M.F.: C9H8ClNO4
M.W.: 229.62 |
| |
| QE160930 | Epinastine Impurity 4
CAS# NA
M.F.: C15H13NO
M.W.: 223.27 |
| |
| QD031227 | Daclatasvir Dihydrochloride
CAS# 1009119-65-6
M.F.: C40H52Cl2N8O6
M.W.: 811.80 |
| |
| QP180104 | Piracetam EP Impurity D
CAS# 53934-76-2
M.F.: C6H9NO3
M.W.: 143.14 |
| |
| QP180101 | Piracetam EP Impurity A
CAS# 616-45-5
M.F.: C4H7NO
M.W.: 85.10 |
| |
| QP122410 | Plerixafor Impurity J
CAS# NA
M.F.: C18H32N4
M.W.: 304.47 |
| |
| QT060371 | Tofacitinib Impurity 71
CAS# NA
M.F.: C14H22N2O
M.W.: 234.34 |
| |
| QT060369 | Tofacitinib Impurity 69
CAS# NA
M.F.: C14H21N5
M.W.: 259.35 |
| |
| QE160929 | Epinastine Impurity 3
CAS# NA
M.F.: C15H12N2O
M.W.: 236.27 |
| |
| QE160928 | Epinastine Impurity 2
CAS# NA
M.F.: C16H16N2
M.W.: 236.31 |
| |
| QE200347 | Entecavir Impurity 47
CAS# NA
M.F.: C13H17N5O4
M.W.: 307.31 |
| |
| QP122409 | Plerixafor Impurity I
CAS# NA
M.F.: C17H30N4O2S
M.W.: 354.51 |
| |
| QT180626 | Tirofiban Impurity Z
CAS# 102878-73-9
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QT180621 | Tirofiban Impurity U
CAS# 2374-68-7
M.F.: C6H14O3S
M.W.: 166.24 |
| |
| QT180620 | Tirofiban Impurity T
CAS# NA
M.F.: C22H30N2O5S
M.W.: 434.55 |
| |
| QT180619 | Tirofiban Impurity S
CAS# NA
M.F.: C36H62N4O3
M.W.: 598.90 |
| |
| QT180617 | Tirofiban Impurity Q
CAS# NA
M.F.: C27H47Cl2N3O3
M.W.: 532.59 |
| |
| QT180616 | Tirofiban Impurity P
CAS# NA
M.F.: C27H33N3O3
M.W.: 447.57 |
| |
| QT180614 | Tirofiban Impurity N
CAS# NA
M.F.: C18H22N2O3
M.W.: 314.38 |
| |
| QT180612 | Tirofiban Impurity L
CAS# NA
M.F.: C18H22N2O3
M.W.: 314.38 |
| |
| QT180600 | Tirofiban HCl
CAS# 142373-60-2;150915-40-5(HCl monohydrate)
M.F.: C22H36N2O5S.HCl
M.W.: 440.60 36.46 |
| |
| QT180610 | Tirofiban Impurity J
CAS# NA
M.F.: C31H49Cl2N3O5S
M.W.: 646.71 |
| |
| QT180604 | Tirofiban Impurity D
CAS# 149490-61-9
M.F.: C22H30N2O5S
M.W.: 434.55 |
| |
| QT180603 | Tirofiban Impurity C
CAS# NA
M.F.: C31H43Cl2N3O5S
M.W.: 640.66 |
| |
| QT251938 | Thymalfasin Impurity Des-Glu21---Asn28-Tal
CAS# NA
M.F.: C92H158O38N24
M.W.: 2208.42 |
| |
| QT251929 | Thymalfasin Impurity Des-Asn28-Tal
CAS# NA
M.F.: C125H209O53N31
M.W.: 2994.24 |
| |
| QP136046 | Pidotimod Impurity 20
CAS# NA
M.F.: C10H16N2O3S2
M.W.: 276.38 |
| |
| QP136045 | Pidotimod Impurity 19
CAS# NA
M.F.: C8H12N2O4S
M.W.: 232.26 |
| |
| QP136044 | Pidotimod Impurity 18
CAS# NA
M.F.: C13H19N3O6S2
M.W.: 377.44 |
| |
| QG200609 | Gatifloxacin Impurity I
CAS# 103460-89-5
M.F.: C18H19F2N3O3
M.W.: 363.36 |
| |
| QU121600 | Ulipristal Acetate
CAS# 126784-99-4
M.F.: C30H37NO4
M.W.: 475.62 |
| |
| QU121608 | Ulipristal acetate Impurity H
CAS# NA
M.F.: C30H37NO4
M.W.: 475.62 |
| |
| QU121607 | Ulipristal acetate Impurity G
CAS# NA
M.F.: C28H35NO3
M.W.: 433.58 |
| |
| QU121606 | Ulipristal acetate Impurity F
CAS# NA
M.F.: C29H35NO4
M.W.: 461.59 |
| |
| QC062009 | Cefathiamidine Impurity I
CAS# NA
M.F.: C19H28N4O7S2
M.W.: 488.58 |
| |
| QA150927 | Atomoxetine EP Impurity F
CAS# NA
M.F.: C17H20FNO
M.W.: 273.35 |
| |
| QP191627 | Phosphocreatine Disodium Salt Impurity 1
CAS# NA
M.F.: C7H16N3O5P
M.W.: 253.19 |
| |
| QL142627 | Linezolid Impurity 27
CAS# 10389-51-2
M.F.: C10H12N2O3
M.W.: 208.21 |
| |
| QL142626 | Linezolid Impurity 26
CAS# 348626-43-7
M.F.: C18H20N2O3
M.W.: 312.36 |
| |
| QL142625 | Linezolid Impurity 25
CAS# 212325-40-1
M.F.: C12H15FN2O3
M.W.: 254.26 |
| |
| QL142624 | Linezolid Impurity 24
CAS# 1138458-15-7
M.F.: C13H14ClFN2O3
M.W.: 300.71 |
| |
| QP160527 | Prednisolone Dicarbonate
CAS# NA
M.F.: C26H34O9
M.W.: 490.54 |
| |
| QI091613 | (S)-Ipratropium EP Impurity E
CAS# 183626-76-8
M.F.: C19H27NO3
M.W.: 317.42 |
| |
| QA070243 | Argatroban Impurity 17
CAS# 188659-43-0
M.F.: C22H34N4O5S
M.W.: 466.59 |
| |
| QT090906 | Thiamine EP Impurity F
CAS# 6309-04-2;10593-44-9(free base)
M.F.: C13H20Br2N4OS
M.W.: 440.20 |
| |
| QT090905 | Thiamine EP Impurity E
CAS# 299-35-4
M.F.: C12H16N4OS2
M.W.: 296.41 |
| |
| QT090903 | Thiamine EP Impurity C
CAS# 7275-24-3
M.F.: C12H16Cl2N4S.HCl
M.W.: 319.25 36.46 |
| |
| QT090901 | Thiamine EP Impurity A
CAS# 2380-61-2
M.F.: C12H16N4O4S2
M.W.: 344.41 |
| |
| QC121305 | Clotrimazole EP Impurity E
CAS# 5162-03-8
M.F.: C13H9ClO
M.W.: 216.66 |
| |
| QP132032 | Pemetrexed Impurity 6
CAS# NA
M.F.: C25H28N6O9
M.W.: 556.52 |
| |
| QB082431 | Bromhexine Impurity V
CAS# 1797894-71-3
M.F.: C14H16Br2N2O
M.W.: 388.10 |
| |
| QT251940 | Thymalfasin Impurity Glu-Asn-OH
CAS# NA
M.F.: C9H15N3O6
M.W.: 261.24 |
| |
| QT251937 | Thymalfasin Impurity Des-Ser1---Glu18-Tal
CAS# NA
M.F.: C51H85O21N13
M.W.: 1216.32 |
| |
| QT251936 | Thymalfasin Impurity Ac-Ser1---Glu18-OH
CAS# NA
M.F.: C80H134O36N20
M.W.: 1952.07 |
| |
| QT251935 | Thymalfasin Impurity Des-Ser1---Lys17-Tal
CAS# NA
M.F.: C56H92O24N14
M.W.: 1345.44 |
| |
| QT251934 | Thymalfasin Impurity Ac-Ser1---Lys17-OH
CAS# NA
M.F.: C75H127O33N19
M.W.: 1822.96 |
| |
| QL040304 | Lidocaine EP Impurity D
CAS# 7728-40-7;7729-94-4(HCl salt)
M.F.: C12H18N2O
M.W.: 206.28 |
| |
| QC-D091501 | Piperonylic Acid
CAS# 94-53-1
M.F.: C8H6O4
M.W.: 166.13 |
| |
| QF191616 | Fosaprepitant Impurity P
CAS# 538-86-3
M.F.: C8H10O
M.W.: 122.16 |
| |
| QF191614 | Fosaprepitant Impurity N
CAS# 1623-08-1
M.F.: C14H15O4P
M.W.: 278.24 |
| |
| QF191610 | Fosaprepitant Impurity J
CAS# NA
M.F.: C23H23F6N4O6P 2C7H17NO5
M.W.: 596.42 390.42 |
| |
| QF191609 | Fosaprepitant Impurity I
CAS# NA
M.F.: C23H23F6N4O6P 2C7H17NO5
M.W.: 596.42 390.42 |
| |
| QP132031 | Pemetrexed Impurity 5
CAS# NA
M.F.: C22H25N5O6
M.W.: 455.46 |
| |
| QL201523 | Letrozole Impurity 23
CAS# NA
M.F.: C17H12N4O2
M.W.: 304.30 |
| |
| QL142213 | Lenvatinib Impurity M
CAS# 1788901-86-9
M.F.: C21H19ClN4O5
M.W.: 442.85 |
| |
| QC120440 | Clindamycin Hydrochloride EP Impurity E
CAS# NA
M.F.: C18H31ClN2O5S
M.W.: 422.97 |
| |
| QD162433 | Dapoxetine Impurity 7
CAS# NA
M.F.: C19H17N3O
M.W.: 303.36 |
| |
| QD162430 | Dapoxetine Impurity 4
CAS# NA
M.F.: C21H23NO
M.W.: 305.41 |
| |
| QP180206 | Pregabalin Impurity F
CAS# NA
M.F.: C16H30N2O2
M.W.: 282.42 |
| |
| QP180205 | Pregabalin Impurity E
CAS# 1083246-65-4
M.F.: C16H32N2O3
M.W.: 300.44 |
| |
| QP202244 | Pitavastatin Impurity 44
CAS# NA
M.F.: C25H22FNO4
M.W.: 419.44 |
| |
| QC062725 | Cefazolin EP Impurity I
CAS# NA
M.F.: C14H16N8O5S3
M.W.: 472.52 |
| |
| QC062724 | Cefazolin Impurity 24
CAS# NA
M.F.: C11H12N6O5S
M.W.: 340.32 |
| |
| QC131405 | Cefminox Sodium impurity 5
CAS# NA
M.F.: C14H18N3NaO8S2
M.W.: 443.43 |
| |
| QP180730 | Pregabalin Impurity 4
CAS# NA
M.F.: C14H25NO6
M.W.: 303.35 |
| |
| QP180729 | Pregabalin Impurity 3
CAS# NA
M.F.: C20H35NO11
M.W.: 465.49 |
| |
| QP180728 | Pregabalin Impurity 2
CAS# 501665-88-9
M.F.: C20H35NO11
M.W.: 465.49 |
| |
| QC062723 | Cefazolin Impurity 23
CAS# NA
M.F.: C14H14N8O4S3
M.W.: 454.51 |
| |
| QC062722 | Cefazolin Impurity 22
CAS# NA
M.F.: C14H14N8O4S3
M.W.: 454.51 |
| |
| QC201837 | Cetirizine Impurity 37;
USP Glyceryl ester of cetirizine
CAS# 1243652-36-9
M.F.: C24H31ClN2O5
M.W.: 462.97 |
| |
| QC201836 | Cetirizine Impurity 36；USP Propylene glycol ester of cetirizine
CAS# NA
M.F.: C24H31ClN2O4
M.W.: 446.97 |
| |
| QF181906 | Furosemide EP Impurity F
CAS# 4793-38-8
M.F.: C12H15ClN2O5S
M.W.: 334.78 |
| |
| QF181905 | Furosemide EP Impurity E
CAS# 50-84-0
M.F.: C7H4Cl2O2
M.W.: 191.01 |
| |
| QF181903 | Furosemide EP Impurity C
CAS# 3086-91-7
M.F.: C7H7ClN2O4S
M.W.: 250.66 |
| |
| QF181902 | Furosemide EP Impurity B
CAS# 2736-23-4
M.F.: C7H5Cl2NO4S
M.W.: 270.09 |
| |
| QF121113 | Fluconazole Impurity M
CAS# NA
M.F.: C11H9F2N3O
M.W.: 237.21 |
| |
| QE151334 | Esomeprazole Impurity 17
CAS# 91219-90-8
M.F.: C11H15NO3
M.W.: 209.24 |
| |
| QE151332 | Esomeprazole Impurity 15
CAS# 102-51-2;59548-39-9(2HCl salt)
M.F.: C7H10N2O
M.W.: 138.17 |
| |
| QP140828 | Penehyclidine Impurity 2
CAS# NA
M.F.: C14H20O2
M.W.: 220.31 |
| |
| QP140827 | Penehyclidine Impurity 1
CAS# 151673-91-5
M.F.: C13H18O2
M.W.: 206.28 |
| |
| QD020747 | Dabigatran Impurity 18
CAS# 1854074-40-0
M.F.: C28H30N6O4
M.W.: 514.58 |
| |
| QD020746 | Dabigatran Impurity 17
CAS# 1408238-39-0
M.F.: C33H38N6O6
M.W.: 614.69 |
| |
| QD020744 | Dabigatran Impurity 15
CAS# 771459-37-1
M.F.: C26H27N7O3
M.W.: 485.54 |
| |
| QD020743 | Dabigatran Impurity 14
CAS# 1422435-39-9;1408238-41-4(free base)
M.F.: C19H22ClN5O2
M.W.: 387.86 |
| |
| QD020742 | Dabigatran Impurity 13
CAS# 1427571-33-2
M.F.: C21H25ClN4O3
M.W.: 416.90 |
| |
| QC030344 | Cinacalcet Impurity 13
CAS# NA
M.F.: C17H17F3O3S
M.W.: 358.38 |
| |
| QC030343 | Cinacalcet Impurity 12
CAS# NA
M.F.: C28H25F3N2O4S
M.W.: 542.57 |
| |
| QC030342 | Cinacalcet Impurity 11
CAS# NA
M.F.: C18H16N2O4S
M.W.: 356.40 |
| |
| QP181604 | Pramipexole EP Impurity D
CAS# 104632-27-1
M.F.: C10H19Cl2N3S
M.W.: 284.25 |
| |
| QA162998 | Apremilast Impurity R
CAS# NA
M.F.: C20H24N2O7S
M.W.: 436.48 |
| |
| QA162997 | Apremilast Impurity Q
CAS# 1831833-38-5
M.F.: C12H16O4S
M.W.: 256.32 |
| |
| QA162994 | Apremilast Impurity N
CAS# 1384439-79-5
M.F.: C19H18N2O7S
M.W.: 418.42 |
| |
| QA162990 | Apremilast Impurity J
CAS# NA
M.F.: C23H26N2O7S
M.W.: 474.53 |
| |
| QA162989 | Apremilast Impurity I
CAS# NA
M.F.: C22H24N2O7S
M.W.: 460.50 |
| |
| QA162986 | Apremilast Impurity F
CAS# NA
M.F.: C34H43N3O11S2
M.W.: 733.85 |
| |
| QA178203 | Artemisinin Impurity 29
CAS# 82596-30-3
M.F.: C15H22O4
M.W.: 266.33 |
| |
| QE200343 | Entecavir USP Related Compound A
CAS# NA
M.F.: C27H31N5O2Si
M.W.: 485.65 |
| |
| QC120435 | Clindamycin Impurity 8
CAS# 22431-46-5
M.F.: C18H33ClN2O6S
M.W.: 440.98 |
| |
| QC120434 | Clindamycin Impurity 7
CAS# 22965-79-3
M.F.: C9H18ClNO4S
M.W.: 271.76 |
| |
| QL140305 | Lincomycin Hydrochloride EP Impurity E
CAS# 6734-79-8;13380-36-4(free base)
M.F.: C9H17NO2.HCl
M.W.: 171.24 36.46 |
| |
| QC062401 | Ceftriaxone EP Impurity A
CAS# 92143-31-2;97164-54-0(2Na salt)
M.F.: C18H18N8O7S3
M.W.: 554.58 |
| |
| QC062405 | Ceftriaxone EP Impurity E
CAS# 58909-56-1
M.F.: C12H13N5O5S2
M.W.: 371.39 |
| |
| QC120433 | Clindamycin Phosphate EP Impurity H;
Clindamycin 2,3-Bisphosphate
CAS# NA
M.F.: C18H35ClN2O11P2S
M.W.: 584.94 |
| |
| QC120432 | Clindamycin Phosphate EP Impurity K
CAS# NA
M.F.: C36H66Cl2N4O15P2S2
M.W.: 991.91 |
| |
| QC120429 | Clindamycin Phosphate EP Impurity I
CAS# 1309048-48-3
M.F.: C18H35ClN2O11P2S
M.W.: 584.94 |
| |
| QC120428 | Clindamycin Phosphate EP Impurity G
CAS# NA
M.F.: C18H33N2O8PS
M.W.: 468.50 |
| |
| QC120427 | Clindamycin Phosphate EP Impurity A;
Clindamycin Hydrochloride EP Impurity A;
Lincomycin
CAS# 154-21-2;859-18-7(HCl salt);
7179-49-9(hydrochloride monohydrate)
M.F.: C18H34N2O6S
M.W.: 406.54 |
| |
| QC062404 | Ceftriaxone EP Impurity D
CAS# 80756-85-0
M.F.: C13H10N4O2S3
M.W.: 350.44 |
| |
| QC062403 | Ceftriaxone EP Impurity C
CAS# 58909-39-0
M.F.: C4H5N3O2S
M.W.: 159.17 |
| |
| QC160731 | Clopidogrel EP Impurity F
CAS# 141109-20-8
M.F.: C15H16ClNO2S
M.W.: 309.81 |
| |
| QA202263 | Atorvastatin Impurity 13
CAS# 1316291-19-6 (Na salt);873950-17-5
M.F.: C33H35FN2O7
M.W.: 590.64 |
| |
| QC160719 | Clopidogrel Amide Racemate
CAS# 90055-68-8 (free base)
M.F.: C15H16Cl2N2OS
M.W.: 343.27 |
| |
| QI132033 | Imatinib Impurity 33
CAS# 581076-64-4
M.F.: C8H12N4
M.W.: 164.21 |
| |
| QL220106 | Levalbuterol USP Related Compound F
CAS# 174607-68-2
M.F.: C20H27NO3
M.W.: 329.43 |
| |
| QL220101 | Levalbuterol USP Related Compound A
CAS# 1823256-56-9
M.F.: C13H21NO2
M.W.: 223.31 |
| |
| QA164109 | Avanafil Impurity I
CAS# 1452128-53-8
M.F.: C18H17ClN6O3
M.W.: 400.82 |
| |
| QP160454 | Paliperidone Impurity 28
CAS# 1138463-56-5
M.F.: C11H13ClN2O2
M.W.: 240.69 |
| |
| QE201805 | Emtricitabine Impurity E
CAS# NA
M.F.: C8H9FN2O4S
M.W.: 248.23 |
| |
| QE200341 | Entecavir Impurity 41
CAS# NA
M.F.: C12H15N5O4
M.W.: 293.28 |
| |
| QP020317 | Palbociclib Impurity Q
CAS# 827022-35-5
M.F.: C33H45N7O4
M.W.: 603.75 |
| |
| QP202241 | Pitavastatin Impurity 41
CAS# 1611499-16-1;2276678-27-2(Na salt)
M.F.: C25H24FNO5
M.W.: 437.46 |
| |
| QE192016 | Escitalopram EP Impurity L oxalate
CAS# 1093072-86-6;1026009-77-7(free base)
M.F.: C20H22N2O.C2H2O4
M.W.: 306.40 90.03 |
| |
| QE192015 | Escitalopram Impurity P
CAS# NA
M.F.: C20H21FN2O.C2H2O4
M.W.: 324.40 90.03 |
| |
| QV010337 | Valaciclovir Impurity K
CAS# NA
M.F.: C13H21ClN6O4
M.W.: 360.80 |
| |
| QT130203 | Trimebutine Impurity C
CAS# NA
M.F.: C10H11NO
M.W.: 161.08 |
| |
| QA121803 | Allura Red Impurity 3
CAS# 61551-82-4
M.F.: C20H12Na2O7S2
M.W.: 474.41 |
| |
| QA121802 | Allura Red Impurity 2
CAS# 6471-78-9
M.F.: C8H11NO4S
M.W.: 217.24 |
| |
| QA121801 | Allura Red Impurity 1
CAS# 135-76-2;93-01-6(free base)
M.F.: C10H7NaO4S
M.W.: 246.21 |
| |
| QP190333 | Posaconazole Impurity 2
CAS# NA
M.F.: C47H52N8O5
M.W.: 808.97 |
| |
| QE221329 | Everolimus Impurity 29
CAS# 1708118-13-1
M.F.: C53H83NO14
M.W.: 958.22 |
| |
| QC242020 | Cefoxitin Impurity 20
CAS# NA
M.F.: C16H17N3O7S2
M.W.: 427.45 |
| |
| QD170600 | Diquafosol sodium
CAS# 211427-08-6
M.F.: C18H22N4Na4O23P4
M.W.: 878.23 |
| |
| QC031232 | Cefaclor Impurity 6
CAS# NA
M.F.: C15H14ClN3O5S
M.W.: 383.81 |
| |
| QP180736 | Pregabalin Impurity 10
CAS# 181289-34-9
M.F.: C9H17NO3
M.W.: 187.24 |
| |
| QB151429 | Bromfenac Impurity 3
CAS# 1644279-16-2
M.F.: C30H18Br2N2O3
M.W.: 614.28 |
| |
| QB151431 | Bromfenac Impurity 5 Sodium Salt
CAS# 1391052-54-2;241825-87-6(free base)
M.F.: C15H9BrNNaO4
M.W.: 370.13 |
| |
| QB151430 | Bromfenac Impurity 4 Sodium salt
CAS# 241496-82-2 (free base)
M.F.: C14H9BrNNaO3
M.W.: 342.12 |
| |
| QC202437 | Cefotaxime Impurity 11
CAS# NA
M.F.: C32H34N10O14S4
M.W.: 910.93 |
| |
| QC202435 | Cefotaxime Impurity 9
CAS# NA
M.F.: C15H19N5O6S2
M.W.: 429.47 |
| |
| QC202434 | Cefotaxime Impurity 8
CAS# NA
M.F.: C16H19N5O8S2
M.W.: 473.48 |
| |
| QC202431 | Cefotaxime Impurity 5
CAS# 64485-89-8
M.F.: C27H25N3O3S
M.W.: 471.57 |
| |
| QC202430 | Cefotaxime Impurity 4
CAS# 64485-88-7
M.F.: C8H11N3O3S
M.W.: 229.26 |
| |
| QC202429 | Cefotaxime Impurity 3
CAS# NA
M.F.: C7H10BrNO4
M.W.: 252.06 |
| |
| QC202428 | Cefotaxime Impurity 2
CAS# 66340-86-1
M.F.: C7H11NO4
M.W.: 173.17 |
| |
| QT060367 | Tofacitinib Impurity 67
CAS# NA
M.F.: C26H26Cl2N8
M.W.: 521.44 |
| |
| QE201803 | Emtricitabine Impurity C
CAS# NA
M.F.: C8H9FN2O5S
M.W.: 264.23 |
| |
| QS061902 | Sulfasalazine EP Impurity B
CAS# 1391062-49-9
M.F.: C29H22N8O7S2
M.W.: 658.66 |
| |
| QT060366 | Tofacitinib Impurity 66
CAS# 10132-07-7
M.F.: C4H3Cl2N3
M.W.: 163.99 |
| |
| QA261933 | Azilsartan
CAS# 147403-03-0
M.F.: C25H20N4O5
M.W.: 456.45 |
| |
| QT140654 | Tenofovir Impurity 27
CAS# NA
M.F.: C12H20N5O4P
M.W.: 329.29 |
| |
| QT140652 | Tenofovir Impurity 25
CAS# 2488598-61-2
M.F.: C15H18N5O4P
M.W.: 363.31 |
| |
| QT140647 | Tenofovir Impurity 21
CAS# NA
M.F.: C6H13NO2
M.W.: 131.17 |
| |
| QT140646 | Tenofovir Impurity 20
CAS# 147127-19-3
M.F.: C9H14N5O4P
M.W.: 287.21 |
| |
| QP812518 | Paclitaxel EP Impurity R
CAS# 158948-96-0
M.F.: C45H55NO14
M.W.: 833.92 |
| |
| QP812517 | Paclitaxel EP Impurity Q
CAS# 2243233-98-7
M.F.: C46H55NO14
M.W.: 845.93 |
| |
| QP812516 | Paclitaxel EP Impurity P
CAS# 173101-56-9
M.F.: C48H53NO14
M.W.: 867.93 |
| |
| QP812515 | Paclitaxel EP Impurity O;
N-cinnamoyl-N-debenzoylpaclitaxel
CAS# 219783-77-4
M.F.: C49H53NO14
M.W.: 879.94 |
| |
| QP812514 | Paclitaxel EP Impurity N;Baccatin III
CAS# 27548-93-2
M.F.: C31H38O11
M.W.: 586.63 |
| |
| QP812513 | Paclitaxel EP Impurity M
CAS# NA
M.F.: C47H53NO15
M.W.: 871.92 |
| |
| QP812512 | Paclitaxel EP Impurity L
CAS# 92950-39-5
M.F.: C49H53NO15
M.W.: 895.94 |
| |
| QP812511 | Paclitaxel EP Impurity K
CAS# 148930-55-6
M.F.: C53H65NO14Si
M.W.: 968.17 |
| |
| QP812510 | Paclitaxel EP Impurity J
CAS# NA
M.F.: C49H53NO15
M.W.: 895.94 |
| |
| QP812509 | Paclitaxel EP Impurity I
CAS# 2157462-42-3
M.F.: C61H62N2O16
M.W.: 1079.15 |
| |
| QP812504 | Paclitaxel EP Impurity D;7-epi-Cephalomannine
CAS# 150547-36-7
M.F.: C45H53NO14
M.W.: 831.90 |
| |
| QP812503 | Paclitaxel EP Impurity C;Paclitaxel C
CAS# 153415-45-3
M.F.: C46H57NO14
M.W.: 847.94 |
| |
| QP812502 | Paclitaxel EP Impurity B;
Cephalomannine
CAS# 71610-00-9
M.F.: C45H53NO14
M.W.: 831.90 |
| |
| QP812501 | Paclitaxel EP Impurity A
CAS# 173101-54-7
M.F.: C45H53NO14
M.W.: 831.90 |
| |
| QP812500 | Paclitaxel;Docetaxel EP Impurity F
CAS# 33069-62-4
M.F.: C47H51NO14
M.W.: 853.91 |
| |
| QE122029 | Erlotinib Impurity 3
CAS# 183320-15-2
M.F.: C23H23N3O5
M.W.: 421.45 |
| |
| QE122028 | Erlotinib Impurity 2
CAS# 2512209-22-0;2712530-31-7(HCl salt)
M.F.: C15H23NO6
M.W.: 313.35 |
| |
| QE122027 | Erlotinib Impurity 1
CAS# 183322-21-6
M.F.: C12H11Cl3N2O2
M.W.: 321.59 |
| |
| QI220226 | Ivabradine N-Oxide
CAS# 2511244-97-4
M.F.: C27H36N2O6
M.W.: 484.58 |
| |
| QA202261 | Atorvastatin Impurity 11
CAS# NA
M.F.: C44H56FN3O8
M.W.: 773.93 |
| |
| QA202234 | Atorvastatin Impurity O
CAS# NA
M.F.: C37H42F2N2O5
M.W.: 632.74 |
| |
| QA202249 | Atorvastatin Impurity Ⅵ
CAS# NA
M.F.: C37H44N2O5
M.W.: 596.76 |
| |
| QA202247 | Atorvastatin Impurity Ⅳ
CAS# 693793-87-2
M.F.: C40H46F2N2O5
M.W.: 672.80 |
| |
| QA202244 | Atorvastatin Impurity Ⅲ
CAS# 1105067-91-1
M.F.: C40H48N2O5
M.W.: 636.82 |
| |
| QA202243 | Atorvastatin Impurity Ⅱ
CAS# 125995-13-3
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202242 | Atorvastatin Impurity Ⅰ
CAS# 125971-96-2
M.F.: C26H24FNO3
M.W.: 417.47 |
| |
| QA202260 | Atorvastatin Impurity 10
CAS# 2088732-01-6
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202258 | Atorvastatin Impurity 8
CAS# 947586-93-8
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202257 | Atorvastatin Impurity 7
CAS# 125971-94-0
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QA202254 | Atorvastatin Impurity 4
CAS# 444577-70-2
M.F.: C26H25NO3
M.W.: 399.48 |
| |
| QA202252 | Atorvastatin Impurity 2
CAS# 125971-57-5
M.F.: C19H19NO2
M.W.: 293.36 |
| |
| QA202251 | Atorvastatin Impurity 1
CAS# 124401-38-3
M.F.: C12H15NO2
M.W.: 205.25 |
| |
| QC-P131201 | Pimelic acid;Adipic acid EP Impurity C
CAS# 111-16-0
M.F.: C7H12O4
M.W.: 160.17 |
| |
| QL091627 | Lipoic Acid Impurity 1
CAS# NA
M.F.: C18H32N2O2S4
M.W.: 436.72 |
| |
| QP190336 | Posaconazole Impurity 36
CAS# 213381-02-3
M.F.: C37H42F2N8O4
M.W.: 700.78 |
| |
| QP190342 | Posaconazole Impurity 42
CAS# 2243785-96-6
M.F.: C37H42F2N8O4
M.W.: 700.78 |
| |
| QF140207 | Fenofibrate EP Impurity G
CAS# 217636-48-1
M.F.: C24H27ClO6
M.W.: 446.92 |
| |
| QF140201 | Fenofibrate EP Impurity A
CAS# 42019-78-3
M.F.: C13H9ClO2
M.W.: 232.66 |
| |
| QP190334 | Posaconazole Impurity 34
CAS# 2173414-68-9
M.F.: C13H20N2O2
M.W.: 236.31 |
| |
| QP190332 | Posaconazole Impurity 19
CAS# NA
M.F.: C20H18ClF2N3O4S
M.W.: 469.89 |
| |
| QP190331 | Posaconazole Impurity 16
CAS# 2243786-07-2
M.F.: C20H18ClF2N3O4S
M.W.: 469.89 |
| |
| QP190330 | Posaconazole Impurity 15
CAS# 2423024-27-3
M.F.: C20H18ClF2N3O4S
M.W.: 469.89 |
| |
| QC061229 | Cephalexin Impurity 3
CAS# NA
M.F.: C16H19N3O5S
M.W.: 365.40 |
| |
| QC061228 | Cephalexin Impurity 2
CAS# 6485-67-2
M.F.: C8H10N2O
M.W.: 150.18 |
| |
| QC061226 | Cephalexin Impurity 1
CAS# 19883-41-1;24461-61-8(free base)
M.F.: C9H12ClNO2
M.W.: 201.65 |
| |
| QC221210 | Clavulanate Potassium EP Impurity A
CAS# 4744-51-8
M.F.: C8H12N2O2
M.W.: 168.19 |
| |
| QC242006 | Cefoxitin Sodium EP Impurity F (S-methoxy cefoxitin)
CAS# NA
M.F.: C17H19N3O8S2
M.W.: 457.48 |
| |
| QC242010 | Cefoxitin Sodium EP Impurity E (R-methoxy cefoxitin)
CAS# NA
M.F.: C17H19N3O8S2
M.W.: 457.48 |
| |
| QL062415 | Levofloxacin Impurity I
CAS# 431058-46-7
M.F.: C15H14FNO4
M.W.: 291.27 |
| |
| QC081331 | Calcitriol EP Impurity A
CAS# 73837-24-8
M.F.: C27H44O3
M.W.: 416.65 |
| |
| QC061851 | Cefuroxime Impurity 10
CAS# NA
M.F.: C16H15N4NaO9S
M.W.: 462.37 |
| |
| QT060358 | Tofacitinib Impurity 32
CAS# NA
M.F.: C20H24ClN5
M.W.: 369.89 |
| |
| QT060357 | Tofacitinib Impurity 31
CAS# NA
M.F.: C20H24ClN5
M.W.: 369.89 |
| |
| QT060356 | Tofacitinib Impurity 30
CAS# NA
M.F.: C20H24ClN5
M.W.: 369.89 |
| |
| QL052228 | Levocetirizine Impurity 2
CAS# 300543-56-0
M.F.: C17H19ClN2
M.W.: 286.81 |
| |
| QG130306 | Gemcitabine Impurity E
CAS# NA
M.F.: C23H19F2N3O6
M.W.: 471.41 |
| |
| QG130307 | Gemcitabine Impurity G
CAS# NA
M.F.: C16H16ClF2N3O5
M.W.: 403.77 |
| |
| QG130331 | Gemcitabine EP Impurity B
CAS# 95058-85-8;122111-05-1 (HCl salt)
M.F.: C9H11F2N3O4
M.W.: 263.20 |
| |
| QG130329 | Gemcitabine Impurity 3
CAS# 1173824-58-2
M.F.: C19H16F2O6
M.W.: 378.32 |
| |
| QG130328 | Gemcitabine Impurity 2
CAS# 134877-43-3
M.F.: C20H18F2O8S
M.W.: 456.41 |
| |
| QG130327 | Gemcitabine Impurity 1
CAS# 134877-42-2
M.F.: C20H18F2O8S
M.W.: 456.41 |
| |
| QC061849 | Cefuroxime Impurity 8
CAS# NA
M.F.: C8H10N2O4S
M.W.: 230.24 |
| |
| QF141928 | Finasteride Impurity 2
CAS# NA
M.F.: C23H36N2O3
M.W.: 388.54 |
| |
| QC071203 | Carglumic Acid Impurity 3
CAS# NA
M.F.: C7H11N3O6
M.W.: 233.18 |
| |
| QC071202 | Carglumic Acid Impurity 2
CAS# NA
M.F.: C11H17N3O8
M.W.: 319.27 |
| |
| QC071201 | Carglumic Acid Impurity 1
CAS# NA
M.F.: C12H18N4O9
M.W.: 362.29 |
| |
| QH042407 | Hydroxychloroquine O-Acetate
CAS# 47493-14-1
M.F.: C20H28ClN3O2
M.W.: 377.92 |
| |
| QT060355 | Tofacitinib Impurity 29
CAS# 2504210-38-0
M.F.: C19H22N8
M.W.: 362.43 |
| |
| QT060354 | Tofacitinib Impurity 28
CAS# NA
M.F.: C23H31N7O3
M.W.: 453.54 |
| |
| QT060353 | Tofacitinib Impurity 27
CAS# 2227199-31-5
M.F.: C20H29N5O3
M.W.: 387.48 |
| |
| QA070231 | Argatroban Impurity 5
CAS# 20668-20-6
M.F.: C10H13N
M.W.: 147.22 |
| |
| QE022002 | Ebastine EP Impurity B
CAS# 943-27-1
M.F.: C12H16O
M.W.: 176.25 |
| |
| QA122210 | Alvimopan (2R, 3S, 4S)-Isomer
CAS# NA
M.F.: C25H32N2O4
M.W.: 424.53 |
| |
| QC160718 | 2-Oxo Clopidogrel Hydrochloride
CAS# 1219432-42-4 ;109904-27-0(free base)
M.F.: C16H17Cl2NO3S
M.W.: 374.28 |
| |
| QT261841 | Tazarotenic Acid Sulfoxide
CAS# 603952-64-3
M.F.: C19H17NO3S
M.W.: 339.42 |
| |
| QD031230 | Daclatasvir Impurity 30
CAS# NA
M.F.: C38H48N8O4
M.W.: 680.84 |
| |
| QD031235 | Daclatasvir Impurity 35
CAS# NA
M.F.: C41H52N8O6
M.W.: 752.90 |
| |
| QC031208 | Cefaclor EP Impurity H
CAS# NA
M.F.: C23H21ClN4O5S
M.W.: 500.95 |
| |
| QA201804 | Aztreonam USP Impurity D
CAS# 102579-59-9 (free base)
M.F.: C13H17N5O5S.C2HF3O2
M.W.: 355.37 114.02 |
| |
| QA040628 | Adefovir Impurity 1
CAS# NA
M.F.: C26H42N5O10P
M.W.: 615.61 |
| |
| QA040627 | Adefovir Dipivoxil Intermediate
CAS# 116384-53-3
M.F.: C12H20N5O4P
M.W.: 329.29 |
| |
| QD122040 | Dolutegravir
CAS# 1051375-16-6;1051375-19-9(Na salt)
M.F.: C20H19F2N3O5
M.W.: 419.38 |
| |
| QD020739 | Dabigatran Impurity 10
CAS# 1610758-19-4
M.F.: C35H43N7O5
M.W.: 641.76 |
| |
| QD020736 | Dabigatran Impurity 7
CAS# NA
M.F.: C10H14N2O2
M.W.: 194.23 |
| |
| QS180609 | Sorafenib tosylate Impurity I
CAS# 1129683-83-5
M.F.: C14H10ClF3N2O2
M.W.: 330.69 |
| |
| QA070227 | Argatroban Impurity 1
CAS# 153886-69-2
M.F.: C10H9NO3S
M.W.: 223.25 |
| |
| QA200328 | Atracurium Besylate Impurity 2
CAS# NA
M.F.: C58H74N2O15S
M.W.: 1071.28 |
| |
| QL220327 | Levocarnitine Impurity 27
CAS# 2788-28-5
M.F.: C7H15ClN2O
M.W.: 178.66 |
| |
| QT260422 | Trazodone hydrochloride Impurity V
CAS# NA
M.F.: C13H18Cl2N4O
M.W.: 317.21 |
| |
| QT260419 | Trazodone hydrochloride Impurity S
CAS# NA
M.F.: C19H22ClN5O2
M.W.: 387.86 |
| |
| QT260418 | Trazodone hydrochloride Impurity R
CAS# 1263358-12-8;1263278-79-0(HCl salt)
M.F.: C19H21Cl2N5O
M.W.: 406.31 |
| |
| QT260417 | Trazodone hydrochloride Impurity Q
CAS# NA
M.F.: C19H22ClN5O3
M.W.: 403.86 |
| |
| QT260413 | Trazodone hydrochloride Impurity M
CAS# NA
M.F.: C14H21Cl2N3
M.W.: 302.24 |
| |
| QT260412 | Trazodone hydrochloride Impurity L
CAS# 32229-98-4
M.F.: C13H19ClN2O
M.W.: 254.76 |
| |
| QT260411 | Trazodone hydrochloride Impurity K
CAS# NA
M.F.: C10H14Cl2N2
M.W.: 233.14 |
| |
| QT260409 | Trazodone hydrochloride Impurity I
CAS# NA
M.F.: C15H14N6O2
M.W.: 310.31 |
| |
| QT260408 | Trazodone hydrochloride Impurity H
CAS# 6323-09-7;2408971-27-5(2HCl salt)
M.F.: C23H30Cl2N4
M.W.: 433.42 |
| |
| QT260407 | Trazodone hydrochloride EP Impurity G
CAS# 2470436-00-9;2470441-00-8(HCl salt)
M.F.: C17H27ClN2O
M.W.: 310.86 |
| |
| QT260405 | Trazodone hydrochloride Impurity E
CAS# 1346599-35-6
M.F.: C21H26ClN5O
M.W.: 399.92 |
| |
| QT260403 | Trazodone hydrochloride Impurity C
CAS# 157072-19-0;1263278-77-8(HCl salt)
M.F.: C19H22ClN5O
M.W.: 371.86 |
| |
| QT260402 | Trazodone hydrochloride Impurity B
CAS# 62337-66-0
M.F.: C19H23N5O
M.W.: 337.42 |
| |
| QE151331 | Esomeprazole Impurity 14
CAS# 1227380-90-6;2227107-89-1(NH4+ salt)
M.F.: C16H15N3O4
M.W.: 313.31 |
| |
| QI220224 | Ivabradine Impurity 5
CAS# 304464-98-0
M.F.: C26H34N2O5
M.W.: 454.56 |
| |
| QB031431 | Bucinnazine hydrochloride Impurity 5
CAS# NA
M.F.: C9H18N2O
M.W.: 170.25 |
| |
| QB031429 | Bucinnazine hydrochloride Impurity 3
CAS# NA
M.F.: C13H18N2O
M.W.: 218.29 |
| |
| QB031428 | Bucinnazine hydrochloride Impurity 2
CAS# NA
M.F.: C14H18N2O
M.W.: 230.31 |
| |
| QB031427 | Bucinnazine hydrochloride Impurity 1
CAS# NA
M.F.: C5H10N2O
M.W.: 114.15 |
| |
| QA070241 | Argatroban Impurity 15
CAS# NA
M.F.: C11H11NO3S
M.W.: 237.27 |
| |
| QA070240 | Argatroban Impurity 14
CAS# NA
M.F.: C12H13NO3S
M.W.: 251.30 |
| |
| QA070237 | Argatroban Impurity 11
CAS# 2423016-01-5
M.F.: C23H35N5O6S
M.W.: 509.62 |
| |
| QL040327 | Lidocaine Impurity 1
CAS# 294852-91-8
M.F.: C18H22N2O
M.W.: 282.38 |
| |
| QC030340 | Cinacalcet Impurity 9
CAS# NA
M.F.: C22H23ClF3NO
M.W.: 409.87 |
| |
| QC030339 | Cinacalcet Impurity 8
CAS# 1224568-02-8;1273259-50-9(HCl)
M.F.: C22H22F3NO
M.W.: 373.41 |
| |
| QC120430 | Clindamycin Phosphate EP Impurity D;
Clindamycin 4-Phosphate
CAS# 54887-30-8
M.F.: C18H34ClN2O8PS
M.W.: 504.96 |
| |
| QC182534 | 1-Methoxy Canagliflozin
CAS# 1358581-37-9
M.F.: C25H27FO6S
M.W.: 474.54 |
| |
| QC060427 | Cefodizime Impurity 1
CAS# 120533-30-4
M.F.: C20H20N6O7S4
M.W.: 584.67 |
| |
| QB201438 | Bortezomib Impurity 12
CAS# NA
M.F.: C24H38BClN2O3
M.W.: 448.83 |
| |
| QB201436 | Bortezomib Impurity 10
CAS# NA
M.F.: C24H38BClN2O3
M.W.: 448.83 |
| |
| QP182446 | Paroxetine Impurity 8
CAS# NA
M.F.: C14H21NO2
M.W.: 235.32 |
| |
| QP182445 | Paroxetine Impurity 7
CAS# NA
M.F.: C13H19NO
M.W.: 205.30 |
| |
| QP136040 | Pidotimod Impurity 14
CAS# NA
M.F.: C10H12N2O4S
M.W.: 256.28 |
| |
| QP180631 | Pirfenidone Impurity 5
CAS# NA
M.F.: C13H13N3O2
M.W.: 243.26 |
| |
| QP180630 | Pirfenidone Impurity 4
CAS# NA
M.F.: C25H21N5O4
M.W.: 455.47 |
| |
| QP180628 | Pirfenidone Impurity 2
CAS# 284462-78-8
M.F.: C13H13N3O2
M.W.: 243.26 |
| |
| QP180627 | Pirfenidone Impurity 1
CAS# 1153328-25-6
M.F.: C13H13N3O2
M.W.: 243.26 |
| |
| QF132009 | Formoterol EP Impurity I
CAS# 532414-36-1
M.F.: C19H24N2O4
M.W.: 344.40 |
| |
| QP081815 | Phloroglucinol EP Impurity O
CAS# 137-19-9
M.F.: C6H4Cl2O2
M.W.: 179.00 |
| |
| QP081812 | Phloroglucinol EP Impurity L
CAS# 626-43-7
M.F.: C6H5Cl2N
M.W.: 162.02 |
| |
| QP081809 | Phloroglucinol EP Impurity I
CAS# 87-65-0
M.F.: C6H4Cl2O
M.W.: 163.00 |
| |
| QP081805 | Phloroglucinol EP Impurity E
CAS# 533-73-3
M.F.: C6H6O3
M.W.: 126.11 |
| |
| QP081804 | Phloroglucinol EP Impurity D
CAS# 491-45-2
M.F.: C12H10O5
M.W.: 234.20 |
| |
| QP081801 | Phloroglucinol EP Impurity A
CAS# 87-66-1
M.F.: C6H6O3
M.W.: 126.11 |
| |
| QC202600 | Ceftizoxime sodium
CAS# 68401-82-1
M.F.: C13H12N5NaO5S2
M.W.: 405.38 |
| |
| QP156507 | Progesterone EP Impurity G
CAS# 2257421-79-5
M.F.: C27H38O2
M.W.: 394.59 |
| |
| QP156503 | Progesterone EP Impurity C
CAS# 145-15-3
M.F.: C21H32O2
M.W.: 316.49 |
| |
| QP156501 | Progesterone EP Impurity A
CAS# 24377-08-0
M.F.: C21H28O2
M.W.: 312.45 |
| |
| QD241332 | Dexamethasone Acetate EP Impurity I
CAS# 3949-26-6
M.F.: C26H33FO7
M.W.: 476.53 |
| |
| QD241309 | Dexamethasone EP Impurity I
CAS# 14622-47-0
M.F.: C22H28O5
M.W.: 372.45 |
| |
| QP131215 | Pomalidomide Impurity O
CAS# 50-35-1
M.F.: C13H10N2O4
M.W.: 258.23 |
| |
| QP131206 | Pomalidomide Impurity F
CAS# 191732-76-0
M.F.: C13H11N3O4
M.W.: 273.24 |
| |
| QP131213 | Pomalidomide Impurity M
CAS# 5434-20-8;6946-22-1(HCl salt)
M.F.: C8H7NO4
M.W.: 181.15 |
| |
| QP131205 | Pomalidomide Impurity E
CAS# 19171-18-7
M.F.: C13H9N3O6
M.W.: 303.23 |
| |
| QP131203 | Pomalidomide Impurity C
CAS# 918314-45-1
M.F.: C13H13N3O5
M.W.: 291.26 |
| |
| QP131210 | Pomalidomide Impurity J
CAS# 2635-64-5
M.F.: C13H13N3O5
M.W.: 291.26 |
| |
| QP131202 | Pomalidomide Impurity B
CAS# 497147-11-2
M.F.: C13H11N3O5
M.W.: 289.24 |
| |
| QF030333 | Famciclovir Impurity 7
CAS# 127205-22-5
M.F.: C10H15N5O3
M.W.: 253.26 |
| |
| QB131600 | Bimatoprost Acid
CAS# 38344-08-0
M.F.: C23H32O5
M.W.: 388.50 |
| |
| QB131627 | Bimatoprost Impurity 1;
(15R)-Bimatoprost
CAS# 1163135-92-9
M.F.: C25H37NO4
M.W.: 415.57 |
| |
| QT060352 | Tofacitinib Impurity 26
CAS# 1812890-23-5
M.F.: C13H21N5
M.W.: 247.34 |
| |
| QT060351 | Tofacitinib Impurity 25
CAS# NA
M.F.: C16H20N6O2
M.W.: 328.37 |
| |
| QT060350 | Tofacitinib Impurity 24
CAS# 2459302-85-1
M.F.: C21H27N7O3
M.W.: 425.48 |
| |
| QT060348 | Tofacitinib Impurity 22
CAS# 1640972-35-5;1809002-40-1(citrate salt)
M.F.: C16H22N6O
M.W.: 314.39 |
| |
| QA120712 | Alogliptin Impurity L
CAS# NA
M.F.: C18H22N4O4
M.W.: 358.39 |
| |
| QA120711 | Alogliptin Impurity K
CAS# 865758-98-1
M.F.: C17H19N5O2
M.W.: 325.37 |
| |
| QA120710 | Alogliptin Impurity J
CAS# 2089611-85-6
M.F.: C18H21N5O2
M.W.: 339.39 |
| |
| QL050318 | Lercanidipine Impurity 4
CAS# 1119226-97-9
M.F.: C35H37N3O6
M.W.: 595.68 |
| |
| QT120200 | Tulobuterol Hydrochloride
CAS# 56776-01-3;41570-61-0(free base)
M.F.: C12H19Cl2NO
M.W.: 264.19 |
| |
| QA070203 | Argatroban Impurity C
CAS# 951130-92-0
M.F.: C23H32N6O5S
M.W.: 504.60 |
| |
| QA070201 | Argatroban Impurity A
CAS# 1448301-07-2
M.F.: C23H35N7O7S
M.W.: 553.63 |
| |
| QC030337 | Cinacalcet Impurity 7
CAS# NA
M.F.: C23H25ClF3N
M.W.: 407.90 |
| |
| QC030336 | Cinacalcet Impurity 6
CAS# 1020414-33-8 ;802918-35-0(free base)
M.F.: C22H25ClF3N
M.W.: 395.89 |
| |
| QC030335 | Cinacalcet Impurity 5
CAS# NA
M.F.: C13H15N
M.W.: 185.26 |
| |
| QC030334 | Cinacalcet Impurity 4
CAS# NA
M.F.: C12H16ClN
M.W.: 209.72 |
| |
| QC030332 | Cinacalcet Impurity 2
CAS# NA
M.F.: C12H18ClN
M.W.: 211.73 |
| |
| QD020735 | Dabigatran Etexilate Impurity 6
CAS# NA
M.F.: C13H14N4O
M.W.: 242.28 |
| |
| QD020734 | Dabigatran Etexilate Impurity 5
CAS# NA
M.F.: C11H14N2O4
M.W.: 238.24 |
| |
| QD020733 | Dabigatran Etexilate Impurity 4
CAS# 104961-64-0
M.F.: C8H10N2O2
M.W.: 166.18 |
| |
| QD020732 | Dabigatran Etexilate Impurity 3
CAS# 89-41-8
M.F.: C8H7NO5
M.W.: 197.14 |
| |
| QD020730 | Dabigatran Etexilate Impurity 1
CAS# 36242-50-9
M.F.: C9H10N2O4
M.W.: 210.19 |
| |
| QH042430 | Hydroxychloroquine sulfate EP Impurity G
CAS# 86-98-6
M.F.: C9H5Cl2N
M.W.: 198.05 |
| |
| QH042429 | Hydroxychloroquine sulfate Impurity 3
CAS# 86-99-7
M.F.: C9H6ClNO
M.W.: 179.60 |
| |
| QH042428 | Hydroxychloroquine sulfate Impurity 2
CAS# 5891-21-4
M.F.: C5H9ClO
M.W.: 120.58 |
| |
| QH042427 | Hydroxychloroquine sulfate Impurity 1
CAS# 21617-18-5
M.F.: C9H5Cl2N
M.W.: 198.05 |
| |
| QC182533 | Canagliflozin Impurity 7
CAS# NA
M.F.: C24H25FO5S
M.W.: 444.52 |
| |
| QE200331 | Entecavir EP Impurity F
CAS# 649761-24-0
M.F.: C27H31N5O2Si
M.W.: 485.65 |
| |
| QP080504 | Phenytoin Sodium EP Impurity D
CAS# 5157-15-3
M.F.: C16H14N4O2
M.W.: 294.32 |
| |
| QT041243 | Tadalafil Impurity 21
CAS# NA
M.F.: C19H17ClN2O4
M.W.: 372.80 |
| |
| QT022001 | Terbutaline EP Impurity A
CAS# 99-10-5
M.F.: C7H6O4
M.W.: 154.12 |
| |
| QT060347 | Tofacitinib Impurity 21
CAS# NA
M.F.: C23H26N6O3S
M.W.: 466.56 |
| |
| QE131927 | Exemestane Impurity 1
CAS# NA
M.F.: C19H26O2
M.W.: 286.41 |
| |
| QO022031 | Obeticholic Acid Impurity 5
CAS# 1537866-49-1
M.F.: C26H46O3
M.W.: 406.65 |
| |
| QO022029 | Obeticholic Acid Impurity 3
CAS# 1908444-28-9
M.F.: C52H86O7
M.W.: 823.24 |
| |
| QO022027 | Obeticholic Acid Impurity 1
CAS# 1708092-13-0
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QO022028 | Obeticholic Acid Impurity 2
CAS# 915038-27-6
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QL191833 | Lesinurad Impurity 13
CAS# NA
M.F.: C17H13Br2N3O2S
M.W.: 483.18 |
| |
| QL191832 | Lesinurad Impurity 12
CAS# NA
M.F.: C17H12Br3N3O2S
M.W.: 562.07 |
| |
| QL191831 | Lesinurad Impurity 11
CAS# NA
M.F.: C17H14BrN3O2S
M.W.: 404.28 |
| |
| QL191824 | Lesinurad Impurity 4
CAS# 1533519-97-9
M.F.: C17H14BrN3O2S
M.W.: 404.28 |
| |
| QL191830 | Lesinurad Impurity 10
CAS# NA
M.F.: C16H14BrN3O2S
M.W.: 392.27 |
| |
| QL191828 | Lesinurad Impurity 8
CAS# 1158970-49-0
M.F.: C15H12BrN3O2S
M.W.: 378.25 |
| |
| QG131814 | Gimeracil Impurity 14
CAS# 89942-45-0
M.F.: C8H7NO
M.W.: 133.15 |
| |
| QH042406 | Hydroxychloroquine sulfate EP Impurity F
CAS# 6281-58-9
M.F.: C14H15ClN2
M.W.: 246.74 |
| |
| QH042405 | Hydroxychloroquine sulfate EP Impurity E
CAS# 10500-64-8
M.F.: C14H17ClN2O
M.W.: 264.75 |
| |
| QC182532 | Canagliflozin Impurity 6
CAS# 542-69-8
M.F.: C4H9I
M.W.: 184.02 |
| |
| QC182531 | Canagliflozin Impurity 5
CAS# NA
M.F.: C24H25FO5S
M.W.: 444.52 |
| |
| QC182530 | Canagliflozin Impurity 4
CAS# 2005454-69-1
M.F.: C18H15FS
M.W.: 282.38 |
| |
| QC182529 | Canagliflozin Impurity 3
CAS# 2338840-88-1
M.F.: C18H15FOS
M.W.: 298.37 |
| |
| QC182528 | Canagliflozin Impurity 2
CAS# NA
M.F.: C24H27FO6S
M.W.: 462.53 |
| |
| QA261930 | Azilsartan Impurity 2
CAS# 147403-52-9
M.F.: C26H22N4O5
M.W.: 470.48 |
| |
| QE201927 | LCZ696
CAS# 936623-90-4
M.F.: C48H55N6Na3O8.5/2H2O
M.W.: 912.96 45.05 |
| |
| QA261929 | Azilsartan Impurity 1
CAS# 1403474-70-3
M.F.: C27H24N4O5
M.W.: 484.50 |
| |
| QI071832 | Iguratimod Impurity 6
CAS# 76838-72-7
M.F.: C13H13NO2
M.W.: 215.25 |
| |
| QI071831 | Iguratimod Impurity 5
CAS# 84594-95-6
M.F.: C13H11NO4
M.W.: 245.24 |
| |
| QI071827 | Iguratimod Impurity 1
CAS# 16156-59-5
M.F.: C7H8O3S
M.W.: 172.20 |
| |
| QE151330 | Esomeprazole Impurity 13
CAS# 615-05-4;614-94-8(2HCl salt)
M.F.: C7H10N2O
M.W.: 138.17 |
| |
| QE151328 | Esomeprazole Impurity 11
CAS# 610-81-1
M.F.: C6H6N2O3
M.W.: 154.12 |
| |
| QC160729 | Clopidogrel Impurity 29
CAS# 53885-64-6
M.F.: C14H11Cl2NS
M.W.: 296.21 |
| |
| QT140688 | Tenofovir Impurity 54
CAS# NA
M.F.: C19H25N6O5P
M.W.: 448.41 |
| |
| QT140687 | Tenofovir Impurity 53
CAS# NA
M.F.: C21H29N6O5P
M.W.: 476.47 |
| |
| QT140684 | Tenofovir Impurity 50
CAS# NA
M.F.: C16H20N5O4P
M.W.: 377.33 |
| |
| QT140683 | Tenofovir Impurity 49
CAS# NA
M.F.: C16H20N5O4P
M.W.: 377.33 |
| |
| QT140682 | Tenofovir Impurity 48
CAS# 383365-04-6
M.F.: C21H29N6O5P
M.W.: 476.47 |
| |
| QP132610 | Promethazine Sulfone
CAS# 13754-56-8
M.F.: C17H20N2O2S
M.W.: 316.42 |
| |
| QC190604 | Caspofungin Impurity D
CAS# NA
M.F.: C50H82N8O16
M.W.: 1051.23 |
| |
| QC190602 | Caspofungin Impurity B
CAS# NA
M.F.: C52H88N10O15
M.W.: 1093.31 |
| |
| QC190610 | Caspofungin Impurity I
CAS# NA
M.F.: C52H88N10O15
M.W.: 1093.31 |
| |
| QG021800 | Glibornuride (Mixture of Diastereomers)
CAS# 26944-48-9
M.F.: C18H26N2O4S
M.W.: 366.48 |
| |
| QC061848 | Cefuroxime axetil dimer
CAS# 1202925-10-7
M.F.: C36H38N8O17S2
M.W.: 918.86 |
| |
| QT182628 | Terazosin EP Impurity N
CAS# 63074-07-7
M.F.: C9H16N2O2
M.W.: 184.24 |
| |
| QT182627 | Terazosin Impurity 1
CAS# 16874-33-2
M.F.: C5H8O3
M.W.: 116.12 |
| |
| QP136039 | Pidotimod Impurity 13
CAS# NA
M.F.: C8H13NO3S
M.W.: 203.26 |
| |
| QT022010 | Terbutaline Impurity 10
CAS# 52144-90-8;28924-20-1(HBr salt)
M.F.: C26H29NO3
M.W.: 403.51 |
| |
| QD171203 | Dequalinium chloride EP Impurity C
CAS# NA
M.F.: C50H69I3N6
M.W.: 1134.84 |
| |
| QD171202 | Dequalinium chloride EP Impurity B
CAS# 171980-52-2(Cl-)
M.F.: C30H39IN4
M.W.: 582.56 |
| |
| QD030432 | Diclofenac Impurity 32
CAS# 90798-25-7
M.F.: C10H9Cl2NO2
M.W.: 246.09 |
| |
| QD030431 | Diclofenac Impurity 31
CAS# NA
M.F.: C20H13Cl4NO2
M.W.: 441.13 |
| |
| QD030430 | Diclofenac Impurity 30
CAS# 123790-84-1
M.F.: C12H9BrClN
M.W.: 282.56 |
| |
| QD030428 | Diclofenac Impurity 28
CAS# NA
M.F.: C22H15Cl4NO4
M.W.: 499.17 |
| |
| QL141236 | Linagliptin Impurity 36
CAS# NA
M.F.: C10H6D3BrN4O2
M.W.: 300.13 |
| |
| QF226829 | Fasudil Impurity 3
CAS# 1423155-03-6
M.F.: C14H17N3O2S
M.W.: 291.37 |
| |
| QP181328 | Pramipexole Impurity 2
CAS# 1052691-22-1
M.F.: C10H19N3S
M.W.: 213.34 |
| |
| QD201927 | 5β-Dutasteride Impurity
CAS# 957229-52-6
M.F.: C27H30F6N2O2
M.W.: 528.53 |
| |
| QD201908 | Dutasteride EP Impurity G
CAS# 1430804-85-5
M.F.: C27H28F6N2O2
M.W.: 526.51 |
| |
| QN140438 | Intedanib Impurity 12
CAS# 1139453-98-7
M.F.: C14H20N4O3
M.W.: 292.33 |
| |
| QN140437 | Intedanib Impurity 11
CAS# 2653-16-9
M.F.: C9H9ClN2O3
M.W.: 228.63 |
| |
| QN140436 | Intedanib Impurity 10
CAS# 100-15-2
M.F.: C7H8N2O2
M.W.: 152.15 |
| |
| QN140435 | Intedanib Impurity 9
CAS# 98-07-7
M.F.: C7H5Cl3
M.W.: 195.47 |
| |
| QN140434 | Intedanib Impurity 8
CAS# 1125-88-8
M.F.: C9H12O2
M.W.: 152.19 |
| |
| QN140433 | Intedanib Impurity 7;
Guaiacol EP Impurity E
CAS# 93-58-3
M.F.: C8H8O2
M.W.: 136.15 |
| |
| QN140432 | Intedanib Impurity 6
CAS# 707-07-3
M.F.: C10H14O3
M.W.: 182.22 |
| |
| QN140431 | Intedanib Impurity 5
CAS# 40872-87-5
M.F.: C8H8ClNO2
M.W.: 185.61 |
| |
| QN140430 | Intedanib Impurity 4
CAS# 2840-28-0
M.F.: C7H6ClNO2
M.W.: 171.58 |
| |
| QN140429 | Intedanib Impurity 3
CAS# 1160293-27-5
M.F.: C13H13NO8
M.W.: 311.24 |
| |
| QN140428 | Intedanib Impurity 2
CAS# 14719-83-6
M.F.: C8H6ClNO4
M.W.: 215.59 |
| |
| QN140427 | Intedanib Impurity 1
CAS# 96-99-1
M.F.: C7H4ClNO4
M.W.: 201.56 |
| |
| QN032005 | Nicotinic Acid EP Impurity E;
Isoniazid EP Impurity A
CAS# 55-22-1
M.F.: C6H5NO2
M.W.: 123.11 |
| |
| QI210429 | Ibuprofen Impurity 3
CAS# NA
M.F.: C15H22O3
M.W.: 250.33 |
| |
| QI210428 | Ibuprofen Impurity 2
CAS# 623-61-0
M.F.: C5H10O3
M.W.: 118.13 |
| |
| QP122407 | Plerixafor Impurity G
CAS# 771464-86-9
M.F.: C46H84N12
M.W.: 805.24 |
| |
| QP122405 | Plerixafor Impurity E
CAS# 176252-20-3
M.F.: C18H32N4O
M.W.: 320.47 |
| |
| QP122404 | Plerixafor Hydrochloride
CAS# 155148-31-5
M.F.: C28H54N8
M.W.: 502.78 |
| |
| QI220222 | Ivabradine Impurity 3
CAS# 1132667-04-9;1204612-29-2(HCl salt)
M.F.: C12H17NO2
M.W.: 207.27 |
| |
| QE130401 | Emedastine EP Impurity F
CAS# NA
M.F.: C15H24N4O
M.W.: 276.38 |
| |
| QP136038 | Pidotimod Impurity 12
CAS# 4128-37-4
M.F.: C7H16N2O
M.W.: 144.21 |
| |
| QP136037 | Pidotimod Impurity 11
CAS# 42258-90-2
M.F.: C5H9NO2S
M.W.: 147.20 |
| |
| QE042236 | Edaravone Impurity 10
CAS# 53341-66-5
M.F.: C11H13NO3
M.W.: 207.23 |
| |
| QE042235 | Edaravone Impurity 9
CAS# 100-65-2
M.F.: C6H7NO
M.W.: 109.13 |
| |
| QE042234 | Edaravone Impurity 8
CAS# NA
M.F.: C10H12N2O
M.W.: 176.22 |
| |
| QE042233 | Edaravone Impurity 7
CAS# 92-43-3
M.F.: C9H10N2O
M.W.: 162.19 |
| |
| QE042230 | Edaravone Impurity 4
CAS# 177415-76-8
M.F.: C20H18N4O2
M.W.: 346.38 |
| |
| QD141627 | Donepezil Impurity 1;
Donepezil EP Impurity B
CAS# 2107-69-9
M.F.: C11H12O3
M.W.: 192.22 |
| |
| QC061847 | Cefuroxime Axetil Impurity 7
CAS# NA
M.F.: C9H11N3O5S
M.W.: 273.27 |
| |
| QC061846 | Cefuroxime Axetil Impurity 6
CAS# NA
M.F.: C15H17N3O8S
M.W.: 399.38 |
| |
| QC061843 | Cefuroxime Axetil Impurity 3
CAS# 69384-96-9
M.F.: C7H7NO4
M.W.: 169.13 |
| |
| QC061842 | Cefuroxime Axetil Impurity 2
CAS# NA
M.F.: C6H12O3
M.W.: 132.16 |
| |
| QC061841 | Cefuroxime Axetil Impurity 1
CAS# NA
M.F.: C4H6Br2O2
M.W.: 245.90 |
| |
| QP202239 | Pitavastatin Impurity 13
CAS# 2124275-54-1
M.F.: C13H22O5
M.W.: 258.31 |
| |
| QP202238 | Pitavastatin Impurity 12
CAS# NA
M.F.: C13H22O5
M.W.: 258.31 |
| |
| QF226828 | Fasudil Impurity 2
CAS# NA
M.F.: C9H7NO3S
M.W.: 209.22 |
| |
| QL130609 | Lamivudine EP Impurity I
CAS# 145918-75-8
M.F.: C8H11N3O4
M.W.: 213.19 |
| |
| QD190627 | Doxofylline Impurity 1
CAS# 1429636-74-7
M.F.: C10H16N4O3
M.W.: 240.26 |
| |
| QC180802 | Chlorphenamine EP Impurity B
CAS# 1202-34-2
M.F.: C10H9N3
M.W.: 171.20 |
| |
| QC180801 | Chlorphenamine EP Impurity A
CAS# 1246816-57-8
M.F.: C16H24ClN3
M.W.: 293.83 |
| |
| QE151316 | Esomeprazole Impurity 7
CAS# 727375-13-5
M.F.: C8H11NO2
M.W.: 153.18 |
| |
| QE151313 | Esomeprazole Impurity 4
CAS# 73590-93-9
M.F.: C8H10ClN.HCl
M.W.: 155.63 36.46 |
| |
| QL040302 | Lidocaine EP Impurity B;Lidocaine N-oxide
CAS# 2903-45-9
M.F.: C14H22N2O2
M.W.: 250.34 |
| |
| QL050315 | Lercanidipine Impurity 1
CAS# 74936-72-4
M.F.: C16H16N2O6
M.W.: 332.31 |
| |
| QC121201 | Cholecalciferol EP Impurity A;
trans-Cholecalciferol;trans-Vitamin D3
CAS# 22350-41-0
M.F.: C27H44O
M.W.: 384.64 |
| |
| QI220220 | Ivabradine Impurity 1
CAS# 2247881-26-9
M.F.: C26H34N2O5
M.W.: 454.56 |
| |
| QS120716 | Saxagliptin (S,R,S,R)-Isomer
CAS# 1564266-03-0
M.F.: C18H25N3O2
M.W.: 315.41 |
| |
| QS120711 | Saxagliptin (S,S,S,R)-Isomer
CAS# 1564265-93-5
M.F.: C18H25N3O2
M.W.: 315.41 |
| |
| QA260312 | Azacitidine Impurity L
CAS# 16352-06-0
M.F.: C4H6N4O
M.W.: 126.12 |
| |
| QA260310 | Azacitidine Impurity J
CAS# 1415316-72-1
M.F.: C12H16N4O7
M.W.: 328.28 |
| |
| QA260309 | Azacitidine Impurity I
CAS# NA
M.F.: C10H14N4O6
M.W.: 286.24 |
| |
| QA260308 | Azacitidine Impurity H
CAS# NA
M.F.: C9H14N4O5
M.W.: 258.23 |
| |
| QA260313 | Azacitidine Impurity 13
CAS# 105331-00-8
M.F.: C8H13N5O5
M.W.: 259.22 |
| |
| QA260307 | Azacitidine Impurity G
CAS# 504-08-5
M.F.: C3H5N5
M.W.: 111.11 |
| |
| QS142012 | Sunitinib Ketone Impurity
CAS# 2411816-47-0
M.F.: C22H25FN4O3
M.W.: 412.47 |
| |
| QE151310 | Esomeprazole Impurity 1
CAS# 862270-90-4
M.F.: C7H12Cl2N2O
M.W.: 211.09 |
| |
| QC042029 | Cefditoren pivaloyl
CAS# 878002-84-7
M.F.: C30H36N6O8S3
M.W.: 704.84 |
| |
| QA261928 | Azilsartan Impurity (U-3)
CAS# 1417576-00-1
M.F.: C28H20N4O8
M.W.: 540.48 |
| |
| QC120422 | Clindamycin Hydrochloride EP Impurity B;
Clindamycin B
CAS# 18323-43-8
M.F.: C17H31ClN2O5S
M.W.: 410.96 |
| |
| QP132029 | Pemetrexed Impurity 3
CAS# 1075-59-8
M.F.: C5H7N3O3
M.W.: 157.13 |
| |
| QP132028 | Pemetrexed Impurity 2
CAS# NA
M.F.: C22H25N5O6
M.W.: 455.46 |
| |
| QP132027 | Pemetrexed Impurity 1;
DL-Glutamic acid
CAS# 617-65-2
M.F.: C5H9NO4
M.W.: 147.13 |
| |
| QC042419 | Cefadroxil Dimer Trifluoroacetate
CAS# NA
M.F.: C34H33F3N6O11S2
M.W.: 822.78 |
| |
| QC042417 | N-Phenylglycyl delta-3 cefadroxil
CAS# NA
M.F.: C24H24N4O7S
M.W.: 512.53 |
| |
| QC042416 | Cefadroxil ethyl homolog
CAS# 2243976-70-5
M.F.: C17H19N3O5S
M.W.: 377.41 |
| |
| QC042406 | Cefadroxil EP Impurity F
CAS# NA
M.F.: C24H24N4O7S
M.W.: 512.53 |
| |
| QC042404 | Cefadroxil EP Impurity D;L-Cefadroxil
CAS# 144790-28-3
M.F.: C16H17N3O5S
M.W.: 363.39 |
| |
| QC042403 | Cefadroxil EP Impurity C
CAS# NA
M.F.: C16H19N3O6S
M.W.: 381.40 |
| |
| QP136036 | Pidotimod Impurity 10
CAS# NA
M.F.: C6H11NO3S
M.W.: 177.22 |
| |
| QC160610 | Ciprofloxacin EP Impurity C HCl
CAS# 528851-31-2
M.F.: C15H17ClFN3O3
M.W.: 341.77 |
| |
| QP202228 | Pitavastatin Impurity 2
CAS# 1044518-75-3
M.F.: C13H22O5
M.W.: 258.31 |
| |
| QT140645 | Tenofovir Impurity 19
CAS# 2053424-82-9;2055343-42-3(fumarate)
M.F.: C21H29N6O5P
M.W.: 476.47 |
| |
| QT060345 | Tofacitinib Impurity 20
CAS# 1092578-48-7+1092578-46-5
M.F.: C16H20N6O
M.W.: 312.37 |
| |
| QP160414 | Paliperidone hydroxybenzoyl analog
CAS# 152542-03-5
M.F.: C23H28FN3O4
M.W.: 429.48 |
| |
| QS120635 | Solifenacin EP Impurity I
CAS# 180272-28-0
M.F.: C23H26N2O3
M.W.: 378.46 |
| |
| QS120634 | Solifenacin EP Impurity H
CAS# 732228-02-3;862207-71-4(succinate salt)
M.F.: C23H26N2O2
M.W.: 362.46 |
| |
| QS120630 | Solifenacin EP Impurity D
CAS# NA
M.F.: C31H28N2O
M.W.: 444.57 |
| |
| QS120629 | Solifenacin EP Impurity C
CAS# 1534326-81-2
M.F.: C31H28N2O
M.W.: 444.57 |
| |
| QS120627 | Solifenacin EP Impurity A
CAS# 118864-75-8
M.F.: C15H15N
M.W.: 209.29 |
| |
| QP182010 | Paracetamol EP Impurity J
CAS# 539-03-7
M.F.: C8H8ClNO
M.W.: 169.61 |
| |
| QP182009 | Paracetamol EP Impurity I
CAS# 118-93-4
M.F.: C8H8O2
M.W.: 136.15 |
| |
| QP182008 | Paracetamol EP Impurity H
CAS# 2623-33-8
M.F.: C10H11NO3
M.W.: 193.20 |
| |
| QP182007 | Paracetamol EP Impurity G
CAS# 34523-34-7
M.F.: C8H9NO2
M.W.: 151.16 |
| |
| QP182005 | Paracetamol EP Impurity E
CAS# 99-93-4
M.F.: C8H8O2
M.W.: 136.15 |
| |
| QP182003 | Paracetamol EP Impurity C
CAS# 3964-54-3
M.F.: C8H8ClNO2
M.W.: 185.61 |
| |
| QP182002 | Paracetamol EP Impurity B
CAS# 1693-37-4
M.F.: C9H11NO2
M.W.: 165.19 |
| |
| QP182001 | Paracetamol EP Impurity A
CAS# 614-80-2
M.F.: C8H9NO2
M.W.: 151.16 |
| |
| QT081106 | Trihexyphenidyl Impurity F
CAS# NA
M.F.: C20H29N
M.W.: 283.45 |
| |
| QT081101 | Trihexyphenidyl Impurity A
CAS# 886-06-6 ;73-63-2(free base)
M.F.: C14H20ClNO
M.W.: 253.77 |
| |
| QL130610 | Lamivudine EP Impurity J
CAS# 145986-07-8
M.F.: C8H10N2O4S
M.W.: 230.24 |
| |
| QP182213 | Peramivir Amino acid Impurity
CAS# NA
M.F.: C6H9NO2
M.W.: 127.14 |
| |
| QP182212 | Peramivir Methyl Ester Impurity
CAS# NA
M.F.: C7H11NO2
M.W.: 141.17 |
| |
| QP182208 | Peramivir Impurity 8
CAS# 229614-37-3;1352062-19-1(HCl salt)
M.F.: C14H26N2O4
M.W.: 286.37 |
| |
| QP182207 | Peramivir Impurity 7
CAS# NA
M.F.: C15H28N2O4
M.W.: 300.39 |
| |
| QP182210 | Peramivir Impurity 10
CAS# 316173-29-2
M.F.: C18H34N2O5
M.W.: 358.47 |
| |
| QP182206 | Peramivir Impurity 6
CAS# 1988779-15-2
M.F.: C20H36N2O6
M.W.: 400.51 |
| |
| QP182204 | Peramivir Impurity 4
CAS# 383910-24-5
M.F.: C18H30N2O5
M.W.: 354.44 |
| |
| QC160928 | Cefpirome Impurity 2;
Cefepime EP Impurity C
CAS# 104301-63-5
M.F.: C8H10N4O3S
M.W.: 242.26 |
| |
| QP182202 | Peramivir Impurity 2
CAS# 229613-93-8
M.F.: C18H30N2O5
M.W.: 354.44 |
| |
| QP182211 | Peramivir Impurity 11
CAS# NA
M.F.: C15H28N4O4
M.W.: 328.41 |
| |
| QF120401 | Fluocinonide Impurity A
CAS# NA
M.F.: C26H30F2O7
M.W.: 492.51 |
| |
| QL162001 | Lapatinib Impurity 1 (O-De(3-fluorobenzyl) Lapatinib)
CAS# 1268997-70-1
M.F.: C22H21ClN4O4S
M.W.: 472.95 |
| |
| QA202202 | Atorvastatin EP Impurity B
CAS# NA
M.F.: C33H34FN2O5 . 1/2Ca
M.W.: 577.67 |
| |
| QC030331 | Cinacalcet USP RC E
CAS# 78573-45-2
M.F.: C10H11F3O
M.W.: 204.19 |
| |
| QC030327 | Cinacalcet Impurity 27
CAS# 21172-43-0
M.F.: C11H13F3O3S
M.W.: 282.28 |
| |
| QG031902 | Glucosamine EP Impurity B;Fructosazine
CAS# 13185-73-4
M.F.: C12H20N2O8
M.W.: 320.30 |
| |
| QC160935 | Cefpirome Impurity 9
CAS# NA
M.F.: C22H22N6O6S2
M.W.: 530.58 |
| |
| QC160933 | Cefpirome Impurity 7
CAS# NA
M.F.: C22H22N6O5S2
M.W.: 514.58 |
| |
| QC160930 | Cefpirome Impurity 4
CAS# NA
M.F.: C22H22N6O5S2
M.W.: 514.58 |
| |
| QI200330 | Irinotecan Impurity 4
CAS# 176515-52-9
M.F.: C32H38N4O4
M.W.: 542.68 |
| |
| QI210616 | Ibuprofen EP Impurity P
CAS# 36039-36-8
M.F.: C13H20O
M.W.: 192.30 |
| |
| QI210614 | Ibuprofen EP Impurity N
CAS# 3585-52-2
M.F.: C11H14O2
M.W.: 178.23 |
| |
| QI210613 | Ibuprofen EP Impurity M
CAS# 60057-62-7
M.F.: C13H18O3
M.W.: 222.28 |
| |
| QI210610 | Ibuprofen EP Impurity J
CAS# 65813-55-0
M.F.: C13H16O3
M.W.: 220.27 |
| |
| QI210606 | Ibuprofen EP Impurity F
CAS# 65322-85-2
M.F.: C13H18O2
M.W.: 206.29 |
| |
| QI210604 | Ibuprofen EP Impurity D
CAS# 938-94-3
M.F.: C10H12O2
M.W.: 164.21 |
| |
| QP182444 | Parecoxib Sodium Impurity M
CAS# 75115-00-3
M.F.: C16H13NO
M.W.: 235.28 |
| |
| QB201427 | Bortezomib Impurity 1
CAS# 289472-78-2
M.F.: C19H24N4O3
M.W.: 356.42 |
| |
| QC120309 | Celecoxib Impurity I
CAS# 720-94-5
M.F.: C11H9F3O2
M.W.: 230.18 |
| |
| QL141232 | Lenalidomide Impurity 7
CAS# NA
M.F.: C13H16N4O3
M.W.: 276.29 |
| |
| QC060406 | Cefodizime Impurity F
CAS# NA
M.F.: C20H20N6O7S4
M.W.: 584.67 |
| |
| QF022452 | Febuxostat Impurity 8
CAS# 528607-60-5
M.F.: C12H13NO3
M.W.: 219.24 |
| |
| QF022451 | Febuxostat Impurity 25
CAS# NA
M.F.: C16H18N2O4S
M.W.: 334.39 |
| |
| QT060344 | Tofacitinib Impurity 19
CAS# NA
M.F.: C14H22N2O
M.W.: 234.34 |
| |
| QL062427 | Levofloxacin Impurity 1;
Ofloxacin EP Impurity A
CAS# 82419-35-0
M.F.: C13H9F2NO4
M.W.: 281.21 |
| |
| QC030804 | Cinchocaine EP Impurity D
CAS# 10222-61-4
M.F.: C14H15NO3
M.W.: 245.27 |
| |
| QC030803 | Cinchocaine EP Impurity C
CAS# 87864-08-2
M.F.: C16H21N3O2
M.W.: 287.36 |
| |
| QC030802 | Cinchocaine EP Impurity B
CAS# 15733-89-8
M.F.: C10H7NO3
M.W.: 189.17 |
| |
| QC030801 | Cinchocaine EP Impurity A
CAS# 87864-14-0
M.F.: C16H20ClN3O
M.W.: 305.80 |
| |
| QL141204 | Lenalidomide Impurity D
CAS# 295357-66-3
M.F.: C13H14N2O5
M.W.: 278.26 |
| |
| QC061728 | Cefoperazone Impurity 1
CAS# 62893-24-7
M.F.: C15H17N3O6
M.W.: 335.31 |
| |
| QL201522 | Letrozole Impurity 22
CAS# 123-56-8
M.F.: C4H5NO2
M.W.: 99.09 |
| |
| QL201513 | Letrozole Impurity 13
CAS# 128-08-5
M.F.: C4H4BrNO2
M.W.: 177.98 |
| |
| QL201521 | Letrozole Impurity 21
CAS# 394-47-8
M.F.: C7H4FN
M.W.: 121.11 |
| |
| QL201516 | Letrozole Impurity 16
CAS# 529-19-1
M.F.: C8H7N
M.W.: 117.15 |
| |
| QL201508 | Letrozole Impurity 8
CAS# 22115-41-9
M.F.: C8H6BrN
M.W.: 196.04 |
| |
| QL201505 | Letrozole Impurity 3
CAS# 28188-41-2
M.F.: C8H6BrN
M.W.: 196.04 |
| |
| QC132426 | Cefmenoxime Impurity 26
CAS# 94088-75-2
M.F.: C13H10N4O2S3
M.W.: 350.44 |
| |
| QC132420 | Cefmenoxime Impurity 20
CAS# 149-30-4
M.F.: C7H5NS2
M.W.: 167.25 |
| |
| QC132415 | Cefmenoxime Impurity 15
CAS# 120-78-5
M.F.: C14H8N2S4
M.W.: 332.49 |
| |
| QC132413 | Cefmenoxime Impurity 13
CAS# 126437-69-2
M.F.: C11H13N5O3S2
M.W.: 327.38 |
| |
| QC132412 | Cefmenoxime Impurity 12
CAS# 392718-98-8
M.F.: C4H6N4OS
M.W.: 158.18 |
| |
| QC132408 | Cefmenoxime Impurity 8
CAS# NA
M.F.: C12H14N6O4S2
M.W.: 370.41 |
| |
| QC132402 | Cefmenoxime Impurity 2
CAS# NA
M.F.: C16H21N7O6S2
M.W.: 471.51 |
| |
| QS161828 | Sulpiride Impurity 2
CAS# NA
M.F.: C15H22N2O5S
M.W.: 342.41 |
| |
| QT060343 | Tofacitinib Impurity 18
CAS# 2028267-73-2
M.F.: C16H20N6O2
M.W.: 328.37 |
| |
| QP182443 | Parecoxib Impurity 11
CAS# 181696-12-8
M.F.: C16H14N2O3S
M.W.: 314.36 |
| |
| QP202233 | Pitavastatin Impurity 7
CAS# NA
M.F.: C32H36FNO4
M.W.: 517.65 |
| |
| QP202236 | Pitavastatin Impurity 10
CAS# NA
M.F.: C32H36FNO4
M.W.: 517.65 |
| |
| QP202231 | Pitavastatin Impurity 5
CAS# NA
M.F.: C32H36FNO4
M.W.: 517.65 |
| |
| QL052020 | Levetiracetam EP Impurity E
CAS# 3886-69-9
M.F.: C8H11N
M.W.: 121.18 |
| |
| QI091612 | Ipratropium Bromide Impurity L
CAS# 3979-14-4
M.F.: C11H14O3
M.W.: 194.23 |
| |
| QI091611 | Ipratropium Bromide Impurity K
CAS# 17838-69-6
M.F.: C11H12O3
M.W.: 192.21 |
| |
| QI091610 | Ipratropium Bromide Impurity J
CAS# NA
M.F.: C13H24BrNO2
M.W.: 306.24 |
| |
| QI091609 | Ipratropium Bromide Impurity I
CAS# 3423-28-7
M.F.: C10H17NO
M.W.: 167.25 |
| |
| QI091608 | Ipratropium Bromide Impurity H
CAS# NA
M.F.: C22H32BrNO4
M.W.: 454.40 |
| |
| QC061313 | Cefotiam Impurity 13
CAS# NA
M.F.: C18H25N9O5S3
M.W.: 543.64 |
| |
| QS061904 | Sulfasalazine EP Impurity D
CAS# 66364-70-3
M.F.: C17H14N4O3S
M.W.: 354.39 |
| |
| QE201207 | Estriol EP Impurity G
CAS# 793-89-5
M.F.: C18H24O3
M.W.: 288.39 |
| |
| QE161229 | Epalrestat Impurity 3
CAS# 682775-71-9
M.F.: C17H17NO3S2
M.W.: 347.45 |
| |
| QP132018 | Pemetrexed Impurity F
CAS# NA
M.F.: C20H19N5Na2O7
M.W.: 487.37 |
| |
| QV122212 | Valaciclovir EP Impurity L;Aciclovir EP Impurity K
CAS# 1797131-64-6
M.F.: C17H22N10O6
M.W.: 462.42 |
| |
| QC120903 | Calcipotriol EP Impurity C;
(5E)-Calcipotriol
CAS# 113082-99-8
M.F.: C27H40O3
M.W.: 412.62 |
| |
| QE161228 | Epalrestat Impurity 2
CAS# 23176-01-4
M.F.: C7H9NO3S2
M.W.: 219.28 |
| |
| QE161227 | Epalrestat Impurity 1
CAS# 82159-06-6
M.F.: C12H9NO3S2
M.W.: 279.33 |
| |
| QC120414 | Clindamycin B 2-Palmitate HCl
CAS# 68206-99-5(base)
M.F.: C33H61ClN2O6S HCl
M.W.: 649.37 36.46 |
| |
| QC120413 | Clindamycin 2-Palmitate HCl
CAS# 25507-04-4
M.F.: C34H64Cl2N2O6S
M.W.: 699.85 |
| |
| QC221207 | Clavulanate Potassium EP Impurity G
CAS# 374816-32-7
M.F.: C13H15NO6
M.W.: 281.26 |
| |
| QC221206 | Clavulanate Potassium EP Impurity F
CAS# 1260857-16-6
M.F.: C13H14N2O5
M.W.: 278.26 |
| |
| QC221205 | Clavulanate Potassium EP Impurity E
CAS# 1260617-10-4
M.F.: C16H18N2O10
M.W.: 398.32 |
| |
| QC221204 | Clavulanate Potassium EP Impurity D
CAS# 404839-11-8
M.F.: C7H9NO3
M.W.: 155.15 |
| |
| QC221203 | Clavulanate Potassium EP Impurity C
CAS# 86917-74-0
M.F.: C10H16N2O2
M.W.: 196.25 |
| |
| QC221202 | Clavulanate Potassium EP Impurity B
CAS# 96681-85-5
M.F.: C11H16N2O4
M.W.: 240.26 |
| |
| QP020330 | Palbociclib Impurity 4
CAS# 1376615-91-6
M.F.: C24H31N7O2
M.W.: 449.56 |
| |
| QC162635 | Cefprozil Impurity 35
CAS# NA
M.F.: C26H26N4O7S
M.W.: 538.57 |
| |
| QF121304 | Flumazenil EP Impurity D
CAS# 78755-80-3
M.F.: C10H9FN2O2
M.W.: 208.19 |
| |
| QF121305 | Flumazenil EP Impurity E
CAS# 78756-03-3
M.F.: C15H15N3O3
M.W.: 285.3 |
| |
| QC182527 | Canagliflozin Dimer Impurity 1
CAS# NA
M.F.: C48H48F2O10S2
M.W.: 887.02 |
| |
| QL141201 | Lenalidomide Impurity A
CAS# 1198299-72-7
M.F.: C13H13N3O6
M.W.: 307.26 |
| |
| QR121602 | rac-Lipoic Acid Impurity 2 (S-Oxide)
CAS# 6992-30-9
M.F.: C8H14O3S2
M.W.: 222.33 |
| |
| QR121601 | rac-Lipoic Acid Impurity 1 (S-Oxide)
CAS# 108015-78-7
M.F.: C8H14O3S2
M.W.: 222.33 |
| |
| QA262007 | Azathioprine EP Impurity G
CAS# 5581-52-2
M.F.: C9H8N8O2S
M.W.: 292.28 |
| |
| QA262005 | Azathioprine EP Impurity E
CAS# 35681-68-6 (sodium salt)
M.F.: C4H4N3NaO3
M.W.: 165.08 |
| |
| QA262004 | Azathioprine EP Impurity D
CAS# 6339-54-4
M.F.: C4H5N3O2S
M.W.: 159.17 |
| |
| QA262002 | Azathioprine EP Impurity B
CAS# 157930-13-7
M.F.: C5H4N4S
M.W.: 152.18 |
| |
| QA262001 | Azathioprine EP Impurity A
CAS# 4531-54-8
M.F.: C4H6N4O2
M.W.: 142.12 |
| |
| QH040310 | Hydrocortisone EP Impurity J
CAS# 16463-74-4
M.F.: C23H32O6
M.W.: 404.50 |
| |
| QH040308 | Hydrocortisone EP Impurity H
CAS# NA
M.F.: C21H30O6
M.W.: 378.46 |
| |
| QH040305 | Hydrocortisone EP Impurity E
CAS# 600-99-7
M.F.: C21H28O5
M.W.: 360.44 |
| |
| QC061429 | Cefdinir Related Compound B
CAS# 79350-10-0
M.F.: C14H14N4O4S2
M.W.: 366.41 |
| |
| QC061428 | Cefdinir USP Related Compound A
CAS# 178422-42-9
M.F.: C14H15N5O6S2
M.W.: 413.43 |
| |
| QC061427 | Cefdinir Impurity 1
CAS# NA
M.F.: C13H13N5O5S2
M.W.: 383.41 |
| |
| QP136032 | Pidotimod Impurity 6
CAS# NA
M.F.: C9H12N2O4S
M.W.: 244.27 |
| |
| QP136030 | Pidotimod Impurity 4
CAS# 1116-22-9
M.F.: C10H16N2O7
M.W.: 276.24 |
| |
| QA260306 | Azacitidine Impurity F
CAS# NA
M.F.: C13H20N4O9
M.W.: 376.32 |
| |
| QC022010 | Cabazitaxel Impurity 10
CAS# 145514-62-1
M.F.: C14H19NO5
M.W.: 281.31 |
| |
| QC022015 | Cabazitaxel Impurity 15
CAS# 859498-34-3
M.F.: C22H25NO6
M.W.: 399.44 |
| |
| QC022026 | Cabazitaxel Impurity 26
CAS# NA
M.F.: C30H38O10
M.W.: 558.62 |
| |
| QC202405 | Cefotaxime EP Impurity E;Ceftriaxone EP Impurity B
CAS# 66340-33-8
M.F.: C14H13N5O5S2
M.W.: 395.41 |
| |
| QC202404 | Cefotaxime EP Impurity D Sodium Salt
CAS# 65715-12-0;63527-53-7(free base)
M.F.: C16H16N5NaO7S2
M.W.: 477.45 |
| |
| QC202401 | Cefotaxime EP Impurity A
CAS# 65052-63-3
M.F.: C14H15N5O5S2
M.W.: 397.42 |
| |
| QL011307 | Lamotrigine EP Impurity G
CAS# 38943-76-9
M.F.: C9H7Cl2N5
M.W.: 256.09 |
| |
| QL011305 | Lamotrigine EP Impurity E
CAS# 50-45-3
M.F.: C7H4Cl2O2
M.W.: 191.01 |
| |
| QL011302 | Lamotrigine EP Impurity B
CAS# 94213-24-8
M.F.: C9H7Cl2N5
M.W.: 256.09 |
| |
| QC162630 | Cefprozil Impurity 4
CAS# NA
M.F.: C36H36N6O9S2
M.W.: 760.84 |
| |
| QC162628 | Cefprozil Impurity 2
CAS# NA
M.F.: C18H19N3O5S
M.W.: 389.43 |
| |
| QC162627 | Cefprozil Impurity 1
CAS# NA
M.F.: C17H19N3O6S
M.W.: 393.41 |
| |
| QC162614 | Cefprozil EP Impurity N
CAS# NA
M.F.: C21H23N3O7S
M.W.: 461.49 |
| |
| QC162613 | Cefprozil EP Impurity M
CAS# NA
M.F.: C21H23N3O7S
M.W.: 461.49 |
| |
| QC162611 | Cefprozil EP Impurity K
CAS# NA
M.F.: C18H19N3O5S
M.W.: 389.43 |
| |
| QC162610 | Cefprozil EP Impurity J
CAS# NA
M.F.: C26H26N4O7S
M.W.: 538.57 |
| |
| QC162609 | Cefprozil EP Impurity I
CAS# NA
M.F.: C18H21N3O6S
M.W.: 407.44 |
| |
| QC162608 | Cefprozil EP Impurity H
CAS# NA
M.F.: C26H26N4O7S
M.W.: 538.57 |
| |
| QC162607 | Cefprozil EP Impurity G
CAS# NA
M.F.: C18H21N3O6S
M.W.: 407.44 |
| |
| QC162605 | Cefprozil EP Impurity E
CAS# NA
M.F.: C26H26N4O7S
M.W.: 538.57 |
| |
| QC162604 | Cefprozil EP Impurity D
CAS# 106447-44-3
M.F.: C10H12N2O3S
M.W.: 240.28 |
| |
| QC162602 | Cefprozil EP Impurity B;Cefadroxil
CAS# 50370-12-2;66592-87-8(monohydrate)
M.F.: C16H17N3O5S
M.W.: 363.39 |
| |
| QL201534 | Letrozole Impurity 7
CAS# 134521-16-7
M.F.: C15H10N2O
M.W.: 234.25 |
| |
| QL201533 | Letrozole Impurity D
CAS# 10466-37-2
M.F.: C15H10N2
M.W.: 218.25 |
| |
| QL201532 | Letrozole Impurity 6
CAS# NA
M.F.: C26H18N6
M.W.: 414.46 |
| |
| QL201531 | Letrozole Impurity 5
CAS# 1644566-39-1
M.F.: C17H13N3O4
M.W.: 323.3 |
| |
| QL201530 | Letrozole Impurity 4
CAS# NA
M.F.: C18H13N5
M.W.: 299.33 |
| |
| QI591803 | Imidacloprid Guanidine Impurity
CAS# NA
M.F.: C9H11ClN4
M.W.: 210.66 |
| |
| QI591802 | Imidacloprid Nitrosimine Impurity
CAS# NA
M.F.: C9H10ClN5O
M.W.: 239.66 |
| |
| QI210624 | Ibuprofen Impurity X
CAS# NA
M.F.: C22H29NO3
M.W.: 355.47 |
| |
| QO022016 | 6-epi-Obeticholic Acid
CAS# 915038-27-6
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QK202007 | Ketotifen EP Impurity G
CAS# 43076-16-0
M.F.: C19H17NO2S
M.W.: 323.41 |
| |
| QK202005 | Ketotifen EP Impurity E
CAS# 1346603-71-1
M.F.: C19H19NOS
M.W.: 309.43 |
| |
| QK202004 | Ketotifen EP Impurity D
CAS# 88456-70-6
M.F.: C19H19NO2S
M.W.: 325.42 |
| |
| QK202003 | Ketotifen EP Impurity C
CAS# 126939-27-3
M.F.: C19H21NO2S
M.W.: 327.44 |
| |
| QK202001 | Ketotifen EP Impurity A
CAS# 4673-38-5
M.F.: C19H19NS
M.W.: 293.43 |
| |
| QD030408 | Diclofenac EP Impurity F
CAS# 560075-65-2
M.F.: C14H10Cl3NO
M.W.: 314.59 |
| |
| QF226813 | Fasudil Impurity M
CAS# NA
M.F.: C14H18ClN3O2S
M.W.: 327.83 |
| |
| QI200310 | Irinotecan Impurity 10
CAS# 176515-52-9
M.F.: C32H38N4O4
M.W.: 542.67 |
| |
| QE201609 | Eletriptan Impurity 9
CAS# 143322-57-0
M.F.: C14H17BrN2
M.W.: 293.21 |
| |
| QP181510 | (S)-Propranolol HCl
CAS# 4199-10-4
M.F.: C16H22ClNO2
M.W.: 295.8 |
| |
| QA260305 | Azacitidine Impurity E
CAS# 3530-56-1
M.F.: C9H13N3O5
M.W.: 243.22 |
| |
| QC160316 | Capecitabine Impurity 16
CAS# NA
M.F.: C13H16FN3O6
M.W.: 329.28 |
| |
| QC160313 | Capecitabine EP Impurity C
CAS# 161599-46-8
M.F.: C13H16FN3O6
M.W.: 329.28 |
| |
| QC160308 | Capecitabine Impurity 8
CAS# 1262133-64-1
M.F.: C20H30FN3O9
M.W.: 475.48 |
| |
| QA032030 | Acotiamide Impurity 4
CAS# NA
M.F.: C13H14N2O4S
M.W.: 294.33 |
| |
| QC181310 | Clarithromycin EP Impurity M
CAS# 127182-43-8
M.F.: C37H68N2O13
M.W.: 748.94 |
| |
| QC031903 | Cyclophosphamide USP RC C
CAS# 1071-28-9
M.F.: C3H10NO4P
M.W.: 155.09 |
| |
| QC181300 | Clarithromycin
CAS# 81103-11-9
M.F.: C38H69NO13
M.W.: 747.95 |
| |
| QC181318 | Clarithromycin Impurity R;
Erythromycin EP Impurity B;
3″-N-Demethylerythromycin A
CAS# 992-62-1
M.F.: C36H65NO13
M.W.: 719.90 |
| |
| QC181306 | Clarithromycin EP Impurity F
CAS# 128940-83-0
M.F.: C39H71NO13
M.W.: 761.98 |
| |
| QC181305 | Clarithromycin EP Impurity E;
6,11-di-O-methylerythromycin A
CAS# 81103-14-2
M.F.: C39H71NO13
M.W.: 761.98 |
| |
| QP136028 | Pidotimod Impurity 2
CAS# NA
M.F.: C9H12N2O5S
M.W.: 260.27 |
| |
| QT130202 | Trimebutine Impurity B
CAS# 144095-19-2
M.F.: C10H14N2O
M.W.: 178.23 |
| |
| QT130201 | Trimebutine Impurity A
CAS# 298689-33-5
M.F.: C10H13ClN2
M.W.: 196.68 |
| |
| QC031207 | Cefaclor EP Impurity G
CAS# NA
M.F.: C16H17N3O4S
M.W.: 347.40 |
| |
| QC062007 | Cefathiamidine Impurity G
CAS# NA
M.F.: C17H26N4O4S2
M.W.: 414.54 |
| |
| QL201504 | Letrozole Impurity 2
CAS# [NA]
M.F.: C17H11N5
M.W.: 285.30 |
| |
| QC160717 | Clopidogrel N-Methyl Impurity I HCl
CAS# 1346605-15-9 (free base)
M.F.: C16H19Cl2NO2S
M.W.: 360.3 |
| |
| QC160716 | Clopidogrel Ethyl Ester Sulfate
CAS# 1332612-57-3
M.F.: C17H20ClNO6S2
M.W.: 433.93 |
| |
| QE200330 | Entecavir EP Impurity D
CAS# 1367369-80-9
M.F.: C12H15N5O3
M.W.: 277.29 |
| |
| QD121819 | USP Desloratadine Related Compound A
CAS# 117796-50-6
M.F.: C19H19BrN2
M.W.: 355.27 |
| |
| QU190409 | Ursodeoxycholic Acid EP Impurity I
CAS# 130593-75-8
M.F.: C24H42O3
M.W.: 378.60 |
| |
| QU190407 | Ursodeoxycholic Acid EP Impurity G;
Chenodeoxycholic acid EP Impurity G
CAS# 10538-55-3
M.F.: C25H42O4
M.W.: 406.60 |
| |
| QU190408 | Ursodeoxycholic Acid EP Impurity H
CAS# 78919-26-3
M.F.: C24H40O4
M.W.: 392.58 |
| |
| QU190406 | Ursodeoxycholic Acid EP Impurity F;
Chenodeoxycholic acid EP Impurity F
CAS# 4651-67-6
M.F.: C24H38O4
M.W.: 390.56 |
| |
| QU190405 | Ursodeoxycholic Acid EP Impurity E;
Chenodeoxycholic acid EP Impurity E;
Deoxycholic acid
CAS# 83-44-3;302-95-4(Na salt)
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QU190404 | Ursodeoxycholic Acid EP Impurity D;
Chenodeoxycholic acid EP Impurity D
CAS# 2955-27-3
M.F.: C24H40O5
M.W.: 408.58 |
| |
| QU190403 | Ursodeoxycholic Acid EP Impurity C;
Chenodeoxycholic acid EP Impurity C;
Lithocholic acid
CAS# 434-13-9
M.F.: C24H40O3
M.W.: 376.57 |
| |
| QU190402 | Ursodeoxycholic Acid EP Impurity B;
Chenodeoxycholic acid EP Impurity B
CAS# 81-25-4
M.F.: C24H40O5
M.W.: 408.57 |
| |
| QU190401 | Ursodeoxycholic Acid EP Impurity A ;
Chenodeoxycholic acid
CAS# 474-25-9
M.F.: C24H40O4
M.W.: 392.57 |
| |
| QF226812 | Fasudil Impurity L
CAS# NA
M.F.: C14H17N3O3S
M.W.: 307.37 |
| |
| QC031231 | Cefaclor Impurity 5
CAS# NA
M.F.: C30H26Cl2N6O7S2
M.W.: 717.59 |
| |
| QC031230 | Cefaclor Impurity 4
CAS# NA
M.F.: C23H21ClN4O5S
M.W.: 500.95 |
| |
| QC031229 | Cefaclor Impurity 3
CAS# NA
M.F.: C23H21ClN4O5S
M.W.: 500.95 |
| |
| QC031228 | Cefaclor Impurity 2
CAS# NA
M.F.: C15H16ClN3O4S
M.W.: 369.82 |
| |
| QD141616 | Donepezil Impurity P
CAS# NA
M.F.: C24H31NO2
M.W.: 365.51 |
| |
| QD141615 | Donepezil Impurity O
CAS# 120014-07-5
M.F.: C24H27NO3
M.W.: 377.49 |
| |
| QL142623 | Linezolid Impurity N;rac-Linezolid
CAS# 224323-50-6
M.F.: C16H20FN3O4
M.W.: 337.35 |
| |
| QL040308 | Lidocaine EP Impurity H
CAS# 1131-01-7
M.F.: C10H12ClNO
M.W.: 197.67 |
| |
| QL040303 | Lidocaine EP Impurity C
CAS# 2198-53-0
M.F.: C10H13NO
M.W.: 163.22 |
| |
| QD192400 | Desoximetasone;
Dexamethasone EP Impurity F
CAS# 382-67-2
M.F.: C22H29FO4
M.W.: 376.46 |
| |
| QL040301 | Lidocaine EP Impurity A;Xylazine EP Impurity A;
Ropivacaine EP Impurity H;Bupivacaine EP Impurity F;
Mepivacaine EP Impurity A
CAS# 87-62-7;21436-98-6(HCl salt)
M.F.: C8H11N
M.W.: 121.18 |
| |
| QC121801 | Chloroquine Impurity A
CAS# 6281-58-9
M.F.: C14H15ClN2
M.W.: 246.74 |
| |
| QE200210 | Eltrombopag Dimer Impurity
CAS# NA
M.F.: C50H42N8O8
M.W.: 882.94 |
| |
| QE201600 | Eletriptan
CAS# 143322-58-1;177834-92-3(HBr salt)
M.F.: C22H26N2O2S
M.W.: 382.52 |
| |
| QE201620 | Eletriptan N-Oxide
CAS# 1217641-89-8
M.F.: C22H26N2O3S
M.W.: 398.52 |
| |
| QC031610 | E-Cefcapene Pivoxil
CAS# NA
M.F.: C23H29N5O8S2
M.W.: 567.64 |
| |
| QC202406 | Cefotaxime EP Impurity F
CAS# 175032-97-0
M.F.: C30H30N10O12S4
M.W.: 850.88 |
| |
| QB031211 | Bicalutamide EP Impurity F
CAS# 1080647-26-2
M.F.: C18H14F4N2O3S
M.W.: 414.37 |
| |
| QE181410 | Eplerenone Impurity J (11α-Hydroxy Canrenone)
CAS# NA
M.F.: C22H28O4
M.W.: 356.46 |
| |
| QE181408 | Eplerenone EP Impurity D
CAS# 209253-82-7
M.F.: C23H28O6
M.W.: 400.46 |
| |
| QE181407 | Eplerenone EP Impurity C
CAS# NA
M.F.: C24H30O5
M.W.: 398.49 |
| |
| QB162228 | (R)-Bupivacaine HCl
CAS# 27262-46-0;27262-45-9(free base)
M.F.: C18H28N2O.HCl
M.W.: 288.44 36.46 |
| |
| QC061834 | Cefuroxime Axetil EP Impurity D; Cefuroxime Sodium
CAS# 56238-63-2;55268-75-2(free base)
M.F.: C16H15N4NaO8S
M.W.: 446.37 |
| |
| QL052011 | Levetiracetam Impurity K
CAS# NA
M.F.: C9H16ClNO3
M.W.: 221.68 |
| |
| QL052010 | Levetiracetam Impurity J
CAS# NA
M.F.: C8H14ClNO3
M.W.: 207.65 |
| |
| QL052009 | Levetiracetam Impurity I
CAS# 358629-51-3
M.F.: C9H15NO3
M.W.: 185.22 |
| |
| QC131404 | Cefminox Sodium impurity 4
CAS# NA
M.F.: C16H20N3NaO9S2
M.W.: 485.46 |
| |
| QP160451 | Paliperidone Impurity 25
CAS# 16867-03-1
M.F.: C5H6N2O
M.W.: 110.11 |
| |
| QP160446 | Paliperidone Impurity 20
CAS# 517-23-7
M.F.: C6H8O3
M.W.: 128.13 |
| |
| QP160437 | Paliperidone Impurity 11
CAS# 70381-47-4
M.F.: C11H12N2O2
M.W.: 204.23 |
| |
| QP160436 | Paliperidone Impurity 10
CAS# 260273-82-3;849727-62-4(HCl salt)
M.F.: C11H11ClN2O2
M.W.: 238.67 |
| |
| QP160431 | Paliperidone Impurity 5
CAS# 1008796-22-2
M.F.: C18H18N2O3
M.W.: 310.35 |
| |
| QP160430 | Paliperidone Impurity 4
CAS# 147687-17-0
M.F.: C18H17ClN2O2
M.W.: 328.79 |
| |
| QP160427 | Paliperidone Impurity 1
CAS# 24016-03-3
M.F.: C12H12N2O
M.W.: 200.24 |
| |
| QT041241 | Tadalafil Impurity T
CAS# 629652-40-0
M.F.: C22H19ClN2O5
M.W.: 426.85 |
| |
| QT041237 | Tadalafil Impurity 15
CAS# 629652-44-4
M.F.: C22H19ClN2O5
M.W.: 426.85 |
| |
| QT041239 | Tadalafil Impurity Ⅵ
CAS# 171596-42-2
M.F.: C20H18N2O4
M.W.: 350.37 |
| |
| QT041236 | Tadalafil Impurity 7
CAS# NA
M.F.: C20H18N2O4
M.W.: 350.37 |
| |
| QP032011 | Procaterol Impurity 11
CAS# 68304-21-2
M.F.: C10H7NO3
M.W.: 189.17 |
| |
| QC-P221900 | Pravastatin Sodium Salt
CAS# 81131-70-6;81093-37-0(free base)
M.F.: C23H35NaO7
M.W.: 446.51 |
| |
| QE061404 | Efinaconazole Impurity D
CAS# NA
M.F.: C12H11F2N3O
M.W.: 251.23 |
| |
| QE061403 | Efinaconazole Impurity C
CAS# NA
M.F.: C12H11F2N3O
M.W.: 251.23 |
| |
| QE061401 | Efinaconazole Impurity A
CAS# NA
M.F.: C12H13F2N3O2
M.W.: 269.25 |
| |
| QC132602 | Cefmetazole Impurity B
CAS# NA
M.F.: C15H17N7O5S3
M.W.: 471.53 |
| |
| QP136017 | Pidotimod Impurity Q
CAS# NA
M.F.: C11H16N2O4S
M.W.: 272.32 |
| |
| QP136015 | Pidotimod Impurity O
CAS# NA
M.F.: C11H16N2O4S
M.W.: 272.32 |
| |
| QS221802 | Controlled Substance
(Suvorexant Impurity B)
CAS# 1030377-80-0
M.F.: C23H23ClN6O2
M.W.: 450.92 |
| |
| QS221801 | Suvorexant Impurity A
CAS# 1276666-19-3
M.F.: C23H23ClN6O2
M.W.: 450.92 |
| |
| QE042206 | Edaravone Related Compound
CAS# 19735-89-8
M.F.: C10H10N2O
M.W.: 174.2 |
| |
| QD121227 | Diallylacetic Acid
CAS# 99-67-2
M.F.: C8H12O2
M.W.: 140.18 |
| |
| QA261914 | Azilsartan Impurity N
CAS# 1397836-41-7
M.F.: C26H26N4O4
M.W.: 458.51 |
| |
| QB121414 | Blonanserin Impurity N
CAS# 132813-14-0
M.F.: C17H17ClFN
M.W.: 289.77 |
| |
| QC061811 | Cefuroxime Sodium EP Impurity E
CAS# 97232-97-8
M.F.: C16H16N4O8S
M.W.: 424.39 |
| |
| QA190206 | Ascorbic Acid EP Impurity F Sodium Salt
CAS# 6381-77-7
M.F.: C6H7NaO6
M.W.: 198.11 |
| |
| QP136013 | Pidotimod Impurity M
CAS# NA
M.F.: C9H14N2O5S
M.W.: 262.28 |
| |
| QP136012 | Pidotimod Impurity L
CAS# NA
M.F.: C9H12N2O4S
M.W.: 244.27 |
| |
| QT081505 | Theophylline EP Impurity E
CAS# 944-73-0
M.F.: C7H8N4O3
M.W.: 196.16 |
| |
| QT081503 | Theophylline EP Impurity C;Caffeine EP Impurity B
CAS# 7597-60-6
M.F.: C7H10N4O3
M.W.: 198.18 |
| |
| QC061804 | Cefuroxime Sodium EP Impurity A
CAS# 56271-94-4
M.F.: C15H15N3O7S
M.W.: 381.36 |
| |
| QT151604 | Tiopronin Impurity D
CAS# 21269-37-4
M.F.: C10H16N2O6S2
M.W.: 324.37 |
| |
| QT151603 | Tiopronin Impurity C
CAS# 21709-90-0
M.F.: C5H9NO3
M.W.: 131.13 |
| |
| QF041809 | Fludarabine Phosphate EP Impurity I
CAS# 7561-54-8
M.F.: C10H15N6O7P
M.W.: 362.24 |
| |
| QF041808 | Fludarabine Phosphate EP Impurity H
CAS# 548774-57-8
M.F.: C10H10FN5O3
M.W.: 267.22 |
| |
| QF041804 | Fludarabine Phosphate EP Impurity D
CAS# 700-49-2
M.F.: C5H4FN5
M.W.: 153.12 |
| |
| QC062005 | Cefathiamidine Impurity E
CAS# 2986-17-6
M.F.: C7H16N2S
M.W.: 160.28 |
| |
| QC062002 | Cefathiamidine Impurity B
CAS# NA
M.F.: C19H28N4O6S2
M.W.: 472.58 |
| |
| QA202241 | Atorvastatin Lactone Diepoxide
CAS# 1046118-40-4
M.F.: C33H33FN2O6
M.W.: 572.62 |
| |
| QA161904 | Acetylsalicylic Acid EP Impurity D;
Carbasalate calcium EP Impurity B;
DL-Lysine acetylsalicylate EP Impurity L
CAS# 530-75-6
M.F.: C16H12O6
M.W.: 300.27 |
| |
| QA161906 | Aspirin Impurity F;
Acetylsalicylic Acid EP Impurity F;
Carbasalate calcium EP Impurity A
CAS# 1466-82-6
M.F.: C18H14O7
M.W.: 342.30 |
| |
| QA161905 | Aspirin Impurity E;
Acetylsalicylic Acid EP Impurity E;
Carbasalate calcium EP Impurity D;
DL-Lysine acetylsalicylate EP Impurity M
CAS# 552-94-3
M.F.: C14H10O5
M.W.: 258.23 |
| |
| QA161902 | Aspirin Impurity B ;Acetylsalicylic Acid EP Impurity B
CAS# 636-46-4
M.F.: C8H6O5
M.W.: 182.13 |
| |
| QA161901 | Acetylsalicylic Acid EP Impurity A;
Propyl Parahydroxybenzoate EP Impurity A;
Sodium ethyl parahydroxybenzoate EP Impurity A;
Butyl parahydroxybenzoate EP Impurity A
CAS# 99-96-7
M.F.: C7H6O3
M.W.: 138.12 |
| |
| QC061207 | Cefalexin Impurity 7
CAS# 72820-16-7
M.F.: C11H14N2O5S
M.W.: 286.31 |
| |
| QC061227 | Cephalexin Diketopiperazine
CAS# 59865-11-1
M.F.: C16H17N3O4S
M.W.: 347.39 |
| |
| QT182612 | Terazosin EP Impurity L
CAS# 40172-95-0
M.F.: C9H12N2O2
M.W.: 180.2 |
| |
| QC060429 | Cefodizime Impurity 3
CAS# NA
M.F.: C20H20N6O9S4
M.W.: 616.67 |
| |
| QB082428 | Bromhexine EP Impurity B
CAS# 50910-55-9
M.F.: C7H5Br2NO
M.W.: 278.93 |
| |
| QB082427 | Bromhexine EP Impurity A
CAS# 50739-76-9
M.F.: C7H7Br2NO
M.W.: 280.95 |
| |
| QF210616 | Flurbiprofen impurity Ⅵ
CAS# 927-68-4
M.F.: C4H7BrO2
M.W.: 167 |
| |
| QF210615 | Flurbiprofen impurity Ⅴ
CAS# 108-05-4
M.F.: C4H6O2
M.W.: 86.09 |
| |
| QF210611 | Flurbiprofen impurityⅠ
CAS# 41604-19-7
M.F.: C12H8BrF
M.W.: 251.09 |
| |
| QT140678 | Tenofovir Alafenamide Impurity 1
CAS# NA
M.F.: C27H33N6O6PS
M.W.: 600.63 |
| |
| QG121907 | Granisetron EP Impurity G
CAS# 34252-44-3
M.F.: C9H8N2O2
M.W.: 176.18 |
| |
| QI192209 | Isavuconazole Impurity I
CAS# 2170932-49-5
M.F.: C13H14F2N4OS
M.W.: 312.34 |
| |
| QT140676 | Tenofovir Disoproxil Impurity 76
CAS# NA
M.F.: C19H30N5O10P
M.W.: 519.45 |
| |
| QC061419 | Cefdinir Impurity S
CAS# NA
M.F.: C16H15N5O6S2
M.W.: 437.45 |
| |
| QA200305 | Atracurium Besylate Impurity 5
CAS# 1075727-04-6
M.F.: C24H31NO6
M.W.: 429.52 |
| |
| QA200304 | Cisatracurium Besylate EP Impurity F Iodide
CAS# NA
M.F.: C29H42NO7. I
M.W.: 516.65 |
| |
| QI192208 | Isavuconazole Impurity H
CAS# 219872-85-2
M.F.: C13H14F2N4O2
M.W.: 296.27 |
| |
| QI192207 | Isavuconazole Impurity G
CAS# 368421-58-3
M.F.: C13H14F2N4OS
M.W.: 312.34 |
| |
| QI192206 | Isavuconazole Impurity F
CAS# 241479-74-3
M.F.: C13H12F2N4O
M.W.: 278.26 |
| |
| QC141507 | Cinepazide Impurity G
CAS# 20329-98-0
M.F.: C12H14O5
M.W.: 238.24 |
| |
| QP136011 | Pidotimod Impurity K
CAS# NA
M.F.: C4H7NO3S
M.W.: 149.17 |
| |
| QF041803 | Fludarabine phosphate EP impurity C
CAS# 548774-53-4
M.F.: C10H14FN5O10P2
M.W.: 445.2 |
| |
| QF041801 | Fludarabine phosphate EP Impurity A
CAS# 62314-92-5
M.F.: C10H14N5O8P
M.W.: 363.23 |
| |
| QB191411 | Bosentan Impurity
CAS# 1218951-81-5
M.F.: C35H38N6O6S2
M.W.: 702.84 |
| |
| QM191613 | Mosapride Impurity M
CAS# 1215825-20-9(free base)
M.F.: C27H29ClFN3Na2O9
M.W.: 639.96 |
| |
| QM191610 | Mosapride Impurity J
CAS# 152013-26-8
M.F.: C14H20ClN3O3
M.W.: 313.78 |
| |
| QD261605 | Diazepam EP Impurity E
CAS# 20927-53-1
M.F.: C15H11ClN2O
M.W.: 270.72 |
| |
| QC061415 | Cefdinir Impurity O
CAS# 178601-89-3
M.F.: C14H13N5O5S2
M.W.: 395.41 |
| |
| QS060226 | Sofosbuvir Impurity 2
CAS# 1714114-25-6
M.F.: C18H17F5NO5P
M.W.: 453.30 |
| |
| QC122200 | Clevidipine
CAS# 167221-71-8
M.F.: C21H23Cl2NO6
M.W.: 456.32 |
| |
| QA121200 | Apronal
CAS# 528-92-7
M.F.: C9H16N2O2
M.W.: 184.24 |
| |
| QF120370 | Folic Acid Impurity 70
CAS# 1391194-56-1
M.F.: C7H6ClN5O
M.W.: 211.61 |
| |
| QF120369 | Folic Acid Impurity 69
CAS# 35011-47-3
M.F.: C4H9N5O5S
M.W.: 239.21 |
| |
| QI650900 | Inosine; Adenosine EP Impurity G;
Didanosine EP Impurity B
CAS# 58-63-9
M.F.: C10H12N4O5
M.W.: 268.23 |
| |
| QT130200 | Trimebutine
CAS# 39133-31-8
M.F.: C22H29NO5
M.W.: 387.47 |
| |
| QD040235 | Disperse Blue 35
CAS# 12222-75-2
M.F.: C20H14N2O5
M.W.: 362.34 |
| |
| QS161807 | Sulpiride EP Impurity G
CAS# 67381-52-6
M.F.: C14H21N3O4S
M.W.: 327.40 |
| |
| QT081109 | Trihexyphenidyl impurity 9
CAS# 6853-22-1
M.F.: C16H25NO
M.W.: 247.38 |
| |
| QT140671 | Tenofovir Impurity 45
CAS# 1607007-18-0
M.F.: C18H26N10O7P2
M.W.: 556.41 |
| |
| QD141613 | Donepezil Impurity M
CAS# 197010-20-1
M.F.: C24H29NO4
M.W.: 395.49 |
| |
| QM140408 | methyl 2-amino-3,5-dibromobenzoate
CAS# 606-00-8
M.F.: C8H7Br2NO2
M.W.: 308.95 |
| |
| QT120601 | Thalifendine
CAS# 4668-19-3;18207-71-1(free base)
M.F.: C19H16ClNO4
M.W.: 357.79 |
| |
| QT140663 | Tenofovir disoproxil Impurity 37
CAS# [NA]
M.F.: C9H14N5O4P
M.W.: 287.21 |
| |
| QT140649 | Tenofovir disoproxil Impurity 23
CAS# [NA]
M.F.: C9H14N5O4P
M.W.: 287.21 |
| |
| QC141502 | Cinepazide Impurity B
CAS# [NA]
M.F.: C16H28N4O2
M.W.: 308.42 |
| |
| QC141503 | Cinepazide Impurity C
CAS# 1227926-25-1
M.F.: C22H31N3O6
M.W.: 433.50 |
| |
| QI091602 | Ipratropium Bromide EP Impurity B
CAS# 58073-59-9
M.F.: C20H30BrNO3
M.W.: 412.36 |
| |
| QV701330 | L-Ascorbic acid
CAS# 50-81-7
M.F.: C6H8O6
M.W.: 176.12 |
| |
| QF141903 | Finasteride EP Impurity C
CAS# 1329611-51-9;1800205-94-0
M.F.: C23H34N2O2
M.W.: 370.53 |
| |
| QF120367 | Folic Acid EP Impurity E
CAS# 1391068-26-0
M.F.: C26H24N12O7
M.W.: 616.54 |
| |
| QF120368 | Folic Acid EP Impurity C;Isofolic acid
CAS# 47707-78-8
M.F.: C19H19N7O6
M.W.: 441.40 |
| |
| QF120366 | Folic Acid Isomer
CAS# [NA]
M.F.: C19H19N7O6
M.W.: 441.40 |
| |
| QT060341 | Tofacitinib Impurity 16
CAS# [NA]
M.F.: C29H38N10O2
M.W.: 558.68 |
| |
| QT050241 | Tofacitinib Impurity 11
CAS# [NA]
M.F.: C13H11N3O3S
M.W.: 289.31 |
| |
| QA130301 | Aminocaproic acid Impurity A
CAS# 2014-58-6
M.F.: C12H24N2O3
M.W.: 244.33 |
| |
| QP132016 | Pemetrexed EP Impurity E
CAS# 182009-04-7;937370-10-0(2Na salt)
M.F.: C20H21N5O6
M.W.: 427.41 |
| |
| QT021407 | Terbinafine Impurity G;
Terbinafine N-Oxide
CAS# [NA]
M.F.: C21H25NO
M.W.: 307.43 |
| |
| QF121306 | Flumazenil EP Impurity A
CAS# 84378-44-9
M.F.: C13H10FN3O3
M.W.: 275.24 |
| |
| QT140641 | Tenofovir disoproxil Impurity 15
CAS# [NA]
M.F.: C15H26N5O4P
M.W.: 371.37 |
| |
| QF226811 | Fasudil Hydrochloride Impurity K
CAS# [NA]
M.F.: C9H7NO3S
M.W.: 209.22 |
| |
| QF226810 | Fasudil Hydrochloride Impurity J
CAS# [NA]
M.F.: C9H7NO3S
M.W.: 209.22 |
| |
| QA690320 | Abscisic acid
CAS# 14375-45-2
M.F.: C15H20O4
M.W.: 264.32 |
| |
| QB702001 | Butyl acetate;Tributyl Acetylcitrate EP Impurity E
CAS# 123-86-4
M.F.: C6H12O2
M.W.: 116.16 |
| |
| QB701400 | 1-Butanol;Tri-n-butyl Phosphate EP Impurity C;Tributyl Acetylcitrate EP Impurity D
CAS# 71-36-3
M.F.: C4H10O
M.W.: 74.12 |
| |
| QA690345 | (+)-Abscisic acid-D6
CAS# 721948-65-8
M.F.: C15H14D6O4
M.W.: 270.35 |
| |
| QT060324 | Tofacitinib Impurity X
CAS# 1252883-90-1
M.F.: C20H25N5
M.W.: 335.45 |
| |
| QE200305 | Entecavir Impurity 5
CAS# [NA]
M.F.: C13H16N4O3
M.W.: 276.29 |
| |
| QF191606 | Fosaprepitant Impurity F
CAS# 1242175-34-3
M.F.: C23H21F7N4O3
M.W.: 534.43 |
| |
| QL091601 | Lipoic Acid Impurity A
CAS# 728854-75-9
M.F.: C10H20N2OS2
M.W.: 248.41 |
| |
| QB640900 | Sodium benzoate
CAS# 532-32-1
M.F.: C7H5NaO2
M.W.: 144.10 |
| |
| QA690340 | (+)-Abscisic acid
CAS# 21293-29-8
M.F.: C15H20O4
M.W.: 264.32 |
| |
| QC242001 | Cefoxitin Sodium EP Impurity A
CAS# 54333-94-7
M.F.: C15H16N2O6S2
M.W.: 384.43 |
| |
| QF120304 | Folic Acid EP Impurity D
CAS# 119-24-4
M.F.: C14H12N6O3
M.W.: 312.28 |
| |
| QC-L131100 | L(-)-Malic acid
CAS# 97-67-6
M.F.: C4H6O5
M.W.: 134.09 |
| |
| QB640302 | Benzoic acid;Glycopyrronium Bromide EP Impurity D;Mefenamic Acid EP Impurity D;Tiaprofenic acid EP Impurity D
CAS# 65-85-0
M.F.: C7H6O2
M.W.: 122.12 |
| |
| QF210605 | Flurbiprofen EP Impurity E
CAS# 137045-30-8
M.F.: C13H9FO2
M.W.: 216.21 |
| |
| QL050303 | Lercanidipine Impurity C
CAS# 77888-05-2
M.F.: C21H26N2O6
M.W.: 402.45 |
| |
| QC061905 | Ceftaroline Fosamil Impurity E
CAS# 1427207-46-2
M.F.: C9H8N2S2
M.W.: 208.31 |
| |
| QC061902 | Ceftaroline Fosamil Impurity B
CAS# 1240196-56-8
M.F.: C24H22N8O6S4
M.W.: 646.74 |
| |
| QC061901 | Ceftaroline Fosamil Impurity A
CAS# 1286218-70-9
M.F.: C22H22N8O6S4
M.W.: 622.72 |
| |
| QE262016 | Ezetimibe Impurity P
CAS# 1296129-16-2
M.F.: C33H30F2N2O5
M.W.: 572.60 |
| |
| QL062003 | Lafutidine Sulfone
CAS# 174583-84-7
M.F.: C22H29N3O5S
M.W.: 447.54 |
| |
| QI210427 | Ibuprofen Impurity 27
CAS# 1009-14-9
M.F.: C11H14O
M.W.: 162.23 |
| |
| QI220213 | Ivabradine Impurity T
CAS# 1616710-50-9
M.F.: C27H34N2O6.HCl
M.W.: 482.58 36.46 |
| |
| QT042635 | Tedizolid Pyrophosphate Ester
CAS# 1239662-48-6
M.F.: C17H17FN6O9P2
M.W.: 530.3 |
| |
| QP142001 | Pantoprazole Impurity A
CAS# [NA]
M.F.: C7H8Cl3NO
M.W.: 228.5 |
| |
| QG130302 | Gemcitabine Impurity B(1’-Epi Gemcitabine 3’,5’-Dibenzoate)
CAS# 134790-40-2
M.F.: C23H19F2N3O6
M.W.: 471.41 |
| |
| QT090302 | Thioctic acid Impurity 2
CAS# 17370-41-1
M.F.: C8H14O4S2
M.W.: 238.32 |
| |
| QD020725 | Dabigatran Etexilate Impurity Y
CAS# [NA]
M.F.: C14H21N3O2
M.W.: 263.34 |
| |
| QD020723 | Dabigatran Etexilate Impurity W
CAS# 1702936-92-2
M.F.: C19H20N4O3
M.W.: 352.39 |
| |
| QD170602 | Diquafosol Impurity B
CAS# 63-39-8 ;19817-92-6(3Na salt);
116295-90-0 (3Na 2H2O salt)
M.F.: C9H15N2O15P3
M.W.: 484.14 |
| |
| QL151800 | L-Ornithine;Arginine EP Impurity C; Lysine acetate EP Impurity E
CAS# 70-26-8
M.F.: C5H12N2O2
M.W.: 132.16 |
| |
| QE200900 | Zoledronic acid EP Impurity D
CAS# 22884-10-2
M.F.: C5H6N2O2
M.W.: 126.11 |
| |
| QA048203 | Aspartic acid Impurity C
CAS# 3184-13-2
M.F.: C5H12N2O2 HCl
M.W.: 132.16 36.46 |
| |
| QA048202 | Aspartic acid Impurity B
CAS# 42538-31-8
M.F.: C5H10N2O.HCl
M.W.: 114.15 36.46 |
| |
| QM162004 | Meptazinol Impurity D
CAS# [NA]
M.F.: C30H44N2O
M.W.: 448.68 |
| |
| QM162002 | Meptazinol Impurity B
CAS# [NA]
M.F.: C15H23N
M.W.: 217.36 |
| |
| QM162001 | Meptazinol Impurity A
CAS# [NA]
M.F.: C15H21NO2
M.W.: 247.34 |
| |
| QL140728 | Linagliptin Impurity Z2
CAS# [NA]
M.F.: C25H28N8O2
M.W.: 472.55 |
| |
| QE122010 | Erlotinib Hydrochloride Impurity J
CAS# 1029721-32-1（free base)
M.F.: C22H24ClN3O4
M.W.: 429.9 |
| |
| QE122009 | Erlotinib Hydrochloride Impurity I
CAS# 2204518-92-1
M.F.: C22H24ClN3O4
M.W.: 429.9 |
| |
| QA261913 | Azilsartan Impurity M
CAS# 1442400-65-8
M.F.: C24H22N4O3
M.W.: 414.47 |
| |
| QN201127 | Methyl naltrexone bromide D3
CAS# NA
M.F.: C21H23D3BrNO4
M.W.: 439.36 |
| |
| QI210432 | (S)-Ibuprofen D3
CAS# 98649-76-4
M.F.: C19H26O8
M.W.: 382.4 |
| |
| QI222027 | Hydroxy Itraconazole D8
CAS# 1217516-26-1
M.F.: C35H30Cl2D8N8O5
M.W.: 729.68 |
| |
| QG062027 | Gefitinib D8
CAS# 857091-32-8
M.F.: C22H16ClD8FN4O3
M.W.: 454.95 |
| |
| QE262040 | Ezetimibe d4
CAS# 1093659-90-5
M.F.: C24H17D4F2NO3
M.W.: 413.45 |
| |
| QF210601 | Flurbiprofen EP Impurity A
CAS# 6341-72-6
M.F.: C15H14O2
M.W.: 226.28 |
| |
| QD152427 | Doxylamine d5
CAS# 1216840-94-6
M.F.: C21H23D5N2O5
M.W.: 393.49 |
| |
| QC061231 | Cephalexin D5 (Racemic)
CAS# 23325-78-2 (unlabeled)
M.F.: C16H12D5N3O4S
M.W.: 352.42 |
| |
| QA150906 | Atomoxetine D7 HCl (Racemic)
CAS# NA
M.F.: C17H15D7ClNO
M.W.: 298.86 |
| |
| QC161818 | Captopril EP Impurity N
CAS# 65134-74-9
M.F.: C8H14O4S2
M.W.: 238.32 |
| |
| QC120307 | Celecoxib Impurity G
CAS# 1061214-06-9
M.F.: C15H17N3O2S
M.W.: 303.38 |
| |
| QC120306 | Celecoxib Impurity F
CAS# 915280-81-8
M.F.: C8H8F3N3O3S
M.W.: 283.23 |
| |
| QD031201 | Daclatasvir Impurity A
CAS# 1009107-27-0
M.F.: C40H50N8O6
M.W.: 738.88 |
| |
| QC161817 | Captopril Impurity Q
CAS# [NA]
M.F.: C18H28N2O5S2
M.W.: 416.56 |
| |
| QC161802 | Captopril EP Impurity B
CAS# 80629-35-2
M.F.: C9H14BrNO3
M.W.: 264.12 |
| |
| QC161816 | Captopril EP Impurity L
CAS# [NA]
M.F.: C19H30N2O6S2
M.W.: 446.58 |
| |
| QC161814 | Captopril EP Impurity M
CAS# [NA]
M.F.: C13H21NO5S2
M.W.: 335.44 |
| |
| QD033500 | N-Dodecanoyl-L-homoserine lactone
CAS# 137173-46-7
M.F.: C16H29NO3
M.W.: 283.41 |
| |
| QD033200 | N-Decanoyl-L-homoserine lactone
CAS# 177315-87-6
M.F.: C14H25NO3
M.W.: 255.35 |
| |
| QO003800 | N-Octanoyl-L-homoserine lactone
CAS# 147852-84-4
M.F.: C12H21NO3
M.W.: 227.30 |
| |
| QH011100 | N-Hexanoyl-L-homoserine lactone
CAS# 147852-83-3
M.F.: C10H17NO3
M.W.: 199.25 |
| |
| QO005900 | N-(3-Oxodecanoyl)-L-homoserine lactone
CAS# 147795-40-2
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QT014700 | N-Tetradecanoyl-DL-homoserine lactone
CAS# 98206-80-5
M.F.: C18H33NO3
M.W.: 311.46 |
| |
| QO006000 | N-(3-Oxotetradecanoyl)-L-homoserine lactone
CAS# 177158-19-9
M.F.: C18H31NO4
M.W.: 325.44 |
| |
| QF201402 | Controlled Substance
(Fentanyl EP Impurity K)
CAS# 1474-02-8
M.F.: C21H26N2O
M.W.: 322.44 |
| |
| QA162434 | Apixaban Impurity N
CAS# [NA]
M.F.: C24H25N5O4
M.W.: 447.49 |
| |
| QD061402 | Diphenoxylate EP Impurity B
CAS# 4370-12-1
M.F.: C2H2N2O
M.W.: 70.05 |
| |
| QS010211 | 5-Hydroxy Salbutamol (5-Hydroxy Albuterol, Levalbuterol Related Compound G)
CAS# 182676-90-0
M.F.: C13H21NO4
M.W.: 255.31 |
| |
| QD032004 | Docetaxel EP Impurity D
CAS# 162784-72-7
M.F.: C43H51NO14
M.W.: 805.86 |
| |
| QD032003 | Docetaxel EP Impurity C;
7-epi-Docetaxel
CAS# 153381-68-1
M.F.: C43H53NO14
M.W.: 807.88 |
| |
| QB201413 | Bortezomib Impurity Q
CAS# [NA]
M.F.: C10H16BN3O3
M.W.: 237.07 |
| |
| QB201412 | Bortezomib Impurity P
CAS# [NA]
M.F.: C20H26N4O3
M.W.: 370.46 |
| |
| QL140727 | Linagliptin Acetamide
CAS# 1803079-49-3
M.F.: C27H30N8O3
M.W.: 514.58 |
| |
| QL140726 | Linagliptin Impurity Z
CAS# NA
M.F.: C26H28N8O3
M.W.: 500.55 |
| |
| QF022445 | Febuxostat Impurity Z19
CAS# 144060-62-8
M.F.: C16H17NO4S
M.W.: 319.38 |
| |
| QE201301 | Etomidate Impurity A
CAS# 56649-48-0
M.F.: C12H12N2O2
M.W.: 216.24 |
| |
| QP150119 | Propylparaben sodium;Sodium Propyl Parahydroxybenzoate
CAS# 35285-69-9;94-13-3(free base)
M.F.: C10H11NaO3
M.W.: 202.18 |
| |
| QL142612 | Linezolid Impurity D
CAS# [NA]
M.F.: C7H12ClNO3
M.W.: 193.63 |
| |
| QD242001 | Dextromethorphan EP Impurity B
CAS# 125-73-5
M.F.: C17H23NO
M.W.: 257.38 |
| |
| QA162432 | Apixaban Impurity L
CAS# 4792-57-8
M.F.: C12H16N2O3
M.W.: 236.27 |
| |
| QA162430 | Apixaban Impurity J
CAS# 1074549-87-3
M.F.: C26H27N5O4
M.W.: 473.52 |
| |
| QI191804 | Isradipine EP Impurity D
CAS# NA
M.F.: C19H19N3O5
M.W.: 369.37 |
| |
| QI191803 | Isradipine EP Impurity C
CAS# NA
M.F.: C17H17N3O5
M.W.: 343.33 |
| |
| QL142211 | Lenvatinib Impurity K
CAS# 1882873-21-3
M.F.: C21H17ClN4O3
M.W.: 408.84 |
| |
| QS142003 | Sunitinib Impurity C
CAS# [NA]
M.F.: C20H23FN4O2
M.W.: 370.42 |
| |
| QA220311 | Avibactam Impurity K
CAS# [NA]
M.F.: C14H17N3O3
M.W.: 275.30 |
| |
| QC061801 | Cefuroxime Impurity 1
CAS# [NA]
M.F.: C16H16N4O8S
M.W.: 424.39 |
| |
| QO022007 | Obeticholic Acid Impurity G
CAS# 865244-30-0
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QO022006 | Obeticholic Acid Impurity F
CAS# 1708092-13-0
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QE262012 | Ezetimibe Impurity L
CAS# 1700622-08-7
M.F.: C24H21ClFNO3
M.W.: 425.88 |
| |
| QC061606 | Cefpodoxime Proxetil EP Impurity F
CAS# 96680-30-7
M.F.: C22H27N5O10S2
M.W.: 585.62 |
| |
| QC061605 | Cefpodoxime Proxetil EP Impurity E
CAS# 217803-89-9
M.F.: C22H27N5O10S2
M.W.: 585.62 |
| |
| QC061604 | Cefpodoxime Proxetil EP Impurity D
CAS# 947692-13-9
M.F.: C21H27N5O9S2
M.W.: 557.61 |
| |
| QC061603 | Cefpodoxime Proxetil EP Impurity C
CAS# 339528-86-8
M.F.: C21H27N5O9S2
M.W.: 557.61 |
| |
| QC061602 | Cefpodoxime Proxetil EP Impurity B
CAS# 947692-14-0
M.F.: C20H25N5O8S2
M.W.: 527.58 |
| |
| QC061601 | Cefpodoxime Proxetil EP Impurity A
CAS# 80210-62-4
M.F.: C15H17N5O6S2
M.W.: 427.46 |
| |
| QT021602 | Tebipenem Pivoxil Impurity 2
CAS# 1391053-29-4
M.F.: C23H35N3O7S2
M.W.: 529.67 |
| |
| QA165113 | Azithromycin EP Impurity M
CAS# 765927-71-7
M.F.: C37H68N2O13
M.W.: 748.96 |
| |
| QB041429 | Budesonide EP Impurity F (Desonide)
CAS# 638-94-8
M.F.: C24H32O6
M.W.: 416.51 |
| |
| QB041427 | Budesonide EP Impurity I
CAS# 113930-13-5
M.F.: C25H34O7
M.W.: 446.53 |
| |
| QB041426 | Budesonide EP Impurity J (Mixture of Diastereomers)
CAS# 313474-59-8
M.F.: C25H33BrO6
M.W.: 509.43 |
| |
| QB041425 | Budesonide Impurity 1 (Mixture of Diastereomers)
CAS# NA
M.F.: C25H32O7
M.W.: 444.53 |
| |
| QB041418 | 6-Beta-Hydroxy Budesonide Sulfate
CAS# NA
M.F.: C25H34O10S
M.W.: 526.61 |
| |
| QB041413 | Budesonide EP Impurity G
CAS# 137174-25-5
M.F.: C25H36O6
M.W.: 432.55 |
| |
| QB041405 | Budesonide (Mixture of Diastereomers)
CAS# 51333-22-3
M.F.: C25H34O6
M.W.: 430.55 |
| |
| QV192003 | Valsartan USP RC C
CAS# 137863-20-8
M.F.: C31H35N5O3
M.W.: 525.64 |
| |
| QV192001 | Valsartan EP Impurity A
CAS# 137862-87-4
M.F.: C24H29N5O3
M.W.: 435.52 |
| |
| QT201605 | Tiotropium EP Impurity E
CAS# 26447-85-8
M.F.: C11H10O3S2
M.W.: 254.33 |
| |
| QT201604 | Tiotropium EP Impurity D
CAS# 136310-66-2
M.F.: C18H19NO3S2
M.W.: 361.48 |
| |
| QT200304 | Topotecan Acid Sodium Salt
CAS# 123949-08-6
M.F.: C23H24N3NaO6
M.W.: 461.44 |
| |
| QT200300H | Topotecan HCl
CAS# 119413-54-6
M.F.: C23H24ClN3O5
M.W.: 457.91 |
| |
| QT192010 | Telmisartan Bromo Acid
CAS# 150766-86-2
M.F.: C14H11BrO2
M.W.: 291.14 |
| |
| QT142404 | Tranexamic Acid EP Impurity D
CAS# 56-91-7
M.F.: C8H9NO2
M.W.: 151.16 |
| |
| QT142403 | Tranexamic Acid EP Impurity C
CAS# 330838-52-3;1803601-44-6(HCl salt)
M.F.: C8H13NO2
M.W.: 155.19 |
| |
| QT142402 | Tranexamic Acid EP Impurity B
CAS# 1197-17-7;3667-38-7(HCl salt)
M.F.: C8H15NO2
M.W.: 157.21 |
| |
| QT142401 | Tranexamic Acid EP Impurity A
CAS# 93940-19-3
M.F.: C16H27NO4
M.W.: 297.39 |
| |
| QT142400 | Tranexamic Acid
CAS# 1197-18-8
M.F.: C8H15NO2
M.W.: 157.21 |
| |
| QT131909 | Tamsulosin EP Impurity I
CAS# 3259-03-8
M.F.: C10H13BrO2
M.W.: 245.11 |
| |
| QT131906 | Tamsulosin EP Impurity F
CAS# 6781-17-5;1051368-80-9(HCl salt)
M.F.: C10H15NO2
M.W.: 181.23 |
| |
| QT120604 | Tadalafil Desmethylene Impurity
CAS# 171489-03-5
M.F.: C21H19N3O4
M.W.: 377.39 |
| |
| QT030300 | Ticarcillin Disodium
CAS# 4697-14-7
M.F.: C15H14N2Na2O6S2
M.W.: 428.39 |
| |
| QS132009 | Sumatriptan Hydrazine Impurity
CAS# 88933-16-8
M.F.: C8H13N3O2S
M.W.: 215.27 |
| |
| QS132003 | Sumatriptan EP Impurity C
CAS# 1797905-62-4
M.F.: C15H23N3O3S
M.W.: 325.43 |
| |
| QS132001 | Sumatriptan EP Impurity A
CAS# 545338-89-4
M.F.: C27H37N5O2S
M.W.: 495.68 |
| |
| QR131603 | Ramipril EP Impurity C
CAS# 99742-35-5
M.F.: C23H39ClN2O5
M.W.: 459.02 |
| |
| QR131601 | Ramipril EP Impurity A
CAS# 108313-11-7
M.F.: C22H30N2O5
M.W.: 402.48 |
| |
| QR131600 | Ramipril
CAS# 87333-19-5
M.F.: C23H32N2O5
M.W.: 416.51 |
| |
| QP240300 | Piroxicam
CAS# 36322-90-4
M.F.: C15H13N3O4S
M.W.: 331.35 |
| |
| QP202202 | Pitavastatin Ethyl Ester
CAS# 167073-19-0
M.F.: C27H28FNO4
M.W.: 449.51 |
| |
| QP201611 | Pantoprazole Sulfide N-Methyl 6-Difluoromethoxy Analog
CAS# NA
M.F.: C17H17F2N3O3S
M.W.: 381.4 |
| |
| QO041905 | Ondansetron EP Impurity E;
Sildenafil EP Impurity E;
Clotrimazole EP Impurity D;
Enalapril maleate EP Impurity I;
Bifonazole EP Impurity C;
Flutrimazole EP Impurity A
CAS# 288-32-4
M.F.: C3H4N2
M.W.: 68.08 |
| |
| QS120604 | Solifenacin Impurity D
CAS# [NA]
M.F.: C22H18N2O4
M.W.: 374.39 |
| |
| QS120602 | Solifenacin Impurity B
CAS# 52250-50-7
M.F.: C15H13N
M.W.: 207.27 |
| |
| QM202607 | Mirtazapine Impurity 7
CAS# 61338-13-4
M.F.: C17H19N3O2
M.W.: 297.35 |
| |
| QM202605 | Mirtazapine EP Impurity E
CAS# 191546-94-8
M.F.: C17H21N3
M.W.: 267.37 |
| |
| QM202604 | Mirtazapine EP Impurity D
CAS# 61337-68-6
M.F.: C16H17N3
M.W.: 251.33 |
| |
| QM202602 | Mirtazapine EP Impurity B
CAS# 61337-89-1
M.F.: C17H21N3O
M.W.: 283.37 |
| |
| QM202601 | Mirtazapine EP Impurity A
CAS# 155172-12-6
M.F.: C17H19N3O
M.W.: 281.35 |
| |
| QT060317 | Tofacitinib Impurity Q
CAS# 1092578-47-6;2174011-55-1(Citrate salt)
M.F.: C16H20N6O
M.W.: 312.37 |
| |
| QT060316 | Tofacitinib Impurity P
CAS# 1092578-48-7;2174011-54-0(Citrate)
M.F.: C16H20N6O
M.W.: 312.37 |
| |
| QL162000 | Lapatinib Ditosylate Hydrate
CAS# 388082-78-8;388082-77-7 (ditosylate salt);231277-92-2 (free base)
M.F.: C43H44ClFN4O11S3
M.W.: 943.48 |
| |
| QL142609 | Linezolid Desacetamide Phthalimide
CAS# 168828-89-5
M.F.: C22H20FN3O5
M.W.: 425.41 |
| |
| QL142607 | Linezolid Descarbonyl Impurity
CAS# 333753-67-6
M.F.: C15H22FN3O3
M.W.: 311.35 |
| |
| QL142606 | Linezolid Desacetamide Hydroxy Impurity
CAS# 168828-82-8
M.F.: C14H17FN2O4
M.W.: 296.29 |
| |
| QL142604 | Linezolid Desfluoro Impurity
CAS# 556801-15-1
M.F.: C16H21N3O4
M.W.: 319.36 |
| |
| QL142601 | Linezolid USP RC A
CAS# 168828-84-0
M.F.: C14H16FN5O3
M.W.: 321.31 |
| |
| QL062405 | Levofloxacin EP Impurity C
CAS# 117678-38-3
M.F.: C18H20FN3O5
M.W.: 377.37 |
| |
| QL062404 | Levofloxacin EP Impurity A;R-Ofloxacin
CAS# 100986-86-5
M.F.: C18H20FN3O4
M.W.: 361.37 |
| |
| QL062403 | Levofloxacin EP Impurity H;
USP Levofloxacin Related Compound C
CAS# 177472-30-9
M.F.: C20H24FN3O4
M.W.: 389.42 |
| |
| QL062402 | Levofloxacin EP Impurity F;
USP Levofloxacin Related Compound B
CAS# 100986-89-8
M.F.: C13H9F2NO4
M.W.: 281.21 |
| |
| QL062401 | Levofloxacin EP Impurity B;
Levofloxacin USP Related Compound A
CAS# 117707-40-1;2254176-11-7(HCl salt)
M.F.: C17H18FN3O4
M.W.: 347.34 |
| |
| QL062001 | Lafutidine Phthalimide Impurity
CAS# 146447-26-9
M.F.: C27H29N3O7
M.W.: 507.54 |
| |
| QL061308 | Leflunomide EP Impurity H
CAS# 24522-30-3
M.F.: C10H7F3N2O
M.W.: 228.17 |
| |
| QL061307 | Leflunomide EP Impurity G
CAS# 724429-16-7
M.F.: C12H12N2O2
M.W.: 216.24 |
| |
| QL061303 | Leflunomide EP Impurity C
CAS# 61643-23-0
M.F.: C12H9F3N2O2
M.W.: 270.21 |
| |
| QL061302 | Leflunomide EP Impurity B;Teriflunomide
CAS# 163451-81-8
M.F.: C12H9F3N2O2
M.W.: 270.21 |
| |
| QL052008 | Levetiracetam Carboxylic Acid
CAS# 102849-49-0
M.F.: C8H13NO3
M.W.: 171.19 |
| |
| QL052003 | Levetiracetam EP Impurity C
CAS# 142-08-5
M.F.: C5H5NO
M.W.: 95.10 |
| |
| QL031601 | Levocloperastine Fendizoic Acid Impurity
CAS# 84627-04-3
M.F.: C20H14O4
M.W.: 318.32 |
| |
| QL031600H | Levocloperastine Hydrochloride
CAS# NA
M.F.: C20H25Cl2NO
M.W.: 366.32 |
| |
| QL031600F | Levocloperastine Fendizoate
CAS# 220329-19-1
M.F.: C40H38ClNO5
M.W.: 648.19 |
| |
| QK201604 | Ketoprofen EP Impurity D
CAS# 107257-20-5
M.F.: C17H16O3
M.W.: 268.31 |
| |
| QK201601 | Ketoprofen EP Impurity A
CAS# 66067-44-5
M.F.: C15H12O2
M.W.: 224.25 |
| |
| QI200308 | Irinotecan Acid Sodium Salt
CAS# NA
M.F.: C33H39N4NaO7
M.W.: 626.68 |
| |
| QI200303 | Irinotecan EP Impurity E
CAS# 86639-52-3
M.F.: C22H20N2O5
M.W.: 392.4 |
| |
| QI200301 | Irinotecan EP Impurity A
CAS# 103816-16-6
M.F.: C31H34N4O6
M.W.: 558.62 |
| |
| QI192013 | Irbesartan N1-Trityl Impurity
CAS# 138402-10-5
M.F.: C44H42N6O
M.W.: 670.84 |
| |
| QI032611 | Itraconazole Dioxolonyl Impurity
CAS# 67914-86-7
M.F.: C14H15Cl2N3O5S
M.W.: 408.26 |
| |
| QI032610 | Itraconazole Methoxy Nitro Impurity
CAS# NA
M.F.: C17H21N3O
M.W.: 283.37 |
| |
| QI032604 | Itraconazole EP Impurity D
CAS# 89848-49-7
M.F.: C34H36Cl2N8O4
M.W.: 691.61 |
| |
| QH041204 | Hydralazine Triazolo Methyl Impurity
CAS# 20062-41-3
M.F.: C10H8N4
M.W.: 184.2 |
| |
| QH032004 | Hydrochlorothiazide 5-Chloro Impurity
CAS# 5233-42-1
M.F.: C7H7Cl2N3O4S2
M.W.: 332.18 |
| |
| QH032003 | Hydrochlorothiazide EP Impurity C
CAS# 402824-96-8
M.F.: C15H16Cl2N6O8S4
M.W.: 607.49 |
| |
| QH032001 | Hydrochlorothiazide EP Impurity A;
Chlorothiazide
CAS# 58-94-6
M.F.: C7H6ClN3O4S2
M.W.: 295.72 |
| |
| QG200607 | Gatifloxacin Despropylene Impurity
CAS# 172426-86-7
M.F.: C16H18FN3O4
M.W.: 335.33 |
| |
| QG200606 | Gatifloxacin Desethylene Impurity
CAS# 172426-87-8
M.F.: C17H20FN3O4
M.W.: 349.36 |
| |
| QG121606 | Glipizide EP Impurity F
CAS# 192118-08-4
M.F.: C11H16N2O4S
M.W.: 272.32 |
| |
| QG121601 | Glipizide EP Impurity A
CAS# 33288-71-0
M.F.: C14H16N4O3S
M.W.: 320.37 |
| |
| QG121308 | Glimepiride EP Impurity H
CAS# NA
M.F.: C24H28N4O5S
M.W.: 484.57 |
| |
| QG121305 | Glimepiride EP Impurity E
CAS# NA
M.F.: C16H21N3O4S
M.W.: 351.1253 |
| |
| QG121304 | Glimepiride EP Impurity D
CAS# 791104-62-6
M.F.: C24H34N4O5S
M.W.: 490.62 |
| |
| QG121303 | Glimepiride EP Impurity C
CAS# 119018-30-3
M.F.: C18H23N3O6S
M.W.: 409.46 |
| |
| QG121302 | Glimepiride EP Impurity B
CAS# 119018-29-0
M.F.: C16H21N3O4S
M.W.: 351.42 |
| |
| QG121301 | Glimepiride EP Impurity A
CAS# 684286-46-2
M.F.: C24H34N4O5S
M.W.: 490.62 |
| |
| QF192007 | Fesoterodine Diol Dimer
CAS# 1428856-45-4
M.F.: C44H60N2O3
M.W.: 664.96 |
| |
| QF192006 | Fesoterodine Phenol Aldehyde Impurity
CAS# NA
M.F.: C22H29NO2
M.W.: 339.47 |
| |
| QF192005 | Fesoterodine Isobutyrate Aldehyde Impurity
CAS# NA
M.F.: C26H35NO3
M.W.: 409.56 |
| |
| QF192004 | Fesoterodine Fumarate Ester
CAS# 1254942-29-4
M.F.: C30H39NO6
M.W.: 509.63 |
| |
| QF192003 | Fesoterodine Diol Fumarate Ester
CAS# 1428856-47-6
M.F.: C26H33NO5
M.W.: 439.54 |
| |
| QF192001 | Fesoterodine Fumarate S-Isomer
CAS# 1431511-18-0
M.F.: C30H41NO7
M.W.: 527.65 |
| |
| QF192000 | Fesoterodine Fumarate
CAS# 286930-03-8
M.F.: C30H41NO7
M.W.: 527.65 |
| |
| QF191408 | Fosinopril USP RC H
CAS# NA
M.F.: C10H15O3P
M.W.: 214.2 |
| |
| QF191407 | Fosinopril USP RC G
CAS# NA
M.F.: C12H17O4P
M.W.: 256.23 |
| |
| QF191406 | Fosinopril USP RC B
CAS# NA
M.F.: C30H46NO7P
M.W.: 563.66 |
| |
| QF191405 | Fosinopril EP Impurity F
CAS# NA
M.F.: C29H44NO7P
M.W.: 549.64 |
| |
| QF191404 | Fosinopril EP Impurity E
CAS# NA
M.F.: C30H40NO7P
M.W.: 557.61 |
| |
| QF191403 | Fosinopril EP Impurity D
CAS# NA
M.F.: C30H46NO7P
M.W.: 563.66 |
| |
| QF191402 | Fosinopril EP Impurity C
CAS# NA
M.F.: C30H46NO7P
M.W.: 563.66 |
| |
| QF191401 | Fosinopril EP Impurity A
CAS# 95399-71-6
M.F.: C23H34NO5P
M.W.: 435.49 |
| |
| QF191400NA | Fosinopril Sodium
CAS# 88889-14-9
M.F.: C30H45NNaO7P
M.W.: 585.64 |
| |
| QF190400NA | Fusidate Sodium
CAS# 751-94-0
M.F.: C31H47NaO6
M.W.: 538.69 |
| |
| QF141908 | Finasteride Dehydro Carboxylic Acid Methyl Ester
CAS# NA
M.F.: C20H27NO3
M.W.: 329.43 |
| |
| QF141907 | Finasteride Dehydro Carboxylic Acid
CAS# NA
M.F.: C19H25NO3
M.W.: 315.41 |
| |
| QF141906 | Finasteride Dihydro Carboxylic Acid Methyl Ester
CAS# NA
M.F.: C20H31NO3
M.W.: 333.47 |
| |
| QF141905 | Finasteride Dihydro Carboxylic Acid
CAS# NA
M.F.: C19H29NO3
M.W.: 319.44 |
| |
| QF141901 | Finasteride EP Impurity A
CAS# 98319-24-5
M.F.: C23H38N2O2
M.W.: 374.56 |
| |
| QF122404 | Fluoxetine R-Isomer HCl
CAS# 114247-09-5
M.F.: C17H19ClF3NO
M.W.: 345.79 |
| |
| QF122403 | Fluoxetine EP Impurity C
CAS# 79088-29-2
M.F.: C17H19ClF3NO
M.W.: 345.79 |
| |
| QF122011 | Fluticasone Carboxylic Acid
CAS# 28416-82-2
M.F.: C21H26F2O5
M.W.: 396.42 |
| |
| QF122010 | Fluticasone USP RC B
CAS# 219719-95-6
M.F.: C22H24F2O5S
M.W.: 438.48 |
| |
| QF122009 | Fluticasone Propionate EP Impurity I
CAS# 960071-64-1
M.F.: C48H58F4O10S3
M.W.: 967.16 |
| |
| QF122008 | Fluticasone Propionate EP Impurity H
CAS# 201812-64-8
M.F.: C48H58F4O10S2
M.W.: 935.09 |
| |
| QF122005 | Fluticasone Propionate EP Impurity E
CAS# 105613-90-9
M.F.: C25H33F3O5S
M.W.: 502.59 |
| |
| QF122004 | Fluticasone Propionate EP Impurity D
CAS# 73205-13-7
M.F.: C25H32F2O5S
M.W.: 482.58 |
| |
| QF122002 | Fluticasone Propionate EP Impurity B
CAS# 948566-12-9
M.F.: C24H30F2O6S
M.W.: 484.55 |
| |
| QF122000P | Fluticasone Propionate
CAS# 80474-14-2
M.F.: C25H31F3O5S
M.W.: 500.57 |
| |
| QF061300 | Fosfomycin Trometamol
CAS# 78964-85-9
M.F.: C3H7O4P.C4H11NO3
M.W.: 138.06 121.14 |
| |
| QE200313 | Entacapone EP Impurity C
CAS# 116313-85-0
M.F.: C7H5NO5
M.W.: 183.12 |
| |
| QE181406 | Eplerenone delta-9,11-Analog
CAS# 95716-70-4
M.F.: C24H30O5
M.W.: 398.49 |
| |
| QE181404 | Eplerenone 6-beta-Hydroxy Analog
CAS# 209253-80-5
M.F.: C24H30O7
M.W.: 430.49 |
| |
| QE181403 | Eplerenone Impurity - Canrenone;Spironolactone EP Impurity F
CAS# 976-71-6
M.F.: C22H28O3
M.W.: 340.46 |
| |
| QE181402 | Eplerenone Impurity - 11-alpha-Hydroxy Canrenone
CAS# 192569-17-8
M.F.: C22H28O4
M.W.: 356.46 |
| |
| QE181401 | Eplerenone Impurity - 9,11-Didehydro Canrenone
CAS# 95716-71-5
M.F.: C22H26O3
M.W.: 338.44 |
| |
| QE162002 | Epothilone B
CAS# 152044-54-7
M.F.: C27H41NO6S
M.W.: 507.69 |
| |
| QE151303 | Esomeprazole EP Impurity C;Ufiprazole
CAS# 73590-85-9
M.F.: C17H19N3O2S
M.W.: 329.42 |
| |
| QE141209 | Enalapril Alanyl Proline Impurity
CAS# 13485-59-1
M.F.: C8H14N2O3
M.W.: 186.21 |
| |
| QE141202 | Enalapril maleate EP Impurity B ;
Quinapril EP Impurity B;
Ramipril EP Impurity F;
Spirapril EP Impurity C
CAS# 82717-96-2
M.F.: C15H21NO4
M.W.: 279.33 |
| |
| QE141200M | Enalapril Maleate
CAS# 76095-16-4
M.F.: C24H32N2O9
M.W.: 492.52 |
| |
| QE021900NA | Ecabet Sodium
CAS# 86408-72-2
M.F.: C20H27NaO5S
M.W.: 402.48 |
| |
| QD261204 | Dorzolamide EP Impurity D
CAS# 154154-90-2 (base);164455-27-0 (HCl salt)
M.F.: C8H13ClN2O4S3
M.W.: 332.85 |
| |
| QD261203 | Dorzolamide EP Impurity C
CAS# NA
M.F.: C10H17BN2O6S3
M.W.: 368.26 |
| |
| QD261202 | Dorzolamide EP Impurity B
CAS# 120279-37-0
M.F.: C10H17ClN2O4S3
M.W.: 360.9 |
| |
| QD261200 | Dorzolamide HCl
CAS# 130693-82-2
M.F.: C10H17ClN2O4S3
M.W.: 360.9 |
| |
| QD242607 | Doxazosin EP Impurity G;
Prazosin EP Impurity C;
Terazosin EP Impurity C
CAS# 60547-97-9
M.F.: C14H19N5O2
M.W.: 289.33 |
| |
| QD242606 | Doxazosin EP Impurity F;
Prazosin EP Impurity A;
Terazosin EP Impurity A;
Alfuzosin EP Impurity B
CAS# 23680-84-4
M.F.: C10H10ClN3O2
M.W.: 239.66 |
| |
| QD242605 | Doxazosin EP Impurity E
CAS# 27631-29-4
M.F.: C10H8Cl2N2O2
M.W.: 259.09 |
| |
| QD242604 | Doxazosin EP Impurity D
CAS# 28888-44-0
M.F.: C10H10N2O4
M.W.: 222.2 |
| |
| QD242603 | Doxazosin EP Impurity C
CAS# 617677-53-9
M.F.: C22H22N2O6
M.W.: 410.42 |
| |
| QD242601 | Doxazosin EP Impurity A
CAS# 3663-80-7
M.F.: C9H8O4
M.W.: 180.16 |
| |
| QD242600M | Doxazosin Mesylate
CAS# 77883-43-3
M.F.: C24H29N5O8S
M.W.: 547.58 |
| |
| QD241300SP | Dexamethasone Sodium Phosphate
CAS# 2392-39-4
M.F.: C22H28FNa2O8P
M.W.: 516.4 |
| |
| QD221208 | Desvenlafaxine Spiro Impurity
CAS# NA
M.F.: C16H23NO2.HCl
M.W.: 261.37 36.46 |
| |
| QD221207 | Desvenlafaxine N-Desmethyl Impurity
CAS# 135308-74-6
M.F.: C15H23NO2
M.W.: 249.35 |
| |
| QD221206 | Desvenlafaxine S-Isomer
CAS# NA
M.F.: C16H25NO2
M.W.: 263.38 |
| |
| QD221204 | Desvenlafaxine R-Isomer
CAS# 142761-11-3
M.F.: C16H25NO2
M.W.: 263.38 |
| |
| QD221202 | Desvenlafaxine N,N-Didesmethyl Impurity
CAS# 135308-76-8
M.F.: C14H21NO2.HCl
M.W.: 235.33 36.46 |
| |
| QD221201 | Desvenlafaxine Phenol Impurity
CAS# 539-15-1;62493-39-4(H2SO4 salt)
M.F.: C10H15NO
M.W.: 165.23 |
| |
| QD181600 | Doripenem Monohydrate
CAS# 364622-82-2;148016-81-3(free base)
M.F.: C15H24N4O6S2.H2O
M.W.: 420.50 18.02 |
| |
| QD180609 | Darifenacin Pyrrolidine Impurity S-Isomer
CAS# 134002-26-9
M.F.: C22H26N2O7
M.W.: 430.45 |
| |
| QD180608 | Darifenacin Pyrrolidine Impurity Racemate
CAS# 103887-32-7
M.F.: C18H20N2O
M.W.: 280.36 |
| |
| QD180607 | Darifenacin Dimer-2 Impurity
CAS# NA
M.F.: C38H40N2O3
M.W.: 572.74 |
| |
| QD180606 | Darifenacin Dimer-1 Impurity
CAS# NA
M.F.: C38H40N2O3
M.W.: 572.74 |
| |
| QD180605 | Darifenacin Dehydro Impurity
CAS# NA
M.F.: C28H28N2O2
M.W.: 424.53 |
| |
| QD180604 | Darifenacin Cyano Impurity
CAS# 1159977-31-7
M.F.: C23H26N2O2
M.W.: 362.46 |
| |
| QD180603 | Darifenacin Carboxylic Acid Impurity
CAS# 69999-16-2
M.F.: C10H10O3
M.W.: 178.18 |
| |
| QD180602 | Darifenacin Bromo Impurity
CAS# 127264-14-6
M.F.: C10H11BrO
M.W.: 227.1 |
| |
| QD180601 | Darifenacin R-Isomer
CAS# NA
M.F.: C28H31BrN2O2
M.W.: 507.46 |
| |
| QD180600H | Darifenacin HBr
CAS# 133099-07-7
M.F.: C28H31BrN2O2
M.W.: 507.46 |
| |
| QD161801 | Dipyridamole EP Impurity A
CAS# 16982-40-4
M.F.: C25H40N8O2
M.W.: 484.64 |
| |
| QD160405 | Domperidone EP Impurity E
CAS# 1346602-50-3
M.F.: C32H34ClN7O3
M.W.: 600.11 |
| |
| QD160404 | Domperidone EP Impurity D
CAS# 1614255-34-3
M.F.: C32H34ClN7O3
M.W.: 600.11 |
| |
| QD160403 | Domperidone Impurity C
CAS# 118435-03-3
M.F.: C22H24ClN5O3
M.W.: 441.91 |
| |
| QD160402 | Domperidone EP Impurity B
CAS# 1346598-11-5
M.F.: C13H14ClN3O2
M.W.: 279.72 |
| |
| QD160401 | Domperidone EP Impurity A
CAS# 53786-28-0
M.F.: C12H14ClN3O
M.W.: 251.71 |
| |
| QD141612 | Donepezil Aldehyde Impurity
CAS# 22065-85-6
M.F.: C13H17NO
M.W.: 203.28 |
| |
| QD141611 | Donepezil Keto Acid Impurity
CAS# NA
M.F.: C24H29NO5
M.W.: 411.49 |
| |
| QD141610 | Donepezil Hydroxy Acid Impurity
CAS# NA
M.F.: C24H31NO5
M.W.: 413.51 |
| |
| QD141609 | Donepezil Pyridine Dihydro Impurity
CAS# NA
M.F.: C17H15NO3
M.W.: 281.31 |
| |
| QD141607 | Donepezil Hydroxy Keto Impurity
CAS# 197010-20-1
M.F.: C24H29NO4
M.W.: 395.49 |
| |
| QD141606 | Donepezil Dihydro Impurity
CAS# 120012-04-6
M.F.: C24H31NO3
M.W.: 381.51 |
| |
| QD141605 | Donepezil Desbenzyl Impurity
CAS# 120013-39-0
M.F.: C17H23NO3.HCl
M.W.: 289.38 36.46 |
| |
| QD141603 | Donepezil Dehydro Deoxy Impurity
CAS# 120013-45-8
M.F.: C24H29NO2
M.W.: 363.49 |
| |
| QD141602 | Donepezil Benzyl Bromide
CAS# 844694-85-5
M.F.: C31H36BrNO3
M.W.: 550.53 |
| |
| QD141600 | Donepezil Hydrochloride
CAS# 120011-70-3;884740-09-4(HCl monohydrate)
M.F.: C24H29NO3.HCl
M.W.: 379.50 36.46 |
| |
| QD122411 | Duloxetine Impurity 11
CAS# 132335-44-5
M.F.: C9H15NOS
M.W.: 185.29 |
| |
| QD122410 | Duloxetine N-Desmethyl Metabolite
CAS# 178273-35-3
M.F.: C17H17NOS
M.W.: 283.39 |
| |
| QD122409 | Duloxetine Impurity 9
CAS# 132335-46-7;132335-47-8(Oxalate)
M.F.: C19H21NOS
M.W.: 311.44 |
| |
| QD122408 | Duloxetine USP RC H
CAS# 199191-66-7
M.F.: C22H23NO4S
M.W.: 397.49 |
| |
| QD122405 | Duloxetine EP Impurity E
CAS# 1033803-59-6
M.F.: C18H19NOS
M.W.: 297.41 |
| |
| QD122402 | Duloxetine EP Impurity B
CAS# 116539-55-0
M.F.: C8H13NOS
M.W.: 171.26 |
| |
| QD122401 | Duloxetine EP Impurity A
CAS# 116539-60-7;910138-96-4(HCl salt)
M.F.: C18H19NOS
M.W.: 297.41 |
| |
| QD122400 | Duloxetine Hydrochloride
CAS# 136434-34-9;116539-59-4(free base)
M.F.: C18H20ClNOS
M.W.: 333.88 |
| |
| QD061802 | Aspirin Impurity C;
Mesalazine EP Impurity H;
Lamivudine EP Impurity C;
Acetylsalicylic Acid EP Impurity C;
Sulfasalazine EP Impurity H;
Carbasalate calcium EP Impurity C;
DL-Lysine acetylsalicylate EP Impurity A
CAS# 69-72-7
M.F.: C7H6O3
M.W.: 138.12 |
| |
| QD061801 | Deferasirox Benzamide Impurity
CAS# 65-45-2
M.F.: C7H7NO2
M.W.: 137.14 |
| |
| QD030410 | Diclofenac Desacetate Impurity
CAS# 15307-93-4
M.F.: C12H9Cl2N
M.W.: 238.11 |
| |
| QD030409 | Diclofenac 4-Bromo Analog
CAS# NA
M.F.: C19H11BrClN02
M.W.: 340.6 |
| |
| QD030406 | Diclofenac Carboxylic Acid
CAS# 13625-57-5
M.F.: C13H9Cl2NO2
M.W.: 282.12 |
| |
| QD030405 | Diclofenac EP Impurity E
CAS# 59-48-3
M.F.: C8H7NO
M.W.: 133.15 |
| |
| QD030403 | Diclofenac EP Impurity C
CAS# 27204-57-5
M.F.: C13H11Cl2NO
M.W.: 268.14 |
| |
| QD030402 | Diclofenac EP Impurity B
CAS# 22121-58-0
M.F.: C13H9Cl2NO
M.W.: 266.12 |
| |
| QD030401 | Diclofenac EP Impurity A
CAS# 15362-40-0
M.F.: C14H9Cl2NO
M.W.: 278.13 |
| |
| QC261200NA | Cefazolin Sodium
CAS# 27164-46-1;25953-19-9(free base)
M.F.: C14H13N8NaO4S3
M.W.: 476.49 |
| |
| QC250100M | Cyamemazine Maleate
CAS# NA
M.F.: C19H21N3S C4H4O4
M.W.: 323.46 116.07 |
| |
| QC242000NA | Cefoxitin Sodium
CAS# 33564-30-6
M.F.: C18H16N3NaO7S2
M.W.: 449.43 |
| |
| QC221200 | Clavulanate Potassium
CAS# 61177-45-5;58001-44-8(free base)
M.F.: C8H8KNO5
M.W.: 237.25 |
| |
| QC201813 | Cetirizine EP Impurity B Ethyl Ester
CAS# NA
M.F.: C21H25ClN2O2
M.W.: 372.89 |
| |
| QC201812 | Cetirizine 4-Chlorobenzophenone Impurity (USP)
CAS# 134-85-0
M.F.: C13H9ClO
M.W.: 216.66 |
| |
| QC201811 | Cetirizine 4-Chlorobenzhydrol Impurity (USP);
Meclizine USP RC A;Meclozine EP Impurity B
CAS# 119-56-2
M.F.: C13H11ClO
M.W.: 218.68 |
| |
| QC201803 | Cetirizine EP Impurity C;USP 2-Chlorocetirizine
CAS# 2702511-37-1;83881-59-8 (free base)
M.F.: C21H25ClN2O3 2HCl
M.W.: 388.89 72.92 |
| |
| QC200600 | Ceftiofur Sodium
CAS# 104010-37-9
M.F.: C19H16N5NaO7S3
M.W.: 545.54 |
| |
| QC192042 | Candesartan Methyl Ester N1-Trityl Methoxy Analog
CAS# 1246815-58-6
M.F.: C43H34N6O3
M.W.: 682.77 |
| |
| QC192041 | Candesartan N2-Trityl Methoxy Analog
CAS# NA
M.F.: C42H32N6O3
M.W.: 668.74 |
| |
| QC192039 | Candesartan N1-Trityl Methoxy Analog
CAS# 1246820-94-9
M.F.: C42H32N6O3
M.W.: 668.74 |
| |
| QC192038 | Candesartan N2-Trityl Impurity
CAS# NA
M.F.: C43H34N6O3
M.W.: 682.77 |
| |
| QC192037 | Candesartan Cilexetil N2-Trityl Methoxy Analog
CAS# NA
M.F.: C51H46N6O6
M.W.: 838.95 |
| |
| QC192036 | Candesartan Cilexetil Desethyl N2-Trityl Analog
CAS# NA
M.F.: C50H44N6O6
M.W.: 824.92 |
| |
| QC192035 | Candesartan Cilexetil Desethyl N1-Trityl Analog
CAS# 934495-65-5
M.F.: C50H44N6O6
M.W.: 824.92 |
| |
| QC192034 | Candesartan Methyl Ester N2-Trityl Analog
CAS# NA
M.F.: C44H36N6O3
M.W.: 696.8 |
| |
| QC192033 | Candesartan Cilexetil N2-Trityl Analog
CAS# NA
M.F.: C52H48N6O6
M.W.: 852.97 |
| |
| QC192032 | Candesartan Cilexetil N1-Trityl Methoxy Analog
CAS# 1246818-56-3
M.F.: C51H46N6O6
M.W.: 838.95 |
| |
| QC192030 | Candesartan Ethyl Ester N2-Cilexetil Analog
CAS# NA
M.F.: C35H38N6O6
M.W.: 638.71 |
| |
| QC192029 | Candesartan Benzimidazole Methoxy Impurity
CAS# 1246817-06-0
M.F.: C10H10N2O3
M.W.: 206.2 |
| |
| QC192028 | Candesartan Ethyl Ester N2-Trityl Analog
CAS# NA
M.F.: C45H38N6O3
M.W.: 710.82 |
| |
| QC192027 | Candesartan Methyl Ester N1-Trityl Analog
CAS# 150058-29-0
M.F.: C44H36N6O3
M.W.: 696.8 |
| |
| QC192025 | Candesartan Cilexetil Methoxy Analog
CAS# 1026042-12-5
M.F.: C32H33ClN6O6
M.W.: 633.09 |
| |
| QC192023 | Candesartan Ethyl Ester N1-Cilexetil Analog
CAS# NA
M.F.: C35H38N6O6
M.W.: 638.71 |
| |
| QC192022 | Candesartan Benzimidazole Ethoxy Impurity
CAS# 150058-27-8
M.F.: C11H12N2O3
M.W.: 220.22 |
| |
| QC192021 | Candesartan N2-Ethyl Impurity
CAS# 1246819-02-2
M.F.: C26H24N6O3
M.W.: 468.51 |
| |
| QC192020 | Candesartan N1-Ethyl Impurity
CAS# NA
M.F.: C26H24N6O3
M.W.: 468.51 |
| |
| QC192019 | Candesartan Ethyl Ester Desethyl Analog
CAS# NA
M.F.: C24H20N6O3
M.W.: 440.45 |
| |
| QC192018 | Candesartan Methyl Ester Desethyl Analog
CAS# NA
M.F.: C23H18N6O3
M.W.: 426.43 |
| |
| QC192017 | Candesartan Ethyl Ester Desethyl N2-Cilexetil Analog
CAS# NA
M.F.: C33H34N6O6
M.W.: 610.66 |
| |
| QC192016 | Candesartan Ethyl Ester Desethyl N1-Cilexetil Analog
CAS# NA
M.F.: C33H34N6O6
M.W.: 610.66 |
| |
| QC192011 | Candesartan Bromo N1-Trityl Impurity
CAS# NA
M.F.: C33H25BrN4
M.W.: 557.48 |
| |
| QC192010 | Candesartan Ethyl Ester N1-Trityl Analog
CAS# 856414-35-2
M.F.: C45H38N6O3
M.W.: 710.82 |
| |
| QC192009 | Candesartan Cilexetil EP Impurity I
CAS# 139481-69-9
M.F.: C25H22N6O3
M.W.: 454.48 |
| |
| QC192008 | Candesartan Cilexetil EP Impurity H
CAS# 170791-09-0
M.F.: C52H48N6O6
M.W.: 852.97 |
| |
| QC192007 | Candesartan Cilexetil EP Impurity G ;
Candesartan
CAS# 139481-59-7
M.F.: C24H20N6O3
M.W.: 440.45 |
| |
| QC192006 | Candesartan Cilexetil EP Impurity F
CAS# 914613-36-8
M.F.: C35H38N6O6
M.W.: 638.71 |
| |
| QC192005 | Candesartan Cilexetil EP Impurity E
CAS# 914613-35-7
M.F.: C35H38N6O6
M.W.: 638.71 |
| |
| QC192004 | Candesartan Cilexetil EP Impurity D
CAS# 1185256-03-4
M.F.: C33H34N6O6
M.W.: 610.66 |
| |
| QC192003 | Candesartan Cilexetil EP Impurity C
CAS# 1185255-99-5
M.F.: C33H34N6O6
M.W.: 610.66 |
| |
| QC192002 | Candesartan Cilexetil EP Impurity B
CAS# 869631-11-8
M.F.: C31H30N6O6
M.W.: 582.61 |
| |
| QC192001 | Candesartan Cilexetil EP Impurity A
CAS# 139481-58-6
M.F.: C26H24N6O3
M.W.: 468.51 |
| |
| QC192000 | Candesartan Cilexetil
CAS# 145040-37-5
M.F.: C33H34N6O6
M.W.: 610.66 |
| |
| QC191602 | Cyclosporin B
CAS# 63775-95-1
M.F.: C61H109N11O12
M.W.: 1188.58 |
| |
| QC191200 | Cefsulodin Sodium
CAS# 52152-93-9
M.F.: C22H19N4NaO8S2
M.W.: 554.53 |
| |
| QC162000 | Camptothecin;Irinotecan EP Impurity D
CAS# 7689-03-4
M.F.: C20H16N2O4
M.W.: 348.35 |
| |
| QC161810 | Captopril Ethyl Ester
CAS# NA
M.F.: C11H19NO3S
M.W.: 245.34 |
| |
| QC161809 | Captopril EP Impurity J
CAS# 64838-55-7
M.F.: C11H17NO4S
M.W.: 259.32 |
| |
| QC161808 | Captopril EP Impurity G
CAS# 33325-40-5
M.F.: C6H10O3S
M.W.: 162.21 |
| |
| QC161807 | Captopril EP Impurity F
CAS# 63250-36-2
M.F.: C9H15NO3S
M.W.: 217.29 |
| |
| QC161806 | Captopril EP Impurity E
CAS# 23500-15-4
M.F.: C9H15NO3
M.W.: 185.22 |
| |
| QC161805 | Captopril EP Impurity D
CAS# 56970-78-6
M.F.: C4H7BrO2
M.W.: 167.00 |
| |
| QC161804 | Captopril Acid Amine Salt
CAS# NA
M.F.: C18H23NO2S
M.W.: 317.45 |
| |
| QC161803 | Captopril EP Impurity C
CAS# 26473-47-2
M.F.: C4H8O2S
M.W.: 120.17 |
| |
| QC161801 | Captopril EP Impurity A
CAS# 64806-05-9
M.F.: C18H28N2O6S2
M.W.: 432.55 |
| |
| QC161800 | Captopril
CAS# 62571-86-2
M.F.: C9H15NO3S
M.W.: 217.29 |
| |
| QC160700BS | Clopidogrel Bisulfate
CAS# 120202-66-6
M.F.: C16H16ClNO2S . H2SO4
M.W.: 321.81 |
| |
| QC160604 | Ciprofloxacin EP Impurity D
CAS# 133210-96-5(free base); 526204-10-4
M.F.: C17H18ClN3O3.HCl
M.W.: 347.80 36.46 |
| |
| QC141805 | Cinnarizine EP Impurity E
CAS# 216581-01-0
M.F.: C30H30N2
M.W.: 418.57 |
| |
| QC141804 | Cinnarizine EP Impurity D
CAS# NA
M.F.: C35H36N2
M.W.: 484.67 |
| |
| QC141803 | Cinnarizine EP Impurity C
CAS# 95062-18-3
M.F.: C35H37ClN2
M.W.: 521.13 |
| |
| QC141802 | Cinnarizine EP Impurity B
CAS# 750512-44-8
M.F.: C26H28N2
M.W.: 368.51 |
| |
| QP151426 | 13,14-dihydro-16,16-difluoro Prostaglandin E1;15-hydroxy Lubiprostone
CAS# 475992-30-4
M.F.: C20H34F2O5
M.W.: 392.5 |
| |
| QC141801 | Cinnarizine EP Impurity A
CAS# 841-77-0
M.F.: C17H20N2
M.W.: 252.35 |
| |
| QC132002 | Cimetidine EP Impurity E;Cimetidine Sulfoxide
CAS# 54237-72-8
M.F.: C10H16N6OS
M.W.: 268.34 |
| |
| QC130400NA | Cefamandole Sodium
CAS# 30034-03-8
M.F.: C18H17N6NaO5S2
M.W.: 484.48 |
| |
| QC130400N | Cefamandole Nafate
CAS# 42540-40-9
M.F.: C19H17N6NaO6S2
M.W.: 512.49 |
| |
| QC120303 | Celecoxib Carboxylic Acid
CAS# 170571-01-4
M.F.: C17H12F3N3O4S
M.W.: 411.36 |
| |
| QC120302 | Celecoxib EP Impurity B
CAS# 331943-04-5
M.F.: C17H14F3N3O2S
M.W.: 381.37 |
| |
| QC061205 | Cefalexin EP Impurity E;
Cefadroxil EP Impurity H;
Cefradine EP Impurity G
CAS# 146794-70-9
M.F.: C13H18N2O4S
M.W.: 298.36 |
| |
| QC061204 | Cefalexin EP Impurity D;
Cefadroxil EP Impurity G;
Cefradine EP Impurity F
CAS# 34876-35-2
M.F.: C5H6O2S
M.W.: 130.16 |
| |
| QC061203 | Cefalexin EP Impurity C
CAS# 72528-40-6
M.F.: C24H24N4O5S
M.W.: 480.54 |
| |
| QC061202 | Cefalexin EP Impurity B;
Cefadroxil EP Impurity B;
Cefradine EP Impurity A;
7-ADCA
CAS# 22252-43-3
M.F.: C8H10N2O3S
M.W.: 214.24 |
| |
| QC061201 | Cefalexin EP Impurity A;
Cefaclor EP Impurity A
CAS# 875-74-1
M.F.: C8H9NO2
M.W.: 151.16 |
| |
| QC061200 | Cefalexin Monohydrate
CAS# 23325-78-2;15686-71-2 (anhydrous)
M.F.: C16H17N3O4S.H2O
M.W.: 347.39 18.02 |
| |
| QC060600 | Choline Fenofibrate
CAS# 856676-23-8
M.F.: C22H28ClNO5
M.W.: 421.91 |
| |
| QC030308 | Cinacalcet N-Oxide
CAS# 1229224-94-5
M.F.: C22H22F3NO
M.W.: 373.41 |
| |
| QC030307 | Cinacalcet Impurity F
CAS# 1271930-12-1 (base)
M.F.: C22H29ClF3N
M.W.: 399.92 |
| |
| QC030306 | Cinacalcet Impurity E
CAS# 253337-60-9
M.F.: C22H25N
M.W.: 303.44 |
| |
| QC030305 | Cinacalcet Impurity D
CAS# 1271930-15-4(free base)
M.F.: C32H31F6N.HCl
M.W.: 543.60 36.46 |
| |
| QC030304 | Cinacalcet Impurity C
CAS# NA
M.F.: C22H21ClF3N
M.W.: 391.86 |
| |
| QC030303 | Cinacalcet Impurity B
CAS# NA
M.F.: C19H20ClN
M.W.: 297.82 |
| |
| QC030301 | Cinacalcet S-Isomer
CAS# 694495-47-1;1217809-88-5(HCl salt)
M.F.: C22H22F3N
M.W.: 357.41 |
| |
| QB221400 | Brivanib Alaninate
CAS# 649735-63-7
M.F.: C22H24FN5O4
M.W.: 441.46 |
| |
| QB191803 | Benserazide EP Impurity C
CAS# NA
M.F.: C10H13N3O5
M.W.: 255.23 |
| |
| QB191802 | Benserazide EP Impurity B
CAS# 2472968-83-3
M.F.: C17H21N3O8
M.W.: 395.36 |
| |
| QB191801 | Benserazide EP Impurity A
CAS# 64616-76-8;55819-71-1(HCl salt)
M.F.: C3H9N3O2
M.W.: 119.12 |
| |
| QB191618 | Bisoprolol Carboxylic Acid Impurity
CAS# 72570-70-8
M.F.: C13H19NO4
M.W.: 253.29 |
| |
| QB191617 | Bisoprolol Epoxide Impurity
CAS# 66722-57-4
M.F.: C15H22O4
M.W.: 266.33 |
| |
| QB191616 | Bisoprolol Impurity 16
CAS# 623-05-2
M.F.: C7H8O2
M.W.: 124.14 |
| |
| QB191615 | Bisoprolol EP Impurity S
CAS# 123-08-0
M.F.: C7H6O2
M.W.: 122.12 |
| |
| QB191611 | Bisoprolol Impurity 11
CAS# 177034-57-0
M.F.: C12H18O3
M.W.: 210.27 |
| |
| QB191608 | Bisoprolol Impurity 8
CAS# NA
M.F.: C15H24O5
M.W.: 284.35 |
| |
| QB191601 | Bisoprolol EP Impurity A
CAS# 62572-93-4
M.F.: C13H21NO3
M.W.: 239.31 |
| |
| QB191410 | Bosentan Sulfoxide
CAS# NA
M.F.: C27H29N5O5S
M.W.: 535.61 |
| |
| QB191409 | Bosentan Sulfide
CAS# NA
M.F.: C27H29N5O4S
M.W.: 519.62 |
| |
| QB191408 | Bosentan O-Desmethyl Impurity
CAS# 253688-61-8
M.F.: C26H27N5O6S
M.W.: 537.59 |
| |
| QB191407 | Bosentan Hydroxymethyl O-Desmethyl Impurity
CAS# 253688-62-9
M.F.: C26H27N5O7S
M.W.: 553.59 |
| |
| QB191406 | Bosentan Hydroxymethyl Impurity
CAS# 253688-60-7
M.F.: C27H29N5O7S
M.W.: 567.61 |
| |
| QB191405 | Bosentan USP RC E
CAS# 6292-59-7
M.F.: C10H15NO2S
M.W.: 213.3 |
| |
| QB191404 | Bosentan USP RC D
CAS# 150728-13-5
M.F.: C15H10Cl2N4O2
M.W.: 349.17 |
| |
| QB191403 | Bosentan USP RC C
CAS# 1097263-60-9
M.F.: C52H52N10O10S2
M.W.: 1041.16 |
| |
| QB191402 | Bosentan USP RC B
CAS# 174227-14-6
M.F.: C25H25N5O5S
M.W.: 507.56 |
| |
| QB191401 | Bosentan USP Related Compound A
CAS# 150727-06-3
M.F.: C25H24ClN5O4S
M.W.: 526.01 |
| |
| QB161814 | Buspirone N-Oxide (Oxalate)
CAS# 220747-81-9(free base)
M.F.: C21H31N5O3.C2H2O4
M.W.: 401.51 90.03 |
| |
| QB161813 | Buspirone 6-Hydroxy Metabolite
CAS# 125481-61-0
M.F.: C21H31N5O3
M.W.: 401.5 |
| |
| QB161812 | Buspirone 5-Hydroxy Metabolite
CAS# 105496-33-1
M.F.: C21H31N5O3
M.W.: 401.5 |
| |
| QB161810 | Buspirone EP Impurity J
CAS# 2726492-72-2
M.F.: C34H52N6O5
M.W.: 624.81 |
| |
| QB161809 | Buspirone EP Impurity I
CAS# 2725354-99-2
M.F.: C21H30ClN5O2
M.W.: 419.95 |
| |
| QB161808 | Buspirone EP Impurity H
CAS# 2708578-34-9
M.F.: C33H50N8O4
M.W.: 622.81 |
| |
| QB161807 | Buspirone EP Impurity G
CAS# 84746-24-7
M.F.: C12H14N6
M.W.: 242.28 |
| |
| QB161806 | Buspirone EP Impurity F
CAS# 2512210-24-9
M.F.: C33H51N9O3
M.W.: 621.82 |
| |
| QB161805 | Buspirone EP Impurity E
CAS# 257877-43-3;257877-46-6 (HCl salt)
M.F.: C21H33N5O3
M.W.: 403.52 |
| |
| QB161804 | Buspirone EP Impurity D
CAS# 2724726-67-2
M.F.: C24H38N8O
M.W.: 454.61 |
| |
| QB161803 | Buspirone EP Impurity C
CAS# 257877-45-5
M.F.: C20H30N8
M.W.: 382.51 |
| |
| QB161802 | Buspirone EP Impurity B
CAS# 81461-73-6
M.F.: C12H19BrN4
M.W.: 299.21 |
| |
| QB161801 | Buspirone EP Impurity A
CAS# 20980-22-7;78069-54-2(HCl salt)
M.F.: C8H12N4
M.W.: 164.21 |
| |
| QB161800 | Buspirone HCl
CAS# 33386-08-2;36505-84-7(free base)
M.F.: C21H32ClN5O2
M.W.: 421.96 |
| |
| QB161616 | Bupropion ThioMorpholine Acid
CAS# 1246812-57-6
M.F.: C12H14ClNO3S
M.W.: 287.76 |
| |
| QB161614 | Bupropion Morpholinol Impurity (HCl Salt)
CAS# 106083-71-0
M.F.: C13H19Cl2NO2
M.W.: 292.2 |
| |
| QB161613 | Bupropion Morpholinol Impurity
CAS# 357399-43-0
M.F.: C13H18ClNO2
M.W.: 255.74 |
| |
| QB161611 | Bupropion 3',5'-Dichloro Impurity
CAS# 1193779-48-4;1346603-00-6(HCl salt）
M.F.: C13H17Cl2NO
M.W.: 274.19 |
| |
| QB161610 | Bupropion 3',4'-Dichloro Impurity
CAS# 1346598-72-8;1193779-34-8(free base)
M.F.: C13H17Cl2NO.HCl
M.W.: 274.19 36.46 |
| |
| QB161609 | Bupropion 2-Bromo Impurity
CAS# 34911-51-8
M.F.: C9H8BrClO
M.W.: 247.52 |
| |
| QB161608 | Bupropion Des-t-Butylamino Impurity
CAS# 34841-35-5
M.F.: C9H9ClO
M.W.: 168.62 |
| |
| QB161607 | Bupropion 2-Chloro Analog
CAS# 1049718-57-1
M.F.: C13H19Cl2NO
M.W.: 276.2 |
| |
| QB161606 | Bupropion USP Related Compound F
CAS# 857233-13-7
M.F.: C9H9ClO2
M.W.: 184.62 |
| |
| QB161605 | Bupropion USP Related Compound E
CAS# 10557-17-2
M.F.: C9H7ClO2
M.W.: 182.6 |
| |
| QB161604 | Bupropion USP Related Compound D (HCl Salt)
CAS# 63199-74-6
M.F.: C13H20ClNO
M.W.: 241.76 |
| |
| QB161603 | Bupropion USP Related Compound C
CAS# 152943-33-4
M.F.: C9H9ClO2
M.W.: 184.62 |
| |
| QB161602 | Bupropion USP Related Compound B (HCl Salt)
CAS# 1049718-43-5;1049974-35-7(free base)
M.F.: C13H19BrClNO
M.W.: 320.65 |
| |
| QB161601 | Bupropion USP Related Compound A
CAS# 1049718-72-0
M.F.: C13H19Cl2NO
M.W.: 276.2 |
| |
| QB161600 | Bupropion Hydrochloride
CAS# 31677-93-7;34911-55-2(free base)
M.F.: C13H18ClNO.HCl
M.W.: 239.74 36.46 |
| |
| QB031209 | Bicalutamide S-Isomer
CAS# 113299-38-0
M.F.: C18H14F4N2O4S
M.W.: 430.061 |
| |
| QB031202 | Bicalutamide 2-Fluoro Isomer
CAS# NA
M.F.: C18H14F4N2O4S
M.W.: 430.061 |
| |
| QA221800 | Alverine Citrate
CAS# 5560-59-8
M.F.: C26H35NO7
M.W.: 473.57 |
| |
| QA221301 | Avermectin B1a Dihydro Analog
CAS# 70288-86-7
M.F.: C48H74O14
M.W.: 875.09 |
| |
| QA201401 | Atenolol EP Impurity A
CAS# 17194-82-0
M.F.: C8H9NO2
M.W.: 151.16 |
| |
| QA181616 | Aripiprazole Chlorobutoxyquinoline Impurity (USP)
CAS# 120004-79-7
M.F.: C13H16ClNO2
M.W.: 253.72 |
| |
| QA181615 | Aripiprazole Hydroxybutyl Impurity
CAS# 870765-38-1
M.F.: C14H21Cl3N2O
M.W.: 339.69 |
| |
| QA181614 | Aripiprazole Desethylene Impurity
CAS# 1216394-63-6
M.F.: C21H25Cl2N3O2
M.W.: 422.35 |
| |
| QA181613 | Aripiprazole EP Impurity G
CAS# 1797986-18-5
M.F.: C48H56Cl4N6O4
M.W.: 922.81 |
| |
| QA181612 | Aripiprazole N,N-Dioxide
CAS# 573691-13-1
M.F.: C23H27Cl2N3O4
M.W.: 480.38 |
| |
| QA181609 | Aripiprazole Bromo Impurity
CAS# 129722-34-5
M.F.: C13H16BrNO2
M.W.: 298.18 |
| |
| QA181606 | Aripiprazole USP RC H
CAS# 1796928-63-6
M.F.: C27H35Cl2N3O3
M.W.: 520.49 |
| |
| QA181605 | Aripiprazole EP Impurity E
CAS# 129722-25-4
M.F.: C23H25Cl2N3O2
M.W.: 446.37 |
| |
| QA181604 | Aripiprazole EP Impurity F
CAS# 573691-09-5
M.F.: C23H27Cl2N3O3
M.W.: 464.38 |
| |
| QA181603 | Aripiprazole EP Impurity B HCl
CAS# 119532-26-2;41202-77-1(free base)
M.F.: C10H12Cl2N2.HCl
M.W.: 231.12 36.46 |
| |
| QA132401 | Amoxicillin EP Impurity A ;
Ampicillin EP Impurity A;
Oxacillin sodium monohydrate EP Impurity A
CAS# 551-16-6
M.F.: C8H12N2O3S
M.W.: 216.26 |
| |
| QA121631 | Allopurinol Nitrile Impurity
CAS# 16617-46-2
M.F.: C4H4N4
M.W.: 108.1 |
| |
| QA121603 | Allopurinol EP Impurity C
CAS# 1346604-13-4
M.F.: C6H6N6O
M.W.: 178.15 |
| |
| QT200301 | Tetrahydrofolic Acid
CAS# 135-16-0
M.F.: C19H23N7O6
M.W.: 445.4 |
| |
| QA180319 | Adrenic Acid (Solution in ethanol)
CAS# 28874-58-0
M.F.: C22H36O2
M.W.: 332.52 |
| |
| QA122206 | Alvimopan Impurity F
CAS# [NA]
M.F.: C24H31NO3
M.W.: 381.51 |
| |
| QA122204 | Alvimopan Impurity D
CAS# [NA]
M.F.: C24H31NO3
M.W.: 381.51 |
| |
| QA122201 | Alvimopan Impurity A
CAS# [NA]
M.F.: C13H19NO
M.W.: 205.30 |
| |
| QA161816 | Aprepitant Impurity P
CAS# 1242175-34-3
M.F.: C23H21F7N4O3
M.W.: 534.43 |
| |
| QA161814 | Aprepitant Impurity N
CAS# 1242175-40-1
M.F.: C23H21F7N4O3
M.W.: 534.43 |
| |
| QA161812 | Aprepitant Impurity L
CAS# 172822-28-5
M.F.: C23H21F7N4O3
M.W.: 534.43 |
| |
| QA161811 | Aprepitant Impurity K
CAS# 1185502-97-9
M.F.: C23H21F7N4O3
M.W.: 534.43 |
| |
| QA161809 | Aprepitant Impurity I
CAS# [NA]
M.F.: C23H21F7N4O3
M.W.: 534.43 |
| |
| QA161803 | Aprepitant Impurity C
CAS# 1185503-48-3 (free base)
M.F.: C20H19ClF7NO2
M.W.: 473.81 |
| |
| QE192010 | Escitalopram Impurity 10
CAS# NA
M.F.: C20H23FN2O2
M.W.: 342.41 |
| |
| QP190313 | Posaconazole Impurity M
CAS# 2243785-99-9
M.F.: C37H42F2N8O4
M.W.: 700.78 |
| |
| QF022440 | Febuxostat Impurity Z14
CAS# [NA]
M.F.: C12H15NO4
M.W.: 237.25 |
| |
| QF022429 | Febuxostat Impurity Z3
CAS# [NA]
M.F.: C14H14N2O4S
M.W.: 306.34 |
| |
| QF022427 | Febuxostat Impurity Z1
CAS# [NA]
M.F.: C14H15NO5S
M.W.: 309.34 |
| |
| QF022426 | Febuxostat Impurity Z
CAS# [NA]
M.F.: C16H19NO5S
M.W.: 337.39 |
| |
| QF022425 | Febuxostat Impurity Y
CAS# 161798-02-3
M.F.: C14H12N2O3S
M.W.: 288.32 |
| |
| QF022420 | Febuxostat Impurity T
CAS# 1657014-33-9
M.F.: C16H16N2O3S
M.W.: 316.37 |
| |
| QF022417 | Febuxostat Impurity Q
CAS# [NA]
M.F.: C12H9NO5S
M.W.: 279.27 |
| |
| QF022416 | Febuxostat Impurity P
CAS# [NA]
M.F.: C8H8N2OS2
M.W.: 212.29 |
| |
| QF022414 | Febuxostat Impurity N
CAS# [NA]
M.F.: C22H24N2O5S2
M.W.: 460.57 |
| |
| QF022413 | Febuxostat Impurity M
CAS# 1335202-60-2
M.F.: C15H16N2OS
M.W.: 272.37 |
| |
| QF022412 | Febuxostat Impurity L
CAS# [NA]
M.F.: C18H22N2O4S
M.W.: 362.44 |
| |
| QF022410 | Febuxostat Impurity J
CAS# 160844-75-7
M.F.: C18H20N2O3S
M.W.: 344.43 |
| |
| QF022406 | Febuxostat Impurity F
CAS# 144060-97-9
M.F.: C17H21NO3S
M.W.: 319.42 |
| |
| QF022405 | Febuxostat Impurity E
CAS# 1239233-86-3
M.F.: C16H18N2O4S
M.W.: 334.39 |
| |
| QE261207 | Enzalutamide Impurity G
CAS# [NA]
M.F.: C12H16N2O3
M.W.: 236.27 |
| |
| QE261203 | Enzalutamide Impurity C
CAS# [NA]
M.F.: C8H6BrFO2
M.W.: 233.03 |
| |
| QE261201 | Enzalutamide Impurity A
CAS# [NA]
M.F.: C7H4BrFO2
M.W.: 219.01 |
| |
| QB121410 | Blonanserin Impurity J
CAS# [NA]
M.F.: C17H19FN2
M.W.: 270.34 |
| |
| QB121406 | Blonanserin Impurity F
CAS# [NA]
M.F.: C7H16N2
M.W.: 128.22 |
| |
| QB121405 | Blonanserin Impurity E
CAS# [NA]
M.F.: C17H17ClFNO
M.W.: 305.77 |
| |
| QB121402 | Blonanserin Impurity B
CAS# 1648791-23-4
M.F.: C29H43N5
M.W.: 461.69 |
| |
| QC122209 | Clevidipine Impurity I
CAS# 253597-20-5
M.F.: C15H15Cl2NO2
M.W.: 312.19 |
| |
| QD160708 | Dapagliflozin Impurity H
CAS# NA
M.F.: C21H27ClO7
M.W.: 426.89 |
| |
| QD160707 | Dapagliflozin Impurity G
CAS# NA
M.F.: C42H48Cl2O12
M.W.: 815.73 |
| |
| QC201206 | Cetilistat Impurity F
CAS# [NA]
M.F.: C11H11NO3
M.W.: 205.21 |
| |
| QC201205 | Cetilistat Impurity E
CAS# [NA]
M.F.: C8H7NO2
M.W.: 149.15 |
| |
| QC201201 | Cetilistat Impurity A
CAS# 2835-98-5
M.F.: C7H9NO
M.W.: 123.15 |
| |
| QT161809 | Topiroxostat Impurity I
CAS# 2307-69-9
M.F.: C10H14O3S
M.W.: 214.28 |
| |
| QT161807 | Topiroxostat Impurity G
CAS# 80-40-0
M.F.: C9H12O3S
M.W.: 200.25 |
| |
| QT161805 | Topiroxostat Impurity E
CAS# 4329-78-6
M.F.: C12H9N5
M.W.: 223.23 |
| |
| QT161804 | Topiroxostat Impurity D
CAS# [NA]
M.F.: C12H8N4O
M.W.: 224.22 |
| |
| QP242008 | Pixantrone maleate Impurity H
CAS# [NA]
M.F.: C13H5F2NO2
M.W.: 245.18 |
| |
| QP242007 | Pixantrone maleate Impurity G
CAS# [NA]
M.F.: C13H7F2NO3
M.W.: 263.20 |
| |
| QP242006 | Pixantrone maleate Impurity F
CAS# [NA]
M.F.: C15H13N3O3
M.W.: 283.28 |
| |
| QP242005 | Pixantrone maleate Impurity E
CAS# [NA]
M.F.: C15H14N4O2
M.W.: 282.30 |
| |
| QP242004 | Pixantrone maleate Impurity D
CAS# [NA]
M.F.: C15H11N3O3
M.W.: 281.27 |
| |
| QP242003 | Pixantrone maleate Impurity C
CAS# [NA]
M.F.: C33H32N8O4
M.W.: 604.66 |
| |
| QP242002 | Pixantrone maleate Impurity B
CAS# [NA]
M.F.: C17H17N5O2
M.W.: 323.35 |
| |
| QP242001 | Pixantrone maleate Impurity A
CAS# [NA]
M.F.: C15H12FN3O2
M.W.: 285.27 |
| |
| QT132603 | Temozolomide EP Impurity B
CAS# 113942-30-6
M.F.: C6H5N5O3
M.W.: 195.14 |
| |
| QD192004 | Dasatinib Impurity D
CAS# 910297-51-7
M.F.: C20H22ClN7OS
M.W.: 443.95 |
| |
| QD192002 | Dasatinib Impurity B
CAS# [NA]
M.F.: C22H24ClN7O3S
M.W.: 501.99 |
| |
| QD192001 | Dasatinib Impurity A
CAS# 910297-52-8
M.F.: C22H26ClN7O3S
M.W.: 504.00 |
| |
| QU121605 | Ulipristal acetate Impurity E
CAS# [NA]
M.F.: C30H37NO4
M.W.: 475.62 |
| |
| QU121604 | Ulipristal acetate Impurity D
CAS# [NA]
M.F.: C28H33NO4
M.W.: 447.57 |
| |
| QU121603 | Ulipristal acetate Impurity C
CAS# [NA]
M.F.: C30H37NO4
M.W.: 475.62 |
| |
| QU121602 | Ulipristal acetate Impurity B
CAS# NA
M.F.: C29H35NO4
M.W.: 461.59 |
| |
| QU121601 | Ulipristal acetate Impurity A
CAS# NA
M.F.: C23H31O5
M.W.: 387.49 |
| |
| QA260304 | Azacitidine Impurity D
CAS# 645-92-1
M.F.: C3H5N5O
M.W.: 127.10 |
| |
| QT161803 | Topiroxostat Impurity C
CAS# [NA]
M.F.: C13H9N5O2
M.W.: 267.24 |
| |
| QT161802 | Topiroxostat Impurity B
CAS# 1992028-94-0
M.F.: C13H10N6O
M.W.: 266.26 |
| |
| QT161801 | Topiroxostat Impurity A
CAS# [NA]
M.F.: C13H8N6O
M.W.: 264.24 |
| |
| QF140606 | Fenofibric acid Impurity F;
Fenofibrate EP Impurity F
CAS# 154356-96-4
M.F.: C16H15ClO2
M.W.: 274.74 |
| |
| QF140605 | Fenofibric acid Impurity E;
Fenofibrate EP Impurity C
CAS# 217636-47-0
M.F.: C17H15ClO3
M.W.: 302.75 |
| |
| QF140604 | Fenofibric acid Impurity D
CAS# 1797121-54-0
M.F.: C21H21ClO6
M.W.: 404.84 |
| |
| QF140603 | Fenofibric acid Impurity C;
Fenofibrate EP Impurity E
CAS# 42019-08-9
M.F.: C19H19ClO4
M.W.: 346.80 |
| |
| QF140602 | Fenofibric acid;Fenofibrate EP Impurity B
CAS# 42017-89-0;258834-37-6(Na salt)
M.F.: C17H15ClO4
M.W.: 318.75 |
| |
| QF140601 | Fenofibric acid Impurity A;
Fenofibrate EP Impurity D
CAS# 42019-07-8
M.F.: C18H17ClO4
M.W.: 332.78 |
| |
| QT060315 | Tofacitinib Impurity O
CAS# 1092578-46-5;2174011-53-9(Citrate)
M.F.: C16H20N6O
M.W.: 312.37 |
| |
| QT060309 | Tofacitinib Impurity I
CAS# [NA]
M.F.: C13H19N5
M.W.: 245.32 |
| |
| QT060305 | Tofacitinib Impurity E
CAS# [NA]
M.F.: C27H31N5O2S
M.W.: 489.63 |
| |
| QT060302 | Tofacitinib Impurity B
CAS# [NA]
M.F.: C27H31N5O2S
M.W.: 489.63 |
| |
| QB182605 | Brinzolamide Impurity E
CAS# [NA]
M.F.: C13H20N2O7S3
M.W.: 412.50 |
| |
| QB182604 | Brinzolamide Impurity D
CAS# [NA]
M.F.: C10H16N2O6S3
M.W.: 356.44 |
| |
| QB182603 | Brinzolamide Impurity C
CAS# 171273-35-1
M.F.: C10H14N2O5S3
M.W.: 338.42 |
| |
| QB182602 | Brinzolamide Impurity B
CAS# [NA]
M.F.: C11H19N3O5S3
M.W.: 369.48 |
| |
| QB182601 | Brinzolamide Impurity A
CAS# 154127-19-2
M.F.: C12H21N3O5S3
M.W.: 383.51 |
| |
| QA261909 | Azilsartan Impurity I
CAS# 2171316-29-1
M.F.: C23H19N3O4
M.W.: 401.41 |
| |
| QA261908 | Azilsartan Impurity H
CAS# 1499167-72-4
M.F.: C23H20N4O4
M.W.: 416.43 |
| |
| QA261907 | Azilsartan Impurity G
CAS# 147404-76-0
M.F.: C25H23N3O4
M.W.: 429.47 |
| |
| QA261905 | Azilsartan Impurity E
CAS# 2244031-86-3
M.F.: C22H17N3O4
M.W.: 387.39 |
| |
| QA261903 | Azilsartan Impurity C
CAS# NA
M.F.: C22H18N4O4
M.W.: 402.40 |
| |
| QA261901 | Azilsartan Impurity A
CAS# 1696392-11-6
M.F.: C24H21N3O4
M.W.: 415.44 |
| |
| QL140706 | Linagliptin Impurity 6
CAS# [NA]
M.F.: C25H23F3N8O3
M.W.: 540.50 |
| |
| QL140705 | Linagliptin Impurity 5
CAS# [NA]
M.F.: C24H24N8O3
M.W.: 472.50 |
| |
| QL140704 | Linagliptin Impurity 4
CAS# [NA]
M.F.: C18H14N6O3
M.W.: 362.34 |
| |
| QL140703 | Linagliptin Impurity 3
CAS# NA
M.F.: C15H20N4
M.W.: 256.35 |
| |
| QL140702 | Linagliptin Impurity 2
CAS# [NA]
M.F.: C28H32N8O4
M.W.: 544.60 |
| |
| QP181910 | Prasugrel Impurity J
CAS# 1359829-52-9
M.F.: C11H10BrFO
M.W.: 257.10 |
| |
| QP181909 | Prasugrel Impurity I
CAS# 1359829-72-3
M.F.: C11H10BrFO
M.W.: 257.10 |
| |
| QP181908 | Prasugrel Impurity H
CAS# 34650-68-5
M.F.: C11H11BrO
M.W.: 239.11 |
| |
| QP181907 | Prasugrel Hydrochloride EP Impurity G
CAS# 1391054-37-7
M.F.: C11H9FO2
M.W.: 192.19 |
| |
| QP181906 | Prasugrel Impurity F
CAS# [NA]
M.F.: C20H21BrFNO3S
M.W.: 454.35 |
| |
| QP181904 | Prasugrel Hydrochloride EP Impurity C
CAS# 1391194-50-5
M.F.: C20H20FNO3S
M.W.: 373.44 |
| |
| QP181903 | Prasugrel Hydrochloride EP Impurity B
CAS# 1391194-39-0
M.F.: C20H20FNO3S
M.W.: 373.44 |
| |
| QP181902 | Prasugrel Hydrochloride EP Impurity A
CAS# 1391194-45-8;1391053-53-4(HCl salt)
M.F.: C20H21NO3S
M.W.: 355.45 |
| |
| QL142207 | Lenvatinib Impurity G
CAS# 417714-14-8
M.F.: C21H20N4O4
M.W.: 392.41 |
| |
| QL142204 | Lenvatinib Impurity D
CAS# 417717-04-5
M.F.: C20H17ClN4O4
M.W.: 412.83 |
| |
| QL142202 | Lenvatinib Impurity B
CAS# 417721-36-9
M.F.: C11H9ClN2O2
M.W.: 236.65 |
| |
| QL142201 | Lenvatinib Impurity A
CAS# 796848-79-8
M.F.: C10H11ClN2O2
M.W.: 226.66 |
| |
| QD162404 | Dapoxetine Impurity D
CAS# 2242008-38-2 (HCl salt)
M.F.: C30H31NO2
M.W.: 437.57 |
| |
| QD162402 | Dapoxetine Impurity B
CAS# 119357-18-5(free base)
M.F.: C20H21NO.HCl
M.W.: 291.39 36.46 |
| |
| QC122206 | Clevidipine Impurity F
CAS# 175688-79-6
M.F.: C21H19Cl2N3O4
M.W.: 448.30 |
| |
| QA120707 | Alogliptin Impurity G
CAS# NA
M.F.: C18H21N5O2
M.W.: 339.39 |
| |
| QA120706 | Alogliptin Impurity F
CAS# 2749281-73-8
M.F.: C25H25N5O3
M.W.: 443.50 |
| |
| QA120705 | Alogliptin Impurity E
CAS# [NA]
M.F.: C23H25N7O4
M.W.: 463.49 |
| |
| QE262006 | Ezetimibe Impurity F
CAS# 1478664-02-6
M.F.: C24H21F2NO3
M.W.: 409.43 |
| |
| QE262005 | Ezetimibe Impurity E
CAS# 1593543-00-0
M.F.: C24H21F2NO3
M.W.: 409.43 |
| |
| QE262004 | Ezetimibe Impurity D
CAS# 1478664-18-4
M.F.: C24H21F2NO3
M.W.: 409.43 |
| |
| QE262003 | Ezetimibe Impurity C
CAS# 1376614-99-1
M.F.: C24H21F2NO3
M.W.: 409.43 |
| |
| QT140601 | Tenofovir disoproxil Impurity A
CAS# 851456-00-3
M.F.: C15H25N6O5P
M.W.: 400.37 |
| |
| QR182403 | Brexpiprazole Impurity C
CAS# 2059954-32-2
M.F.: C17H21Cl2NO2
M.W.: 342.26 |
| |
| QR182402 | Brexpiprazole Impurity B
CAS# 2116542-19-7
M.F.: C22H20N2O4
M.W.: 376.41 |
| |
| QR182421 | Brexpiprazole Impurity U
CAS# 2094559-58-5
M.F.: C38H40N4O4S
M.W.: 648.81 |
| |
| QR182420 | Brexpiprazole Impurity T
CAS# 1420987-86-5
M.F.: C20H18N2S2
M.W.: 350.50 |
| |
| QR182419 | Brexpiprazole Impurity S
CAS# [NA]
M.F.: C25H29N3O2S
M.W.: 435.58 |
| |
| QR182418 | Brexpiprazole Impurity R
CAS# 102-92-1
M.F.: C9H7ClO
M.W.: 166.60 |
| |
| QR182417 | Brexpiprazole Impurity Q
CAS# [NA]
M.F.: C9H5BrO2S
M.W.: 257.10 |
| |
| QR182415 | Brexpiprazole Impurity O
CAS# [NA]
M.F.: C33H33N3O2S2
M.W.: 567.76 |
| |
| QR182414 | Brexpiprazole Impurity N
CAS# 1420987-85-4
M.F.: C20H20N2S2
M.W.: 352.52 |
| |
| QR182412 | Brexpiprazole Impurity L
CAS# [NA]
M.F.: C26H28N2O5
M.W.: 448.51 |
| |
| QR182411 | Brexpiprazole Impurity K
CAS# 146121-18-8
M.F.: C12H12ClNO2
M.W.: 237.68 |
| |
| QR182409 | Brexpiprazole Impurity I
CAS# 1886188-97-1
M.F.: C13H15NO3
M.W.: 233.26 |
| |
| QR182408 | Brexpiprazole Impurity H
CAS# 913614-15-0
M.F.: C16H22N2OS
M.W.: 290.42 |
| |
| QI132008 | Imatinib EP Impurity B
CAS# 581076-65-5
M.F.: C21H28N6O
M.W.: 380.49 |
| |
| QI132006 | Imatinib EP Impurity C
CAS# 404844-02-6
M.F.: C28H29N7O
M.W.: 479.58 |
| |
| QI132004 | Imatinib EP Impurity J
CAS# 571186-91-9
M.F.: C29H31N7O2
M.W.: 509.60 |
| |
| QI132003 | Imatinib Impurity 3
CAS# 938082-57-6
M.F.: C29H31N7O2
M.W.: 509.60 |
| |
| QI132002 | Imatinib Impurity 2
CAS# 571186-93-1
M.F.: C29H31N7O3
M.W.: 525.60 |
| |
| QI132001 | Imatinib Impurity 1
CAS# 571186-92-0
M.F.: C29H31N7O2
M.W.: 509.60 |
| |
| QT120828 | Trelagliptin Impurity Z2
CAS# [NA]
M.F.: C17H22FN5O
M.W.: 331.39 |
| |
| QT120827 | Trelagliptin Impurity Z1
CAS# [NA]
M.F.: C17H21N5O2
M.W.: 327.38 |
| |
| QT120825 | Trelagliptin Impurity Y
CAS# [NA]
M.F.: C15H14FN3O3
M.W.: 303.29 |
| |
| QT120824 | Trelagliptin Impurity X
CAS# [NA]
M.F.: C14H12FN3O3
M.W.: 289.26 |
| |
| QT120822 | Trelagliptin Impurity V
CAS# [NA]
M.F.: C10H9ClN4O4
M.W.: 284.66 |
| |
| QT120821 | Trelagliptin Impurity U
CAS# [NA]
M.F.: C18H24FN5O2
M.W.: 361.41 |
| |
| QT120816 | Trelagliptin Impurity P
CAS# [NA]
M.F.: C13H9ClFN3O2
M.W.: 293.68 |
| |
| QT120815 | Trelagliptin Impurity 15
CAS# [NA]
M.F.: C18H20FN5O2
M.W.: 357.38 |
| |
| QT120808 | Trelagliptin Impurity H
CAS# [NA]
M.F.: C23H24FN7O4
M.W.: 481.48 |
| |
| QT120807 | Trelagliptin Impurity G
CAS# [NA]
M.F.: C18H13ClFN5O4
M.W.: 417.78 |
| |
| QC182579 | Canagliflozin Impurity I
CAS# [NA]
M.F.: C32H33FO9S
M.W.: 612.66 |
| |
| QC182577 | Canagliflozin Impurity G
CAS# [NA]
M.F.: C10H11FS
M.W.: 182.26 |
| |
| QC182574 | Canagliflozin Impurity D
CAS# [NA]
M.F.: C24H26O5S
M.W.: 426.53 |
| |
| QK201803 | Ketorolac EP Impurity I
CAS# 113502-55-9
M.F.: C14H13NO
M.W.: 211.26 |
| |
| QK201801 | Ketorolac EP Impurity A
CAS# 154476-25-2
M.F.: C14H13NO2
M.W.: 227.26 |
| |
| QI161804 | Ipriflavone Impurity D
CAS# NA
M.F.: C17H18O3
M.W.: 270.32 |
| |
| QI161803 | Ipriflavone Impurity C
CAS# NA
M.F.: C17H14O3
M.W.: 266.29 |
| |
| QI161802 | Ipriflavone Impurity B
CAS# 13057-72-2
M.F.: C15H10O3
M.W.: 238.24 |
| |
| QI161801 | Ipriflavone Impurity A
CAS# NA
M.F.: C14H12O3
M.W.: 228.24 |
| |
| QP141205 | Phenylephrine EP Impurity E
CAS# 71786-67-9
M.F.: C16H17NO2.HCl
M.W.: 255.31 36.46 |
| |
| QP141204 | Phenylephrine EP Impurity D
CAS# 1367567-95-0(free base)
M.F.: C16H19NO2.HCl
M.W.: 257.33 36.46 |
| |
| QE044320 | Etoricoxib Impurity T
CAS# NA
M.F.: C25H20ClN3O3S
M.W.: 477.96 |
| |
| QK161808 | Kyprolis Impurity H
CAS# [NA]
M.F.: C40H57N5O7
M.W.: 719.91 |
| |
| QK161806 | Kyprolis Impurity F
CAS# [NA]
M.F.: C26H46N4O6
M.W.: 510.67 |
| |
| QK161804 | Kyprolis Impurity D
CAS# [NA]
M.F.: C9H17NO2
M.W.: 171.24 |
| |
| QK161803 | Kyprolis Impurity C
CAS# [NA]
M.F.: C9H17NO2
M.W.: 171.24 |
| |
| QK161802 | Kyprolis Impurity B
CAS# [NA]
M.F.: C9H17NO2
M.W.: 171.24 |
| |
| QK161801 | Kyprolis Impurity A
CAS# [NA]
M.F.: C34H46N4O6
M.W.: 606.75 |
| |
| QP020315 | Palbociclib Impurity O
CAS# [NA]
M.F.: C42H61N9O6
M.W.: 787.99 |
| |
| QP020313 | Palbociclib Impurity M
CAS# [NA]
M.F.: C23H38N6O4
M.W.: 462.59 |
| |
| QP020311 | Palbociclib Impurity K
CAS# [NA]
M.F.: C24H29N7O2
M.W.: 447.53 |
| |
| QP020310 | Palbociclib Impurity J
CAS# [NA]
M.F.: C33H45N7O4
M.W.: 603.75 |
| |
| QP020309 | Palbociclib Impurity I
CAS# [NA]
M.F.: C27H34BrN7O3
M.W.: 584.51 |
| |
| QP020304 | Palbociclib Impurity D
CAS# [NA]
M.F.: C14H20BrN3O2
M.W.: 342.23 |
| |
| QP020303 | Palbociclib Impurity C
CAS# 153747-97-8
M.F.: C14H20BrN3O2
M.W.: 342.23 |
| |
| QP020302 | Palbociclib Impurity B
CAS# 1072-97-5
M.F.: C5H5BrN2
M.W.: 173.01 |
| |
| QP020301 | Palbociclib Impurity A
CAS# 39856-50-3
M.F.: C5H3BrN2O2
M.W.: 202.99 |
| |
| QO022005 | Obeticholic Acid Impurity E
CAS# 915038-25-4
M.F.: C26H42O4
M.W.: 418.61 |
| |
| QO022004 | Obeticholic Acid Impurity D
CAS# NA
M.F.: C26H42O4
M.W.: 418.61 |
| |
| QO022003 | Obeticholic Acid Impurity C
CAS# 1908444-28-9
M.F.: C52H86O7
M.W.: 823.24 |
| |
| QO022002 | Obeticholic Acid Impurity B
CAS# [NA]
M.F.: C26H42O4
M.W.: 418.61 |
| |
| QO022001 | Obeticholic Acid Impurity A
CAS# 865244-30-0
M.F.: C26H44O4
M.W.: 420.63 |
| |
| QE200304 | Entecavir Impurity 4
CAS# 188399-46-4
M.F.: C12H15N5O3
M.W.: 277.28 |
| |
| QE200302 | Entecavir Impurity 2
CAS# 1367369-76-3
M.F.: C12H15N5O3
M.W.: 277.28 |
| |
| QA220305 | Avibactam Impurity E
CAS# [NA]
M.F.: C7H9N3Na2O9S2
M.W.: 389.27 |
| |
| QP180308 | Piperacillin Sodium EP Impurity H;
Flucloxacillin sodium EP Impurity C;
Cloxacillin Sodium EP Impurity C;
Bacampicillin hydrochloride EP Impurity A
CAS# 551-16-6
M.F.: C8H12N2O3S
M.W.: 216.26 |
| |
| QP180307 | Piperacillin Sodium EP Impurity G
CAS# 63422-71-9
M.F.: C15H17N3O5
M.W.: 319.32 |
| |
| QP180306 | Piperacillin EP Impurity F;
Piperacillin Sodium EP Impurity F
CAS# [NA]
M.F.: C25H31N5O9S
M.W.: 577.62 |
| |
| QP161805 | Piperacillin EP Impurity E ;
Piperacillin Sodium EP Impurity E
CAS# 59702-31-7
M.F.: C6H10N2O2
M.W.: 142.16 |
| |
| QH240300 | Hexanoic acid;Caprylic acid EP Impurity A
CAS# 142-62-1
M.F.: C6H12O2
M.W.: 116.16 |
| |
| QH160315 | Heptanoic acid;Caprylic acid EP Impurity B
CAS# 111-14-8
M.F.: C7H14O2
M.W.: 130.18 |
| |
| QA250919 | Amobarbital sodium
CAS# 64-43-7
M.F.: C11H17N2NaO3
M.W.: 248.25 |
| |
| QT031480 | D-delta-Tocotrienol
CAS# 25612-59-3
M.F.: C27H40O2
M.W.: 396.61 |
| |
| QT031470 | D-gamma-Tocotrienol
CAS# 14101-61-2
M.F.: C28H42O2
M.W.: 410.63 |
| |
| QT031460 | D-beta-Tocotrienol
CAS# 490-23-3
M.F.: C28H42O2
M.W.: 410.63 |
| |
| QT031450 | D-alpha-Tocotrienol
CAS# 58864-81-6
M.F.: C29H44O2
M.W.: 424.67 |
| |
| QT031880 | RRR-α-Tocopherol EP Impurity A;
RRR-δ-tocopherol
CAS# 119-13-1
M.F.: C27H46O2
M.W.: 402.65 |
| |
| QT031870 | D-gamma-Tocopherol;
RRR-α-Tocopherol EP Impurity C
CAS# 54-28-4
M.F.: C28H48O2
M.W.: 416.68 |
| |
| QT031860 | D-beta-Tocopherol;
RRR-α-Tocopherol EP Impurity B
CAS# 16698-35-4
M.F.: C28H48O2
M.W.: 416.68 |
| |
| QT201460 | 1-Tetradecanol
CAS# 112-72-1
M.F.: C14H30O
M.W.: 214.39 |
| |
| QM242000 | 22-Oxacalcitriol
CAS# 103909-75-7
M.F.: C26H42O4
M.W.: 418.61 |
| |
| QC081332 | Calcitriol EP Impurity B
CAS# 66791-71-7
M.F.: C27H44O3
M.W.: 416.64 |
| |
| QH323420 | 1-Hydroxy Vitamin D2;Doxercalciferol
CAS# 54573-75-0
M.F.: C28H44O2
M.W.: 412.65 |
| |
| QP151330 | Provitamin D3;
Cholecalciferol EP Impurity B
CAS# 434-16-2
M.F.: C27H44O
M.W.: 384.64 |
| |
| QD323370 | 1,24-Dihydroxy Vitamin D3;Tacalcitol
CAS# 57333-96-7;93129-94-3(monohydrate)
M.F.: C27H44O3
M.W.: 416.63 |
| |
| QD768010 | 24,25-Dihydroxy Vitamin D2
CAS# 58050-55-8
M.F.: C28H44O3
M.W.: 428.65 |
| |
| QC081330 | 1,25-Dihydroxy Vitamin D3;Calcitriol
CAS# 32222-06-3
M.F.: C27H44O3
M.W.: 416.64 |
| |
| QC081320 | 1,25-Dihydroxy Vitamin D2
CAS# 60133-18-8
M.F.: C28H44O3
M.W.: 428.65 |
| |
| QC041330 | 25-Hydroxy Vitamin D3
CAS# 19356-17-3;63283-36-3(monohydrate)
M.F.: C27H44O2
M.W.: 400.64 |
| |
| QC041320 | 25-Hydroxy Vitamin D2
CAS# 21343-40-8
M.F.: C28H44O2
M.W.: 412.65 |
| |
| QP885200 | 12-oxo Phytodienoic Acid
CAS# 85551-10-6
M.F.: C18H28O3
M.W.: 292.41 |
| |
| QT041303 | Trifluridine/tipiracil (TAS-102) Impurity C
CAS# NA
M.F.: C6H7ClN2O3
M.W.: 190.58 |
| |
| QT041301 | Trifluridine/tipiracil (TAS-102) Impurity A
CAS# NA
M.F.: C9H10ClN3O3
M.W.: 243.65 |
| |
| QT090301 | Thioctic Acid EP Impurity A
CAS# 1204245-29-3
M.F.: C8H14O2S3
M.W.: 238.39 |
| |
| QF120365 | Folic Acid-13C11
CAS# 59-30-3 (unlabeled)
M.F.: C813C11H19N7O6
M.W.: 452.32 |
| |
| QA048218 | Aspartic acid condensate
CAS# 60079-22-3
M.F.: C8H12N2O7
M.W.: 248.19 |
| |
|
